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Summary
Long term gastric inflammation (chronic gastritis) and its coupled tumourigenic 
inflammatory milieu (Reactive Oxygen/ Nitrogen Species (RO/NS), cytokines, etc.) is 
seen to impact cells at several levels, and as such is seen to be a major driving force o f 
gastric carcinogenesis.
The goal o f  this investigation was to examine the impact o f  inflammation, with a 
special focus on the oxidative stress component, on signal transduction and gene 
expression changes in gastric epithelial cells at the levels o f Mitogen Activated Protein 
Kinase (MAPK) and Nuclear Factor Kappa-B (NFkB) pathways and downstream gene 
expression targets. Both in vitro and in vivo studies were performed, and a combination 
o f microarray, real-time PCR, and western blot methodologies were employed to evaluate 
signalling and gene expression changes.
Two in vitro models were utilised, comprising an initial chemically induced 
oxidative stress model, in which cells were exposed to hydrogen peroxide (H2O2), and a 
more elaborate inflammatory model whereby cells were exposed to leukocytes optimised 
to undergo an oxidative burst response. In both cases, MAPK and NFkB signal 
transduction pathways were seen to be affected, at the levels o f  the pathways themselves, 
and downstream gene expression targets, with over-expression o f c-fos and interleukin -  
8  (IL-8) being the most consistently observed changes.
Analysis o f  pre-malignant gastric biopsy specimens brought to light the potential 
importance o f aberrant MAPK signalling and c-fos over-expression in the earliest stages 
o f disease pathogenesis, the changes being observed most commonly in chronic 
inflammation/ gastritis tissues, so translating in vitro findings to a more clinically 
relevant setting.
Overall, the findings provide strength to the notion that oxidative stress is a key 
player in gastric carcinogenesis, seen here at the levels o f  signalling and gene expression 
changes. Oxidative stress and the MAPK and NFkB pathways emerge as potential 
therapeutic targets for the management o f gastric cancer.
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Chapter 1 
General Introduction
1.1 Cancer
Cancer is a major health burden and cause of morbidity in the UK, more than
270,000 new cases were registered in the year 2 0 0 0  alone, over half of these cases 
being fatal if past trends continue (Working Group on Diet and Cancer, 1998). More 
than one in three people will be diagnosed with cancer in their lifetime, and one in 
four people will die from the disease.
Cancer is a complex disease. The first historical description of the condition 
was in relation to breast carcinoma (discovered in Egypt and dates back to 
approximately 1600 B.C. The Edwin Smith Papyrus, thought the term cancer was not 
used). The term ‘cancer’ now encompasses over 200 different forms of the disease, 
characterised by uncontrolled, abnormal growth of cells that have the potential to 
invade surrounding tissues and spread locally or throughout the body via the 
bloodstream and lymphatics. Almost eveiy tissue in the human body is susceptible to 
the development of cancer and cancers at the different sites are considered different 
forms of the disease, each with different aetiology, pathogenesis, clinical 
manifestations, prognosis, and treatment regimes. Cancer is the result o f aberrant 
changes in cells leading to abnormal cellular proliferation whereby cells divide 
uncontrollably and gain the potential to invade and destroy surrounding normal 
tissues.
The disease has a recognised genetic basis. In fact this notion has held strong 
since 1914 when Theadore Boveri hypothesised that clonal chromosomal changes 
were responsible for cancer development (Cowell, 2001). However, unlike other types 
of genetic disorder, for most cancers the genetic changes leading to the disease are not 
inherited but rather arise in somatic cells as a result o f environmental exposures/ 
factors. Hence, genes and environment play important roles in carcinogenesis. In 
addition, cancer, unlike conventional genetic diseases, is usually the end result of an 
accumulation of multiple genetic defects giving cells a growth advantage driving 
clonal expansion and ultimately progression to a neoplasm. Advances in molecular
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cancer research have provided an explosion of evidence supporting the link between 
genetic instability and malignancy. This instability manifests itself in the form of tiny 
aberrations such as point mutations through to gross chromosomal abnormalities. 
Genomic aberrations frequently cited in the expanding body of literature connecting 
cancer development with genetics include:-
- Presence of damaged and/ or aberrant numbers of chromosomes in tumour 
cells.
- Defective DNA repair mechanisms eliciting increased susceptibility to cancer 
development.
- DNA sequence alterations which may be caused by mutagenic compounds that 
have hence been deemed carcinogenic.
- Inheritance of defective genes that cause hereditary syndromes that predispose 
to various types of cancer (Bishop, 1987).
- Gene expression changes in malignant cells.
On these grounds, cancer is considered a phenotype, resulting from the accumulation 
of multiple molecular defects that progressively drive multi-step tumourigenesis from 
a normal cell, through pre-malignant foci (benign tumours) to localised tumours (in 
situ carcinomas) and ultimately truly malignant invasive and metastatic cancers 
(Loeb, 1991).
Most o f the factors that cause cancer act by damaging genes through induction 
o f genetic mutations, either directly or indirectly (Bishop & Weinberg, 1996). The 
molecular changes that drive cancer development include gene mutations (point 
mutations, deletions, insertions); chromosomal aberrations (aneuploidy, structural 
rearrangements); and gene and protein expression changes.
1.1.1 Multi-step nature of Carcinogenesis
It is now widely accepted that malignant tumours develop through a multi-step 
mechanism resulting from accumulation of numerous genetic errors in critical 
regulatoiy pathways. The detectable presence of multiple genetic alterations in 
tumour cells strongly implicated and supported the idea that the molecular 
abnormalities accumulate in cells in a step-wise fashion during neoplastic progression
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(Yokota, 2000). This concept is supported by both molecular and clinical 
observations. From a clinical view-point, the step-wise nature of cancer development 
is reflected in the several types of morphological and histological pre-malignant 
lesions, such as hyperplasia, metaplasia, and dysplasia detected on the road to 
malignant tumour development in many diverse tissues. This is exemplified by the 
progression of colorectal carcinogenesis (Vogelstein and Kinzler, 1993). At the 
molecular level, comparative molecular analyses between pre-malignant, and early 
and late stage tumours frequently show an increase in frequency of genetic aberrations 
at the later stages (Yokota, 2000). Again this verifies the multi-step accumulation of 
genetic changes that accompany cancer formation. Further support comes from 
epidemiological studies, which show that, with the exception of some rare childhood 
cancers, cancer is generally a disease of old age (King, 1996; Vogelstein and Kinzler, 
1993).
Cells are seen to undergo marked changes in behaviour and morphology 
during cancer development and this is considered to be a consequence of the build-up 
o f sequential genetic changes. On the whole, the tumours that develop from these 
cells go on to become more and more aggressive and malignant in time. This 
phenomenon is termed tumour progression (Nowell, 1986), following on from 
initiation and promotion, all together comprising the three recognised stages in multi- 
step carcinogenesis (summarised in table 1.1 and fig. 1.1) Progression is possibly the 
most critical stage of carcinogenesis, as at this time, cells within localised/ in situ 
tumours acquire the capacity to invade surrounding tissues (by detaching from 
neighbouring tumour cells and cells of the resident tissue) and metastasise to 
secondary, often distant sites in the body (by migrating along nerves, vessels, and 
lymphatics (McKinnell et al. 1998)). These two acquired characteristics define 
malignancy, and often lead to morbidity and mortality. It is thus fundamental from a 
clinical perspective to gain further understanding o f carcinogenesis in order to be able 
to potentially intervene at earlier stages, hence putting brakes on, or preventing 
malignancy.
In the present research gastric cancer and its pre-malignant stages are of 
particular interest.
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Table 1.1 The three stages o f carcinogenesis.
Stage Description
Initiation The stage at which an initial molecular change is introduced into a cell
giving it potential to develop further into a pre-malignant population 
of cells. Initiating events are normally induced by endogenous (e.g. 
hormonal stimuli, endogenous metabolic processes leading to free 
radical generation and damage to critical cellular macromolecules) or 
exogenous (environmental exposures/ insults) carcinogens.
Promotion An event stimulating proliferation o f an initiated transformed cell
giving rise to a pre-neoplastic/ neoplastic population of cells.
May occur as a result of exposure to promoting agents or due to the 
acquisition of further random genetic changes in the initiated cell(s).
Progression The final step in the conversion o f benign to fully malignant cells.
At this stage cells show all o f the classic attributes of cancer cells. 
Cells exhibit autonomous growth, often show more rapid growth, 
invasiveness, metastasis, and increased genetic instability.
Figure 1.1 Multi-step nature of carcinogenesis. Step 1 -  initiation (induction of an oncogenic 
mutation, reversible step DNA damage vs. repair), 2 -  promotion (stimulated proliferation o f initiated 
transformed cell, reversible step since cell cycle homeostasis can be normalised by removal of 
promoting stimulus), and 3 -  progression -  adoption of a truly malignant phenotype (irreversible).
Normal cell 
population.
Any tissue may 
be affected
Transformed 
pre-neoplastic 
cell (lilac) due 
to genetic insult. 
Dysregulated 
cell growth
Neoplastic 
population o f cells, 
t proliferative 
potential, 
t aggressive 
growth
Local/ in situ 
tumour mass. 
Further mutation 
and epigenetic 
changes
Increased 
malignancy, 
invasiveness 
& metastasis.
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1.2 The Stomach
The stomach is a dilated muscular portion o f the gastrointestinal (GI) tract, the 
major function of which is storage and partial digestion of fragmented food entering 
via the oesophagus. Anatomically, the organ lies in the upper left of the abdomen just 
under the diaphragm, and is between the oesophagus and duodenum (the first part of 
the small intestine). The primary roles of the stomach are to retain fragmented food 
while it is partially broken down and digested, to begin digestion o f proteins, to aid in 
the absorption of vitamin B 12 , and to store food prior to its passage to the small 
intestine. The stomach is well adapted to its roles. Unlike the two muscular layers 
found in the rest of the gastrointestinal tract, the stomach has three muscular layers in 
its wall, -  circular, longitudinal, and oblique, contractions of which cause the stomach 
wall to begin powerful wave-like contractions that assist in the mixing up and 
breaking down o f food into a semi-liquid paste, or chyme. The muscular contractions 
mix the food up with the secretions of the gastric mucosa (stomach juices) containing 
hydrochloric acid (HC1) and pepsin. HC1 has antibacterial properties and helps to 
optimise the pH for stomach enzymes, whilst pepsin digests proteins.
At the gross anatomical level, the stomach has different areas, in which the 
stomach lining varies at the histological level. These are the: cardia, fundus, antrum, 
and pylorus (fig. 1.2). The gastric epithelium in the different areas contains 
specialised cells that produce various secretions including mucus (produced by mucus 
cells), HC1 (produced by oxyntic or parietal cells), digestive enzymes (produced by 
chief or peptic cells), and hormones (produced by enteroendocrine cells). The major 
functions of the gastric epithelium are to secrete acid and digestive enzymes. It also 
secretes mucus to protect the stomach lining from the corrosive effects of the acid and 
enzymes, as well as to lubricate ingested food.
The stomach tissues, like most other tissues in the body are susceptible to 
malignancy (Weinberg, 1997), with cancers o f the gastric epithelium being the most 
common.
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Figure 1.2 External and internal anatomy o f the human stomach (taken from Tortora and Grabowski, 
1996).
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1.2.1 Cancer of the Stomach
Over the past few decades the overall worldwide incidence and mortality rates 
o f gastric cancer, or cancer of the stomach, have declined (Parkin et al, 2002; Munoz 
and Franceschi, 1997; Parkin et al., 1993). Despite this decrease in incidence, gastric 
cancer is still one of the most commonly diagnosed malignancies and remains the 
second largest cause of cancer related death worldwide (Hohenberger et al, 2003; 
Peek and Blaser, 2002; Chan et al., 1999) with approximately 649,000 people dying 
from this malignancy each year (Correa, 2004). Gastric cancer is recognised as an 
important form of malignant disease, with clear and significant socio-economic, 
ethnic, and geographical differences in distribution. In the UK alone, gastric cancer 
accounts for 6% of all cancers in men, and 2% of all cancer cases in women. Stomach 
cancer is the 5lh most common cancer in men and the 9th most common cancer in 
women in the UK. Each year, there are nearly 6,300 new cases o f stomach cancer in 
men and nearly 3,500 cases in women. The incidence rate for the UK in 1999 was
12.3 (age standardized rate (ASR) per 100,000), with the highest rates found in 
Scotland and Wales (data from www.cancerresearchuk.org). In 1998 the ASR for
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gastric cancer incidence for both sexes was 12.15, and the ASR for mortality rates for 
both sexes in the same year was 8.97 (Ferlay et a l , 1998). It is thus estimated that in 
the UK, around 12,000 new cases of gastric cancer are diagnosed each year 
(www.nchod.nhs.uk: MacDonald and Ford, 1997), and over half o f these cases will 
be fatal. It is clear from such data that gastric cancer is a significant cause of 
morbidity and mortality in the UK and the rest of the world, constituting a clear health 
burden. Gastric cancer typically invades the muscularis propria (the major muscle 
wall surrounding the stomach) prior to diagnosis and 5-year survival rates are poor, 
for example, less than 15% in the United States (Correa, 2004).
Malignant tumours of the stomach can be classified based on gross 
morphological and histo-pathological features. It has been reported based on 
pathological studies/ examinations that more than 90% of stomach cancers are 
adenocarcinomas (i.e. epithelial in origin), the remainder being non-Hodgkin’s 
lymphomas or leiomyosarcomas (Fuchs and Mayer, 1995). The prognosis and 
treatment of the different types of cancer differs, thus distinction between them is 
critical. For more than a century, morphological observations o f the human stomach 
have accumulated and this has led to the classification system of Laurdn (1965). This 
classification recognizes that gastric carcinomas can be divided into two subtypes: an 
intestinal type and a diffuse type.
The intestinal (or well-differentiated) type o f tumour is characterized by large 
distinct neoplastic cells with large and irregular nuclei. These cells are cohesive and 
from gland-like tubular structures (StadtlSnder and Waterbor, 1999; Fuchs and Mayer, 
1995). The diffuse (or undifferentiated) type of gastric cancer is a poorly 
differentiated tumour. Malignant cells are discohesive and instead infiltrate the 
stomach wall as individual small solitary cells leading to thickening of the stomach 
wall (Faraji and Frank, 2002; Stadtl&nder and Waterbor, 1999; Fuchs and Mayer,
1995). The two types appear to evolve through different pathways, have a different 
prognosis, and preferentially affect different age and population groups. The recent 
decline in gastric cancer is largely due to a decline in the incidence of the intestinal 
subtype (Correa and Chen, 1994). Intestinal type gastric cancer more frequently 
affects elderly individuals, with males having a greater tendency to develop the 
disease. This type predominates in high risk areas and is preceded by a long 
precancerous process characterized by successive tissular changes.
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In the Correa model, the currently accepted model of human gastric 
carcinogenesis based on epidemiological, pathological, and clinical observations 
(Correa and Shiao, 1994; Correa, 1992; Correa, 1988; Correa et al, 1975), the 
development of intestinal type gastric cancer is preceded by a prolonged multi-step 
precancerous process. This precancerous process involves a progression through 
distinct precursor lesions involving superficial gastritis (inflammation of the gastric 
mucosa), chronic atrophic gastritis, intestinal metaplasia (IM) (Munoz and Matko, 
1972), and dysplasia before evolving into invasive neoplasia. The proposed 
progression sequence for the development of the intestinal type of human gastric 
cancer is shown in figure 1.3.
Figure 13 Pathway for Human Gastric Carcinogenesis for Intestinal type Gastric Cancer.
Superficial —* Chronic atrophic —> Intestinal Metaplasia (IM) —*■ Dysplasia —* Cancer 
gastritis gastritis
(small IM -*  colonic metaplasia)
Studies of various markers of cellular differentiation led to the proposal of the 
neoplastic progression sequence. Changes in levels, nature, or presence/ absence of 
digestive enzymes, mucins, antigens, and oncogenes led to the speculation that 
gastritis is followed by IM whereby cells express phenotypic markers of ‘mature’ 
intestinal cells. These mature cells then ‘de-differentiate’ giving rise to primitive cells 
in dysplasia that express phenotypic markers reminiscent of gastric stem cells or 
multipotential neck cells (Correa, 1988). This would then lead to the suggestion that 
the precancerous process may activate dormant cellular capacities, e.g. alleviate 
repression of expression of certain genes, and in doing so, drive the evolution to 
neoplasia. Abnormal phenotypic expression of markers can also be used to identify 
high-risk subjects for neoplastic transformation (Correa, 1992). Epidemiological 
studies continue to provide data on gastric cancer risk factors and preventative factors, 
some of which will be discussed later (section 1.4). These factors can effectively 
trigger a cascade of changes in the gastric mucosa that eventually lead to the 
development of intestinal-type gastric cancer.
8
In contrast to the intestinal type, the diffuse type of gastric cancer usually 
presents at an earlier age and its incidence is similarly high in most populations 
(Stadtlander and Waterbor, 1999). The prognosis of the diffuse type is less favourable 
than for the intestinal type (Fuchs and Mayer, 1995). Unlike intestinal subtype, the 
diffuse type has no clearly defined precursor lesions (Hohenberger and Gretschel, 
2003).
The present studies focus on gastric cancer o f the intestinal type since this 
subtype has been more extensively studied and develops through pre-malignant 
stages, the progression of which is believed to be largely driven by chronic 
inflammation of the gastric mucosa (Merchant, 2005; De Luca and laquinto, 2004; 
Oshima et al, 2003; Ernst, 1999; Pignatelli et al, 1998; Crabtree, 1996).
1.3 Precursor gastric lesions
As previously detailed, gastric cancer of the intestinal subtype develops 
through a series of pre-malignant precursor gastric lesions, starting with superficial 
gastritis and progressing through atrophic gastritis, intestinal metaplasia, dysplasia, 
and ultimately gastric cancer collectively referred to as Correa’s pathway/ cascade to 
gastric cancer (Correa, 1988; Correa et al, 1975). The sections that follow detail the 
pre-malignant lesions.
1.3.1 Gastritis
A number of morphological changes have been observed in the progression 
sequence, notably inflammation, atrophy, and loss o f cellular differentiation. The 
inflammatory changes effectively constitute gastritis, inflammation of the gastric 
mucosa. Gastritis can be acute or chronic. Acute gastritis is an inflammatoiy response 
in the gastric mucosa resulting in extensive infiltration of neutrophils at the surface 
epithelium (Lee, 1997). Chronic gastritis is a long-term inflammatory condition that 
can persist in an individual for decades, and usually begins in the antrum and 
progresses in a proximal manner with age. The severity of chronic gastritis also 
increases with age (Siurala et al, 1985; Morson et al, 1980). Chronic gastritis can be 
non-atrophic or atrophic. The pathology o f non-atrophic gastritis is essentially
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inflammation, and can be classified as superficial gastritis (also known as antral- 
predominant gastritis) or pangastritis (also known as non-ulcer gastritis).
Interestingly, the major causative factor o f chronic gastritis is chronic 
Helicobacter pylori (H pylori) infection (Marshall, 1986). It is seen that virtually all 
patients in whom infection persists into older ages develop chronic gastritis. The 
variable clinical outcomes of the H. pylori -  induced gastritis are dependent on a 
number o f factors, a key factor being level o f stomach acid secretion (Suerbaum and 
Michetti, 2002). This is summarised in figure 1.4. The different types o f gastritis also 
predispose affected individuals to development o f other GI disorders, including 
duodenal ulcer, gastric ulcer, and gastric neoplasia.
Figure 1.4 Possible clinical outcomes of H. pylori infection depending upon the background gastric 
acid levels.
High acid 
Secretion
Antrum -predom inant
Gastritis
-► Increased risk of
Duodenal ulcer
H. pylori 
infection
Low acid 
secretion
Corpus-predom inant 
gastritis or evenly  
distributed
Gastric ulcer
-► Atrophic^-"" r  
Gastritis
Increased risk of
Gastric
cancer
It is clear from figure 1.4 that the greatest concern with regard to precursor 
lesions to gastric cancer is atrophic gastritis. This type of chronic gastritis increases 
the risk o f gastric cancer by approximately six-fold and also increases the risk of 
gastric ulcer disease. In fact, atrophic gastritis predominates in populations at high
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risk o f intestinal type gastric cancer (Faraji and Frank, 2002; Correa et al, 1990). The 
condition is characterised by chronic inflammation of the gastric mucosa in the 
antrum and body with accompanying gland loss (atrophy) and thinning o f the mucosa 
believed to be a result o f enhanced apoptosis in gastritis tissues (Mannick et al,
1996). This results in a decrease in gastric acid secretion and a change in the gastric 
environment, most likely to one favouring carcinogenesis. It is vital for the clinician 
to distinguish between non-atrophic and atrophic gastritis (Rugge et al, 2002) since 
only the latter has been linked to subsequent development of intestinal type gastric 
cancer, following progression through IM and dysplasia (Faraji and Frank, 2002; 
Genta, 1997). The aetiology of this gastric lesion involves a combination of H. pylori 
infection (Asaka et al, 1996) and environmental and host genetic factors, all o f which 
may trigger the development of atrophic gastritis and/ or its progression to gastric 
cancer in some individuals.
1.3.2 Intestinal Metaplasia
Intestinal metaplasia (IM) is defined as the replacement of normal gastric 
mucosa with cell types not formal for the tissue. In this case the metaplastic cells are 
intestinal-type cells like goblet cells, columnar cells and Paneth cells (Leung and 
Sung, 2002). IM results when atrophic gastritis is accompanied by de-differentiation 
of gastric mucosal cells. The gastric epithelial cells are effectively replaced by 
intestinal-type cells, resulting from a change in cell population due to altered selective 
pressures and/ or microenvironment (Slack, 1986). Not all individuals with atrophic 
gastritis develop IM. Increased pH due to loss of glands, subsequent increase in 
bacterial growth and increased generation o f N/O mutagens has been implicated in 
driving progression to IM. It is believed that this stage in the progression sequence 
involves successive genetic changes, which lead to loss o f cellular differentiation and 
acquisition of an altered phenotype. Mutagens generated in the stomach may cause 
these genetic changes.
IM is clearly recognized as a pre-malignant lesion in the Correa model of 
gastric carcinogenesis (Correa, 1988; Correa et al., 1975). It is frequently seen as an 
intermediate step prior to dysplasia and adenocarcinoma (Faraji and Frank, 2002; 
Leung and Sung, 2002; Correa, 1988). A ten-fold increased risk of gastric cancer in 
individuals with IM has been predicted on epidemiological grounds compared to
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individuals without IM (Leung and Sung, 2002; Filipe et al, 1994). Despite this, the 
majority o f individuals with IM never progress further. This may relate to exposures 
to environmental factors, variation in host genetics, or to there being histological 
subtypes of IM that are associated with variable cancer risk. In the most widely used 
classification system for IM, proposed by Jass and Filipe (1980) there are two classes 
of IM: complete and incomplete. Type I or the complete type resembles the small 
intestine phenotype and hence is also referred to as small intestinal metaplasia (SIM) 
and is generally associated with a low risk of progression to gastric cancer (Leung and 
Sung, 2002). Incomplete metaplasia (which encompasses types II and III) resembles 
the large intestine and hence is known as Colonic metaplasia (CM). There is a 
progressive series of changes from type I through to type El IM, with type III IM 
possessing the highest malignant potential (Leung and Sung, 2002; Celso et al, 1999; 
Wu et al, 1998; Filipe et al, 1994; Rokkas et al, 1991; Silva et al, 1990), 
individuals with type III IM having a four-fold increased risk of gastric cancer 
compared to individuals with type I.
In a subset of individuals with IM, the metaplastic tissues undergo further 
genomic and phenotypic alterations leading to progression to dysplasia.
1.3.3 Dysplasia
Dysplastic tissues show loss o f organization due to the presence of 
undifferentiated or partially differentiated cells interspersed amongst differentiated 
ones (McKinnell et a l , 1998). Gastric dysplasia characteristically shows disordered 
polarity, nuclear stratification, disappearance of goblet and Paneth cells and glandular 
overcrowding. The lesions can be polypoid, ulcerative, or flat and indistinctive (Faraji 
and Frank, 2002). Dysplasia can progress further to intestinal-type gastric cancer 
(neoplasia). This progression is slow and can take several months to years (Fengolio- 
Preiser et a l, 1989).
In the presence of the appropriate stimuli or etiological forces dysplasia will 
progress to carcinoma. Interestingly, some researchers have reported that upon 
removal of the causative stimulus, atrophic gastritis, IM and dysplasia may disappear 
(Dixon, 2001; Correa et al, 2000; Oberhuber et al, 1998); this however remains 
controversial (Leung and Sung, 2002; McKinnell et al, 1998). If  this is true, then 
identification and removal of the stimuli may prevent development of gastric cancer
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and hence dramatically decrease the risk of intestinal type gastric cancer. Hence it is 
important to identify risk factors that may trigger or drive gastric cancer development.
1.4 Gastric Cancer Risk Factors
Extensive research over the past few decades, in particular from 
epidemiological studies has helped to identify risk factors or forces implicated in 
gastric cancer aetiology. Factors can be subdivided into a number of categories, 
namely precursor conditions, genetics, and environmental factors.
1.4.1 Precursor Conditions and Genetics
Precursor conditions that predispose individuals to gastric cancer are atrophic 
gastritis and IM as already discussed. Several investigators have demonstrated an 
apparent correlation between incidence of atrophic gastritis, IM and gastric cancer, 
the precursor lesions having the highest prevalence in regions of the world where 
gastric cancer rates are high (Nardone et al, 2007; Week and Brenner, 2006; Chen et 
al, 2001; You et al, 1993; Correa et al., 1990). These observations suggest that 
atrophic gastritis and IM are important precursor lesions to endemic intestinal-type 
gastric cancer. However, the fact that both lesions have been reported in otherwise 
healthy individuals who do not go on to develop gastric cancer indicates that these 
factors alone are insufficient to cause gastric cancer. On these grounds gastric cancer 
is believed to be a complex, multifactorial disease, its development being influenced 
by a complex interaction between precursor conditions, genetic predisposition, 
infection, and environmental factors in particular diet (Hohenberger and Gretschel, 
2003).
Other precursor conditions documented to predispose to gastric cancer include 
pernicious anaemia (Hsing et al., 1993), partial gastrectomy (Tersmette et al., 1990), 
Menetrier’s disease, and gastric adenomatous polyps (Fuchs and Mayer, 1995).
The importance of genetic factors in the pathogenesis of gastric cancer is well 
documented. For example, family members of an affected individual have two- to 
three- times the risk of developing gastric cancer compared with the general 
population (Nomura, 1982), indicating a genetically mediated susceptibility to gastric 
cancer.
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Host genetic variability can act as a background on which other risk factors 
can act. For example, El-Omar et al. (2000) reported that genetic polymorphisms in 
Interleukin- (IL-) //? can increase susceptibility of gastric cancer by enhancing the 
inflammatory response against endogenous or exogenous factors such as H. pylori 
infection, a well-known risk factor for gastric cancer. The biological basis for this 
observation is that IL-lp is a proinflammatory cytokine and is also a potent inhibitor 
o f gastric acid secretion. H. pylori infection or other stimuli trigger an inflammatory 
response which is heightened in individuals with the IL-lf} polymorphism, leading to 
atrophic gastritis of the gastric body and concomitant hypochlorhydia (reduced gastric 
acid), both of which markedly increase the risk of gastric cancer. Similarly, absence 
of the DQA1*0102 allele of the HLA-DQAI gene (a component of human MHC 
(major histocompatability complex)) has been linked to increased risk of H. pylori 
gastritis, and hence, intestinal-type gastric cancer (Azuma et al.9 1998). Such 
observations may help to explain why not all individuals with precursor lesions go on 
to develop gastric cancer.
1.4.2 Age, Sex, and Socio-economic status
Age and sex are also recognized risk factors for gastric carcinoma. For the 
majority o f cases, gastric cancer incidence and mortality rates increase with age, and 
are higher in males than in females (Parkin et al, 2002; Hass and Schottenfeld, 1975).
Gastric cancers are generally more frequently found in people of socio­
economically deprived classes (Sugimura and Sasako, 1997; Sitas et al, 1992). This 
is reflected in the observed sharp decline in gastric cancer mortality rates over the past 
decades, particularly in developed countries where improved living conditions are 
found. In addition, the risk of distal gastric cancer throughout the world is inversely 
associated with socio-economic status, the lower the socio-economic status, the 
greater the risk of distal gastric cancer (Fuchs and Mayer, 1995).
1.4.3 Environmental and Geographic factors
Interestingly, a pronounced worldwide/ geographical variation in gastric 
cancer incidence and mortality rates has been well documented (Parkin et al, 2002; 
Stadtlander and Waterbor, 1999; Whelan et al, 1993). This well documented
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geographic variation of rates is a known feature o f the disease (Yamiguchi and 
Kakizoe, 2001). Worldwide, the highest incidence rates are found in Japan, China, 
South America (Chile, Costa Rica), the Russian Federation, and the former Soviet 
Union. The lowest rates occur in the United States, the UK (Northern Europe), 
Canada, Australia, and parts of Africa (e.g. Uganda) (Faraji and Frank, 2002; 
Holcombe, 1992). Recently the incidence of gastric cancer has been declining on an 
annual basis in the United States and other industrialized countries. However, even 
within the US there exist sub-groups, which can be classed as high-risk groups due to 
reports of high incidences of gastric cancer in these areas (Wiggins et al, 1989; 
Haenszel, 1958). It is through epidemiological studies that these geographical and 
ethnic differences in incidence rates and gastric tumour types have been discovered. 
Some of the most interesting epidemiological observations come from migrant studies 
(McMicheal et al, 1980; Haenszel et al, 1972). Individuals/ populations migrating 
from high risk to low risk areas of gastric cancer may still display a high risk in the 
new location, despite a change in lifestyle. An example of such a study is provided by 
the work of Haenszel etal. (1972). Japanese immigrants in Hawaii were studied and it 
was found that the individuals from the high risk population (Japan) still had a high 
risk of developing gastric cancer despite having adopted a Western lifestyle. 
Interestingly, a decrease in cancer risk is apparent in their second and third generation 
offspring. This indicates that environmental factors play an important part in the 
aetiology of gastric cancers at an early stage. Early exposures to environmental 
factors can imprint a high gastric cancer risk that remains even after a change of 
environment. Similarly, in America it has been noted that Hispanics, American 
Indians, blacks, & immigrants from Latin America, Asia, and Northern Europe are at 
higher risk of developing gastric cancer than that of Native white Americans (Neuget 
et a l , 1996; Correa, 1992; Wiggins et al, 1989). Such data on dramatic geographical 
variation in disease incidence lead one to speculate that gastric cancer is influenced 
greatly by environmental factors (Chan et a l , 1999; Fuchs and Mayer, 1995), and that 
there are geographical differences in causative factors. Interactions between genetic 
and environmental risk factors may help to explain the worldwide variation in gastric 
cancer rates.
The decrease in gastric cancer throughout the world over the last 50 years is 
largely due to a decrease in cancer of the distal stomach (gastric body and antrum, see
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fig. 1.2) (Fuchs and Mayer, 1995). It has been speculated that this decrease can be 
attributed to increased consumption of fresh fruit and vegetables (Palli, 2000; World 
Cancer Research Fund (WCRF) panel, 1997), decreased consumption of salty and 
smoked foods, and improved methods for preserving food such as refrigeration 
(Hohenberger and Gretschel, 2003; Terry et al., 2002).
The described geographic variation in gastric cancer rates may be accounted 
for by geographic variation in environmental influences/ exposures, and interaction of 
environmental factors with genetic variations. One such important environmental 
factor is diet.
1.4.4 Diet
Diet plays a significant role in gastric carcinogenesis (StadtlStnder and 
Waterbor, 1999). Dietary irritants such as salt (NaCl) have been, through 
epidemiological observations, linked to higher gastric cancer risk (Chen et al, 1990a; 
Joosens and Geboers, 1981), and diets rich in salted, smoked, or pickled foods have 
been linked to an increased risk of gastric cancer (Ramon et al., 1993). This may 
explain the high risk of gastric cancer in Eastern countries, like Japan, where diets are 
rich in salted, smoked, and dried foods. The recent decline in deaths from gastric 
cancer in Japan has been correlated with a parallel decrease in consumption o f salty 
foods. In experimental models of gastric cancer, NaCl is seen to potentiate the effects 
of chemical carcinogens such as methyl N ’-nitro-N-nitrosoguanidine (MNNG) 
(Watanabe et al, 1992; Takahashi et al, 1983). Salt may thus act as a tumour 
promoter.
Excessively salty diets have been shown to induce gastric atrophy in 
laboratory mice (Kodoma et al, 1984). Salt may induce gastritis by causing irritation 
to the gastric mucosa by damaging the protective mucous layer and underlying 
epithelial cells, leading to an inflammatory response. More significantly, high intake 
of salt has been shown to increase cellular replication (Correa, 1992), and in doing so 
makes cells more susceptible to mutagenesis and carcinogenesis (Chamley and 
Tannenbaum, 1985) since DNA damage can be converted into fixed mutations more 
readily (Ames and Gold, 1990), increasing the endogenous mutation rate. 
Consumption of excessively salty foods may therefore, over time, lead to atrophic
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gastritis and so increase the risk of gastric cancer development (Fuchs and Mayer, 
1999).
Foods rich in nitrates, nitrites, and secondary amines have also been shown to 
be a cause for concern, as these compounds may form N-nitroso compounds, potent 
carcinogens shown to induce gastric tumours in animals (Correa et al., 1975). N- 
nitroso compounds are found naturally in cured meat and fish, and fried or grilled 
meat (Yamaguchi and Kakizoe, 2001). In addition, N-nitroso compounds can be 
generated in the gastric lumen, in the presence of dietary nitrates, by bacteria, which 
can flourish in the gut of patients with hypochlorhydia (reduced acid secretion). This 
may be a particular problem in regions of the world where dietary components are 
rich in nitrates (Sierra et al., 1991). Another problem is that nitrates in the gut can 
combine with mutagenic precursors in foods to give rise to potent mutagens (Correa, 
1992; Chen et al, 1990b; Wakabayashi et al., 1985; Yang et al., 1984). In addition, 
nitrite, nitrate, and nitrosating agents can also be synthesized by infiltrating 
macrophages and neutrophils during gastric inflammation.
The great interest in diet and cancer emanates from the hope that dietaiy 
changes can be made to reduce the incidence and mortality rates of gastric cancer 
(Correa et al, 2003; Correa et al, 2000; Palli, 2000; Correa, 1992). One approach is 
to reduce intake of excessively salty, pickled, and smoked foods. An increasing body 
of evidence suggests that increasing intake of fresh fruits and vegetables can decrease 
gastric cancer risk (Hohenberger and Gretschel, 2003; StadtlSnder and Waterbor, 
1999). Regular consumption of fresh fruits and vegetables provides the necessary 
vitamins and antioxidants to maintain a healthy nutritional status. Most research into 
dietaiy cancer preventative agents in the diet has focused on antioxidants (Kobayashi 
et al, 2002; Serafim et al, 2002; Su et al, 2000; Correa et a l , 1998; Correa, 1995; 
Correa, 1992).
Antioxidants include ascorbate (Vitamin C), P-carotene (a component of 
vitamin A), and a-tocopherol (vitamin E), all of which are abundant in fresh fruit and 
vegetables and the levels of such micronutrients in the serum of patients has been 
related to gastric cancer risk (You et al, 2000; Ruiz et al, 1994; Haenszel et al, 
1985). Antioxidants inhibit the reduction of nitrate to nitrite (Correa, 1992) and it has 
also been shown that the mutagenicity of nitric oxide (NO, an inflammatory mediator/ 
radical produced by macrophages which may be present in inflamed mucosa) can be 
inhibited by p-carotene and a-tocopherol (Arroyo et al., 1992). Ascorbate is thought
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to be protective against gastric cancer as it is a scavenger of reactive oxygen species 
(ROS) produced in the gastric mucosa and heavily implicated in gastric 
carcinogenesis (Stadtlander and Waterbor, 1999; Leaf et al., 1991; Stemmerman and 
Mower, 1981). ROS induce DNA damage and therefore increase the risk of 
mutations, which can lead to cancer (see section 1.6.1).
1.4.5 Helicobacter pylori
Figure 1.5 The bacterium Helicobacter pylori (H  pylori) a major causative factor in gastric 
carcinogenesis.
‘M icrobial pathogens contribute to the genesis o f a substantial num ber o f malignancies 
worldwide and nearly 1.2 million cases o f cancer per year are attributable to infectious agents' 
(Peek and Crabtree, 2006; Coussens and W erb, 2002).
Epidemiologic studies consistently demonstrate a link between gastric cancer 
risk and H. pylori infection (Correa, 2004; Peek and Blaser, 2002; Helicobacter and 
Cancer collaborative group, 2001; Danesh, 1999; Watanabe et al., 1997; Correa, 
1996; O’Conner et al., 1996; Webb and Forman, 1995; Hu et al, 1994; IARC, 1994; 
Sipponen et al., 1992; Forman et al., 1991; Parsonnet et al., 1991). H. pylori is likely 
to be the most significant etiological factor in gastric carcinogenesis. Several studies 
suggest that there are very few patients with gastric cancer who are not infected with
H. pylori (Uemura et al., 2001). Data from the Eurogast study group indicates an
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international association between H. pylori infection and gastric cancer, the 
prevalence of H. pylori infection correlating with the incidence of gastric cancer in 13 
countries (The Eurogast study group, 1993) possibly accounting for the geographic 
variation in the prevalence of the disease (Hohenberger and Gretschel, 2003; Parkin et 
al, 2 0 0 2 ).
H. pylori is a spiral-/ helicoidal-shaped, microaerophic, gram negative 
bacterium (fig. 1.5), and is a well known gastric pathogen (Suerbaum and Michetti, 
2002) selectively colonising the gastric mucosa (Peek and Crabtree, 2006). H. pylori 
infection is causally linked to several gastric conditions. The bacterium was isolated 
for the first time in 1982 from gastritis and peptic ulcer biopsy specimens (Marshall 
and Warren, 1984). Since then, several studies have linked persistent H. pylori 
infection with chronic atrophic gastritis, a known inflammatory precursor of gastric 
adenocarcinoma (section 1.3.1) (Uemura et al., 2001; Sipponen and Marshall, 2000; 
IARC, 1994; Nomura et al., 1991; Parsonnet et al., 1991; Marshall, 1986). Indeed 
virtually all infected individuals develop a co-existing gastritis which can exist for 
decades.
Several serological studies in different populations have established a strong 
correlation between gastric cancer and infection/ prior infection with H. pylori 
(Tatsuta et al., 1993; Forman et al., 1991; Karnes et al, 1991; Nomura et al., 1991; 
Parsonnet et al., 1991; Correa et al, 1990). All studies led to the conclusion that 
infection with H. pylori increased the risk of developing gastric cancer. In fact, based 
on several reports, it has been estimated that individuals infected/ previously infected 
with H. pylori have a three- to eight- fold higher risk o f gastric cancer compared to 
non-infected counterparts (Rokkas, 2000; Fuchs and Mayer, 1995) with an average of 
approximately six-fold increased risk {Helicobacter and Cancer collaborative group, 
2001; Eurogast study group, 1993; Parsonnet et al, 1991).
H. pylori infection is thus seen as an aetiological factor in the development of 
gastric cancer; both adenocarcinomas and gastric mucosa associated lymphoid tissue 
(MALT) lymphomas (Versalovic, 2003). The H. pylori -  gastric cancer link seems to 
be restricted to cancers of the distal stomach as opposed to cancers of the 
gastroesophageal junction and gastric cardia (Parsonnet et al., 1991). H. pylori 
infection in particular appears to increase the risk o f intestinal-type gastric cancer by 
inducing gastritis and atrophic changes. There are also some reports that H. pylori
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infection can also influence development of diffuse-type gastric cancer (Solcia et al., 
1996; Kikuchi et al., 1995; Parsonnet et al, 1991).
A consequence of this epidemiological data is that H. pylori has been 
classified as a definite human carcinogen by the International Agency for Research on 
Cancer (IARC, 1994) (the first bacterium to be classified in this manner). As a result 
there has been an explosion in H. pylori research in recent years. H. pylori has been 
detected in populations throughout the world and may be acquired in early childhood 
by transmission via the oral-oral and faecal-oral routes (Blaser, 1998; IARC, 1994). 
The infection in adults is usually chronic and persists throughout life unless 
appropriate therapy is provided. Interestingly, the incidence and prevalence of H. 
pylori infection shows geographic variation (Suerbaum and Michetti, 2002), and is 
related is to socio-economic conditions, with infection being more prevalent in low 
socio-economic classes where poor housing and hygiene are problems (IARC, 1994). 
The infection is acquired via oral ingestion of the bacterium (which has been detected 
in drinking water), and is transmitted within families in early childhood. Familial 
clustering of gastric cancer may therefore be associated with a familial clustering of
H. pylori infection (Brenner et al., 2000; IARC, 1994). The prevalence of the 
bacterium declines with improved hygiene and food preservation and this may help to 
account for the decreasing incidence of gastric cancer over the last fifty years.
H. pylori research has brought to light several interesting observations 
regarding the pathogenesis of H. pylori associated conditions. Infection with the 
bacterium is associated with several clinical outcomes including gastritis, duodenal/ 
gastric ulcer disease and gastric cancer (Hohenberger and Gretschel, 2003). H. pylori 
infection is the most common cause o f chronic gastritis (Torres et al., 2000) which 
involves extensive infiltration of inflammatory polymorphonuclear (PMN) leukocytes 
and consequent inflammation. It is believed that the extent of this inflammatory 
response may determine whether gastritis progresses to atrophy and possibly even to 
cancer. This may vary from individual to individual due to environmental and host 
genetic factors. For example, as stated in section 1.4.1, individuals with an IL-lfi 
polymorphism exhibit a heightened inflammatory response to H. pylori infection and 
hence may have a greater risk of neoplastic progression than individuals without the 
polymorphism (El-Omar et al., 2000). Also, several reports indicate that high salt 
diets may enhance H. pylori -  induced gastric carcinogenesis, possibly by enhancing
H. pylori colonization (Fox et al., 1999) or adding to gastric irritation and
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inflammation. Thus H  pylori does not appear to act alone to increase the risk of 
gastric cancer development. Genetic and environmental co-factors are also required 
and only a subset of H  pylori infected individuals will develop gastric cancer. In fact, 
only 1% of H. pylori infections are estimated to lead to gastric cancer (Farthing,
1998).
H. pylori infection is virtually always accompanied by inflammation of the 
gastric mucosa (Dixon 1991). The severity of the inflammatory response to infection, 
and the associated risk of precancerous and cancerous changes in the gastric mucosa 
appear to depend on the strain of H. pylori. There is marked genetic variability in H. 
pylori strains resulting in differing degrees of virulence (Israel et al, 2001). Two 
disease related alleles have been studied extensively, being the cagA, and vacA genes 
(Peek and Crabtree, 2006; Akopypants et al, 1998; Censini et al, 1996; Fox et al, 
1992). The cagA gene is part of a segment of the genome termed the cag 
pathogenicity island (PAI). It has been seen that whilst all H. pylori strains can. induce 
the development of gastritis (albeit to differing degrees), cag strains tend to result in 
a more severe gastritis accompanied by a heightened inflammatory response and 
increased risk of atrophic changes, IM and cancer development (Nogueria et al, 
2001; Webb et al, 1999; Queiroz et al, 1998; Shimoyama et al, 1998; Torres et al, 
1998; Parsonnet et al, 1997; Rudi et al, 1997; Beales et al, 1996; Crabtree et al, 
1996; Blaser et al, 1995; Crabtree et al, 1995; Kuipers et al, 1995; Peek et al, 1995; 
Crabtree et al, 1993; Crabtree et al, 1991). In a review paper published in 2006, Peek 
and Crabtree conclude that differential host inflammatoiy responses to the bacterium, 
and hence, clinical outcome, are a consequence of substantial genotypic diversity 
between isolates (Peek and Crabtree, 2006). It is important to note however, that 
carcinogenesis is ultimately driven by a synergy of host and bacterial factors, host 
genetic diversity, particularly involving polymorphisms in immune response genes 
such as IL-lp and TNF-a, can increase the risk o f an individual developing intestinal 
type gastric cancer (Garza-Gonzalez et al., 2005; Ohyauchi et al, 2005; Chen et al, 
2004; El Omar et al, 2003; Rad et al, 2003; Zeng et al, 2003; Machado et al, 2001; 
El Omar et al, 2000). As such it is believed that the outcome of chronic H. pylori 
infection is largely dependent upon a combination o f host and bacterial factors 
(summarised in fig. 1.6 ), and it has been suggested that genotyping of host 
polymorphisms and bacterial variation, in conjunction with endoscopic surveillance 
may help to identify individuals at heightened risk of developing gastric cancer (Peek
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and Crabtree, 2006; Correa and Schneider, 2005; Correa et al, 2004; Figueiredo et 
al., 2002).
Figure 1.6 Host and bacterial factors affecting the outcome of infection. Adapted from Correa et al. 
(2004).
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1.4.5.1 Possible mechanism(s) of H. pylori -  associated gastric pathogenesis
H. pylori infection of the gastric mucosa sets in motion a well co-ordinated 
inflammatory response. It is believed that the bacterium is capable o f breaking down 
the protective mucous barrier in the stomach (possibly by impairing the secretion of 
mucins (Correa and Miller, 1998)) and damaging the underlying gastric epithelial 
cells so instigating an inflammatory response. This response is characterised by 
extensive infiltration of inflammatory polymorphonuclear (PMN) leukocytes, 
primarily neutrophils at first (Naito and Yoshikawa, 2002), later being accompanied 
by monocytes and tissue macrophages, which are recruited to the mucosa by 
chemotactic factors (such as cytokines) produced by the gastric epithelium and by the
22
bacterium itself. The leukocytes attempt to deal with the infection by phagocytosing 
bacteria at the surface of the epithelium and employing bactericidal factors such as 
ROS to kill H. pylori. Unfortunately for the host, the bacterium has evolved 
mechanisms of evading the host response (Baldari et al., 2005), for example, by the 
production of detoxifying enzymes that protect against the effects of ROS (Bernard et 
al., 2004). The consequence o f this is a sustained inflammatory response, since the 
stimulus (H. pylori) remains at the site, leading to further recruitment and activation 
of leukocytes. The infection has been reported to induce a Thl type inflammatory 
response with respect to the array of cytokines and chemokines that are detected at the 
infection site, being characterised by IFNy (as oppose to IL-4 in a Th2 response) 
(Crabtree et al, 2004; Smythies et al, 2000; Bamford et al, 1998; Crabtree, 1998) as 
well as TNFa, IL-ip, IL-6 , and EL-8  that originate from leukocytes and gastric 
epithelium (in particular IL-ip, IL-6 , and EL-8 ) (Lindholm et al, 1998; Messa et al, 
1996; Mohammadi et al, 1996; Weigert et al, 1996; Crabtree et al, 1995; Karttunen 
et al, 1995; Crabtree et al., 1994a; Crabtree et al, 1994b; Moss et al, 1994; Noach et 
al., 1994). These pro-inflammatory mediators may contribute to H. pylori induced 
pathologies (Ernst et al, 1999) by recruitment and activation of more inflammatory 
cells and driving the generation of RO/NS (e.g. TNFa and IL-8  (Naito and 
Yoshikawa, 2002; Garcia-Ruiz et al, 1997; Lo and Cruz, 1995)). Neutrophils 
generate bactericidal RO/NS, such as hydrogen peroxide (H2O2), superoxide radical 
(Q2 0 > and nitric oxide (NO) (Peek and Blaser, 2002), in an attempt to destroy 
infection (Crabtree, 1996a; Crabtree, 1996b). Since H. pylori can evade this, the 
RO/NS cause damage to host epithelial cells instead, damaging vital macromolecules 
such as lipids, proteins and DNA.
It is clear then that infection with H. pylori results in an inflammatory 
response, which can often be long-term leading to changes in the gastric 
microenvironment, driving physiological and molecular changes in the gastric 
mucosa which could ultimately favour gastric carcinogenesis. Extensive review of the 
large body of literature brings attention to several components of the infection and its 
associated inflammatory response that may underlie the pathogenesis of gastric 
cancer. These include:-
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- Disruption of proliferation -  apoptosis balance.
The bacterium has been shown to increase the rate of cellular proliferation of 
gastric epithelial cells, inducing hyperproliferation of the gastric epithelium as well as 
alterations in apoptosis (Correa and Miller, 1998; Jones et al, 1997; Peek et al, 1997; 
Cahill et al, 1996; Lynch et al, 1995; IARC, 1994; Cahill et al., 1993; Buset et a l , 
1992). H. pylori has been shown to induce apoptosis in the gastric epithelium 
(Yoshimura et al, 2 0 0 0 ), both directly, through bacterial cytotoxins, and indirectly 
via the cytokines and RO/NS produced in the immune response to infection (Jones et 
al, 1997). The increase in apoptosis results in an increase in cellular proliferation in 
order to balance cell kinetics (Leung and Sung, 2002; Xia et a l , 2001). Unfortunately 
the balance can be lost and this can lead to cancer through cellular accumulation and 
loss of gastric integrity (Pritchard and Crabtree, 2006; Piotrowiski et al, 1997; Bechi 
et al, 1996; Fan et al, 1996; Moss et al, 1996). In particular, infection with cagA+
H. pylori strains has been reported to result in increased proliferation and apoptosis of 
the gastric epithelium (Le’Negrate et al, 2001; Moss et al, 2001; Rokkas et al,
1999). Oxidative stress is a favoured hypothetical explanation for the alterations in 
the proliferation -  apoptosis balance associated with infection (Correa and Miller,
1998).
- Chronic Inflammatory response and infiltration of leukocytes.
It is well documented that the chronic gastric inflammation associated with 
infection greatly and significantly increases the risk of developing gastric cancer 
(Correa, 2004; Peek and Blaser, 2002; Helicobacter and Cancer Collaborative Group, 
2001; Jaiswal and LaRusso, 2002; Correa, 1996; Forman et al. 1991). Inflammatory 
responses result in the release of large amounts o f inflammatory mediators such as 
RO/NS from PMN leukocytes and macrophages. The bacterium causes the activation 
o f neutrophils (Unemo et al, 2005) and disrupts their release of ROS (mainly 
superoxide) such that instead of being released into the phagosome (that forms within 
cells upon phagocytosis) and killing engulfed H. pylori, the metabolites are released 
extracellularly (Allen et al, 2005). A consequence of this is increased risk o f gastric 
carcinogenesis via induction of oxidative DNA damage in adjacent cells (Correa,
1997). Indeed the greater the severity of inflammation the greater the risk of 
malignancy perhaps owing to increased generation of RO/NS and so a greater degree
24
of DNA damage (Farinati et al, 2003; Yoshimura et al, 2000; Correa and Miller,
1995) and peroxidative damage (Danese et al, 2001; Baik et al, 1996; Farinati et al, 
1996; Davies et al, 1994). The accumulation of oxidative DNA damage may lead to 
gene modifications and an ultimate cancer endpoint (Nishibayashi et al, 2003; Ernst,
1999).
- Oxidative DNA damage.
In vivo studies indicate that H. pylori may induce increased synthesis of 
RO/NS in the gastric mucosa of infected patients (Obst et al., 2000; Suzuki et al, 
1996; Davies et al, 1994). Oxidative stress is frequently observed in infected 
individuals (Felley et al., 2002). Strong evidence suggests that RO/NS play an 
important role in carcinogenesis, and are heavily implicated in the aetiology o f gastric 
carcinogenesis. RO/NS have a knock on effect on DNA synthesis, mutation, and 
apoptosis. H. pylori can thus act as an initiator of gastric carcinogenesis via the 
induction o f oxidative DNA damage (Yoshimura et al, 2000). Oxidative DNA 
damage usually results in the induction of DNA repair pathways or apoptosis in order 
to avoid mutation. Unfortunately if the levels of DNA damage are overwhelming and 
DNA repair pathways are inhibited (nitric oxide has been reported to inhibit DNA 
repair (Laval and Wink, 1994)) and the cells fail to execute apoptosis the result can be 
mutated transformed cells (Yoshimura et al, 2000). Indeed H. pylori infection has 
been reported to induce mutations in the big blue transgenic mouse model (Jenks et 
al, 2003; Touati et al, 2003) and interestingly the mutation frequency was strongly 
related to the degree o f inflammatory cell infiltrate suggesting that the inflammatory 
leukocytes may play an active role. Gastric biopsies from H. pylori -  infected 
individuals show elevated levels of ROS compared to uninfected counterparts, and 
gastric cancer patients are seen to have higher levels o f oxidative DNA damage in 
tumour tissues compared to normal tissues (Lee et al, 1998). Thus inflammation and 
its associated RO/NS are likely key players in H. pylori associated gastric 
carcinogenesis (Jenks et al, 2003).
- Decreased levels of antioxidants.
Ascorbate (Vitamin C) acts as a potent free radical scavenger and as such is 
seen to be protective against gastric cancer (Drake et al, 1996). H. pylori has been
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reported to cause decreased levels of ascorbate in the gastric juice of infected subjects 
(Hohenberger and Gretschel, 2003; IARC, 1994; Ruiz et al, 1994). This results in a 
marked decrease in radical scavengers, and hence accumulation o f generated oxygen 
and nitrogen radicals. This can result in enhanced levels of oxidative DNA damage. 
Vitamin C supplementation coupled with eradication of H. pylori has been reported to 
result in significantly reduced levels of DNA damage (Correa et al, 2000; Rokkas et 
al, 1995) and apoptosis, as well as prevention of cancer cell growth (Zhang et al, 
2002).
- Altered Gastric Acidity,
Chronic infection with H. pylori can disrupt gastric physiology at the level of 
the pH of the gastric juice. Inflammatory cytokines are important here, for example, 
both IL-1 p and TNFa released at sites of infection are potent inhibitors of gastric acid 
secretion (Beales et al, 1998). Certain polymorphisms in inflammatory genes, e.g. 
IL-lfi, can lead to both a heightened inflammatory response to infection and 
decreased acid levels (hypochlorydia), resulting in an increased risk of gastric cancer 
(El-Omar et al, 2000). In addition, atrophic changes induced by H. pylori can lead to 
hypochlorydia. The consequence of this is an altered gastric microenvironment which 
can favour carcinogenesis (Dockray et al, 2001; Peek et al, 2000; Yoshimura et al,
2000).
- Mitogenic signalling and oncogenic gene expression changes.
H. pylori can cause molecular changes in the gastric epithelium which 
predispose to cancer development. Infection has been reported to induce mitogenic 
signalling in gastric epithelial cells by way of mitogen activated protein kinase 
(MAPK) signalling (Keates et al, 2005; Zhu et al, 2005; Wallasch et al, 2002; 
Hirata et al, 2001; Meyer-ter-Vehn et al, 2000; Stein et al, 2000; Wessler et al, 
2000; Keates et al, 1999; Segal et al, 1999), as well as the induction of transcription 
factors implicated in inflammation and oncogenesis such as nuclear factor kappa-B 
(NFkB) (Sharma et al, 1998; Keates et al, 1997; Munzenmaier et al, 1997) and 
AP-1 (a downstream transcription factor target o f MAPK signalling) (Naumann et al, 
2001; Naumann et al., 1999), and the expression of potentially oncogenic genes 
including c-FOS (a component of the AP-1 transcription factor complex) (Meyer-ter-
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Vehn et al, 2000) and IL-8 (Fischer et al, 2001; Meyer-ter-Vehn et al, 2000; 
Crabtree et al, 1999; Li et al, 1999; Glocker et al, 1998; Shimoyama et al, 1998; 
Aihara et al, 1997; Crabtree et al, 1995; Crabtree et al., 1994a). The effect of 
infection on intracellular signalling and gene expression is further detailed in section 
3.1.4. The RO/NS produced by leukocytes and gastric epithelial cells in response to 
infection have also been implicated in the induction of signalling and gene expression 
changes via the activation of redox-sensitive transcription factors which may 
adversely affect cellular proliferation (Teshima et al, 2000).
Clearly the link between H. pylori infection and gastric cancer is complex, 
with several factors impacting disease pathogenesis, often in an interrelated 
(synergistic) manner. It is important to gain insight into the pathogenesis of H. pylori- 
induced gastritis and gastric cancer at all of these levels. Identification of molecular 
changes caused by H. pylori could provide a better understanding of the mechanistic 
basis underlying the pathogenesis of gastric cancer.
1.5 Molecular Biology of Gastric Cancer
In the past ten years much has been learnt about the molecular changes in 
gastric cancer and much continues to be learnt. Gastric cancer is effectively the end 
result of progressive genome destabilization. Like all cancers, it is characterised by 
dynamic changes in the genome. Several genetic changes have been detected and at 
least 4-7 genetic ‘hits’ are required to drive gastric carcinogenesis. As a result o f these 
changes, cancer cells generally show six ‘hallmarks’, being -  disregard for 
differentiation signals, insensitivity to anti-proliferative signals, capacity for sustained 
proliferation, evasion of apoptosis, tissue invasion and metastasis, and sustained 
angiogenesis (Hanahan and Weinberg, 2000). Numerous genetic alterations have been 
identified due to vast research efforts in this area, and table 1.2 summarises a handful 
of the changes along with the aspects of cellular physiology that they impact.
Despite advances, a clear-cut genetic basis of gastric cancer remains to be 
defined (Correa and Shiao, 1994). Marked variation in genetic changes is often seen 
between tumours as well as within a tumour mass. This leads one to speculate that the 
molecular pathogenesis o f gastric cancer is influenced by a combination o f factors
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(section 1.4.5.1), H. pylori being the most significant. Large scale studies have 
identified several genes that can be impacted in H. pylori -  associated gastric 
carcinogenesis throughout the pre-malignant stages. These include - up-regulation of 
inflammatory response genes e.g. IL-8, (Wallasch et al., 2002; Maeda et al., 2001; 
Crabtree et al, 1995; Sharma et al., 1995; Crabtree et al., 1994a; Crabtree et al, 
1994b); up-regulation of IkBoi, (Maeda et al., 2001); AP-1 activation via up-regulation 
of c-JUN, JUN-B, c-FOS (Sepulveda et al., 2002); up-regulation of cyclin D1 
(CCND1) (Sepulveda et al., 2002); EGF receptor activation (Wallasch et al, 2002); 
decreased expression of E-cadherin (CDH1) (Sepulveda et al., 2002; Terres et al.,
1998); up-regulation of certain growth factors (GFs), e.g. transforming growth factor 
a  (TGFa), hepatocyte growth factor (HGF), and gastrin (GAST) (Konturek et al, 
2001; Beppu et al., 2000; Choi et al., 1999); increased SURVIVIN expression levels 
(Kania et al., 2003); decreased caspase-3 (CASP3) expression (Kania et al., 2003); 
over-expression of matrix metalloproteinase-7 (MMP-7) (Bebb et al., 2003). This is 
just a ‘snapshot’ of the gene expression changes detected in H. pylori -  associated 
gastric carcinogenesis. The changes drive disease pathogenesis by impacting cellular 
biochemistry and physiology at the levels of cellular proliferation (usually increases), 
apoptosis, mitogenic signalling, angiogenesis, and capacity for invasion and 
metastasis.
In recent years the involvement of inflammatory processes and their related 
generation of RO/NS (and resultant oxidative and nitrosative stress) in gastric 
carcinogenesis have received special attention. A recent study by Ding et al (2007) 
demonstrated that H. pylori infection or H2O2 exposure to gastric epithelial cells could 
induce veiy similar cellular and molecular changes at the levels of increased ROS 
generation (which could be enhanced by pre-treatment with cytokines), and apoptosis, 
both o f which could be inhibited by the addition of antioxidants. Such studies 
emphasise the importance o f the inflammatory response and oxidative stress in 
carcinogenesis.
1.6 Historical Perspectives of Free Radicals
A free radical is a molecule possessing one or more unpaired electrons in its 
outer orbital. These molecules tend to be highly unstable due to their propensity to
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react with adjacent molecules. Many of these molecules are oxygen or nitrogen 
centred, hence Reactive Oxygen/ Nitrogen Species (RO/NS) [throughout this thesis 
the free radicals and their less reactive derivative molecules are collectively termed 
ROS, RNS, or RO/NS]. Under normal circumstances, free radicals are generated in 
cells as a consequence of normal metabolic processes. Their levels in the cell are very 
finely controlled by antioxidant systems -  both enzymatic (e.g. catalase, superoxide 
dismutase (SOD)), and non-enzymatic (e.g. vitamins C and E), which act as free 
radical scavengers, effectively ‘soaking up’ excess free radicals.
Historically, die presence of free radicals in biological materials was first cited 
more than fifty years ago by Commoner et al (1954), and the concept that free 
radicals/ reactive oxygen or nitrogen species (RO/NS) play an important role in 
biology and medicine was proposed in 1969, by Fridovich and McCord who cited the 
existence of a common, nearly ubiquitous cellular protein (now known to be 
Superoxide Dismutase (SOD)) that served to function as a free radical scavenger 
(McCord and Fridovich, 1969). This finding indicated that cells had evolved a 
defence mechanism against endogenously generated RO/NS. This notion was 
ridiculed at the time, giving rise to much scientific controversy, many scientists 
arguing that the sheer toxicity and reactivity of molecules like superoxide radical 
(O2*’) would not allow their existence in living things. However, the explosion of 
research into the field of free radicals later proved their findings to be correct 
(Scanalios, 2002), and prompted further investigations into oxidative damage caused 
by free radicals to DNA, protein, lipids and other cellular constituents (Beckman and 
Ames, 1998). The discovery o f SOD finally provided mechanistic evidence for 
Harman’s free radical theory of ageing, proposed in 1956, in which it was speculated 
that cumulative cellular damage induced by radicals may contribute to the ageing 
process (Harman, 1956).
Indeed, since the evolution of aerobic life, all living organisms have been 
constantly exposed to both endogenously generated RO/NS as well as exogenous 
insults, and have evolved mechanisms to defend against toxicity (the aforementioned 
antioxidant systems), and mechanisms to exploit the potential benefits of the 
metabolites. Obvious positive uses of ROS include the conversion o f food to energy, 
and defence against microorganisms. More recent findings show that RO/NS act as 
signal transducing molecules, having significant roles in the activation of transcription 
factors leading to gene expression (Ahmad et al., 2006; Droge, 2001; Karin et al,
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2001; Sen and Packer, 1996; Storz and Polla, 1996; Schenk, 1994; Whiteside and 
Goodboum, 1993; Kerr et al, 1992).
Intracellular defence mechanisms deal very efficiently with the removal of 
excess RO/NS, thus preventing toxicity and cellular damage. Table 1.3 summarises 
the sources of endogenous and exogenous free radicals, as well as the mechanisms of 
their removal. Figure 1.7 further elaborates on intracellular generation of free radicals.
Table 13 Summary of the Generation and Removal of Reactive Oxygen and Nitrogen Species 
(RO/NS) in the cell.
Cellular oxidants Source Oxidative species
Endogenous Mitochondria o r , h 2o 2, *o h
Cytochrome P450 o 2' \ h 2o 2
Macrophage/inflammatoiy cells 0 2’\ H 20 2, ‘N 0 ,0 C r
Peroxisomes h 2o 2
Exogenous Redox cycling compounds or
Metals (Fenton reaction) *OH
Radiation 'OH
Cellular antioxidants
Enzymatic Nonenzymatic
Superoxide dismutase Vitamin E
Catalase Glutathione
Glutathione peroxidase Vitamin C
Glutaredoxin Catechins
Thioredoxin 3-carotene
1.6.1 Oxidative Stress at the cellular level
Within the eukaryotic cell, most RO/NS originate from mitochondrial 
oxidative metabolism/ phosphorylation due to the leakage of RO/NS from the electron 
transport chain (ETC). Extra -  mitochondrial sources also exist, including the 
endoplasmic reticulum (ER), the plasma membrane, peroxisomes, and the cytosol, 
where RO/NS are formed enzymatically via xanthine oxidase, cytochrome P450, 
reduced Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidases, nitric 
oxide synthase (NOS), as well as other enzymes including those involved in
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arachidonic acid metabolism such as cyclooxygenases (COXs and lipoxygenases 
(LOXs)) (Balaban eta l, 2005; Curtin etal., 2002; Storz, 2006).
Figure 1.7 The formation of cellular RO/NS.
a. Generation of reactive oxygen species via reduction o f molecular oxygen
o2 + e ~  ^0 2* (superoxide anion)
O2*' + H20  -> IIO2’ (hydroperoxyl radical)
H 0 2‘+ e" + H -> H2O2 (hydrogen peroxide) 
at' '
H 2O2 + e' -> OH" + *OH (hydroxyl radical)
b. Production of reactive nitrogen species 
L-ARGININE + 0 2 -» ‘NO (nitric oxide) + L-CITRULLINE r:r:=":r^
0 2*’+ *NO ONOO" (peroxynitrite) ^
ONOO + C 02 ONOOCO2' (nitrosoperoxy carbonate) ----------►
ONOOCO2 *N02 (nitrogen dioxide) + C O / ' (carbonate anion radical)
c. Fenton reaction 
H20 2 + Fe2+ O ff + ‘OH + Fe1+
Research now dictates that the most biologically relevant radicals are 
superoxide (0 2*'), hydroxyl radical (*OH, considered the ultimate reactive metabolite 
(Henle and Linn, 1997)), and Nitric oxide (NO). These radicals have endogenous 
enzymatic origins, 0 2 ‘ being generated by NAD(P)H oxidase (and xanthine oxidase), 
and NO arising as a consequence of activities of the various Nitric oxide synthase
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(NOS) isoforms that exist (Droge, 2002), whilst -OH can be formed as a derivative of 
other species by non-enzymatic means. Figure 1.7 illustrates the generation of various 
radicals. Superoxide anion is formed by the univalent reduction of molecular oxygen. 
This process can be mediated by enzymes, as stated and also non-enzymatically by 
redox reactive compounds (e.g. the semi-ubiquinone compound of the mitochondrial 
electron transport chain). Superoxide can be converted into hydrogen peroxide (H2O2) 
by superoxide dismutase (SOD), and can also be converted, non-enzymatically into 
H2O2 and singlet oxygen (*0 2 ). The highly reactive hydroxyl radical (*OH) may also 
be generated from H2O2 in the presence of reduced transition metals (e.g. ferrous or 
cuprous ions) via the Fenton reaction (Fig. 1.7(c)). Likewise, several derivative 
species can be generated from NO (as summarised in Fig. 1.7(b)). Many of the 
physiological effects of the principle free radicals are brought about through their 
intermediates and by-products. The fact that so many species can co-exist in a given 
cellular environment at any time, makes it very challenging to pinpoint which agents 
are responsible for a given biological effect (Droge, 2002).
RO/NS generally exist in cells at low but measurable concentrations, their 
levels being dependent upon the underlying balance between their rate of production 
(and/ or exposure) and their rate o f removal by antioxidant enzymatic and non- 
enzymatic systems. Antioxidants have been defined in the literature as substances that 
are able to compete with other oxidisable substrates, even at relatively low 
concentrations, hence delaying significantly, oxidation of cellular targets (Halliwell 
and Gutteridge, 1989). This definition includes the non-enzymatic compounds such as 
ascorbate (Vitamin C), a-tocopherol (Vitamin E), p-carotene, and glutathione; and the 
enzymes, SOD, catalase, glutathione peroxidase (GPx), glutaredoxin and thioredoxin 
(table 1.3). When a redox imbalance exists in the cellular environment, the cell/ 
tissue is said to be in a state of oxidative stress. This is usually tightly balanced by the 
aforementioned antioxidant systems, in addition to other cellular components such as 
free amino acids (albeit at high molar concentrations) (DrSge, 2002), and often by the 
RO/NS themselves. A state of increased RO/NS concentrations can elicit negative 
feedback pathways that serve to lower markedly elevated levels. More interestingly, a 
major mechanism in redox homeostasis is now seen to be RO/NS-mediated induction 
of redox sensitive signal cascades that lead to increased expression o f antioxidant 
enzymes, and other cellular antioxidant systems. Thus it is clear that living cells have
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evolved several mechanisms to restore redox balance after exposures to increased 
RO/NS concentrations.
Unfortunately instances of oxidative stress can arise, as a result of 
environmental exposures to toxins, drugs, infection, etc., leading to shifts in the 
balance towards increased levels of RO/NS. This oxidative stress is often the 
underlying mechanism of several pathological conditions, such as chronic 
inflammation, rheumatoid arthritis, atherosclerosis, and cancer.
What impact does oxidative stress have at the cellular level?
Oxidative stress can have detrimental effects on cells, imposing oxidative 
damage on cellular macromolecules that can culminate in DNA damage, lipid 
peroxidation, protein oxidation, and changes in signal transduction and gene 
expression. The deleterious effects of RO/NS have long been known, the direct and 
indirect role these species play in DNA, cellular, and tissue damage, chronic tissue 
injury and disease is well documented (Mohora et a l  2006; Valko et a l 2004; 
Matteucci et al. 2000; Vendemiale et al. 1999; Trueba et al. 2004; Jenner, 1996; 
Knight, 1995; Stohs, 1995; Kehrer, 1993). Figure 1.8 summarises both the 
deleterious, and the beneficial effects of RO/NS.
The stoiy of RO/NS remains one of a double-edged sword -  on the good side, 
they can protect against oxidative stress, maintaining redox balance via redox 
homeostasis; they provide defence against infectious agents, being an integral part of 
the innate (non-specific) immune response. RO/NS are recognised as having an 
important role in infection and inflammation as bactericidal species (Casimir and 
Teahan, 1994; Johnston et al, 1975); they can induce apoptosis and cellular 
senescence (hence may be anti-tumourigenic) (Valko et al, 2006); and they can act as 
second messengers, leading to activation of pathways and genes that regulate cell 
growth. Ironically, this beneficial effect is also one that can lead to an oncogenic 
phenotype through enhanced mitogenesis (Valko et a l , 2007; Klaunig and 
Kamendulis, 2004; Droge, 2002). In situations of chronic inflammation (e.g. as a 
consequence of persistent H. pylori infection) normal host cells in the vicinity can be 
continuously bombarded with RO/NS and their damaging effects, which can, in some 
instances, lead to the development of cancer.
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Figure 1.8 Summary of the beneficial and deleterious effects o f free radicals in biological systems.
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1.6.2 Oxidative Stress and Cancer
As already discussed in section 1.6, RO/NS can induce DNA damage (and 
hence mutations), lipid peroxidation, changes to the cellular proteome, changes in 
apoptosis, cellular senescence and changes in the transduction o f intracellular 
signalling cascades. All o f these changes can result in alterations in a cells 
proliferative capacity, and hence drive and/ or maintain an oncogenic phenotype 
(Valko et al., 2006). Redox imbalance resulting from oxidative stress has been 
observed in many cancer cells when compared to their normal counterparts (Halliwell 
et al., 1992; Szatrowski and Nathan, 1991) and the importance o f oxidative stress to 
carcinogenic processes has become increasingly well documented in the past decades 
(Fukuruma et al., 2006; Ristow, 2006; Valko et al., 2006; Waris and Ahsan, 2006; 
Klaunig and Kamendulis, 2004; Oshima et al., 2003; Klauning et al., 1998; Poulsen et 
al., 1998; Wink et al., 1998; Knight, 1995; Toyokuni et al., 1995; Feig et al., 1994;
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Guyton and Kensler, 1993; Trush and Kensler, 1991; Breimer, 1990; Vuillaume, 
1987; Ames, 1983).
One of the critical ways in which these molecules drive cancer development is 
via DNA mutation. In this way, RO/NS impact the initiation stages of carcinogenesis 
(Valko et a l , 2006). The continued presence of abnormal levels of RO/NS in initiated 
cells can then drive the promotion stage by firing off signal transduction pathways 
that promote cell growth and hence maintain an oncogenic phenotype. RO/NS are 
thus viewed as complete carcinogens since they can impact both the initiation and 
promotion stages of disease pathogenesis.
In a clinical context relevant to gastric carcinogenesis, oxidative stress is 
believed to be a key component of the chronic inflammatory processes that lie at the 
root of the molecular pathogenesis of the disease (Correa, 2006; Farinati et al, 2003; 
Baik et al, 1996; Davies et al, 1994a).
1.7 Inflammation and Cancer
Chronic inflammation has been linked to several human cancers (Hagemann et 
al, 2007; Balkwill et al, 2005; Balkwill and Coussens, 2004; Coussens and Werb, 
2002). The link between inflammation and cancer in fact traces back over two 
millennia to the Greek doctor Galen. In the 19th century Virchow hypothesised that 
tumours arise at sites of chronic inflammation (Coussens and Werb, 2002; Balkwill 
and Mantovani, 2001), and more recently tumours have been likened to ‘wounds that 
do no heaF (Dvorak, 1986) really emphasising the importance of the relationship.
The underlying inflammation may be the result o f chronic/ persistent 
exposures to infectious or physical agents, and indeed several infectious agents have 
now been classified as human carcinogens (Oshima et al., 2003). Analysis o f IARC 
monographs leads to the estimation that 18% of the worldwide cancer incidence was 
attributable to infectious agents in the year 2000 (compared to 16% in 1990), 4.5% 
being linked to H. pylori, which exemplifies the inflammation -  cancer link (IARC, 
1994). As already detailed, chronic infection with H. pylori leads to tissue 
inflammation in the stomach, manifest as chronic gastritis. In addition, inflammatory 
conditions can be caused by chemical and physical agents such as alcohol, tobacco
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smoke, salt, etc. and consequently these are all recognised risk factors for various 
cancers. On these grounds it appears that a significant proportion of the global cancer 
burden can be causally linked to chronic infections and inflammation. The 
mechanistic nature of infection-/ inflammation-induced carcinogenesis is not fully 
elucidated. One hypothesis is that the inflammatory processes release excessive 
amounts of microbicidal reactive oxygen and nitrogen species (RO/NS) leading to a 
situation of oxidative stress, the consequences o f which were outlined in section 1.6 .1. 
The major source o f these highly reactive molecular species in such instances, is the 
bodies defender cells -  the leukocytes (Weitzman and Gordon, 1990) whose main 
purpose is to ward off invaders. Inflamed tissues are characterised by marked 
infiltration of inflammatory leukocytes, predominantly neutrophils and macrophages 
(Kozol, 1992), the innate immune responses effector cells, attempting to deal with the 
infection, and/  or tissue injury present at the affected site. The cells are recruited to 
the affected site and are activated to produce potent inflammatoiy mediators 
(including cytokines and chemokines) and microbicidal factors (e.g. RO/NS) 
primarily to attack and destroy invading microorganisms and foreign bodies. 
Inflammatoiy mediators released into the local tissue microenvironment serve to 
chemo-attract and/ or activate further inflammatoiy cells, leading to a heightened 
inflammatory response (de Visser and Coussens, 2006; Coussens and Werb, 2002a; 
Coussens and Werb, 2002b; Wilson and Balkwill, 2002; Torisu et al, 2000). 
Typically, phagocytic cells (mainly neutrophils and macrophages) become highly 
active and release cytotoxic factors such as RO/NS including singlet oxygen, 
superoxide anion (0 2 * ), hydrogen peroxide (H2O2), and nitric oxide (NO). In addition, 
the inflammatory cells convert these into more highly reactive RO/NS, such as 
hydroxyl radicals (*OH), hypochlorous acid (HOC1), and peroxynitrite (ONOO') 
(D’Alessandro et al, 2003; Oshima et al, 2003). Under normal circumstances the 
inflammatoiy response is tightly controlled, so that upon eradication o f the 
microorganism, foreign bodies, or irritant, the inflammation dampens down, such that 
the response is acute. If however, infection is not resolved rapidly, or if  control of the 
response is not tightly regulated, the inflammation can become chronic.
Chronic inflammation is accompanied by complications that make an 
individual more susceptible to the development of various diseases, including cancer. 
A prolonged inflammatory response leads to the continual activation of inflammatory 
leukocytes and the concomitant release of RO/NS, proteolytic enzymes, and
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inflammatory mediators, creating a hostile microenvironment that can lead to tissue 
damage, and may favour the development of various pathological conditions, such as 
cataracts, macular degeneration (Decanini et al., 2007); pancreatitis (Schulz et a l ,
1999); diabetes (Mohora et al., 2006; Droge, 2002; Matteucci and Giampietro, 2000; 
Stohs, 1995); diabetic retinopathy (Stohs, 1995); diseases of old age such as 
atherosclerosis (Stohs, 1995); rheumatoid arthritis (Dr6 ge, 2002); neurodegenerative 
diseases like Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple 
sclerosis (MS), Friedreich’s Ataxia (Calabrese et al., 2005; Droge, 2002; Borlongan et 
al., 1996; Jenner, 1996); as well as neoplastic diseases (de Visser and Coussens, 2006; 
Balkwill and Coussens, 2004; Klaunig and Kamendulis, 2004; Coussens and Werb, 
2002; Droge, 2002; Balkwill and Mantovani, 2001; Robinson, 1998; Conner and 
Grisham, 1996). On these grounds chronic inflammation has been described as 
‘pathological inflammation’ as oppose to acute inflammation which has been termed 
‘therapeutic inflammation’ due to its ability to fairly rapidly resolve infection and 
injuiy with minimal damage to the host (Aggarwal et al, 2006).
Activated phagocytes have long been documented to play roles in 
carcinogenesis by the induction of point mutations, chromosome damage, deregulated 
DNA methylation, and malignant transformation both in vitro and in vivo (Weitzman 
and Gordon, 1990; Weitzman et al, 1989; Weitzman et al, 1985; Weitberg et al, 
1983; Weitzman and Stossel, 1982; Weitzman and Stossel, 1981). So it has become 
apparent that, in some situations, inflammatory cells; in particular neutrophils and 
macrophages with the aim of dealing with the infection or injury at the site, can, in 
fact, make matters worse by generating and releasing RO/NS and cytokines, both of 
which can drive several aspects of cancer development (Valko et al, 2006; Strieter,
2001).
This is often observed in gastric carcinogenesis, where chronic inflammation 
(an end result o f H. pylori infection, dietary irritation, “or other complications) is 
believed to be a major risk factor (Macarthur et al., 2004; Shacter and Weitzman, 
2002; Ernst, 1999; Oshima et al, 1993). Figure 1.9 summarises the inflammation -  
cancer link.
In addition to impacting cells directly at the genetic level via the induction of 
DNA damage and thus mutations, chronic inflammation (and oxidative stress) also 
affects cells at the epigenetic level by causing changes in cellular signal transduction 
and gene expression, so driving changes in cell behaviour, function, and growth.
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Figure 1.9 The inflammation -  cancer link.
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1.8 Signal Transduction and Cancer
Observations that cancer cells often display dysregulated behaviour in that 
they often proliferate and grow excessively when they should not, and do not die (via 
apoptosis) when they should, has prompted researchers to unravel the molecular 
mechanisms that underlie such changes in behaviour. This led to the realisation that in 
addition to the mutations and chromosomal aberrations frequently reported as 
common features o f malignant disease, changes in signal transduction are also central. 
As such, cancer is more and more frequently being described as a disease o f mis- 
regulated signal transduction (Arbiser, 2004; Eshel et al., 2002; Radisky et al., 2001; 
Fedi et al., 1997; Hunter, 1997; Kohn et al., 1992).
It is unsurprising that signalling pathways are often seen to be perturbed in 
tumour tissues as well as in pre-malignant stages o f disease owing largely to the 
complexity o f the pathways. One small change in a gene involved in a pathway or
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changes in external stimuli (as is often the case in the tumour microenvironment) 
could cause major signalling changes (Fedi et al, 1997) -  owing to the inherent 
complexity of pathways, overlap between pathways, and the signal amplification 
feature of cellular signalling cascades. Figure 1.10 illustrates the intricate networks of 
cellular signal transduction that have been delineated and highlights the complex 
interactions that exist both within and between pathways.
Of particular relevance to the present research are the effects of inflammatory 
processes and associated oxidative stress on signal transduction and gene expression 
changes, since such changes may lead to mitogenic andI or oncogenic changes that 
lead to an ultimate cancer endpoint. Often the aberrant signalling detected in cancer 
results in enhanced cell survival and proliferation, and/ or reduced capacity for 
apoptosis (both hallmarks of cancer (Hanahan and Weinberg, 2000)), thereby causing 
an imbalance in cellular homeostasis, with a shift toward enhanced growth. Mitogen 
Activated Protein Kinase (MAPK) signalling (section 1.8.1) plays a key role in 
maintaining cellular homeostasis, and disruption of the pathway(s) is often manifest in 
many cancers (Dhillon et al, 2007; Li et al, 2003). The Nuclear factor - kappa B 
(NFkB) pathway (section 1.8.2) is also seen to play a pivotal role, mis-regulation of 
which can influence cell survival (Bubici et al, 2006; Beg and Baltimore, 1996). 
Interestingly, both of these pathways have been reported to be affected in 
inflammation associated cancers (Balkwill and Coussens, 2004; Karin, 2004; Li and 
Verma, 2002; Dimitru et al, 2000; Barnes and Karin, 1997; Karin, 1995) including H. 
pylori associated gastric cancer (Naumann and Crabtree, 2004; Maeda et al, 2000; 
Meyer-Ter-Vehn et al, 2000; van Der Brink et al, 2000; Naumann et al, 1999; 
Aihara et al, 1997; Malinin et al, 1997; Muller et al, 1997). Moreover, both 
pathways can be induced by inflammatory mediators including cytokines, e.g. TNFa 
in the case of NFkB (Balkwill and Coussens, 2004; Greten et al, 2004; Pikarsky et 
al, 2004) and RO/NS (Gloire et al, 2006; Takada et al, 2003; Zhang et al, 2001; 
Bowie and O’Neill, 2000; Manna et al, 1998; Wang et al, 1998; Aikawa et al, 1997; 
Qin et al, 1997; Guyton et al, 1996; Rao,1996; Sen and Packer, 1996; Meyer et al, 
1993; Schreck et al, 1991) since both pathways have redox sensitive components.
The major focus of the extensive research carried out here is inflammation and 
oxidative stress induced signal transduction and gene expression changes in gastric 
carcinogenesis, with a particular focus on MAPK and NFkB. As such, the pathways
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and their relevance to cancer are detailed further in relevant sections throughout the 
thesis and are detailed briefly in sections 1.8.1 and 1.8.2 that follow.
Figure 1.10 The integrated networks of signal transduction pathways within a cell, which serve to 
relay extracellular signals through the cytoplasm and to the nucleus where an ultimate effect on gene 
expression and so cell behaviour/ physiology occurs. Amongst the complex pathways are the MAPK 
and NFkB pathways which are discussed in sections 1.8.1 and 1.8.2. Taken from Hanahan and 
Weinberg. 2000.
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1.8.1 Mitogen Activated Protein Kinase (MAPK) pathway
The Mitogen Activated Protein Kinase (MAPK) pathway is an important 
signal transduction pathway consisting of (as its name suggests) a cascade o f MAPK 
enzymes, each leading to the activation of the subsequent enzyme via a 
phosphorylation reaction (Su and Karin, 1996). These kinase enzymes are used
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throughout evolution to control cellular responses to external signals such as stress, 
nutrient status, inductive signals and growth factors (Treisman, 1996), relaying 
messages from cell surface receptors to the nucleus (Turjanski et al, 2007; Chang and 
Karin, 2001). These pathways are unique to eukaryotic cells, and affect many aspects 
of cellular regulation. In recent years it has become increasingly clear that MAPK 
pathways have knock on effects on almost all cellular process, ranging from gene 
expression to cell death (Chang and Karin, 2001; Graves et al, 2000; Treisman,
1996). As a result these pathways can be seen as master controllers, and can influence 
whether a cell grows in a normal or aberrant fashion.
In mammalian systems at least four distinctly regulated groups of MAPK 
pathways have been identified, making up a MAPK superfamily. These include 
extracellular signal regulated kinase 1 (ERK1) and ERK2 (also known as p44(MAPK) 
and p42(MAPK)); Jun amino terminal kinases (JNK1/2/3); ERK5 (or BMK); and p38 
MAPKs (p38a/p/y/5) (Chang and Karin, 2001; Gutkind, 2000). Each MAPK enzyme 
is inactive in the cell, unless an extracellular stimulus sets in motion the pathways that 
lead to their activation and their concomitant effects on cellular physiology.
It is fundamental that the MAPK enzymes and/ pathways have a high level of 
specificity, so that they can control several diverse cellular processes in response to a 
plethora of extracellular stimuli, particularly since this is achieved by all but a few 
specific MAPK enzymes (Chang and Karin, 2001; Schaffer et a l , 1998; Wasserman 
and Matthew, 1998; Xia et a l , 1998). According to the literature, there is substantial 
evidence of the involvement of MAPK cascades in cellular processes including - 
regulation o f gene expression, at both the levels of transcription, and translation; 
regulation o f cell proliferation; control of cell cycle progression; regulation o f cell 
survival; and influencing cell motility (Chang and Karin, 2001; Ichijo, 1999; Su and 
Karin, 1996; Treisman, 1996).
One of the most explored functions o f MAPK signalling cascades is the 
regulation of gene expression in response to extracellular stimuli (Treisman, 1996). A 
key finding was that members of a family of transcription factors known as Activator 
Protein-1 (AP-1), which have been implicated in inflammation related changes in 
gene expression, are dependent on MAPK signalling pathways for their activity 
(Karin, 1995). AP-1 is seen as a ‘master switch’ in the control of cell life and death, 
mis-regulation of which can lead to oncogenic changes (Shaulian and Karin, 2001). 
The way in which MAPK pathways affect AP-1 activity is most commonly via the
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phosphorylation (and hence activation) of Ets transcription factors which, in turn, lead 
to the induction of fos genes, the products of which dimerise with other FOS proteins, 
or JUN proteins to form AP-1 transcription factor complexes, with the c-FOS/ c-JUN 
dimer being the most commonly found in cells (Chang and Karin, 2001; Karin et al, 
1995; Angel and Karin, 1991; Chiu et al, 1988). Further details of the link between 
MAPK signalling and AP-1 activation are outlined in chapter 3, section 3.1.2.1. From 
this well studied example, it is apparent that MAPK signalling modules can directly 
influence gene expression at the level of transcription factors.
Interestingly with respect to the present studies, aberrant MAPK signalling has 
been reported in several cancers (Dhillon et al, 2007; Kohno and Pouyssegur, 2006; 
Dunn et al, 2005; Calipel et al, 2003; Li et al, 2003) including gastric cancer 
(Watari et al., 2007; Liang et al, 2005; Moon et al, 2005; Sepulveda et al, 2002; 
Gong et al, 1999; Barnard et al, 1995; Tahara, 1995b), and can be induced by H. 
pylori infection (Du et al, 2007; Keates et al, 2005; Zhu et al, 2005; Wallasch et al, 
2002; Hirata et al, 2001; Meyer-ter-Vehn et al, 2000; Stein et al, 2000; Wessler et 
al, 2000; Keates et al, 1999; Segal et al, 1999). As such MAPK pathways are 
viewed as a molecular link in the intimate relationship between inflammation and 
cancer (Karin, 2005). Likewise, NFkB signalling is key in this association.
1.8.2 Nuclear Factor Kappa-B (NFkB) pathway
The NFkB family of transcription factors are critical components in the 
complex circuitry of cellular signal transduction and gene expression. The NFkB 
transcription factors are seen as master co-ordinators o f diverse functions including 
immunity, inflammation, differentiation, and cell survival (Claudio et al, 2006; 
Hayden and Ghosh, 2004). NFkB has received much attention in the scientific 
community since its discovery in 1986 (Gilmore and Temin, 1986; Sen and 
Baltimore, 1986) owing to its anti-apoptotic and pro-inflammatory capabilities which 
have frequently been linked to pathogenic states, in particular those associated with 
chronic inflammation, immunodeficiency, and cancer (Aggarwal et al, 2006; 
Courtois and Gilmore, 2006; Dolcet et al, 2005; Rayet and Gelinas, 1999). The 
importance of NFkB is highlighted in the existence o f a website dedicated to NFkB 
research (www.nf-kb.org). with over 25,000 research/ review articles published to 
date (Gilmore, 2006).
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At the level of signal transduction, the NFkB pathway serves as a paradigm of 
the transfer of signals from extracellular stimuli to the cells core at the nucleus 
(Hayden and Ghosh, 2004; Rothwarf and Karin, 1999). A critical step in this pathway 
is the activation of the NFkB transcription factor (comprised of dimers of proteins 
from the NFkB (e.g. p50, p52) and REL (e.g. RELB, RELA (p65)) superfamilies of 
NFkB proteins, with the p50 -  RELA (i.e. p50-p65) dimer being the major form of 
NFkB transcription factor found in cells (Gilmore, 2006). Typically NFkB is 
constitutively expressed in eukaryotic cells in an inactive form, thus, activation of the 
transcription factor does not require de novo gene expression, control being achieved 
at the post-translational level. In its inactive state NFkB is present in the cytoplasm 
sequestered by an inhibitory protein - inhibitor of kappa-B (IkB) (Beg and Baldwin, 
1993; Beg et al., 1992; Baeurele and Baltimore, 1988). When cells are exposed to an 
activating stimulus signals are relayed from the cell surface membrane. Several 
upstream signalling processes have been described in NFkB signalling which vary 
depending upon the activating stimulus and cell type (Gilmore, 2006; Perkins, 2006) 
all of which converge at the activation of IkB kinase (IKK) complexes. IKK serves to 
phosphorylate IkB marking it for subsequent ubiquitination and degradation by the 
cellular proteasome. Degradation of IkB results in liberation of active NFkB which 
translocates to the nucleus where it drives the expression o f NFkB regulated genes, 
including IkB (in a negative feedback manner), genes involved in inflammation, e.g. 
IL-1, IL-6, IL-8, TNFA, adhesion molecules, e.g. VCAM\ ICAM-1, etc. (McKay and 
Cidlowski, 1999).
Diverse stimuli can lead to the activation of NFkB signalling including 
inflammatoiy cytokines, e.g. TNFa (Gilmore, 2006; Balkwill, 2004; McKay and 
Cidlowski, 1999; Schreck et al, 1992), and RO/NS (detailed further in chapter 3 
section 3.1.3) (Gloire et a l, 2006; Takada et al, 2003; Zhang et a l, 2001; Bowie and 
O’Neill, 2000; Manna et al, 1998; Wang et al, 1998; Sen and Packer, 1996; Meyer et 
al, 1993; Schreck et a l, 1991). Figure 1.11 illustrates one o f the possible pathways 
for the activation of NFkB.
Aberrant NFkB signalling has been found to be a common feature of 
inflammation associated cancers (Aggarwal et al, 2006; Courtois and Gilmore, 2006; 
Dolcet et a l, 2005; Balkwill and Coussens, 2004; Jenkins et al, 2004; Karin, 2004; Li 
and Verma, 2002; Dimitru et al, 2000; Rayet and Gdlinas, 1999; Barnes and Karin, 
1997; Karin, 1995) including gastric cancer.
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Figure 1.11 Activation o f the NFkB pathway by TNF. TNF activates NFkB by way of 
TNFR/Traf2/NIK/IKK signalling, which can be inhibited by T rafl. Ultimately IkB is degraded and 
active NFkB is free to enter the nucleus (removal o f IkB results in exposure of nuclear localisation 
sequence (NLS) on NFkB s o  allowing nuclear translocation) where it can switch on target genes 
including IkB , which results in negative feedback as show. TNF = tumour necrosis factor; TNFR = 
tumour necrosis factor receptor; Trafs = tumour necrosis factor receptor -  associated factors; NIK = 
NFkB inducing kinase. Figure adapted from Jenkins et al. (2004).
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Interestingly H. pylori has been seen to rapidly induce the activation of NFkB 
signalling and the expression of target genes such as IL-8 in gastric epithelial cells 
(Naumann and Crabtree, 2004; Maeda et al., 2000; Meyer-Ter-Vehn et al., 2000; 
Naumann et al., 1999; Crabtree, 1998; Shimoyama et al., 1998; Aihara et al., 1997; 
Keates et al., 1997; Malinin et al., 1997; Muller et al., 1997; Crabtree et al., 1995). 
On these grounds the study of NFkB signalling in relation to inflammatory processes 
and oxidative stress in gastric cancer is warranted.
1.9 Aims of the Project
Upon review o f the literature regarding potential pathogenic mechanisms that 
underlie gastric carcinogenesis it becomes quite clear that inflammation and oxidative
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stress are critical components which can act either independently, or in conjunction 
with H. pylori infection to induce a multitude of molecular anomalies within cells.
The present work sets out to gain further insights into the involvement of 
inflammation and oxidative stress in gastric carcinogenesis at the level of signal 
transduction and gene expression changes using in vitro and in vivo models to test the 
hypothesis:-
Chronic gastric inflammation & accompanying generation o f Reactive Oxygen 
Species (ROS) plays a significant role in gastric carcinogenesis by the induction o f 
molecular changes (signal transduction, and gene and protein expression changes).
The broad aim o f the studies was to identify signalling and gene expression 
changes that may be incurred in gastric cancer development, by inflammation and 
oxidative stress, which could potentially occur early on in the progression sequence 
(as early as gastritis). The work was carried out with the hope of identifying 
biomarkers - key molecular changes - that can be used in a clinical context to identify 
patients at high risk of gastric cancer development, enable early diagnosis, 
determination of prognosis, and monitor treatment in patients. The identification of 
signalling changes would also bring to light potential therapeutic targets, and 
recognition of the involvement of inflammation and oxidative stress in gastric cancer 
would add weight to the current prevention strategies employing anti-inflammatory 
drugs and/ or antioxidant supplementation (Correa et al, 2004; Jones-Blackett et al, 
1999).
Two in vitro tissue culture models were employed in the studies -  one in 
which cells were exposed to various doses of a model ROS, hydrogen peroxide 
(H2O2), for varying lengths of time in order to mimic the oxidative stress component 
of a gastric inflammatory response (chapter 3); and one in which gastric epithelial 
adenocarcinoma cells (HGC-27) were co-cultured with inflammatory leukocytes, so 
more realistically mimicking an in vivo inflammatory response (chapter 5). In the 
initial chemically induced model of oxidative stress (by way of H2O2 exposure) three 
cell lines were used - two gastric epithelial adenocarcinoma cell lines -  AGS, derived 
from a primary gastric tumour; and HGC-27, derived from a lymph node metastasis of 
an advanced gastric tumour; and one normal fibroblast cell line - WILLI, derived 
from the foreskin of a one year old boy. The purpose of using three different cell lines
47
was to take into account any cell line differences in responsiveness between cancer 
cells and normal cells, and between cancer cells at different stages of the disease 
(AGS (early) vs. HGC-27 (late)). Obviously using cancer cell lines is not ideal for 
assessing changes in normal cells since the malignant cells are likely to respond 
differently. By using three different cell lines a clearer picture of changes consistently 
induced by ROS can be obtained. In the second in vitro model only the HGC-27 
gastric cancer cell line was utilised due to time restraints and practical reasons. HGC- 
27 was co-cultured with inflammatory leukocytes derived from the HL-60 pro- 
myelocytic cell line optimised to generate ROS so that gastric epithelial cells are 
exposed to ROS from a more biologically relevant source in conjunction with other 
inflammatory mediators that may be released (e.g. cytokines and chemokines). In this 
way gastritis can be mimicked more closely to the in vivo situation. Following 
exposure of cells to H2O2 or inflammatory leukocytes, RNA and protein were 
extracted from cells for downstream signal transduction and gene expression analyses. 
Since the aim was to identify key signalling changes, initial studies involved the use 
of global microarray analysis of H2O2 treated cells in order to identify key pathways 
that are affected by oxidative stress. The findings from the experiments confirmed the 
involvement of MAPK and NFkB signalling in response to oxidative stress and 
helped in identifying downstream gene expression targets to analyse. Following on 
from this the pathways were explored in greater detail by assessing gene expression 
levels of the downstream targets -  c-FOS and VEGF for MAPK, and IL-8 and IkB for 
NFkB by way of quantitative (Q-)/ real time (RT-) PCR. Assessment of MAPK 
pathway activation was achieved via western blots for phosphorylated (and hence 
activated) MAPK proteins (phospho-ERKl/2 (p42/p44), phospho-p38). NFkB 
signalling was assessed further using a green-fluorescent protein (GFP) reporter 
construct in cells by way of transfection and subsequently visualising any cytoplasmic 
to nuclear transclocation of fluorescent, active NFkB protein following exposures by 
way of confocal microscopy. For the co-culture studies only c-FOS and IL-8 gene 
expression were analysed by RT-PCR as markers for inflammation/ oxidative stress 
induced MAPK and NFkB signalling respectively, and MAPK signalling was further 
validated by way o f western blots for phospho-ERKl/2 (p42/p44) (marker of ERK1/2 
signalling).
In order to assess the clinical relevance of the in vitro studies, experimentation 
was subsequently translated to an in vivo study in which the signalling and gene
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expression changes consistently observed in the cell culture studies were assessed in 
pre-malignant gastric biopsies in order to determine whether such changes may be 
truly important in early stages of gastric carcinogenesis (chapter 6 ). Pre-malignant 
biopsies (chronic inflammation/ gastritis, intestinal metaplasia, and H. pylori infected) 
were collected from consenting patients attending outpatient endoscopy clinic, RNA 
and protein extracted from the specimens, c-FOS expression analysed by RT-PCR and 
ERK signalling assessed by western blots for phospho-ERK. In this way the status of 
MAPK signalling and downstream gene expression in pre-malignant gastric tissues 
was assessed.
In brief, the findings from the studies highlight the involvement of oxidative 
stress in gastric carcinogenesis; at the levels of MAPK and NFkB signalling and 
downstream gene expression changes that favour cancer development; strengthening 
the notion that inflammation and oxidative stress are key players in driving the 
progression of cells to an ultimate cancer endpoint. This further emphasises the 
usefulness of therapeutic strategies that centre on blocking the generation of, and/ or 
sequestering excessive RO/NS in pre-malignant tissues such as antioxidant 
supplementation (Correa, 2004) and the use of anti-inflammatory drugs (Nardone and 
Rocco, 2004; Jones-Blackett et al., 1999). In addition, the recognition of the 
involvement of signal transduction aberrations in disease pathogenesis brings forth the 
potential o f targeted therapies. For instance, the identification of the involvement of 
MAPK signalling in gastric carcinogenesis supports the use of novel anti­
inflammatory drugs that specifically target the pathways (Roberts and Der, 2007; 
Kaminska et al, 2005; Karin, 2004) in gastric cancer therapy. Such approaches offer 
hope to aid tremendously in the management of this devastating disease.
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Chapter 2 
General Materials and Methods
Disposable gloves and laboratory coats were worn during all experimental 
manipulations for safety reasons and to avoid cross contamination.
Distilled water used in experiments was purified and deionised with the Milli-Q PF 
Ultrapure Water Purification System (Millipore, Watford, UK).
All general laboratory reagents/ chemicals used were from Sigma-Aldrich (Poole, 
UK) unless otherwise stated.
Specific materials and methods relevant to separate chapters are detailed in the 
materials and methods sections of the relevant chapters.
2.1 General Cell Culture
All cell culture manipulations were carried out using aseptic technique in class 
2 Cytomat Pharmaceutical Safety cabinets (Medical Air Technology Ltd.). The 
cabinet, and all equipment going into it, were wiped down with 70% ethanol prior to 
culturing in order to maintain a good aseptic technique. All glassware and Pasteur 
pipettes used were autoclave sterilised at 121°C and 15psi for thirty minutes (Prior 
Clave Ltd). Disposable, sterile, plastic tissue culture flasks (NUNC, Fischer 
Scientific, Leicestershire, UK), pipettes, and centrifuge tubes (Sterilin, Stattfordshire, 
UK) were used for general culturing techniques. Cells were incubated in LEEC MK11 
proportional temperature controller incubators at 37°C with an atmosphere of 5% 
CO2. Cell culture medium was prepared freshly as and when required and was only 
used if a corresponding sterility test (section 2 .1.1.2 ) was free from contamination. 
Only sterile solutions were used for cell culture and all solutions were pre-warmed in 
a 37°C water bath prior to use. On addition of culture medium to cells, the flasks were 
gassed briefly with CO2 in order to adjust the pH of the medium.
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2.1.1 Cell Lines
A total of four different cell lines were used in the present investigations, three 
attached cells lines -  AGS, HGC-27, and WILLI, and one suspension cell line -  HL- 
60.
2.1.1.1 Attached Cell Lines
The three attached cell lines employed in the experimentation were the gastric 
epithelial adenocarcinoma cell lines AGS and HGC-27, and the primary fibroblast cell 
line WILLI, and are described in section 3.2.1. Signal transduction and gene 
expression changes were examined in all three cell lines following treatment with 
hydrogen peroxide (H2O2). The purpose of using the three different cell lines was to 
establish if any cell line/ type differences existed in terms of response to exposures.
2.1.1.2 Cell Culture Medium
The growth medium used for the three attached cell lines was as follows:-
AGS -  Ham’s F12K (Gibco-BRL, Paisley, UK) plus 10% (v/v) Foetal Bovine Serum 
(FBS) (Gibco-BRL, Paisley, UK).
HGC-27 - Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco-BRL, Paisley, 
UK) supplemented with 10% (v/v) FBS and 1% non-essential amino acids (NEAA) 
(Gibco-BRL, Paisley, UK).
WILLI - DMEM plus 10% (v/v) FBS.
Culture medium was prepared freshly as and when required following the aseptic 
techniques described in section 2.1. Each time fresh medium was prepared 10ml of 
the medium was placed in small 25cm2 culture flasks, gassed with CO2 and incubated 
at 37°C. This comprised a sterility test, and the medium in the flask was routinely 
monitored for cloudiness and particulate matter under the Nikon light microscope 
(Olympus Optical Co (UK) Ltd, London, UK) to check for contamination. Only 
medium that remained clear and free of contamination for at least 2  days in the 
sterility test was used for cell culture.
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2.1.1.3 Initiation of Cell Lines
The cells were stored in freezing media (consisting of heat inactivated calf 
serum (HIS) + 10% Dimethyl Sulfoxide (DMSO)) in cryovials in liquid Nitrogen 
prior to use.
Cells were carefully removed from liquid Nitrogen and rapidly thawed by 
transferring to a 37°C water bath and gently agitating the ciyovial. When completely 
thawed, the cryovials were cleaned with 70% ethanol and the cells were transferred to 
a centrifuge tube and centrifuged at 200 x g (1500rpm) for 8 min using an IEC 
Centra-3M centrifuge in order to pellet the cells. The DMSO was then removed by 
discarding the supernatant and 10ml o f the appropriate pre-warmed medium was 
slowly added to the pellet to generate a cell suspension. The cell suspension was then 
transferred to a small 25cm2 tissue culture flask and gassed with CO2, in order to 
adjust the pH of the medium, and maintained in a 37°C incubator with an atmosphere 
o f 5% CO2 in air.
Cells were initially seeded at 2 -  4 xlO5 cells/ ml (for all three cell lines) into 
25cm2 flasks, incubated at 37°C, and checked regularly under the light microscope for 
inspection of cell growth and general cell health.
2.1.1.4 Sub-Culturing Attached Cell Lines
The three attached/ anchorage-dependent cell lines grew as monolayers 
attached to the bottom of the culture flasks. When cells reached confluency (generally 
between 70-80% ) they were sub-cultured at a ratio of 1:4 for HGC-27, 1:3 for AGS, 
and 1:2 for WILLI into medium 80cm2 flasks as follows. Spent medium was removed 
from cells and the cell monolayer washed twice in 5ml pre-warmed Phosphate 
Buffered Saline (PBS) to remove extracellular serum proteins which act as trypsin 
inhibitors. The adherent cells were then detached from the flasks via 2 x Imin washes 
in ~ 2 - 3ml trypsin/EDTA (pre-warmed to 37°C) (Gibco-BRL). After checking under 
the light microscope that cells had begun to detach from the flasks (evident as cells 
appear round) the trypsin/EDTA was aspirated and the flasks gently agitated by 
tapping until the cells completely detached. The cells were then resuspended in 10ml 
complete medium and subdivided according to the sub-culturing ratios optimised for 
each cell line when carrying out routine sub-culturing. When accurate cell numbers
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were required, e.g. for exposure experiments, the appropriate volume of cell 
suspension constituting 2 -  4 x 105 cells/ml or the cell concentration required for the 
particular experiment (counted using a Haemocytometer) was seeded into medium 
sized 80cm2 flasks followed by the addition of cell culture medium (pre-warmed to 
37°C) to a final volume of 15ml. The flasks were briefly gassed with CO2 prior to 
placement in the 37°C incubator.
Subsequent sub-culturing was performed regularly as described, usually on an 
every other day basis to accommodate for the growth rate of the cells. Cells were 
either sub-cultured into medium-sized (80cm2) or jumbo-sized flasks (175cm2) 
depending on the amount of cells required for further experimental manipulations.
2.1.1.5 Freezing Down Attached Cell Lines
When cells were not in use they were stored in freezing media (consisting of 
heat inactivated calf serum (HIS) (Gibco-BRL, Paisley, UK) + 10% Dimethyl Sulfoxide 
(DMSO)) in cryovials in liquid Nitrogen. Cells at 70% confluence were trypsinised as 
described in section 2 .1.1 .4, and the resulting cell suspension centrifuged at 2 0 0  x g 
(1500rpm) for 8min. The resultant cell pellet was then resuspended in 3ml freezing 
media and divided equally amongst three 1.8ml cryovials. The cryovials were 
subsequently placed in a Biocell biofreezing vessel and placed in a -80°C Kelvinator 
overnight, allowing a slow reduction in temperature, before finally transferring the 
cryovials into a Cryomed liquid Nitrogen freezer for permanent storage until needed for 
experimentation.
2.1.1.6 Suspension Cell line: HL-60
The human promyeloblastic cell line HL-60 (derived from a 36-yr old 
Caucasian female with acute promyelocytic leukaemia) was obtained from the 
American Tissue Culture Collection (ATCC, Teddington, Middlesex, UK). The cell 
line was used in co-culture experimentation (chapter 5) in order to study the effects of 
inflammatory cells on gene expression and signal transduction changes in gastric 
epithelial cells after first optimising the induction o f an inflammatory response in HL- 
60 (chapter 4). Further details about the cell line are provided in section 4.1.3.
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The growth medium used for the culture of HL-60 was RPMI 1640 
supplemented with 10% FBS, 2mM L-glutamine, Penicillin (60 units)/ Streptomycin 
(60pg) (all Gibco-BRL, Paisley, UK). The contents o f the provided cryovials of cells 
were thawed by gentle agitation in a 37°C water bath for 2 minutes. When completely 
thawed, the cryovials were cleaned with 70% ethanol and the contents transferred to a 
25ml centrifuge tube containing 9.0ml pre-warmed medium (37°C). After gentle 
mixing, the contents were centrifuged at 200 x g (1500rpm) for 5 minutes. 
Subsequently the supernatant was decanted and the cells re-suspended in 80cm2 tissue 
culture flasks at a fmal cell concentration of lx l 05 cells/ml in 15ml of complete 
growth media. The flasks were then gassed with 5% CO2 in air and incubated at 37°C. 
After a 24hr incubation period the cells were examined under a light microscope to 
check for signs o f contamination.
Cultures were maintained by the addition of fresh medium followed by 
gassing with CO2, in order to dilute the cell concentration/ml and to provide nutrients, 
on the second or third day in culture depending on the cell densities observed. 
Alternatively, sub-culturing was performed by centrifugation of the cell suspension 
(following prior agitation to loosen cell aggregates) at 200 x g (1500rpm) for 5min, 
followed by removal of spent medium, resuspension of the cell pellet in fresh medium 
and dividing the cell suspension amongst several 80cm2 cell culture flasks with the 
addition of growth medium to a final concentration o f 1 x 105 cells/ml (cell counts 
determined using a haemocytometer). The cells were then gassed with 5% CO2 and 
incubated at 37°C. Cell concentration was not allowed to exceed 1 x 106 cells/ml and 
the cell density was usually maintained between 1 x 105 and 1 x 106 viable cells/ml.
2.1.1.7 Freezing Down HL-60
When cells had grown to a concentration of 1 x 106 cells/ml and were not 
required for experimentation the cell suspension was centrifuged at 200 x g (1500rpm) 
for 5 minutes and the resultant cell pellet was resuspended in 6ml freezing medium 
(RPMI 1640 growth medium supplemented with 4.71% v/v DMSO). Subsequently 
1.5ml of the suspension was pipetted into each of 4 x 1.8ml cryovials. The ciyovials 
were next placed in a Biocell biofreezing vessel and stored at -80°C overnight so 
allowing a gradual freezing of the cell suspension prior to finally transferring the
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cryovials into a Cryomed liquid nitrogen freezer for permanent storage until required 
for experimentation.
2.1.1.8 Cell Counting using the Haemocytometer and Trypan Blue Viability
Assay
Total cell counts as well as the number o f viable cells were regularly 
determined using a combination of haemocytometer counts and the Trypan Blue 
viability assay. Such information was required when sub-culturing cells in preparation 
for chemical treatments in order to ensure that cells were seeded into flasks at equal 
cell number so that cells reached the stage of sub-confluency in concert and that only 
cell populations with viability of 95% or more (unless otherwise stated) were used in 
subsequent experimentation.
Cells were detached from culture flasks by trypsinisation as described in 
section 2.1.1.4 and a cell suspension prepared in fresh growth medium. Next, 5ml of 
cell suspension was spun down by centrifugation at 2 0 0  x g (1500rpm) for 8 minutes 
to pellet the cells and the resultant cell pellet resuspended in 2ml Hank’s balanced salt 
solution (HBSS) (Gibco-BRL, Paisley, UK). Subsequently 0.5ml o f 0,4% (w/v) 
Trypan Blue solution was placed in a test tube and 0.3ml of HBSS and 0.2ml o f the 
cell suspension were subsequently added (resulting in a cell dilution factor of 5). The 
solution was mixed thoroughly and left to stand at room temperature for no longer 
than 10-15 minutes. The haemocytometer was then set up by placing a clean glass 
cover-slip over the haemocytometer chambers, ensuring an air tight seal, and the 
chambers filled with cell suspension by carefully touching the glass cover-slip with a 
filled Pasteur pipette and allowing the cell suspension mixture to fill the chambers by 
capillary action. The numbers of cells in the four comer 1mm squares o f the 
haemocytometer chamber were then counted. Cells counted were those within the 
squares and those touching the top and left perimeter of the squares only. Non-viable 
cells take up the trypan blue stain whilst viable cells do not. On this basis the number 
of viable and non-viable (blue) cells was scored as well as the total number of cells.
The number o f cells per ml suspension was then calculated as follows:
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Cells per ml = average count per square x dilution factor x 104 
Total cells = cells per ml x original volume of fluid from which sample was removed
Cell viability = Total viable cells (unstained) x 100
Total cells
Only cell suspensions with viability > 95% were used for further experimental 
manipulations (unless otherwise stated), and the number of cells was adjusted 
according to requirements by either diluting with the further addition of medium or 
concentrating by harvesting cells via a centrifugation step and resuspending in a 
smaller volume of medium.
2.2 Chemically Induced Oxidative Stress in Attached Cell Cultures: Hydrogen 
Peroxide (H2O2) Exposure
Cells were seeded in 80cm2 (for protein studies) or 175cm2 (for RNA studies) 
cell culture flasks at 2 -  4 xlO5 cells/ ml from the previously established cultures 
(AGS, HGC-27, and WILLI) described in section 2.1.1.2 -  2.1.1.4 and grown until 
sub-confluent (~ 70%). Prior to dosing cells with hydrogen peroxide (H2O2) complete 
growth medium was aspirated, cells washed 2 X in pre-warmed PBS (37°C) and 
replaced with serum free medium. This was necessary in order to eliminate any 
interactions between H2O2 and serum proteins which would otherwise hinder full 
exposure o f cells to H2O2 and its derivatives. In specially designated fume hoods for 
toxic handling, H2O2 (10 Molar) (Sigma-Aldrich, Poole, UK) diluted in lOmM TE 
buffer (Tris HC1 pH 7.5 + ImM EDTA) was added to culture flasks to make up a 
range of dosing concentrations. Cells were exposed to a dosing regimen consisting of 
4, 8 , or 24hr exposures to 0, 50, 150, 250, and 500pM H2O2. Doses were selected 
based on cytotoxicity studies previously carried out at the University of Wales 
Swansea (Morgan et al., 2003). In these studies 200pM H2O2 was seen to produce a 
50% survival rate, so lower concentrations o f 50 and 150pM, and higher 
concentrations of 250 and 500pM were employed in this study in order to cover a 
wide dose range. The aim was to mimic chronic inflammation in vitro, and since the 
actual levels of ROS in vivo are unknown, a wide dose range was covered (detailed 
further in chapter 3). Also the lower concentrations in the range have previously been
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shown to induce DNA damage (Jenkins et al, 2001) as well as chromosomal damage. 
Cells were incubated at 37°C for either 4, 8 , or 24hr before removal of H2O2 
containing medium (into specially designated toxic disposal flasks) followed by two 
washes in pre-warmed PBS (37°C) prior to proceeding to RNA/ protein extraction 
(sections 2.4 and 2.6 respectively). Controls included in the experiments were 
exposed to lOmM TE and all treatments were carried out in duplicate.
All toxic waste (including solutions, pipettes, pipette tips) was double contained and 
disposed of accordingly in double lined toxic/ biohazard bags ready for incineration.
2.3 MTS Assay
The effect o f chemical treatments on cell proliferation and viability in attached 
cell lines was assessed using the Promega CellTiter 96® AQueous One Solution Cell 
Proliferation Assay (Southampton, UK) [MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3- 
carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) assay] as 
instructed by the manufacturer’s protocol. Stock cultures o f cells were maintained as 
described in section 2 .1.1.3 -  2 .1.1 .4, and the cells used for the bioassay were stock 
cultures 2 days after the last sub-culture. Cells were trypsinised to detach cells from 
the flasks, and washed twice in pre-warmed serum free medium followed by 
centrifugation at 2 0 0  x g (1500rpm) for 8 min and subsequent resuspension in serum 
free medium. The cell number and viability of cells was determined using the 
haemocytometer and trypan blue dye exclusion method (section 2 .1.1 .8), and the cells 
subsequently resuspended to a fmal concentration of 1 x 105/ml medium. Only cells 
with viability greater than 95% were used for testing. Next, 50pl o f the resultant cell 
suspension (i.e. 5,000 cells) was dispensed into the appropriate wells of a sterile 96- 
well plate. The plate was then incubated overnight at 37°C in a 5% CO2 incubator to 
allow the cells to attach to the wells and undergo approximately one cell cycle so 
ensuring adequate cell numbers for the assay. The appropriate concentrations of test 
chemical were then prepared by addition of the chemical to serum free medium. For 
H2O2 the doses made up were 0, 50, 150, 250, and 500pM. For each dose, 50jil was 
aliquotted into wells of a 96-well plate. Since the chemical was added to the cells at a 
1:1 ratio, the doses were made up as 2X stocks to accommodate for the 1 in 2 dilution 
that occurs on addition of the chemical to the wells. For each dose, 2 wells were 
required, one for exposure of cells to the chemical, and one to serve as a control of
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test chemical in the absence of cells to measure background absorbance. Each dose 
was carried out in triplicate. Cell-only and medium-only controls were also included 
in the plates. Three different plate assays were carried out, one for each time point 
used in the study (4, 8 , or 24hrs). The cells were incubated at 37°C in an atmosphere 
of 5% CO2 to make up the full exposure times. Subsequently 20pl of CellTiter 96® 
AQueous One Solution Reagent was added to each well of the assay plate, and the plate 
incubated for 1 hour. Finally the absorbance at 490nm was determined using a 96- 
well plate reader (Anthos HTII plate reader, Labdesign, Sweden).
2.4 RNA Extraction from Cultured Cells
RNA was extracted from AGS, HGC-27 and WILLI following dosing with 
H2O2 (chapter 3) or co-culture treatments (chapter 5). For each dose/ co-culture 
treatment a set of two treatments was carried out in duplicate. One set for protein 
extraction (carried out in 75cm2 flasks) for protein expression studies, and the other 
set for RNA extraction (175cm2 flasks required for good RNA yield).
All RNA extractions were undertaken in a Class 13 Lamina Flow Hood. Prior 
to RNA extraction the hood and all of the equipment to be used (pipettes, reagent 
bottles, filter tip and tube boxes) were thoroughly cleaned with RNase ZAP wipes 
(Ambion Ltd, Cambridgeshire, UK). RNase free filtered pipette tips were used for all 
pipetting and all microfuge tubes used were autoclave sterilised prior to use to remove 
any residual RNase, so minimising degradation of extracted RNA.
RNA was extracted from a minimum of 5 x 106 and a maximum of 1 x 108 
cells using the QIAgen RNeasy Midi Kit (QIAgen, Crawley, West Sussex, UK) 
following the protocol for total RNA extraction from cultured mammalian cells with 
some modifications. Briefly, cells were harvested by detaching the cells from the 
culture vessels via trypsinisation (as described in section 2.1.1.4). The detached cells 
were resuspended in approximately 10ml o f serum containing medium to inactivate 
the trypsin. The number o f cells in each flask was then determined using a 
haemocytometer and the appropriate volumes (to give the desired cell numbers) were 
transferred to appropriately labelled centrifuge tubes and the cells spun down for 8min 
at 200 x g (1500rpm). The supernatant was decanted from the resultant cell pellets 
and any traces of medium were aspirated as the medium can interfere with later steps
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in the protocol and hence reduce RNA yield. Approximately 1 x 10 cells were 
collected from each flask.
Cell pellets were then loosened by vortexing the tubes and 4ml buffer RLT (+ 
1% P-mercaptoethanol) added in order to disrupt and lyse the cells. Subsequently the 
lysate was homogenised by vortexing the sample for lOsec and passing it through a 
sterile, disposable 18-gauge needle fitted to a sterile, disposable 1ml RNase free 
syringe 20-30 times. One volume (i.e. 4ml) 70% ethanol was next added to the 
homogenised lysates, and the solutions mixed thoroughly by vigorous shaking. The 
samples were then loaded onto RNeasy midi columns placed in the sterile 15ml 
RNase free centrifuge tubes provided in the kit. The tubes were closed gently and 
centrifuged at 3000 x g (4000rpm) for 5min using a Sanyo Centaur 2 centrifuge. All 
following centrifugation steps were also carried out at 3000 x g (4000rpm), and flow­
through discarded after each centrifugation.
Subsequently, buffer RW1 was added to the columns at a volume of 4ml, and 
tubes centrifuged for 5min. Next, 2.5ml buffer RPE (+ 4 volumes ethanol) was 
applied to the columns and the tubes centrifuged for 2min to wash the columns. This 
wash step was repeated a second time, but tubes were spun for 5min the second time 
to ensure that no ethanol is carried over during the subsequent elution step. Finally, 
the bound RNA was eluted from the columns in RNase-free water using a 
modification of the manufacturer’s protocol. Briefly, the RNeasy columns were 
transferred carefully into clean 15ml collection tubes provided and 75pi RNase-free 
water was applied directly onto the RNeasy silica-gel membrane. The tubes were left 
to stand for lmin and then centrifuged for 3min. This elution step was then repeated 
with a second 75 pi volume of RNase free water to maximise RNA yield.
2.4.1 Post-extraction Processing of RNA
Following extraction of total RNA from cell lines (or from tissue biopsies 
(chapter 6 )) the RNA was processed to remove any contaminating DNA, the 
concentrations quantified, and RNA quality assessed prior to downstream 
experimentation.
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2.4.2 RNA Quantification
Following extraction of RNA from cells or tissues the RNA samples were 
coded accordingly and quantified spectrophotometrically by measuring the 
absorbance at 260nm (A260) using a Beckman DU530 Spectrophotometer 
(Buckinghamshire, UK). The samples were diluted 25X to a total volume of lOOpl 
(4pi RNA plus 96pl distilled water (dfUO)). The average o f three A260 readings was 
taken for each sample and the value multiplied by 25 to give the RNA concentration 
in pg/ml. The 260/280nm ratio was also observed in order to obtain an idea of RNA 
purity and freedom of DNA contamination. dFLO was used as the blank in all cases.
This initial quantification was carried out in order to determine whether or not 
the RNA extraction had been successful. Following this the RNA was subjected to in­
solution DNase digestion (as described in section 2.4.3 that follows) to remove any 
contaminating genomic DNA which would otherwise hinder further analysis, 
including microarray analysis, and in particular Real-Time PCR analysis.
2.4.3 In-solution DNase treatment of RNA samples
In-solution DNase digestion of RNA samples to remove contaminating 
genomic DNA was carried out using the DNA^/fee™ kit from (Ambion Ltd, 
Cambridgeshire, UK) following manufacturer’s protocol. This involved addition of 
0.1 volumes 10X DNase I buffer (15pl to the 150pl RNA samples in 0.5ml microfuge 
tubes) and lpl DNase I enzyme to the RNA. The solution was mixed gently and 
incubated at 37°C for 25min. Following this incubation the enzyme was removed 
from the RNA samples by the addition of 0.1 volumes (16.5pl) DNase inactivation 
reagent, flicking the tubes, and incubating the tubes for 2min at room temperature, 
ensuring that the inactivation reagent was evenly dispersed throughout by intermittent 
agitation. Finally, the tubes were centrifuged at 10,000 x g (13,000rpm) for lmin to 
pellet the inactivation reagent, the RNA solution (supernatant) removed from the 
pellet and transferred to clean tubes for long term storage. The RNA samples were 
sub-divided into lOpI aliquots in 0.2pl sterile microfuge tubes and stored at -80°C 
until required. Samples were allowed to go through two freeze -  thaw cycles prior to 
discarding in order to maintain RNA integrity.
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2.4.4 Post DNase RNA Quantification
RNA concentration was quantified spectrophotometrically as described in 
section 2.4.2. On average ~ 700pg/ml RNA was isolated per treatment. Again the 260/ 
280nm ratio was assessed, and only samples with ratios > 1.8 were considered free 
from DNA contamination and hence used for further analyses.
2.4.5 Reverse-Transcription PCR for assessment of RNA quality
The set up of all reactions described in this section was performed in dedicated 
Class II Lamina Flow PCR cabinet pre-cleaned (together with all equipment going 
into it -  pipettes, filter tip boxes, tube racks, ice box) with 70% ethanol and exposed 
to UV light for 5-10 minutes prior to proceeding with reaction set up to avoid 
contamination. No tip/ PCR tube boxes were opened outside of the fume hood. Only 
autoclave sterilised pipette filter tips, microfuge tubes (Starlab, Milton Keynes, UK), 
and dedicated PCR pipettors were used for setting up PCR reactions. All reagents 
were thawed at room temperature, and enzymes, RNA, and reaction tubes kept on ice 
throughout.
2.4.5.1 cDNA synthesis
RNA was reverse transcribed into cDNA using the RETROscript kit (Ambion 
Ltd, Cambridgeshire, UK) following the 2-step reverse transcription-PCR protocol 
without heat denaturation of the RNA with some modifications.
Each reaction mix consisted of the following components: -
• 1 pi oligo(dT),
• 1 pi random decamers,
• 2ul 1 OX RT buffer,
• 4pl dNTP mix,
• 1 pi MMLV-Reverse Transcriptase (100U),
+ 500ng RNA sample + nuclease-free H2O to a 20pl final reaction volume.
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When several reverse transcription reactions were being performed simultaneously, a 
master mix consisting of multiples of the above reagents (minus the RNA and H2O) 
was prepared in order to ensure that the same component quantities were present in 
each reaction. The master mix was mixed well by pipetting and 9pl of the master mix 
was aliquotted into 0.2pl microfuge tubes. Volumes corresponding to 500ng RNA 
were then added to the reaction tubes, and the volumes made up to 2 0 fil by the 
addition of nuclease-free H2O. Reaction mixes were mixed thoroughly by pipetting 
and brief centrifugation using an MSE Micro Centaur centrifuge to collect reaction 
components to the bottom of the tubes. Tubes were then incubated at 44°C for lhr 
using a PTC-225 Peltier Thermal Cycler (MJ Research, Essex, UK), followed by a 
lOmin incubation at 90°C to inactivate the reverse transcriptase. Generated cDNA 
was then used in PCR reactions using primers for beta - (p-) actin (ACTS) (refer to 
table 3.2 for primer sequences) to assess DNA contamination, or stored at -20°C until 
required.
2.4.5.2 Polymerase Chain Reaction (PCR)
PCR amplification reaction tubes were set up to contain the following 
components: -
• 5pl Thermophilic DNA polymerase 10X buffer (lOmM Tris-HCl pH 9 + 50mM 
KC1 + 0.1% Triton X-100) (Promega, Southampton, UK),
• 4pl dNTP mix (containing 1.25mM of each dNTP, end concentration = 0.1 mM 
each dNTP),
• 3pl 25mM Magnesium Chloride (Promega, Southampton, UK) (final 
concentration = 1.5mM),
• 1 pi Forward primer (15pmol),
• 1 pi Reverse primer (15pmol),
•  0.5pi Taq Polymerase (5U/pl, final -  2.5U) in storage buffer A (50mM Tris-HCl 
at pH 8 , lOOmM NaCl, O.lmM EDTA, ImM DTT, 50% glycerol, 1% Triton X- 
100) (Promega, Southampton, UK),
• 2pl sample (c)DNA (0.1 pl/ml),
•  34pl sterilised dH2 0  (to a total volume of 50pl).
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Master mixes of the above reaction components were made (minus sample 
DNA) as required. The master mix was mixed by pipetting followed by brief 
centrifugation and 48pl aliquotted into labelled 0.2ml microfuge tubes. Finally 2pl of 
sample DNA was added to appropriate tubes and the contents mixed by vortexing and 
brief centrifugation. A negative control was included for each PCR reaction consisting 
of the same reaction components except for replacing the sample DNA with dH2 0 . To 
check for DNA contamination in isolated RNA samples, controls were also included 
for each sample in which 5 pi of RNA was included in the PCR reactions. Separate 
master mix was prepared for these controls in which 31 pi dH2<3 per reaction was 
included instead of 34pl. PCR product seen in these controls was taken as an 
indication o f genomic DNA contamination in RNA samples, and such samples were 
excluded from further analysis.
Reaction tubes were placed in a PTC-225 Peltier Thermal Cycler (MJ 
Research, Essex, UK), and run on the appropriate program designed to suit the 
parameters and length of DNA to be amplified. Generally primers tended to be 
designed to anneal at 60°C, and so a program consisting o f 94°C - 2 min, 94°C -  
30sec (denaturation), 60°C -  20sec (primer annealing), 72°C -  30sec (extension), for 
30 cycles was used. For analysing RNA quality, primers for p-actin (ACTS) were 
utilised, which have an annealing temperature of 60°C.
2.4.53 Gel Based Detection of PCR products
Required Reagents: -
- lOObp ladder (130ng/pl) (Promega, Southampton, UK) in lOmM Tris-HCl (pH 
7.5) + ImM EDTA,
- 10X TBE (0.89M Tris-base pH8,0.89M boric acid, 0.02M EDTA),
- TEMED (Invitrogen, Paisley, UK),
10% Ammonium Persulphate (APS),
- Acrylamide: Bisacrylamide (37.5: 1) stock solution containing 30% (w/v) 
acrylamide (Severn Biotech Ltd, Worcestershire, UK),
- Gel loading buffer (50% (v/v) glycerol + 10% (v/v) 0.1M EDTA + 1% (w/v) 
Bromophenol Blue +1%  (w/v) SDS),
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- 5OX TAE buffer (1.5M Tris-base pH8 , 0.05M EDTA, 5.7% (v/v) glacial acetic
acid).
Polyacrylamide Gel Preparation: -
PCR products were analysed on 6 % polyacrylamide gels prepared as follows. 
A 6 % solution for 4 gels was made up consisting of 32ml dt^O, 4.5ml 10X TBE 
buffer, and 8ml acrylamide: bisacrylamide solution combined in a Buchner flask. The 
solution was vacuum degassed for 5-10min before the addition of 45pi TEMED and 
220pl 10% APS. The mixture was then quickly placed into 4 individual gel casters 
(Protean III gel system, Bio-Rad, Hertfordshire, UK) at approximately 10ml per cast 
using a syringe. Fifteen-toothed combs were then placed into each cast to form the 
sample wells in the gels. The gels were left to set at room temperature for 45min.
Polyacrylamide Gel Electrophoresis: -
Set polyacrylamide gels were placed in vertical electrophoresis tanks (Bio- 
Rad, Hertfordshire, UK). Subsequently 3pi loading buffer was mixed with lOpl of 
PCR product and samples were loaded into the set wells. A 1 OObp molecular marker 
was also included in the electrophoresis run (lpl lOObp ladder (Promega, 
Southampton, UK), 3pl loading buffer, 9pl (IH2O). Vertical electrophoresis was 
performed in IX TBE buffer at a constant supply of 160V from a Bio-Rad Powerpack 
300 power supply (Bio-Rad, Hertfordshire, UK). Electrophoresis was carried out until 
the blue loading dye was seen to reach the bottom of the gel plate (~ 30min).
Silver Staining o f Polyacrylamide Gels: -
DNA bands in the gel were stained with silver nitrate (Sigma-AIdrich, Dorset, 
UK) by soaking the gels in a 0.1% silver nitrate solution for lOmin, washing twice in 
dH2 0 , followed by soaking in 0.375M sodium hydroxide solution plus 0.4% 
formaldehyde until PCR bands appeared.
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Image Capture and Analysis: -
Silver stained gels were illuminated with white light, and the brightness, size, 
and focus manually adjusted in order to give the best image using the Bio-Rad gel 
documentation system Gel Doc 2000 (Bio-Rad, Hertfordshire, UK) in conjunction 
with the Quantity One version 4.0.3 software for image analysis.
2.5 Gene Expression Analysis
Gene expression levels and/ or changes in cells and tissues at the RNA level 
were examined using quantitative real-time (Q-/ RT-) PCR using primers specific to 
the genes of interest.
2.5.1 Real-Time PCR
*
Only RNA with a 260/280nm ratio of 1.8 or more following in solution DNase 
digestion (as described in section 2.4.3) and giving no PCR products in the test for 
genomic DNA contamination using primers for p-actin {ACTB) (section 2.4.5) was 
used in Real-Time PCR analysis.
cDNA was generated from sample RNA using a RETROscript reverse- 
transcription PCR kit (Ambion Ltd, Cambridgeshire, UK) as described in section 
2.4.5.1.
2.5.1.1 Standard Curve Generation
cDNA was generated from various RNA sources seen to express the gene of 
interest e.g. c-FOS. For example, the source of RNA for p-actin {ACTB) and c-FOS 
standard curve generation was a pool o f RNA from colorectal tumours and HGC-27 
cells seen to express c-FOS. A 1 in 10 serial dilution o f the cDNA was made up from 
10° to 10' 3 to allow for standard curve generation. In a real-time (RT) PCR reaction 
2jil o f each cDNA dilution was analysed with both primers for the ACTB 
housekeeping gene, for ACTB standard curve generation used as an internal control 
for normalisation, and primer pairs for the gene under analysis as described below. 
The same standard curve RNA was used for all repeats in a particular experimental
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run. For example, in chapter 3, all plates carried out for analysis of c-FOS expression 
in AGS, HGC-27, and WILLI included standard curves generated from the same 
RNA, so removing a possible source of variation in the final data.
2.5.1.2 The Reaction
RT-PCR reactions were set up in a laminar flow fume hood as for standard 
PCR using sterile nuclease free pipette filter tips and taking the precautions described 
in section 2.4.5.
Each reaction mix consisted of the following:
• 12.5pl iQ SYBR Green Supermix (Bio-Rad, Hertfordshire, UK),
• 1 pi Forward primer (0.2 pM final concentration),
• lpl Reverse primer (0.2pM final concentration),
• 2pl sample cDNA,
• 8.5pl (IH2O (to a total volume of 25pl).
All reaction tubes were cooled on ice prior to set up, and the reactions made 
up on ice as a master mix containing SYBR Green Supermix, (IH2O, and appropriate
primers prior to template addition to ensure that all reactions contained the same
component quantities. Separate master mixes were prepared for each gene studied and 
the mixes vortexed and briefly centrifuged to ensure that they were homogeneous. 
Next, 2pl of appropriate sample cDNA was pipetted into appropriate wells of a sterile 
pre-chilled 96-well 0.2ml PCR plate (Starlab, Milton Keynes, UK) each dilution for 
the standard curves and each test sample occupying 3 wells in the plate as the 
reactions were each performed in triplicate. Subsequently 23 |il o f the appropriate 
master mix was aliquotted into the appropriate wells in the 96-well plate to make up 
the 25pi total reaction volumes. No template runs o f nuclease free dH2 0  were always 
included in each RT-PCR run for each primer pair to check for contamination. On 
completion of loading the reactions into wells, the plate was sealed with Optical 
Quality Sealing Tape (Bio-Rad, Hertfordshire, UK) and briefly centrifuged using an 
Allegra 21R centrifuge to collect all contents to the bottom of the wells. The set-up of 
a typical RT-PCR plate is illustrated in figure 2.1.
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The sample plate was then placed in the iCycler iQ Thermal Cycler (Bio-Rad, 
Hertfordshire, UK) and run on the following program:
1 _  i
3. 60°C -  45sec (repeat x 2)
4. 95°C -  3min
5. 94°C -  30sec
6 . 60°C -  30sec
7. 72°C -  30sec (repeat x 40 cycles)
8 . 55°C -  30sec
9. 95°C -  30sec
10. lOsec at each 1°C increase in temperature from 55°C to 95°C for melt curve 
generation.
Steps 1 -  3 of the protocol permitted well factor analysis, since well factors 
must be collected at the beginning of each experiment in order to compensate for any 
system or pipetting variations and hence optimise the quality and analysis of 
fluorescent data (from fluorescein in the SYBR Green Supermix). Well factors/ 
optical data collected at step 3 allowed normalisation of the fluorescent signals in 
each well for post-run analysis. Steps 4 - 7  constituted the PCR reaction, the 
fluorescent data for the amplification reaction was collected and analysed in real time 
at step 3. Steps 8 - 1 0  permitted melt-curve analysis, the fluorescent data collected 
and analysed in real-time at step 7 in this case.
Unless otherwise stated, all real time PCR reactions were repeated via intra- 
plate triplicates (as described) to account for pipetting errors, and via inter-plate 
triplicates using different batches of cDNA prepared on three different days to 
account for other possible sources of variation, such as the reverse transcription 
reaction, differences in machine efficiency, etc.
(repeat x 3)
2. 60°C -  30sec
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Figure 2.1 A typical Real-Time PCR plate and reaction set up for analysing Gene Of Interest (GOI).
48 p-actin reactions, therefore 
make up a 48 X master mix with 
P-actin primers
1
Add 2(4.1 appropriate cDNA 
sample (or 2pl dH20  for negative 
controls) into appropriate 
wells1
Aliquot 23(41 of P-actin master 
mix into each P-actin well.1
Repeat for GOI.
2.5.1.3 Post-Run Data Analysis
Data analysis was performed individually for each sample using the iCycler iQ 
software version 2.3B. The specificity o f the PCR reaction products generated was 
first addressed by analysis of the melt curves generated for the samples. Specific PCR 
should yield a single peak of a specific Tm (melting temperature) for each gene under 
analysis across all samples. The presence o f more than one peak indicates the 
presence o f non-specific PCR products and/ or primer-dimers in the sample reaction, 
hence samples without the correct Tm peak were omitted from subsequent analysis.
The relative amounts o f initial cDNA template between controls and samples 
were calculated based on the concept o f threshold cycles (Ct). The Ct is defined as 
the number o f PCR cycles after which a fluorescence signal becomes clearly 
detectable above the background or baseline fluorescence signal seen in the 
amplification plots. The baseline was defined as the range o f cycles during which no 
target amplification above the background signal was detectable. The range was set 
from the second cycle to the point two cycles earlier than the Ct value o f the most
1 2 3
aOOO
BOOO
COOO
DQQQ
E o o o
7 8 9
3 0 0
10 11 12 
O
F # # 0
Gf
f  J  (l-actin standard curve 10" T T )  P-actin test samples 
( A ) - 1 0 ‘3 (D).
(iO l standard curve 
^  10° (E) -  10'3 (H).
GOI test samples
-ve controls 
-  p-actin 
(red); GOI 
(yellow )
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abundant sample -  usually the reaction with ACTB primers and neat cDNA (10°). A 
fixed fluorescence threshold level at a statistically significant point above the baseline 
was then set by the software 10 standard deviations from the baseline. Based on this 
set threshold, C t values were calculated for each reaction. The C t values for 
triplicates were examined and any outliers (values falling greater than 0 .2  out from the 
mean of the triplicates), possibly resultant from experimental error, such as pipetting 
variation, removed from the analysis (leaving at least duplicate readings) as they may 
skew results. A standard curve could then be generated from the ACTB and gene of 
interest (GOI) dilution series data. These curves are invaluable for determining both 
the quality of the cDNA samples (from the ACTB standard curve) and the 
experimental success reflected in the PCR efficiency.
The PCR efficiency was determined by the following relationship:-
E = [l0('"a)] -  1 
Where a — slope of the standard curve.
Real-time PCR data and results were only considered to be reliable, and so included 
in the final analyses, if the PCR efficiency lay within the range of 0.9 -  1.1 (i.e. 
between 90-110% ).
2.6 Protein Extraction from Cultured Cells
Total cellular protein was extracted from cultured cells (AGS, HGC-27, 
WILLI) using a cell scraping and lysis methodology. Following chemical treatments 
or co-culture experiments, medium containing chemical/ cells was carefully removed 
(following the safety procedures outlined in section 2 .2 ) and the attached cell 
monolayer washed 2 X with pre-warmed (37°C) PBS. After the 2nd PBS wash, all 
traces of PBS were removed by carefully aspirating any traces of solution from the 
flasks since residual salts from PBS may interfere with downstream protein 
extraction. Subsequently, 250pl modified RIPA buffer (50mM Tris-HCl pH7.4, ImM 
EDTA, 1% (v/v) IGEPAL, 0.25% (w/v) Sodium Deoxycholate) with protease and 
phosphatase inhibitors added (protease inhibitors: ImM AEBSF, 1 fig/ml leupeptin; 
phosphatase inhibitors: ImM Sodium Orthovanadate, ImM Sodium Fluoride) was 
added to cell culture flasks and cells scraped into the buffer using sterile cell scrapers
69
(Fisher, Leicestershire, UK) resulting in lysis o f cells. The lysate from each flask was 
next aspirated and placed in correspondingly labelled 1.5ml microfuge tubes, and 1 
volume 2X western blot loading buffer (Lamelli buffer) (250mM Tris pH6 .8 , 10% 
(v/v) glycerol, 4% (w/v) SDS, 2% (v/v) p-mercaptoethanol, 0.006% (w/v) 
bromophenol blue) added to each sample and the samples mixed gently by pipetting 
up and down. Samples were subsequently boiled at 100°C for 5min in a heating block, 
prior to cooling on ice.
2.6.1 Protein Quantification
Protein concentration in extracted samples was determined using the 2-D 
Quant Kit (GE Lifesciences, Bucks, UK) as outlined in the manufacturer’s protocol 
and all solutions used were provided in the kit unless otherwise stated. A standard 
curve was first prepared using a 2mg/ml bovine serum albumin (BSA) standard 
solution by setting up a dilution series (in dF^O) in 2 ml microfuge tubes consisting of 
0, 10, 20, 30, 40, and 50pg protein, with the Opg tube serving as the assay blank (i.e. 
dtUO). Next 2ml microfuge tubes were set up to contain 15 pi sample for 
quantification. Both the standard curve tubes and the sample tubes were set up in 
duplicate so that average readings could be obtained. Subsequently, 500pi precipitant 
solution was added to each tube, followed by vortexing and incubating at room 
temperature for 3min. An equal volume (500pl) of co-precipitant solution was next 
added to the tubes followed by brief mixing by inversion o f tubes. The tubes were 
subsequently centrifuged at 10,000 x g (13,000rpm) for 5min to sediment the protein 
precipitates. Supernatants were then decanted from the tubes taking care not to disrupt 
the visible white pellets. To ensure complete removal o f supernatant (which would 
otherwise interfere with accurate quantification) the tubes were quickly centrifuged 
again for a brief pulse to collect any remaining supernatant to the bottom of the tubes, 
after which any solution was carefully aspirated. Next lOOpl copper solution and 
400pl dH2 0  were added to the tubes followed by vortexing to completely resuspend 
the pellets, after which 1ml working colour solution (100 parts colour solution A: 1 
part colour solution B) was quickly added to the samples, the tubes mixed by 
inversion, and incubated at room temperature for 20min. The absorbance of each 
sample was then read using a spectrophotometer at 480nm (A480) using dt^O  as the 
blank/ reference. Average readings were calculated for each tube and a standard curve
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generated from which the concentration of each protein sample was determined. 
Subsequently the samples were aliquotted into 20pl aliquots and stored at -80°C until 
use. As for RNA, protein samples were used for up to two freeze-thaw cycles and 
subsequently discarded.
2.7 Protein Expression Analysis
Protein expression levels in samples were assessed by western blotting using 
antibodies to specific proteins of interest. The particular proteins studied were 
selected based on the results from RNA level gene expression data obtained from 
microarray studies (chapter 3).
2.7.1 Sodium Dodecyl Sulphate (SDS) Polyacrylamide Gel Preparation
Prior to western blotting, protein samples were separated by SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE). Sample volumes constituting 5pg 
protein were loaded into the wells of polyacrylamide gels consisting of an upper 
stacking layer and a lower resolving layer. When preparing the gels the lower 
resolving layer was prepared first, consisting of (for 2  gels): -
• 6 .6ml acrylamide: bisacrylamide solution (Severn Biotech Ltd, 
Worcestershire, UK),
• 2.5ml 3MTrispH8.9,
• 10.5ml dH20 ,
• 200pl 10% SDS,
•  60pl TEMED (Severn Biotech Ltd, Worcestershire, UK),
• 150pl 10% APS.
The mixture was then quickly placed into individual gel casters (Protean III gel 
system, Bio-Rad, Hertfordshire, UK) at approximately 10ml per cast using a syringe, 
leaving at least 1.5 inch at the top of die caster for the upper stacking gel. The 
resolving gel was allowed to set for 45min prior to the addition of the stacking layer 
which consisted of (for 2  gels): -
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• 2.6ml acrylamide: bisacrylamide solution (Severn Biotech Ltd,
Worcestershire, UK),
• 5ml 0.5M Tris pH6 .8 ,
•  12ml dLUO,
• 200|il 10% SDS,
• 60pl TEMED (Severn Biotech Ltd, Worcestershire, UK),
•  150pl APS.
The mixture was loaded on top of the pre-set resolving gel(s) using a syringe filling to 
the top of the caster. Fifteen-toothed combs were then placed into each cast to form 
the sample wells and the gels were left to completely set at room temperature for 
45min. Up to four gels were produced at one time and any gels that were not 
immediately required were placed in an air tight container and stored at 4°C for up to 
three days.
2.7.2 SDS - Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Set polyacrylamide gels were placed in vertical electrophoresis tanks (Bio- 
Rad, Hertfordshire, UK) and samples were loaded into the set wells at volumes 
corresponding to 5pg protein for each sample. A molecular marker was also included 
in the electrophoresis run (Precision Plus Protein Dual Colour Standards (Bio-Rad, 
Hertfordshire, UK) loaded at lOpl in the first well in the gel. Vertical electrophoresis 
was performed in SDS running buffer (25M Tris Base pH8.3, 192mM Glycine, 0.1% 
(w/v) SDS) at a constant supply o f 120V from a Bio-Rad Powerpack 300 power 
supply (Bio-Rad, Hertfordshire, UK). Electrophoresis was carried out until the dual 
colour molecular markers were seen to be clearly separated (1.5 -  2hr).
2.7.3 Western Blotting
Transfer o f Proteins from SDS-polyacrylamide gel to Nitrocellulose Membrane
Following the separation of proteins by SDS-PAGE the proteins were 
transferred to nitrocellulose membranes (Bio-Rad, Hertfordshire, UK). This involved
72
an initial equilibration step whereby the gel(s), membranes, and any filter cards and 
fibre pads to be used in the transfer were incubated in ice-cold transfer buffer (50mM 
Tris Base pH8.1, 380mM Glycine, 0.1% (w/v) SDS, 20% (v/v) methanol) at 4°C for 
20min. Following equilibration, transfer cassette(s), in which the gel was placed 
adjacent to a nitrocellulose membrane, were set up as depicted in figure 2.2. The 
cassettes were set up under transfer buffer to avoid the formation o f bubbles which 
would interfere with the transfer process. Any bubbles that formed were carefully 
removed by applying a gentle even pressure, and horizontal electrophoresis was 
performed in transfer buffer whereby a constant supply of 400mA was applied for lhr 
from the gel side of the cassette to the membrane side from a Bio-Rad Powerpack 300 
power supply (Bio-Rad, Hertfordshire, UK) so ensuring proteins were transferred 
from gel to membrane. A transfer buffer ice-pack was placed in the buffer tank during 
electrophoresis to avoid overheating and loss o f proteins. Upon completion of 
electrophoresis the successful transfer of proteins to membrane(s) could easily be 
determined as the dual protein colour markers could easily be seen.
Figure 2.2 Western blot transfer cassette set-up.
Cassette
Fibre pad 
Filter paper
Membrane 
Gel
Filter paper 
Fibre pad 
Cassette
Western Blotting
Following successful transfer of proteins, the membrane was rinsed 2 X in 
TBS/Tween (20mM Tris HC1 pH8.9, 150mM NaCl, 0.5% (v/v) Tween) to remove all 
traces o f transfer buffer. Next the membrane was incubated (protein side up
73
throughout) in 15ml blocking buffer (10% (w/v) skim milk in TBS/ Tween) in glass 
coplin jars for lhr with gentle agitation at room temperature. After the blocking step, 
blocking buffer was removed and the membrane briefly rinsed in TBS/ Tween 
followed by the addition of 10ml western blot hybridisation buffer (3% BSA in TBS/ 
Tween) plus the appropriate dilution (1:1000) of specific primary antibody in order to 
perform primary antibody hybridisation overnight with gentle agitation at 4°C. The 
particular primary antibodies can be found in chapter specific materials and methods 
sections. In all cases the primary antibodies used were polyclonal antibodies raised in 
rabbit. Following the overnight primary antibody hybridisation step, hybridisation 
buffer was removed and the membrane washed via 4 X 5min washes in TBS/ Tween 
with gentle agitation at room temperature. Hybridisation with secondary antibody 
(goat anti-rabbit IgG -  HRP conjugate (Abeam, Cambridge, UK)) at a dilution of 
1:3000 in hybridisation buffer (3% BSA in TBS/ Tween) was then performed for lhr 
with gentle agitation at room temperature. Upon completion of secondaiy antibody 
hybridisation, hybridisation buffer was removed and the membrane washed in TBS/ 
Tween 4 X 5min. Antibody binding was then visualised using the ECL kit (GE 
Lifesciences, Bucks, UK) following the manufacturer’s protocol. Briefly, equal 
volumes of ECL detection solution 1 and 2 (provided in the kit) were mixed and 1ml 
applied to the protein side of the membrane ensuring that the entire surface of the 
membrane was covered. The membrane was left to incubate for lmin after which 
excess detection solution was allowed to drain from the membrane. The blot(s) was 
then placed protein side up on a fresh piece of clear acetate sheet, and a second sheet 
carefully placed on top taking care to remove all air bubbles. Horse Radish Peroxidase 
(HRP) conjugated to the secondaiy antibody catalyses the conversion of substrates in 
the ECL solution giving rise to chemiluminescence which can be detected using X-ray 
film. As such, the blot was placed in an X-ray film exposure cassette and, in a 
specialised dark room, a piece o f hyperfilm ECL (GE Lifesciences, Bucks, UK) 
placed on top of the blot so allowing chemiluminescence exposure to the film. The 
initial exposure time was 5min, after which the film was developed using an AGFA 
Curix 60 X-ray film developer machine (Agfa UK, Middlesex, UK). If  the bands were 
not clear enough or too intense following the initial 5min exposure, the exposure time 
was adjusted accordingly until the bands could be seen clearly enough with minimal 
background so permitting optimal downstream image analysis.
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Typically in a western blot experiment two blots were performed on the same 
protein samples, one for the protein of interest and one for a loading control -  
typically P-actin {ACTB) to ensure that any observed differences were true and not 
due to loading differences between wells. If a phosphorylated protein (such as 
pERKl/2 (p42/p44)) was analysed, its un-phosphorylated counterpart (ERK1/2 
(p42/p44)) served as the loading control. All Western blot experiments were 
performed in duplicate on different days to ensure reproducibility
Stripping Membranes for Re-use
Membranes could be stripped from bound antibody and re-hybridised up to 2 
times. For complete removal of bound antibodies blots were washed in dFfeO for 
5min, followed by a 5min wash in 0.2M NaOH, and a second 5min wash step in 
dfhO all at room temperature with gentle agitation. The success of the stripping 
protocol was confirmed by carrying out ECL chemiluminscence visualisation (as 
previously described) to check for chemiluminescence from residual antibody 
binding. In the case of incomplete antibody removal the washes were repeated a 
second time, otherwise the membranes were stored in 5ml TBS/ Tween at 4°C until 
use (up to 2 weeks), or experimentation could proceed directly on to the western 
blotting blocking stage preparing the membrane for primary antibody binding, etc.
Image Analysis o f Western Blots
Western blot films were scanned into JPEG format images which were 
subsequently analysed using the ImageJ software downloaded from the national 
institute of health (NIH) website (http://rsb.info.nih.gov/ii/). Images were opened 
using the software which permits selection o f bands for analysis, generating pixel 
intensity data for each area selected. In an analysis it was ensured that the same area 
(cm2) was analysed for each band so that when the pixel intensity was compared 
between bands any sources of variation other than true differences in intensity could 
be ruled out. As such, a small rectangle in centre of each band was analysed. Data was 
obtained for a particular protein of interest and its loading control and the intensity 
data for the protein of interest normalised against the loading control to rule out any 
variation introduced by loading differences between wells. Since all western blot
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experiments were performed in duplicate, both images were analysed for a particular 
experiment, with the final results being the averages of the duplicate readings.
2.8 Data Analysis
All data analysis was performed using Microsoft Excel (Windows XP version) 
unless otherwise stated. Statistical analysis was carried out using the SPSS Version 
13.0 software package.
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Chapter 3
Reactive Oxygen Species (ROS)-induced Changes in Cellular Signal 
Transduction and Gene Expression: MAPK and N F kB .
3.1 Introduction
The origins, historical perspectives, and effects o f  free radicals or reactive 
oxygen/ nitrogen species (RO/NS) were discussed in detail in section 1.6. Molecular 
Oxygen is the primary biological electron acceptor, and its presence in the atmosphere 
drove the evolution o f aerobic life forms, capable o f harvesting vast amounts o f  energy 
through cellular respiration via oxidative phosphorylation (Storz, 2006; Balaban et al, 
2005). Aerobic life yields most o f  its energy through this process, which in eukaryotes 
takes place in the mitochondria. Unfortunately, this tremendous benefit o f  oxygen came 
at a price due to the inherent toxicity o f the element. Coupled with oxygen metabolism 
comes the inadvertent formation o f reactive oxygen species (ROS) such as superoxide 
(Or ', due to leakage o f electrons from the electron transport chain), hydrogen peroxide 
(H2O2, generated from (V )*  and hydroxyl radical (-OH, derived from H2O2 especially in 
the presence o f  transition metals such as iron (Storz, 2006; Balaban et a l, 2005; Curtin et 
al, 2002)) which can pose serious, often lethal threats at the cellular level. As such, very 
early on in evolution, organisms were either made extinct by the presence o f  oxygen in 
the atmosphere, or evolved defence mechanisms to cope with its cytotoxicity associated 
with the generation o f free radicals, which came in the form o f both enzymatic and non- 
enzymatic anti-oxidant systems.
The generation o f RO/NS in cells is an unavoidable by-product o f  cellular 
metabolism. Their levels in the cell are normally very finely controlled by the anti­
oxidant systems, which serve to remove the reactive species at a rate that equals their 
generation in the cell. Unfortunately, this fine balance can be disrupted, leading to 
‘oxidative stress’. As detailed in section 1.6, this oxidative stress has been implicated in
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several pathological conditions, such as chronic inflammation, rheumatoid arthritis, 
atherosclerosis, and cancer (Fukuruma et a l, 2006; Ristow, 2006; Waris and Ahsan, 
2006; Klaunig and Kamendulis, 2004; Oshima et al, 2003; Klaunig et a l, 1998; Poulsen 
et a l, 1998; Wink et a l, 1998; Knight, 1995; Toyokuni et al, 1995; Feig et a l, 1994; 
Guyton and Kensler, 1993; Trush and Kensler, 1991; Breimer, 1990; Vuillaume, 1987; 
Ames, 1983).
With the exception o f pathological states, under normal circumstances, not only 
have aerobic organisms evolved mechanisms for keeping RO/NS levels in check, they 
were also capable o f evolving ways o f exploiting the reactive derivatives for intracellular 
signal transduction and control of gene expression (Ahmad et a l, 2006; Gloire et al, 
2006; Storz, 2006; Hayden and Ghosh, 2004; Droge, 2001; Karin et a l, 2001; Sen and 
Packer, 1996; Storz and Polla, 1996; Schenk, 1994; Whiteside and Goodboum, 1993; 
Kerr etal., 1992).
3.1.1 Effect of RO/NS on Cell Signalling
Signal transduction refers to the mechanisms by which cells sense and relay 
information in their environment to the inner core o f the cell at the nucleus, where these 
signals can then elicit a cellular response at the levels o f cellular physiology, growth, and 
development via alterations in gene expression. The signals typically (but not always) act 
at the cells surface through cell surface receptors, and classically include growth factors, 
hormones, cytokines, and other stimuli such as oxidative stress. On a very basic level, the 
signals/ environmental stimuli activate the cell surface receptors (for example via ligand 
binding), which go on to transmit a signal cascade through the cytoplasm (usually by a 
series o f phosphorylation reactions) transmitting the information through signalling 
molecules (often kinases) and eventually to the nucleus, where changes in gene 
expression can occur, with concomitant changes in cellular behaviour. The general 
picture o f signal transduction emerging from recent studies involves the sensing o f a 
signal and its subsequent transduction to the transcription apparatus thereby affecting 
transcription initiation.
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A number o f key signalling pathways have been identified over the years, 
providing a wealth o f knowledge into how cells respond to their microenvironment. To 
add further complexity, it has been seen that the signalling pathways are highly intricate 
and often overlapping and interrelated, demonstrating high specificity; in terms o f which 
signals they respond to and which subsets o f genes they activate; whilst at the same time 
having a certain level o f  diversity in the signals that can lead to their activation.
Cellular redox status has been seen to be an important factor in eliciting signal 
transduction activation and the subsequent changes in gene expression. In fact, research 
over the past decade has seen such an emphasis on oxidant, antioxidant, and redox state 
regulation o f  gene expression that it is now considered a sub-discipline in molecular 
biology (Sen and Packer, 1996). The fact that RO/NS are at the basis o f  many 
pathological conditions means that this link between RO/NS and gene expression 
(especially disease related/ specific gene expression) offers exciting therapeutic potential.
Gene expression changes are usually the major effect causing result o f signal 
transduction, and several critical steps in a signal transduction cascade can be sensitive to 
redox status (governed by oxidant and antioxidant levels). In fact, the cellular redox state 
can affect very specific steps in a signalling pathway, as well as more general events such 
as protein phosphorylation and transcription factor binding to DNA (Sen and Packer,
1996). It is important to note that, while the focus on redox regulated signal transduction 
and gene expression is often in situations o f cellular stress and pathogenic conditions, it is 
equally important in unperturbed and normal cells, functioning as a key control 
mechanism in cellular biochemistry. Indeed, direct exposure o f  cells to RO/NS activates a 
range o f signalling pathways, but they are also seen to function as ‘second messengers’ in 
normal signalling independent o f RO/NS exposure. The degree to which they act as 
classical second messengers however, is questionable. In some instances ligand binding 
(e.g. TNF-a) can result in an increase in intracellular ROS (Garcia-Ruiz et a l, 1997; Lo 
and Cruz, 1995) which then relay the signal to the nucleus by regulating redox sensitive 
signal transduction pathways (discussed in section 3.1.2 -  3.1.3). In this case the ROS 
may be viewed as classical second messengers o f the primary signal. However, in other 
circumstances, for instance, when the primary signal from ligand binding cannot produce
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enough phosphorylation to allow a full response, RO/NS may act to enhance 
phosphorylation (e.g. by transient inactivation o f phosphatases), and can so be viewed as 
‘secondary messengers’ to the primary signal (Nathan, 2003).
RO/NS from both extracellular and intracellular sources can affect gene 
expression. Extracellular RO/NS can instigate cellular signal transduction through 
generation o f  lipid peroxides within cell membranes (Suzuki et a l, 1997) or by activation 
of growth factor and cytokine receptors independent o f receptor ligands (Huang et a l, 
1996; Rao, 1996; Rosette and Karin, 1996; Nakashima et al, 1994), for example, by 
triggering receptor autophosphorylation. Intracellular RO/NS generation has been seen to 
be induced by a variety o f stimuli. For example, TNF-a provokes a rise in H2O2 
production and release from mitochondria, as well as other ROS, by way o f  NADPH 
oxidase induction (Garcia-Ruiz et al, 1997; Lo and Cruz, 1995). Transient increases in 
intracellular levels o f H2O2 and other ROS have also been seen to occur through 
interaction o f  platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) 
with their receptors (DeYulia et al, 2005; Jackson et a l, 2002). Nitrosative stress is also 
important since it can directly act on pathways regulating redox sensitive transcription 
factors like NFkB and AP-1, leading to either changes in their expression levels, activity, 
stability, or their accessibility to their promoter sites in DNA, hence impacting 
downstream gene expression (Kronke et a l , 2003). Interplay between ROS and RNS can 
also be fundamental in determining the extent o f  gene expression changes, since NO* has 
in some instances been shown to directly inhibit cytokine mediated gene induction at the 
level o f transcription (Peng et a l, 1995), as well as indirectly by scavenging 02*’ in the 
process o f  peroxynitrite formation, hence modulating O2 - dependent transcription.
Presently well over 100 mammalian genes have been recognized to be regulated 
by cellular redox state (Allen and Tresini, 2000; Adler et a l, 1999; Morel and Barouki,
1999), generally at the level o f transcription, although alterations in mRNA stability 
(Chen et a l, 1998; De Kimpe et a l, 1998; Esposito et a l, 1997) and protein stability 
(Adler et al, 1999; Iwai et al, 1998; Shen et al, 1995) have been reported.
The activity o f many transcription factors can be modulated as a consequence o f 
alterations in cellular redox and nitrosative conditions (Allen and Tresini, 2000; Belsham
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and Mellon, 2000; Berendji et a l, 1999). This can occur either directly at the level o f  the 
redox sensitive transcription factors via oxidation/ reduction reactions, or indirectly at the 
level o f  various upstream signalling cascades. The pathways involved remain to be fully 
deciphered, owing to the fact that several o f  the pathways overlap and a host o f  stimuli 
can act within each pathway, at different levels. This goes back to the fine balance 
between signal transduction diversity and specificity which affords cells the ability to 
respond and adapt by different mechanisms, often in a  tissue-/ cell-specific manner, to 
environmental changes. Whilst being highly beneficial to cells, this makes understanding 
the finer details o f redox regulated signal transduction and gene expression very complex, 
although some general consensus findings are beginning to emerge. For example; the 
involvement o f thiol groups in the regulation o f gene expression; the existence o f redox 
sensitive components o f signal transduction pathways (e.g. protein kinases, protein 
phosphatases, phospholipases); the presence o f an antioxidant (/electrophile) response 
element (ARE/ EpRE) in the promoter region o f  redox sensitive genes; the ability o f 
oxidants to stimulate an increase in intracellular level o f  calcium ions, thereby affecting 
signal transduction, and can lead to the generation o f more RO/NS; and the existence o f 
transcription factors that exhibit redox sensitivity (Jackson et al, 2002).
Considering that the scope o f the work presented in this chapter focuses on the 
effects o f  RO/NS on signal transduction and gene expression, I will go on to discuss 
redox sensitive signal transduction pathways and transcription factors. Two o f the best 
studied signalling pathways are the Mitogen Activated Protein Kinase (MAPK) pathways 
and the Nuclear Factor Kappa B (NFkB) pathways.
3.1.2 Mitogen Activated Protein Kinase (MAPK) pathway
The Mitogen Activated Protein Kinase (MAPK) pathway is a fundamental 
cellular signal transduction pathway consisting o f  a cascade o f  MAPK enzymes. These 
enzymes are one o f the most extensively studied families o f protein kinases (Kolch,
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2000) that use ATP as a phosphate donor to phosphorylate downstream protein targets on
either serine or threonine residues (Halliwell and Gutteridge, 2007).
As detailed in section 1.8.1 there are a number o f  major MAPK subfamilies -  
including ERK1/2 (p42/p44) [from here-on-in ERK1/2 (P42/P44) will be referred to as 
ERK], JNK, and p38. In all cases MAPK signalling is characterised by upstream signals 
feeding into a three-tiered cascade o f  core protein kinases. In the ERK pathway, for 
example, the upstream signal is co-ordinated by Ras (a G-protein), which then regulates 
the activity o f  a MAP kinase kinase kinase (termed MAPKKK, MAP3K or MEKK) 
which in turn activates a MAP kinase kinase (MAPKK, MAP2K, MKK, or MEK), which 
subsequently activates a MAP kinase (MAPK, for example, ERK1/2) via phosphorylation 
at each step. This phosphorylation cascade results in signal amplification and the 
potential for multiple levels o f control. Through this phosphorylation cascade, MAPKs 
relay messages from cell surface receptors to the nucleus, hence mediating cellular 
responses to external signals such as stress, nutrient status, inductive signals and growth 
factors.
As their name suggests, the MAPKs arbitrate cellular responses to mitogens -  
stimulants o f proliferation (mitosis). The pathways also orchestrate responses related to 
stress, differentiation, and gene expression. In this way, these pathways affect many 
aspects o f  cellular regulation, and impact almost all cellular processes, ranging from gene 
expression to cell death (Chang and Karin, 2001). As such MAPKs are viewed as master 
controllers.
The three major subfamilies o f MAPKs (ERK, JNK, p38) are all activated by 
overlapping signalling cascades in which sequential phosphorylation is key. Multiple 
layers o f complexity exist as inherent features o f the pathways, lending ability to respond 
to  a wide array o f  signals, whilst maintaining high levels o f  specificity and control. This 
is vital, since MAPK cascades can instigate a variety o f  cellular responses which may 
have detrimental consequences unless tightly controlled. Each pathway seems to be 
involved in particular cellular responses, the ERK pathway being fundamental for cell 
proliferation responses to growth factors, whilst the JNK and p38 pathways have more 
prominent roles in response to cellular stresses such as radiation, heat shock, oxidative
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stress, cytokines (part of inflammatory response), etc. (Halliwell and Gutteridge, 2007).
Accumulating data in the literature is providing evidence that all three major 
MAPK subfamilies can be activated by RO/NS. For example, Lee and Esselman (2002) 
showed that phosphorylation o f ERK, JNK, and p38 could be increased in Jurkat T cells 
(a lymphocyte cell line) by the addition o f H2O2. Peroxynitrite (ONOO ) has also been 
shown, in several different cell types, to cause activation o f  all three MAPK subfamilies 
(Klotz et al, 2002). Several excellent reviews on oxidative stress related activation o f 
MAPK pathways have been published (Genestra, 2007; McCubrey et a l, 2006; Jackson 
et a l, 2002, Sen and Packer, 1996). Interestingly, the outcome o f MAPK activation can 
depend on cell type, and the amount o f RO/NS added, for example, low levels o f  H2O2 
added to alveolar type II cells stimulated proliferation via ERK activation (Sigaud et al, 
2005). In another study, H2O2 treatment o f endothelial cells was shown to have a 
cytoprotective effect, preventing membrane blebbing through activation o f ERK (Houle 
et a l , 2003). Generally speaking, the accumulating evidence suggests that ERK 
activation promotes cell growth and survival. However, ERK activation, whilst essential 
to neuronal cell development and plasticity, has been shown to have detrimental effects 
during oxidative neuronal injury (Chu et al, 2004; Harper and Wilkie, 2003). Still, 
despite these observations, a  very general, and perhaps oversimplified, picture is that 
ERK activation tends to promote cell survival, whereas prolonged JNK activation 
promotes cell death (e.g. via apoptosis). Since both pathways are usually simultaneously 
activated, finely controlled balance between the two is critical in determining cell fate, 
and redox mediated cross-talk between the two pathways may be important (Halliwell 
and Gutteridge, 2007).
In recent years it has become apparent that components o f each o f the MAPKs 
contain redox sensitive sites that provide the potential for redox modulation o f  the 
signalling. ROS have been observed to activate MAPKs via a  Ras-dependent mechanism 
(Aikawa et a l, 1997; Rao, 1996). Indeed oxidative stress has been shown to activate Ras 
(Lander et al, 1995), and accumulating evidence has shown NO* to react with cysteine 
118, on the surface o f Ras, activating the G protein (Lander et a l, 1997; Lander et al,
1995). Activated Ras can stimulate the small G protein Rac that subsequently activates
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membrane bound NADPH oxidase, leading to the concomitant generation o f ROS. 
RO/NS may also act at the level o f dephosphorylation. For example, oxidative stress has 
been seen to be a potent inducer o f expression o f the protein phosphatase CL 100 (Keyse 
and Emslie, 1992). This enzyme can dephosphorylate ERK, leading to its inactivation, 
representing a possible negative feedback loop for ROS induced ERK activation. Thus, it 
seems that redox regulation may modulate MAPK phosphorylation cascades at multiple 
levels (summarised in fig. 3.1), ultimately having profound effects on the cellular gene 
expression profile.
The link between signal transduction and regulation o f gene expression has been 
very well documented (Karin, 1994; Karin and Smeal, 1992; Bohmann, 1990) and only in 
the past decade have the mechanisms by which signalling impacts gene regulation 
become apparent. In brief, extracellular signals regulate gene expression via activation o f 
signal transduction cascades which convey the signal from the cell surface to the nucleus, 
where the activity o f transcription factors is modulated. Most commonly this is achieved 
by changes in the phosphorylation state o f the nuclear proteins (Karin, 1994; Karin and 
Smeal, 1992). So signal transduction pathways and transcription factors (as a  major 
target) are intimately linked in the control o f  gene expression. This is exemplified by the 
ERK MAPK pathway, and its major downstream transcription factor target activator 
protein-1 (AP-1).
3.1.2.1 MAPK and AP-1
The involvement o f  MAPKs in the regulation o f  gene expression (in response to 
extracellular stimuli) has been highlighted in the past decade (Treisman, 1996; Su and 
Karin, 1996). A key finding was that members o f the oncogenic AP-1 transcription factor 
family, which have been implicated in inflammation related changes in gene expression, 
are dependent upon MAPK signalling pathways for their activity (Karin, 1995). 
Regulation o f  the classical c-FOS/ c-JUN heterodimeric AP-1 protein is achieved either
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Figure 3.1 Redox regulation o f Mitogen Activated Protein Kinase (MAPK) cascades. Summary of the 
points at which cellular redox status (or in extreme conditions, oxidative stress) can modulate Extracellular 
signal Regulated Kinase 1/2 (ERKI/2 = p42/p44) signal transduction. Details connected by blue arrows 
show the normal sequence o f events following triggering o f the pathway, starting at the cell surface 
receptor, flowing through core kinase signalling (Raf -  MEK1/2 -  ERKI/2), and ending with gene 
expression. Black arrows highlight the points at which oxidants can impact the signalling, either positively 
(+), negatively (-), or as yet unclear (?). Refer to text for further details. (P = phosphorylated site; CLOO = 
phosphatase; Trxl = thioredoxin; Elk-1 = a redox sensitive transcription factor).
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the level o f induced gene expression o f components (c-FOS and c-JUN), or 
phosphorylation o f nuclear c-FOS and c-JUN proteins (Xanthoudakis and Curran, 1996). 
This relies on upstream signalling pathways -  notably the ERKI/2 (p42/p44) MAPK 
pathway (in the case o f  c-FOS), and the JNK MAPK pathway (in the case o f c-JUN) 
(Jackson et a l , 2002; Karin, 1995; Deng and Karin, 1994).
In many cell types, c-FOS and c-JUN expression can be induced by a variety of 
stimuli including mitogenic signals and changes in cellular redox state (Angel and Karin, 
1991; Abate et al, 1990). The expression o f c-FOS is induced through the ERKI/2 
MAPK pathway via RAS (Deng and Karin, 1994), activated by diverse stimuli including 
RO/NS. Active RAS leads to activation o f the ERKI/2 MAPK pathway, which 
culminates in the phosphorylation o f the Elk-l/TCF transcription factor (Gille et al, 
1992) which subsequently drives the transcription o f c-FOS (fig. 3.1). In this way, the 
ERK MAPK pathway can lead to increased AP-1 activity through increased levels o f c- 
FOS, which combines with pre-existing c-JUN proteins forming a stable AP-1 complex 
(Smeai et al, 1989). c-JUN  is also controlled by an inducible promoter, but most cell 
types contain some c-JUN protein even in the absence o f  stimulation. Activation o f  the 
INK MAPK pathway leads to phosphorylation o f c-Jun protein, which may also drive 
increased c-JUN expression (Ddrijard et a l, 1994). Signal transduction driven 
phosphorylation o f c-FOS may also be important in the regulation o f  AP-1 activity, 
potentiating transcriptional activity (Sutherland et a l, 1992). This appears to be mediated 
by a distinct 88-kDa MAPK termed FRK (Deng and Karin, 1994). Like ERK and JNK 
proteins, FRK is an H-RAS activated proline-directed kinase, and it is believed that c- 
FOS transcriptional activity can be stimulated by FRK directed phosphorylation.
RO/NS can thus impact gene expression at the level o f signal transduction 
pathways upstream o f  transcription factor targets, indirectly leading to changes in 
transcription factor activity, exemplified by the RAS-RAF-ERK1/2 pathway and AP-1. In 
other cases, RO/NS can directly modify transcription factor activity by mediating 
increased/ decreased turnover, expression, or nuclear translocation o f transcription 
factors. This has been seen to occur in the case o f  AP-1 and NFkB (section 3.1.3). Rao et 
a l  (1995) demonstrated that hydroperoxy fatty acids and H2O2 can lead to increased
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c-FOS and c-JUN expression in rat aortic smooth muscle cells. RO/NS can also regulate 
AP-1 activity by influencing its ability to bind to promoter sites in DNA. A basic motif 
containing a conserved cysteine residue exists in both c-FOS and c-JUN proteins. The 
oxidation state o f this residue (controlled by redox factor (REF)-l and thioredoxin 
(TRX1)) is a critical determinant in the affinity o f  AP-1 for its consensus DNA binding 
sites, oxidation negatively interfering with DNA binding (Hirota et a l, 1997). Oxidative 
stress can lead to an increase in cellular TRX1 levels, which favours a reduced state o f 
the conserved cysteine residue in AP-1 components, thus enhancing DNA binding and 
hence transcription factor activity (fig. 3.1). In this way oxidants can indirectly enhance 
AP-1 mediated gene expression.
The mechanisms by which RO/NS can impact MAPK and AP-1 activities is 
summarised in figure 3.1. The redox sensitive transcription factor nuclear factor kappa B 
(NFkB) is subject to similar mechanisms o f control.
3.1.3 Nuclear Factor Kappa Beta (NFkB)
NFkB (discussed in detail in section 1.8.2) has long been seen as the paradigm 
model o f a redox sensitive transcription factor (Li and Karin, 1999, Schreck et a l, 1992). 
There is no shortage o f experimental data linking H2O2 treatment o f  cells to NFkB 
activation (Gloire et a l, 2006; Takada et a l, 2003; Zhang et a l, 2001; Bowie and 
O’Neill, 2000; Manna et al, 1998; Sen and Packer, 1996; Meyer et a l, 1993; Schreck et 
al, 1991), and in fact it was such experiments involving frank exposure o f cells to H2O2 
that first established a strong link between redox regulation and NFkB (Manna et al, 
1998; Schreck et al, 1991), such treatments being seen to trigger nuclear translocation o f 
NFkB in certain cell types (Gloire et al, 2006; Bowie and O ’Neill, 2000). Also, it has 
been reported that intracellular ROS levels regulate NFkB activity in response to a 
variety o f  stimuli through mechanisms which are yet to be clearly defined (Sen and 
Packer, 1996; Anderson et a l, 1994; Schreck and Baeuerle, 1994; Israel et a l, 1992). 
One must be wary o f  such data however, since the outcome appears to be both cell type-,
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and dose dependent, and there is some conflicting evidence in the literature (Hayakawa et 
al, 2003; Bowie and O ’Neill, 2000; Li and Karin, 1999; Bowie et a l, 1997; Anderson et 
al, 1994), with some studies supporting a stance that in some cell types, ROS may 
behave as antagonists rather than agonists o f NFkB activity (Gloire et a l, 2000; Garg and 
Aggarwal, 2002; Haddad, 2002). Other stimuli that also activate NFkB such as phorbol 
esters (e.g. PMA), proinflammatory cytokines, bacterial endotoxins, and bile acids may 
also act via a RO/NS dependent mechanism since treatment with these agents increases 
intracellular ROS levels (Jenkins et a l, 2007; Schreck et a l, 1992).
Further experimental data that supports the involvement o f RO/NS in the 
induction and regulation o f NFkB activity stem from indirect observations in which 
antioxidants, and antioxidant enzyme over-expression inhibit NFkB activation (Schreck 
et a l, 1992), as well as studies that link TNF, IL-1, PMA, LPS, UV light, and ionizing 
radiation (all known inducers o f NFkB) to elevated cellular levels o f ROS (Schreck et a l, 
1992).
Based on these experimental observations it is now largely accepted that in certain 
cell types, but certainly not all, up-regulation o f  NFkB activity is part o f  the cellular 
response to oxidative stress (Li and Karin, 1999). The realisation that different cell types 
respond differently to direct oxidant exposure with respect to NFkB activation, coupled 
with the later finding that NFkB activity could still be regulated by intracellular redox 
status in cells that did not respond to the direct stimulation (e.g. Jurkat cells), led to the 
speculation that two distinct redox stimulated/ regulated mechanisms exist in the NFkB 
signal transduction pathway (Anderson et a l, 1994). One mechanism permits oxidants 
such as H2O2 to trigger signal transduction in responsive cell types, and the other allows 
intracellular redox levels to regulate the extent o f activation; since oxidants can serve as 
essential messengers in downstream signalling; both converging on a common pathway 
that involves intracellular redox regulation. It has been hypothesised that intracellular 
levels o f  reduced glutathione (GSH), the major thiol and RQS scavenger in cells (Aruoma 
et a l, 1989) may be crucial for the cell type specific differences in NFkB activation, 
since levels can differ greatly from one cell type to another, and even in a particular cell 
type under different conditions (Li and Karin, 1999). Excellent experimental evidence
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has been cited in the literature in support o f this hypothesis, since induced increase o f 
cellular GSH (by pre-incubation with N-acetyl-L-cysteine (NAC) -  a precursor for GSH 
synthesis) was seen to abolish H2O2 induced NFkB activation (Schreck et al, 1991), 
whilst depletion o f cellular GSH resulted in clearly detectable H2O2 -  induced NFkB 
activation in cells in which it was previously undetectable.
It is very difficult to decipher the exact mechanisms by which RO/NS regulate 
NFkB signalling and activity, since they appear to act at several levels, and in such short 
frames o f time, and assays that are fast and sensitive enough to measure changes in 
intracellular levels o f oxidants have yet to have been established.
It has been suggested that IkB phosphorylation and subsequent degradation may 
be the crucial step that is responsive to oxidative stress. Since IkB Kinase (IKK) -  
induced phosphorylation o f IkB is the final step in NFkB activation which can be 
controlled before constitutively active components o f the pathway come into play, it 
emerges that unless RO/NS are directly involved in this step, they are unlikely to serve a 
general signalling role in NFkB activation, and they may simply serve to regulate other 
redox sensitive components o f the pathway. Undoubtedly the development o f new more 
sophisticated methods aimed at the specific and highly sensitive detection o f ROS in cells 
will help to clarify the steps at which such redox control occurs. In the meanwhile, 
speculations continue to be made based on the experimental evidence that continues to 
emerge. Hayden and Ghosh (2004) suggest that the ROS regulated step in cytokine 
mediated NFkB signalling may lie just downstream o f  IKK activation at the levels o f 
iKBa-ubiquitin ligase, either affecting the enzymes activity, or the recognition o f  its 
phosphorylated-TkR target. Support for this mechanism is provided by studies which 
show that antioxidants and over-expression o f peroxidase enzymes inhibit IkB 
degradation induced by a range o f stimuli including TNFa, PMA, and LPS (Gloire et al, 
2006; Li and Karin 1999; Manna et a l, 1998). Some researchers in the field disagree with 
this model and speculate that the ROS -  sensitive step in the NFkB activation pathways 
lies at the level o f the IKK complex (Gloire et a l, 2006; Kretz-Remy et a l, 1996). Other 
notable observations that warrant consideration include documentation that whilst low 
doses o f  endogenous ROS may induce NFkB signalling, at higher doses (or above a
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threshold level), they may have an inhibitory effect (Michiels et al, 2002; Marshall et al,
2000). Jaspers et a l (2001) showed that treatment o f cells with high doses o f H2O2 
resulted in elevated levels o f  oxidised GSH which appeared to block proteolysis o f IkB, 
and hence NFkB activation, by negatively impacting the activity o f ubiquitin conjugating 
enzymes. There is also evidence to suggest that RO/NS may have an antagonistic effect 
on NFkB by more direct means, by interfering with the DNA binding activity o f the 
transcription factor itself. Whilst the translocation o f  NFkB from nucleus to cytoplasm 
depends upon oxidising conditions in the cytoplasm, DNA-binding requires reducing 
conditions within the nucleus, supported by observations that reducing agents can 
enhance binding, whilst oxidising agents can inhibit it (Bowie and O’Neill, 2000). 
Indeed, the existence o f  a conserved redox-sensitive cysteine residue, Cys-62, in the Rel 
Homology Domain (RHD) o f p50 that makes direct contact with DNA has been 
demonstrated (Brijelius-Flohe et al, 2004; Haddad, 2002; Michiels et a l, 2002; 
Matthews et a l, 1992), and that oxidation o f this residue may account for antagonistic 
effects o f ROS. Hirota et a l  (1999) cited evidence that Thioredoxin (Trxl) may be 
translocated into the nucleus concomitantly with NFkB, and that it reduces Cys-62 in the 
DNA binding loop, thereby enhancing DNA binding and transcriptional activity 
(Matthews et a l, 1992). Figure 3.2 summarises the outlined potential redox regulated 
steps in the NFkB pathway.
Several potential pathways exist for the activation o f NFkB including amongst 
others, the classical/ canonical pathway and the alternative/ non-canonical pathway 
through which most well known mediators o f  NFkB act (Gilmore, 2006). Research in the 
past few years has brought to light the possibility that exposures to ROS like H2O2 may 
activate NFkB via an unconventional pathway involving phosphorylation o f  tyrosine 
(Tyr-42), threonine, and serine residues within the C-terminal o f  IkB<x by protein tyrosine 
kinases (instead o f at the canonical Ser-32/ Ser-36 sites by IKK), marking it for 
subsequent degradation by calpain proteases (Gloire et a l, 2006; Bowie and O ’Neill, 
2000; Schoonbroodt et al, 2000) (fig. 3.2). The fine details o f  this pathway remain to be 
elucidated.
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Figure 3.2 Summary o f redox regulated steps in the NFkB signal transduction pathway. Details 
connected by blue arrows show the normal sequence o f events following triggering o f the pathway, starting 
with the //cZ?-bound NFkB complex (for more upstream events refer to section 1.8.2 and fig. 1.11) and 
ending with NFkB -  mediated gene expression. Black arrows highlight the points at which RO/NS can 
impact the signalling, either positively (+), negatively (-), or as yet unclear (?). Refer to text for further 
details. (PTK = protein tyrosine kinase, Trxl = thioredoxin, P = phosphorylated site, u = ubiquitinated site).
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Interestingly oxidants may also activate NFkB signalling by way o f MAPK 
pathway cross-talk (fig. 3.2), mediated by NFkB Inducing Kinase (NIK), a member o f the 
MAPK family o f  enzymes, since they have been shown to induce NIK 
autophosphorylation, an event which can culminate in NFkB activation. Oxidant induced 
activation o f RAS-RAF-ERK1/2 (p42/p44) MAPK signalling may also augment NFkB- 
dependent gene expression by way o f MAPK cascade mediated phosphorylation o f p65 
(Jackson et al, 2002). Whilst oxidants appear to have mainly positive effects on NFkB 
activity, NO can, at several levels -  including reduction o f  IkB phosphorylation and 
ubiquitination, inhibit NFkB activation (Colasanti and Persichini, 2000) (fig. 3.2).
So, to date, the mechanisms by which RO/NS affect NFkB signalling and 
subsequent transcription factor activity are yet to be fully defined. What is clear, 
however, is that oxidative and nitrosative stress, and cellular redox status can impact 
NFkB activity in some way at several potential levels, the significance and impact being 
dose and cell type dependent. Figure 3.2 summarises the potential RO/NS sensitive steps 
o f NFkB activation based on the evidence available to date.
The significance o f redox regulated signal transduction and gene expression is 
apparent in several pathological states, exemplified by Helicobacter pylori -  associated 
gastric carcinogenesis.
3.1.4. Involvement of RO/NS in Helicobacter Pylori - associated Gastric 
Carcinogenesis.
As discussed in section 1.4.5.1, excessive levels o f  RO/NS form- a major 
component o f Helicobacter pylori -  associated gastric carcinogenesis, originating from 
the accumulation o f activated inflammatory leukocytes at the vicinity o f the infection, as 
well as enhanced generation o f reactive metabolites by the gastric cells themselves (Ding 
et al., 2007; Obst et al., 2000; Bagchi et al., 1996; Davies et a l, 1994a; Davies et al, 
1994b; Davies and Rampton, 1994; Weiss, 1989). Recently, Xu et a l  (2004)
92
demonstrated that H  pylori resulted in enhanced H2O2 generation in AGS gastric 
epithelial cells via enhanced expression and activity o f Spermine oxidase, resulting in 
H2O2 - induced apoptosis and DNA damage, providing a potential mechanistic link 
between H. pylori infection, oxidative stress, and gastric carcinogenesis. Enhanced 
apoptosis o f gastric epithelial cells can result in increased epithelial permeability and 
mucosal damage, which drive a compensatory increase in cellular proliferation (Peek et 
al, 2000; Peek et a l, 1999) resulting in inflammation, and potentially neoplastic 
development. The oxidative stress induced by infection may also lead to gene expression 
alterations via the redox sensitive AP-1 and NFkB transcription factors (Midler et al,
1997). The increase in cellular proliferation in conjunction with redox sensitive gene 
expression alterations can provide a background upon which carcinogenesis is favoured.
With respect to how H. pylori impacts cellular signal transduction and gene 
expression, H. pylori -  induced IL-8 expression provides a good model. Upon direct 
contact o f  the bacterium with gastric epithelial cells, enhanced IL-8 expression and 
release is induced (one o f the most well studied genes in the disease pathology, amongst 
other gene expression changes), an effect which is enhanced by the presence o f the cag 
pathogenicity island (PAI) in the infecting strain (Crabtree et a l, 1999; Crabtree et al, 
1995; Peek et a l, 1995; Crabtree et a l, 1994b), and is believed to be mediated by NFkB 
activation (Peek, 2001). The release o f  IL-8 results in the infiltration o f neutrophils and 
monocytes via a chemotactic gradient, resulting in an enhanced inflammatory response, 
which can result in chronic gastritis and potential progression to gastric neoplasia in a 
subset o f  individuals.
H. pylori has been demonstrated to rapidly activate NFkB and hence drive 
enhanced IL-8 expression upon contact with gastric cells in vitro (Sharma et a l, 1998; 
Keates et a l, 1997), and the bacterium’s capability to activate NFkB extends to the in 
vivo environment since activated NFkB is present within gastric epithelial cells o f 
infected but not uninfected patients (Keates et a l, 1997). Experimentation by Maeda et 
al (2000) helped in establishing a clearer understanding o f  the cellular signaling that 
drives H. pylori -  induced NFkB activation. The hierarchical series o f events involves H  
pylori driven activation o f NIK via upstream TRAF2 and TRAF6 (members o f the TNF
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receptor associated family (TRAF), serving as effectors o f activated TNF and IL-1 
receptors respectively) by mechanisms which remain elusive, that, in turn, 
phosphorylates and activates IKKs. Activated IKKs subsequently phosphorylate IkB , 
with concomitant proteasome-mediated degradation, culminating in the release and 
nuclear translocation o f NFkB and induction o f NFkB driven gene expression e.g. IL-8 
(Fig. 3.3).
More recently K  pylori has been seen to induce NFkB associated inflammatory 
signalling in gastric epithelial cells by way o f a cag PAI -  dependent mechanism 
involving intracellular nucleotide-binding oligomerisation domain protein (NODI) 
receptor molecule (Viala et a l, 2004). NODI is part o f  a family o f intra-cytoplasmic 
pathogen recognition proteins that recognise bacterial peptidoglycans. With respect to H. 
pylori, peptidoglycan, injected into gastric epithelial cells by way o f the cag PAI type IV 
sectretion system, is recognised by N O D I, which then goes on to directly activate NFkB 
and hence NFkB -  dependent gene expression.
MAPKs have also been implicated in H. pylori -  induced signal transduction and 
gene expression changes. As detailed in section 3.1,3 MAPKs can directly influence 
activation o f NFkB via NIK mediated activation o f IKKs, and via ERK pathway 
mediated phosphorylation o f p65 (Jackson et a l, 2002). In this way MAPKs can 
contribute to the enhanced expression o f inflammatory cytokines (e.g. IL-8) by H. pylori 
infested gastric epithelium. In addition, MAPKs can directly activate transcription factors 
like AP-1 (section 3.1.2.1) which can lead to induction o f IL-8 expression (since the IL-8 
promoter contains both NFkB and AP-1 binding sites) (fig. 3.3).
Dose-dependent activation o f ERK, p38, and JNK MAPK in gastric epithelial 
cells by live H. pylori has been demonstrated (Keates et a l, 1999) which was seen to 
drive up-regulated IL-8 expression. There has been some debate as to whether H. pylori -  
induced IL-8 gene expression is dependent upon activation o f NFkB, MAPK, or both 
(Meyer-Ter-Vehn et al, 2000; Naumann et a l, 1999; Malinin et al, 1997). Studies by 
Aihara et a l  (1997) demonstrated that H. pylori-induced IL-8 gene expression is 
dependent on both NFkB and AP-1 actiyation, and cross-talk between NFkB and MAPK 
pathways may be important. For example, MEKK1 and NIK each can directly activate
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the IKK signalosome, thereby driving NFkB activation (Malinin et a l, 1997; Mercurio et 
al, 1997). However, even though interplay between the two pathways may exist in H. 
pylori infected cells, no clear dependence seems to exist. For example, Keates et a l 
(1999) showed that whilst inhibition o f ERK and p38 MAPK resulted in attenuation o f H. 
pylori - induced IL-8 expression, it did not affect NFkB activation. On these grounds it is 
believed that synergistic interactions between AP-1 and NFkB are required for maximal 
H. pylori-induced IL-8 production. Other observations lead to the idea that there is 
considerable redundancy in the intracellular signalling pathways activated by H. pylori 
(Meyer-Ter-Vehn et al, 2000; Naumann et a l, 1999).
What is clear is that by activating two prominent signal transduction pathways, H. 
pylori has been seen to induce gene expression alterations in infected cells, affecting a 
host o f genes implicated in the carcinogenic process such as spermine oxidase (SMO) 
(Xu et al, 2004), DNA damage response genes such as GADD45A (Myllykangas et al, 
2004), cell cycle genes such as cyclin D1 (CCND1) (Sepulveda et a l, 2002; Hirata et al,
2001), cellular stress response genes such as heat shock proteins (HSP) (Myllykangas et 
al, 2004), oxidative stress response genes e.g. superoxide dismutases (SOD) (Gotz et al,
1996), signalling molecules such as the serine threonine kinase PIM-1 (Sepulveda et al,
2002), growth factors and cytokines such as VEGF (Tucillo et a l, 2005; Strowski et al, 
2004; Caputo et al, 2003), IL-8 (Sharma et al, 1998; Aihara et a l, 1997), and TNFa 
(Crabtree et al, 1991), as well as transcription factors -  notably the AP-1 transcription 
factor via up-regulation o f  c-FOS and c-JUN components (Sepulveda et a l, 2002; Chiou 
et al, 2001; Mitsuno et a l, 2001; Meyer-Ter-Vehn et a l, 2000; Naumann et a l, 1999).
Whilst it is clear that H. pylori infection can lead to cellular signal transduction 
changes, it remains, as yet unclear exactly how this occurs. There appears to be some 
dependence on direct contact between bacterium and host cells for the induction o f NFkB 
and MAPK pathways in gastric epithelial cells (Peek, 2001; Rieder et a l, 1997). Several 
reports, however, suggest that H  pylori can induce cytokine expression in various
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Figure 3.3 Effects o f Helicobacter pylori on cellular signal transduction and gene expression in gastric 
epithelial cells. By mechanisms that are yet to be elucidated, but are likely to involve bacterial factors and 
reactive oxygen/ nitrogen species (RO/NS), the bacterium triggers activation o f NFkB (via several 
mechanisms including Nodi -  see text for further details), ERK MAPK, JNK MAPK, and p38 MAPK (not 
shown) pathways, all o f which result in gene expression alterations via NFkB and AP-1 transcription 
factors, often leading to up-regulation o f cytokine genes e.g. IL-8, IL-6, TNFA, and oncogenes e.g. C-FOS. 
For further details refer to text.
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leukocyte types regardless o f direct cellular contact, implicating soluble bacterial factors 
in the activation mechanism (Bhattacharyya et a l, 2002), which would obviously favour 
enhanced inflammation and a microenvironment that drives carcinogenesis. Clearly then, 
H. pylori can induce cellular signal transduction cascades by a number o f means both via 
direct contact, which is likely to depend upon components o f the cag PAI, and indirectly 
via soluble factors. In both cases, the early steps in signalling induction remain to be 
clearly defined. It is quite plausible that since H. pylori infection causes significant 
oxidative stress and enhanced generation o f  RO/NS in the vicinity o f  the infection (by 
both gastric epithelial cells and leukocytes), coupled with the importance o f the redox 
sensitive NFkB and MAPK pathways in bacterium induced gene expression changes, that 
RO/NS may have a fundamental involvement (Baek et a l, 2004; Seo et a l, 2004; Chu et 
al, 2003; Kim et al, 2001; Lim et a l, 2001; Kim et a l, 2000).
3.1.5 Aims of the Chapter
On the basis o f  the literature reviewed there seems to be a strong grounds for the 
hypothesis that RO/NS play a key role in the pathogenesis o f  gastric cancer -  being 
particularly significant to the H. pylori -  associated and chronic inflammatory 
components o f the pathogenesis o f  the disease. Persistent H. pylori infection and chronic 
inflammation go hand in hand, and together generate a hostile microenvironment within 
the gastric mucosa, characterised by infiltration o f leukocytes, elevated levels o f  pro- 
inflammatory cytokines and enhanced generation o f RO/NS from both leukocyte and 
gastric epithelial cell sources. In addition, H  pylori is well documented to induce 
activation o f redox -  sensitive transcription factors including NFkB and AP-1 via redox -  
sensitive signal transduction cascades including MAPKs, by way o f infection associated 
oxidative stress amongst other mechanisms. This can lead to gene expression alterations 
that may have negative impacts on overall gastric health.
Based on these grounds one can speculate that H  pylori infection and its 
associated inflammation and generation o f RO/NS may contribute to gastric
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carcinogenesis at the molecular level through the induction o f mutations, aberrant signal 
transduction, and gene expression alterations.
The work presented in this chapter aims to dissect the involvement o f  oxidative 
stress in gastric disease by exploring the effects o f a model Reactive Oxygen Species 
(ROS), Hydrogen peroxide (H2O2) (so mimicking the oxidative stress induced by H. 
pylori infection), on human cell lines at the levels o f  gene and protein expression with a 
particular focus on signal transduction changes. H2O2 was selected on the basis that it is a 
diffusible ROS and so can readily diffuse into cells where it can impact signalling and 
gene expression, it can result in the generation o f hydroxyl radical (*OH) which is 
considered the ultimate reactive metabolite (Henle and Linn, 1997), and has been used 
widely in oxidative stress research (Williams et a l, 2005; Jenkins et a l, 2001; Ruiz- 
Laguna and Pueyo, 1999; Wang et a l, 1998; Duthie et a l, 1997; Kleiman et a l, 1990; 
Moraes et a l, 1990). Moreover, tumour cells have been shown to constitutively generate 
H2O2 (Szatrowski and Nathan, 1991). Since the amount o f ROS generated in inflamed 
gastric mucosa is not clearly defined and is subject to continuous change, a dose range 
was selected that fell around the LD50 o f  H2O2 seen in toxicity tests (50 -  500pM), is in 
line with dose ranges that have been employed in the literature (Williams et a l, 2005; 
Jenkins et a l, 2001; Duthie et al, 1997; Kleiman et a l, 1990), and covers the 
concentration range that has been seen to be generated in tumour cell lines (Szatrowski 
and Nathan, 1991) (100 -  500pM /104 cells/ hr).
Three different cell lines were employed in the studies -  WILLI - a normal 
fibroblast cell line, AGS -  a gastric cancer cell line derived from an early non-metastatic 
gastric tumour (generally considered to be a very good model o f a primary gastric 
epithelial cell), and HGC-27 -  a more advanced gastric cancer cell line derived from a 
metastatic stage o f the disease. The importance o f using the three cell lines is two-fold. It 
allows cell line and cell type specific comparisons to be made, as well as the effect o f 
different stages o f disease on responsiveness to oxidative stress, to be analysed.
Signal transduction and gene expression changes induced by H2O2 were analysed 
with the Extra-cellular signal-Regulated Kinase (ERK) Mitogen Activated Protein Kinase 
(MAPK) pathway being a central theme to the studies. The pathway was examined using
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a variety o f techniques (real-time (RT-)/ quantitative (Q-) PCR for downstream genes as 
well as western blots for active components o f the pathway) since aberrant MAPK 
signalling is a common feature o f cancer (Dhillon et a l, 2007), has been seen to be 
induced by H  pylori infection (Crabtree and Naumann, 2006), and has been detected in 
gastric tumours (Watari et a l, 2007; Sepulveda et al., 2002; Gong et a l, 1999; Barnard et 
al, 1995; Tahara, 1995b). The activity o f the NFkB pathway was also studied by RT- 
PCR for IL-8 and IkB  genes, using the level o f expression o f  the NFkB regulated genes as 
a surrogate marker for NFkB activity (Jenkins et a l, 2004).
3.2 M aterials and  M ethods
3.2.1 Cell Culture
3.2.1.1 HGC-27
HGC-27, a human gastric adenocarcinoma permanent cell line derived from a 
lymph node metastasis o f a Japanese patient with gastric adenocarcinoma o f the 
undifferentiated sub-type, was obtained from the European Collection o f Cell Cultures 
(ECACC, Salisbury, Wiltshire, UK, Catalogue number 94042256), and was cultured as 
described in section 2 .1 .1 .
3.2.1.2 AGS
AGS, a hyperdiploid human cell line (modal chromosome number o f 49), was 
derived from fragments o f a primary gastric tumour from a  54 year old female Caucasian 
patient who had received no prior therapy. The cell line originates from a relatively 
poorly differentiated gastric cancer, and was obtained from the American Tissue Culture 
Collection (ATCC) (LGC Promochem, Teddington, Middlesex, UK, Catalogue number 
CRL-1739) and was cultured as described in section 2.1.1.
3.2.1.3 WILL 1
W ILLI, a normal primary fibroblastic cell line derived from the foreskin o f  a one 
year old boy was grown as described in section 2 .1 .1 .
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3.2.2 Gene Expression Analysis
Cells were treated, RNA extracted and gene expression changes analysed using 
membrane cDNA arrays and real-time (RT) PC R
3.2.2.1 Treatment of Cells
Cells o f all three cell lines were treated with a  variety o f doses o f Hydrogen 
Peroxide (H2O2) (Sigma-Aldrich, Poole, UK) as described in section 2.2. Prior to dosing, 
cell viability was assessed using the trypan blue cell viability assay as described in 
section 2.1.1.8 , and only cell cultures with a viability o f > 95% were used in subsequent 
experimentation. MTS assays were also carried out as outlined in section 2.3 over a dose 
range o f H2O2 for different time points in order to identify doses that may cause excessive 
toxicity.
The particular treatment regimens used for each cell line are summarised in table 
3.1. All treatments were performed in duplicate, and the resultant RNA or protein 
extracted was pooled and analysed.
In addition, a preliminary experiment was performed in which cells were pre­
treated for 30min with lOpM o f the ERK MAPK inhibitor U0126 (Favata et a l, 1998) 
(Sigma-Aldrich, Poole, UK) prior to H2O2 dosing for 4hr in order to determine if  a link 
between MAPK activity and H2O2 -  induced c-FOS expression existed.
3.2.2.2 RNA Extraction
Total cellular RNA was extracted from dosed and control cells, and processed as 
described in section 2.4 -  2.4.4. It was fundamental that the RNA be o f a high quality for 
downstream analysis, so RNA quality was assessed by spectrophotometric determination 
o f the 260/280 ratio (only samples with a ratio > 1 .8  were used in subsequent analyses) 
and by reverse transcription-PCR as described in section 2.4.5. Briefly, RNA samples
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T able  3.1 Summary o f Hydrogen Peroxide treatment regimens carried out on cultured cells. All dosing 
was acute, with exposure times ranging from 5min to 24hr over a range o f doses. Short burst treatments 
imvolved rapid exposures o f  cells to 150pM H20 2 in order to assess how rapidly the ROS can elicit MAPK 
pathway activation. Longer exposures were also carried out in order to look at downstream gene expression 
changes. * -  Treatments analysed by western blot.
Cell Line Treatment
AGS, HGC-27, WILLI short burst Long Exposures
EGFpositive * - 4hr control *
Control * - 4hr 50pM H 2O2
- 5min 150pM H2 O2  * - 4hr 150pM H2O2 *
lOmin 150juM H2 O2 * - 4hr 250juM H20 2 *
- 30min 150juM H2 O2 * - 4hr 500pM H20 2 *
- 8hr control *
- 8hr 50pM H2O2
- 8hr 150pM H20 2 *
- 8hr 250pM H20 2 *
- 8hr 500pM H20 2 *
- 24hr control *
- 24hr 50pM H2O2
- 24hr 150pM H20 2 *
- 24hr 250pM  H20 2 *
- 24hr 500pM H20 2 *
1
(500-800ng -  consistent for each cell line) were reverse transcribed for lh r at 44°C using 
a Retroscript kit (Ambion, Warrington, UK), followed by PCR amplification o f both 
cDNA and RNA using primers for P-actin (ACTB) (see table 3.2). Only samples that 
yielded one clear band following polyacrylamide gel visualisation were used in 
downstream experimentation.
3.2.23  Protein Extraction
Total protein was extracted, processed, and quantified from dosed and control 
cells as described in section 2 .6 .
3.2.2.4a Membrane cDNA Arrays
For a  ‘global’ gene expression analysis the GEArray Q series array kits from 
SuperArray (Cambridge, UK) were used as a cDNA gene expression profiling system. 
Array experiments were carried out as described in the manufacturer’s protocol with 
some modifications as described below and summarised diagrammatically in figure 3.4. 
In this study, the Cancer Pathway Finder, and Nitric Oxide Arrays were used, since they 
cover a wide range o f genes involved in cell signalling, apoptosis, proliferation, 
angiogenesis, and inflammation. The array gene tables are shown in Appendix I (sections 
AI.l and AI.2 respectively).
All probe labelling reactions were carried out in Class II Lamina Flow cabinets 
following the same precautions as described for general PCR (section 2.5.4) and all RNA 
and enzymes used were kept on ice throughout All incubations were carried out using an 
MJ Research Peltier Thermal Cycler (PTC)-2000 DNA Engine (Essex, UK). All 
incubations o f  microarrays were carried out in a Hybaid Rotating Hybridisation Incubator 
(Grant Instruments, Cambridgeshire, UK) with agitation.
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Figure 3.4 Outline o f Array Experimental Procedure, adapted from SuperArray Bioscience Corporation 
( Cambridge, UK) GEArray System User Manual (downloaded at www.superarrav.com).
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In all array experiments control arrays hybridised with cDNA generated from the 
RNA o f untreated cells, and arrays hybridised with cDNA from treated cells were 
included. Only RNA from HGC-27 was used in this experimentation due to limitations 
on time and resources. RNA from cells that had been treated under normal and acidic pH 
(medium was acidified by the addition o f hydrochloric acid (HC1) to pH5 (maximum 
acidity tolerable by the cells in culture) and then filter sterilised, treatments subsequently 
carried out as normal) were also included in the study, to assess i f  acidic conditions 
impact gene expression changes as may be the case in the stomach environment.
3.2.2.4b cDNA Probe Generation
RNA samples were converted into biotin labelled cDNA probes using the 
Ampolabelling Kit (Superarray, Cambridge, UK) following the Ampolabelling LPR 
protocol with modifications. For each RNA sample, the following reagents were mixed in 
sterile 0 .2 ml microfuge tubes to make up annealing mixes:-
•  lp g  total RNA,
•  1 pi buffer P (primer mix),
•  RNase-free H2O to a final reaction volume o f lOjil.
The mixtures were then gently mixed by pipetting, and the tubes incubated at 70°C for 
3min to allow for primer annealing, and subsequently cooled to 37°C for lOmin. Whilst 
the annealing mix was incubating, an RT cocktail master mix was prepared consisting o f 
appropriate multiples (depending on the number o f reactions being carried out) o f  the 
following reagents:-
• 4pi buffer BN,
• 4pl RNase-free H2O,
•  1 pi RNase inhibitor,
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• lp l Reverse Transcriptase.
The cocktail was subsequently warmed to 37°C for lm in prior to adding lOpl o f  the mix 
to each annealing mixture. The resultant 20pl mixture was gently mixed with a pipettor 
and incubated at 37°C for 25min, followed by heating to 85°C in order to inactivate the 
reverse transcriptase and hydrolyse the RNA.
A linear polymerase chain reaction (LPR) mix was then prepared for each sample, using 
half the volumes indicated in the manufacturer’s protocol, consisting of:-
•  9pl buffer L,
•  1 pi Biotin-16-dUTP (Roche, East Sussex, UK),
•  4.5pl buffer AF (specific to each type o f array),
•  0.5pl DNA Polymerase (LE).
The LPR mix was mixed well and 15 pi was added to each RT reaction (to a final volume 
o f 3 5 pi) and the resultant mixture mixed well by pipetting. The sample was then heated 
to 85°C for 5 min before undergoing 30 cycles o f  85°C -  lm in; 50°C -  lmin; 72°C -  
lm in in the thermal cycler. The resultant Biotin labelled cDNA target was used to probe 
the arrays.
3.2.2.4c Pre-Hybridisation Treatment of Arrays
During the 2 hour LPR reaction, the membrane arrays were prepared for 
overnight hybridisation with labelled cDNA probe by pre-hybridisation treatment. This 
consisted o f wetting arrays (in the tubes provided) with dLLO and then incubating the 
arrays in 2ml o f  GEAhyb solution (prepared by adding 300pg heat-denatured sheared 
salmon sperm DNA (final concentration lOOpg/ml) (denatured at 100°C for 5 minutes in 
a heating block and then quickly quenched on ice) to 3ml GEAhyb hybridisation solution
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(pre-warmed to 60°C in a water bath) per array) for 1 -  2hr at 60°C with continuous 
agitation in the hybridisation oven.
3.2.2.4d Array Hybridisation
After approximately 2 hours the LPR labelling reaction was immediately stopped 
by the addition o f 5 pi buffer C and chilling on ice. The labelled cDNA probe was then 
denatured by heating at 94°C for 2min and then quickly chilling on ice. The denatured 
probe (35pi per sample) was then added to 0.75ml o f the prepared GEAhyb solution 
(described in section 3.2.2.4c) generating the hybridisation solution. The pre­
hybridisation solution was then discarded from the tubes, after the 1 -  2hr pre- 
hybridisation step, and replaced with the 0.75ml hybridisation solution containing the 
labelled probe. The arrays were then hybridised overnight at 60°C with continuous 
agitation.
3.2.2.4e Post-Hybridisation
Post-hybridisation washes were performed in order to remove unbound probe and 
non-specifically bound probe in order to reduce background. All washes were performed 
at 60°C with continuous agitation in the hybridisation oven. Hybridisation solution was 
discarded and replaced with 5ml o f pre-warmed wash solution 1 (2X SSC/ 1% SDS) and 
incubated for 15min. This wash step was repeated a second time, the wash solution 
discarded, and the wash procedure repeated with wash solution 2 (0.1X SSC/ 0.5% SDS). 
Subsequent steps were performed at room temperature with continuous agitation in the 
hybridisation oven. After the wash steps 2ml pre-warmed (37°C) GEAblocking solution 
Q was added to the hybridisation tubes and the arrays incubated for 40min in order to 
block the arrays. The arrays were then incubated in 2ml IX  buffer F/ 1:8000 alkaline
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phosphatase (AP)-Streptavidin for lOmin. The arrays were then subjected to four 5min 
washes in 4ml IX  buffer F, followed by 2 final rinses in 4ml AP assay buffer G.
3.2.2.4f Chemiluminescent Detection
In the earlier steps the arrays were incubated with AP-Streptavidin. This forms the 
basis o f the chemiluminescence detection system as the Streptavidin binds to the biotin in 
the labelled cDNA probes that bound to the array gene spots, and the AP reacts with 
applied CPD star substrate to generate a detectable chemiluminescence signal.
The arrays were removed from their hybridisation tubes and placed on plastic 
acetate sheets cut to the size o f the arrays. Subsequently, 0.75ml CPD-star substrate was 
applied to each array, the arrays covered with a second acetate sheet and left for 2 min. 
CPD-star was then removed from the arrays by blotting the membranes, and the arrays 
transferred to fresh acetates. The arrays were then exposed to chemiluminescence film 
(Hyperfilm ECL) (GE lifesciences, Bucks, UK) for a period o f 5min. The resultant film 
was developed in a dark room using the AGFA Currix 60 Film Processor (Agfa, 
Middlesex, UK). Depending upon the exposure result, re-exposure o f film for shorter or 
longer periods was sometimes required until an adequate image was obtained.
3.2.2.4g Array Image Capture and Analysis
Approximately lh r after arrays were exposed to CPD-star chemiluminescent 
substrate, the arrays were individually illuminated and an image captured (after manually 
positioning the array, zooming and focussing) using the Bio-Rad chemiluminescence 
documentation system Chemi Doc 2000 (Bio-Rad, Hertfordshire, UK) in conjunction 
with the Quantity One version 4.0.3 software for image analysis. The resultant image was 
converted into volume and density values for each gene spot using the volume array tool
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and volume analysis options, which enable quantification o f gene expression using the 
Superarray GEArray analyser (downloaded from w w w .superarrav.com ) following 
instructions in the user manual.
3.2.2.4h Stripping Arrays
Arrays were stripped and re-used up to 3 times. Stripping to remove bound probe 
was carried out by boiling the arrays in 0.5% SDS for lOmin. They were then left to cool 
for lOmin in the 0.5% SDS solution, rinsed in 2X SSC, and air dried. Arrays were 
subsequently exposed to chemiluminescence film to ensure complete removal o f bound 
probe. The stripped arrays were stored at -20°C until required.
3.2.2.5a Real-Time PCR
All real-time (RT-) PCR experiments were carried out as described in detail in 
section 2.5.1. Specific genes analysed are summarised in table 3.2 together with the 
forward and reverse primer sequences used. Standard curves were generated from pooled 
RNA from cell culture and gastric biopsy specimens. The same standard curve RNA was 
used in each plate o f an experimental run (refer to section 2.5.1.1 for further details).
3.2.2.5b Primer Design
Primers were designed based on sequences obtained from the NCBI website 
fwww.ncbi.nlm.nih.gov). In this case, the VEGF gene sequence was obtained from 
GenBank
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(http://w w w .ncbi.nlm .nih.gov/entrez/viewer.fcgi?db=nucleotide&val=71051577)
using the corresponding gene ID from the Cancer Pathway Finder array (NM 003376). 
The criteria used when designing the primers by eye were:-
- Primer length should be approximately 20bp, with a melting temperature 
o f 55 - 65°C to ensure sequence specificity;
- There should be no/ minimal intra-/ inter-sequence complementarity, 
thereby minimising hairpins, other secondary structures, and primer dimer, 
as this otherwise reduces PCR specificity and efficiency;
- The primers should not hybridise to other genome sequences. A BLAST 
search is carried out through the NBCI website 
(http://www.ncbi.nlm .nih.gov/BLAST/) to ensure that this does not 
occur;
- Ideally, the primer pair should span an intron, thus, if  any genomic DNA 
is amplified it will be o f  a much larger size than sequences amplified from 
RNA;
- PCR product should be approximately lOObp in length.
The forward and reverse VEGF primer sequences designed on this basis are 
shown in table 3.2. Once the primers were designed they were analysed using the 
NetPrimer primer analysis software downloaded from 
http://w w w .prem ierbiosoft.com /petprim er/netprlaupch/netprlaunch.htm l. This 
software evaluates characteristics o f  the primers based on the nucleotide sequences, 
specifically providing important information about their Melting Temperature (Tm), 
likelihood o f hairpins, dimers, palindromes, and the overall rating o f  the primers. 
Primers were synthesised by Sigma Genosys (Sigma Genosys, Sigma-Aldrich, Poole, 
UK) according to the sequences established. The primers were HPLC purified and 
desalted by the manufacturer. The primers were diluted in filter sterilised dH^O to a final 
concentration o f  15pmol/pl, and stored at -20°C until required in 50pl working aliquots.
The primer sequences were tested out on sample RNA by first carrying out 
standard reverse transcription PCR reactions (as described in section 2.4.5), followed by
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standard PCR spanning a temperature gradient from 50°C to 65°C in 2°C increments. 
The PCR products were run on a polyacrylamide gel and visualised by silver staining 
(section 2.4.5.3).
The resultant gels revealed that the primers generated a clean PCR product o f ~100bp in 
length, with no primer dimer or other non-specific products, at an optimal temperature o f 
60°C.
3.2.2.5c Statistical Analysis
One-way ANOVA was performed (using SPSS Version 13.0) on the real-time 
PCR data (after normalising the gene o f interest against p-actin values) on each time 
point separately, in order to identify any significant differences in gene expression 
between treatments and controls (using Tukey and Duncan Post Hoc tests). Statistical 
significance was observed when P < 0.05 at the 95% confidence interval and 0.05 
significance level.
3.2.3 Protein Studies
3.2.3.1 Western Blotting
A series o f Western Blots were carried out on protein extracts from control and 
treated cells as described in section 2.7.3. Proteins o f interest in this study were:-
- ERK1/2 (p42/p44), and its phosphorylated, hence active counterpart 
pERK l/2 in order to assess potential activation o f  the ERK (p42/p44) 
MAPK pathway (Yung et a l, 1997);
- p38, and its active form, phospho p38, again to assess MAPK pathway
activity;
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- c-Fos, a downstream gene expression target o f  MAPK activation;
- Active NFkB in order to assess activation o f NFkB signalling;
- IicBa, a downstream gene expression target o f  NFkB.
All o f these primary antibodies were polyclonal antibodies raised in rabbits and were 
obtained from Abeam (Cambridge, UK) with the exception o f pERK (Sigma-Aldrich, 
Poole, U K ). The primary antibodies were used at a final working dilution o f 1:1000. The 
secondary antibody utilised was Goat Anti-Rabbit Ig-HRP conjugate (Abeam, 
Cambridge, UK) and was used at a final dilution o f 1:3000.
3.2.3.2 Statistical Analysis
One-way ANOVA was performed (followed by Tukey and Duncan post hoc tests) 
to compare protein levels between control and treated samples at the different time 
points, at the P = 0.05 significance level. Statistically significant differences were those 
with P < 0.05.
3.2.4 NFkB Activity Analysis
3.2.4.1 Harvest of Recombinant NFkB-GFP Fusion Reporter Plasmid
E.coli harbouring the NFkB-GFP fusion plasmid shown in figure 3.5 (kindly 
donated by Dr Johannes A. Schmid, Center for Biomolecular Medicine and 
Pharmacology, Vienna, Austria (Schmid et a l, 2000)) was grown in 200ml pre-warmed 
Luria-Bertani (LB) broth (1% NaCL, 1% Bactotryptone, 0.5% Yeast Extract, 25pg/ml 
kanamycin) at 37°C in a shaking incubator overnight. Cells were subsequently harvested
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by centrifugation using a Beckman J-6M/E centrifuge (Buckinghamshire, UK) at 6000 x 
g (6000rpm) for 15min at 4°C and total DNA extracted using the QIAgen Maxi-Prep 
extraction kit (QIAgen, Crawley, West Sussex, UK) as per manufacturers protocol. DNA 
was quantified by spectrophotometry at A260-
3.2.4.2 Transfection of Human Cell Lines with Reporter Plasmid
Cell lines (AGS, HGC-27, W ILLI) were seeded into chambers o f  cell culture 
slides compatible with live cell confocal microscopy (Lab-tek chamber slides with cover, 
Fisher, Leicestershire, UK) at a density o f 1 x 105 cells/ml in complete medium (minus 
antibiotics) and incubated overnight at 37°C in an atmosphere o f 5% CO2. Under these 
conditions cells attached to the slides generated an even spread. It is essential for 
transfection that cells are not too confluent or grow in clumps, as evenly spread out cells 
tend to take up the plasmid with a greater efficiency. The following day the cells were 
incubated in a  transfection cocktail that was prepared as follows for each well (set up as 
master mixes depending on the number o f wells per experiment):-
1.6pg plasmid DNA was diluted in 100pi serum free medium (SFM),
- 3 pi Lipofectamine (Invitrogen, Paisley, UK) was diluted in lOOpl SFM and 
incubated for 5min at room temperature,
- After incubation, the diluted DNA was added to the diluted Lipofectamine, and 
the mixture incubated at room temperature for a further 20min,
- To each well, lOOpl o f the transfection mix was added, together with 400pl 
complete medium,
- Slides were incubated for 24 -  48hr at 37°C in a humidified atmosphere o f  CO2.
Upon a series o f trial experiments it was found that the optimal incubation time 
for AGS and WILLI cell lines was 24hr, after which the transfection mix was removed 
from the cells and replaced with medium containing 5% FBS allowing the cells to
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recover from the stress o f transfection. This reduced background in control and treated 
samples, since the transfection itself can cause N FkB to become active and translocate to 
the nucleus.
Figure 3.5 NFkB-GFP (GFP-p65) reporter construct plasmid (kindly donated by Dr J. A. Schmid 
(Schmid et al., 2000)) used in transfection assays. Successful transfection results in expression o f a 
fluorescent NFkB fusion protein, the cellular localisation o f which can be examined using fluorescence 
microscopy.
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The recovery period allows NFkB to shift back to the cytoplasm. For HGC-27 a very 
poor transfection efficiency was initially observed (< 10%). This was increased to ~  30% 
by allowing for transfection to occur over a 48hr period, however, after 24hr had lapsed, 
200pl o f  the transfection mix was removed, and wells were topped up with 300pl 
complete medium in order to avoid cell death.
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3.2.4.3 Dosing cells with H2O2
Cells were subsequently treated with H2O2 at the following doses and times - 
control, 30min 250pM H2O2, lh r 250^iM H2O2, all in triplicate for each cell line.
3.2.4.4 Confocal M icroscopy
Following dosing cells were observed live using a Zeiss Confocal laser Scanning 
Microscope (CLSM) 510 Meta (Herts, UK) using the Argon 488nm excitation laser and 
the 500nm emission laser to detect green fluorescence from GFP. Cells were observed 
using the 40x oil objective.
3.3 Results
3.3.1 M TS Assay
The MTS assay was carried out on all three cell lines as a preliminary experiment 
to the H2O2 dosing experiments in order to determine cellular toxicity to the model ROS. 
The assay was carried out over a linear dose range from 50pM -  700pM H2O2, as well as 
across time points -  4, 8 , and 24 hours.
A  similar trend o f  decreasing cell number with increasing dose was observed for 
all three cell lines, clearly seen in the graphical representation o f the data in figure 3.6. 
The cell lines responded as expected based on their different growth characteristics in cell 
culture -  with HGC-27 displaying the fastest growth kinetics and W ILLI the slowest. 
The spectrophotometric absorbance at a wavelength o f 490nm (A-490/ A 4 9 0 )  o f the
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Figure 3.6 Mean A490 (A-490) o f HGC-27 treated with dose range o f Hydrogen Peroxide (H20 2) at 
different time points -  (a) 4hr, (b) 8hr, and (c) 24hr. The A490 o f the soluble formazan product o f the assay 
corresponds to the number o f cells present; an increase would indicate cell proliferation. Here it is clear that 
there is a decline in the A490, and hence cell number. This indicates that increasing concentration o f H20 2 
leads to cellular toxicity, and this is heightened at the 24hr time point. At the 4 and 8hr time points the cells 
appear to halve in number at around 150 -  250pM, whereas at 24hr, this occurs at 50pM. Similar trends 
were seen in all three cell lines tested. N = 3 (i.e. data are averages from 3 experimental repeats).
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soluble formazan product produced during the assay (as a result o f  cellular m etabolism ) 
corresponds to the number o f  cells present. An increase in absorbance would indicate cell 
proliferation and increased cell number. Here it is clear that there is actually a decline in
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the A-490, and hence cell number. This indicates that increasing concentrations o f  H2O2 
lead to cellular toxicity. At the 4 and 8 hr time points the cells appear to halve in number 
(reaching the 50% lethal dose (LD50)) at around 150 -  250pM , whereas this appears to 
be more marked at the 24hr time point, where it occurs at 50pM. From this preliminary 
study (and similar studies previously carried out in the laboratory) it was decided that 
concentrations used in the dosing experiments linking H2O2 to signalling and gene 
expression changes would be around the LD50, ranging from 50 -  500pM.
3.3.2 M icroarrays
Several microarray experiments were performed on the HGC-27 cell line as a 
model using a variety o f doses o f  H2O2 and time points, in order to study the effect o f 
dose and exposure duration on cellular signal transduction and gene expression dynamics. 
All experiments were performed in duplicate and excellent reproducibility was observed. 
The purpose o f the microarray experiments was to identify any major signalling changes 
potentially induced by the model ROS, with a particular emphasis on MAPK and NFkB 
pathways.
Figure 3.7 shows an example o f the results obtained. The control genes (consisting o f 
four human housekeeping genes including P-actin (ACTB) and glyceraldehyde-3 
phosphate dehydrogenase (GAPD), and bacterial plasmid DNA (PUC18); refer to 
appendix AI.l for details) on all arrays showed excellent hybridisation signals, hence 
validating RNA quality. At the 4hr time point, the most marked gene expression changes; 
clearly seen by visual observation o f the arrays (highlighted in figure 3.7); were increases 
in the levels o f c-FOS and VEGF  RNA. Levels o f  both o f these genes can be seen to be 
low, if  detectable at all, in the control cells on inspection o f the arrays in figure 3.7. The 
intensity o f  the signals on the arrays corresponding to these genes becomes stronger with 
increasing H2O2 concentration. A very similar pattern o f  gene expression was also 
observed in cells treated for 8 hr, however, the signals appeared to be even more intense
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Figure 3.7 Example result o f a microarray experiment. It is clear that certain genes are expressed at 
higher levels (seen as more intense signals on the arrays) in treated versus control cells. The two most 
obvious changes are highlighted here; being apparent increases in the level o f c-FOS  and VEGF genes. 
These genes appear to be expressed at very low levels in the control cells, the signal becoming more intense 
with increasing H20 2 concentration. See text for further details. N = 2.
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in treated versus control cells in this case. At the 24hr time point,these previously clearly 
detectable changes in signal intensity (and hence corresponding gene levels) had 
diminished, and instead what was seen was high levels o f  expression o f both o f  these 
genes in control as well as treated cells. It is possible that this is due to the sheer stress of 
being cultured in the presence o f H2O2 for this lengthier time point. Another possible 
explanation for this observation is that over the 24hr duration, the cells are going through 
a cell cycle, and it is likely that a mitogenic response is taking place (regardless o f the 
presence/ absence o f H2O2) leading to the observed gene expression profile.
Arrays carried out using RNA from cells treated in acidic (pH5) medium showed the 
same patterns of gene expression alterations as those observed at neutral pH, and so all 
subsequent dosing experiments were carried out at neutral pH (for practical ease).
Several other genes present on the arrays appeared to be up- or down-regulated 
following H2O2 treatment, and these gene expression alterations are listed in Table 3.3. 
Some very interesting gene expression changes as a result o f  H2O2 treatments were 
observed in the arrays (both Cancer Pathway finder and Nitric Oxide arrays) including 
genes that impact oxidative stress responses, inflammatory signalling, signal 
transduction, cell cycle control, DNA damage response, apoptosis and cellular 
senescence, cellular adhesion, angiogenesis, and invasion and metastasis, all o f  which are 
impacted during cancer development. Interestingly, gene expression changes appeared to 
come about in ‘waves’ based on timing, the first wave (predominantly 4hr post exposure) 
brought about up-regulation o f DNA damage response genes and cell cycle control genes 
(e.g. GADD45A and B, CDKN1A (p21)), oxidative stress response genes (e.g. superoxide 
dismutase (SOD1), thioredoxin reductase (TR1)), some signal transduction and 
transcription factor genes (e.g. MAPK14 (p38), c-FOS), and some changes in genes 
involved in adhesion, angiogenesis (VEGF), and invasion and metastasis. Later changes, 
or a  second wave o f gene expression alterations (perhaps as a consequence o f  the signal 
transduction and transcription factor changes), predominantly included genes involved in 
apoptosis and inflammation, as well as further genes involved in angiogenesis and 
invasion and metastasis. This observation is very interesting, and ties in with cellular
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Table 3.3 Other H20 2 induced gene expression alterations. Genes listed are those whose expression was 
seen to be consistently altered in duplicate array experiments, and only genes that showed a very clear 
change in signal intensity compared to controls were considered as expression changes. The genes are 
categorised according to function. The centre column reflects whether an up- or down-regulation was 
observed, and the right hand column indicates the time point(s) at which the changes were observed. See 
text for further details. N  = 2.
Gene u Tim e point Dose(s)
Cell cycle, DNA dam age and  rep a ir genes
- CDKN1A (p21Wafl /p21cipl) t 4hr 250fiM
- GADD45A and B T 4, 8 ,24hr 250|xM
- OGGI (8-oxoguanine DNA glycosylase) T 24hr 250pM
-MDM2 I 30min 150pM,
4hr 150pM
Apoptosis and cell senescence genes
- BAD (BCL-2-antagonist o f  cell death) T 4hr 50, 150pM
-BCL-2 t 24hr 250, 500jxM
Signal transduction molecules and  transcrip tion  factors
- C-FOS T 1 t  4hr 50, 150,
250fiM
|  8hr 250, 500^M
I  24hr 500pM
-JU N t 24hr 250p.M
-RAF-1 t 4hr 250pM
- MAPK14 (p38 mitogen activated protein kinase) f 4hr 250pM
- TNFRSF1A 1 24hr 250pM
-FGF2 t 30min 150pM
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Table 3.3 continued.
Gene fj, Tim e point Dose(s)
Oxidative Stress Response
- GCLC (Glutamate cysteine ligase) t 4hr 250pM
- TRJ (Thioredoxin reductase) t 4hr 150p,M
- SOD1 (Superoxide dismutase I (soluble)) f 8 hr 250, 500pM
Inflam m ation
-RANTES t 4hr 150,250pM
- IL-6 T 24hr 250pM
- TNF (TNFA) t 4hr 250pM,
24hr 500pM
Adhesion
- ITGA V (Integrin aV) j 30min 150pM,
4hr 250pM,
24hr 500pM
- VCAM1 t 4, 8 hr 250pM
Angiogenesis
- VEGF (Vascular Endothelial Growth Factor) | 4hr 150pM,
8 hr 150,250pM
- EGFR (Epidermal Growth Factor Receptor) f 24hr 500pM
Invasion and m etastasis
- MMP-2 (Gelatinase A) | 4hr 250pM,
8 hr 2 5 0 ,500pM
- PAI-1 (Plasminogen Activator Inhibitor type 1) j 4hr 250pM
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responses to oxidative stress, and also relates with several aspects o f  inflammation and 
carcinogenesis.
The array images obtained using the Chemi Doc, as detailed in section 3.2.2.4g, 
were assessed visually, as well as using the array analysis software downloaded from the 
SuperArray website. From the extensive data analysis carried out it became apparent that 
often, the changes clearly seen by eye did not match up to the data output from the 
software. It is plausible that this discrepancy be attributable to varying levels o f 
background signal on the arrays, leading to normalisation functions by the software that 
may adversely affect the results. Based on this it was decided that the changes detected 
by visual observation (using the criteria that the gene should be barely detectable, if  
detectable at all, in the control experiments when looking at up-regulated genes in treated 
samples, and showing very intense signals in the control samples, which then become 
barely detectable in the treated samples, when looking at down-regulation), were 
sufficient on the grounds o f these experiments since the gene expression changes noted 
were to be quantified further using quantitative real-time PCR analysis.
3.3.3 Real-Time PCR -  MAPK related Gene Expression
3.3.3.1 c-FOS Expression
Real-Time PCR was performed on HGC-27 RNA samples that had been used in 
the microarray analysis, in order to both validate and quantify the results. Unfortunately 
due to the toxicity o f  higher dose treatments at the 24hr time point, some RNA samples 
were o f  poor quality and had to be omitted from the final analyses. In addition, RNA 
extracted from AGS and WILLI cell lines that had been treated with H2O2 as described 
in section 3.2.2.1, table 3.1, was also analysed by Real-Time PCR for c-FOS expression. 
The doses that AGS and WILLI were exposed to were based upon the doses that had 
been seen to cause the most obvious changes in HGC-27. For all three cell lines, the same 
time points were utilised, and a dose range experiment o f H2O2 treatments performed at
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each time point. Unfortunately, in the final real-time PCR analyses, some doses had to be 
omitted due to RNA quality being poor, resulting in a lack o f reproducibility in the data. 
The results o f the experiments are represented graphically in figure 3.8.
One-way ANOVA (with subsequent Tukey and Duncan post hoc tests) carried out 
on each time point revealed statistically significant differences in c-FOS gene expression 
levels between control and treated cells for all three cell lines. Significant data (at the 
95% confidence interval and 0.05 significance level) are highlighted graphically in figure
3.8.
3.3.3.1a c-FOS Expression in AGS
From figure 3.8(a) it can be seen that for AGS, at the 4hr treatment time, there is 
neither a noticeable trend in c-FOS levels, nor any statistically significant difference 
between control and treated cells.
At 8 hr, both H2O2 treatments are significantly different to the control, c-FOS 
levels being approximately 2.4-fold, and 2-fold greater than the control level at the 
250pM and 500pM H2O2 doses respectively.
Interestingly, c-FOS expression levels show statistically significant decreases in 
AGS cells 24hr post treatment, the 250pM H2O2 treatment resulting in an approximately 
3.1-fold decrease, and the 500pM dose leading to an approximately 1.4-fold decrease in 
c-FOS levels.
When contrasting the control levels o f c-FOS expression at the three different 
time points in AGS, some clear differences come to light. At 4hr, control AGS cells have 
a relative c-FOS expression level o f  5.03E-02, which decreases to 2.89E-02 in the 8 hr 
control (1.7-fold decrease), then dramatically increases to 1.28E-01 in the 24hr control 
(2.5-fold and 4.4-fold increases compared to 4hr and 8 hr controls respectively).
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Figure 3.8 Graphs illustrating c-FOS gene expression (analysed by real-time PCR relative to p-actin 
(ACTB)) in control and H20 2 treated cells over different time points in (a) AGS, (b) HGC-27, and (c) 
WILLI. Standard error bars shown Statistically significant differences (P < 0.05) are highlighted with red 
stars. See text for further details (based on one way ANOVA). N = 2.
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This interesting finding may reflect tissue culture conditions. For example, at 24hr, cells 
may be stressed due to a longer duration o f serum starvation (all treatments are carried 
out in serum-free culture medium, section 2 .2 ), dosing with H2O2 would then add further 
stress leading to decreases in gene expression and cytotoxicity, the two being intimately 
linked. At the 4hr and 8 hr time points, low levels o f c-FOS expression in controls may 
reflect an unstressed cellular environment, dosing then either leads to no significantly 
detectable changes in gene expression (as at 4hr) or significant increases in c-FOS levels 
(as at 8hr). The cellular stress that may be a factor in the time point differences may be 
related to the fact that cell culture conditions can impose a state o f oxidative stress on the 
cells (Halliwell, 2003), and that as more time elapses, the oxidative stress becomes more 
intense, leading to enhanced redox sensitive changes in gene expression, and potentially 
accounting for the high level o f  c-FOS mRNA in 24hr control cells compared to their 4hr 
and 8 hr counterparts.
A second possible explanation is that cancer cells themselves produce ROS, a 
phenomenon which has been well documented (Schumacker, 2006; Waris and Ahsan, 
2006; Halliwell et al, 1992; Szatrowski and Nathan, 1991), and as such, the ROS levels 
build up over time leading to the observed time dependent gene expression changes. At 
24hr control cells may be saturated by oxidative stress to a  point that addition o f  H2O2 
leads to cytotoxicity, and so an overall decrease in gene expression.
3.3.3.1b c-FOS Expression in HGC-27
Initial review o f figure 3.8(b) leads to the observation that there appear to be both 
dose -, and time - dependent components in the H2O2 -  induced changes in c-FOS levels 
in the HGC-27 cell line. Dose dependent increases in c-FOS levels are apparent at both 
the 4hr and 8 hr exposure times. For example, at the 4hr 150jiM and 250pM H2O2 doses, 
c-FOS levels increase by approximately 3.1- and 4.5-fold respectively compared to the 
control, with both increases being statistically significant (P < 0.05).
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At the 8hr time point, a clear dose dependent response is manifest, c-FOS levels 
increasing by a significant 7.2-fold increase compared to the control at the 250pM 
treatment and by a significant 12.4-fold increase at the 500pM treatment. Both HGC-27 
and AGS display this clear dose dependent response in c-FOS expression at the 8 hr 
exposure time point. Perhaps 8 hr into culture the cells are accustomed to the cell culture 
conditions enough that the control cells’ expression levels represent that in the unstressed 
state, exposure to H2O2 then elicits a true redox sensitive response in gene expression, 
reflected in the increased c-FOS levels, since c-FOS expression can be induced via redox 
sensitive MAPK signal transduction pathways (Marais et a l, 1993; Gille et al., 1992).
Interestingly, HGC-27 cells display the same trend with respect to decreasing c- 
FOS levels at the 24hr time point as AGS. Relative c-FOS levels decrease approximately 
9.9-fold at the SOOjxM treatment dose compared to the control in a statistically significant 
manner. This may again be due to the time enhanced onset/ effect o f oxidative stress in 
the cell culture microenvironment, or due to enhanced generation o f ROS from the cancer 
cells themselves, as discussed in section 3.3.3.1a. The decline in c-FOS expression 
following exposure to H2O2 was most probably accountable to cytotoxicity. Indeed, 
microscopic observation o f dosed HGC-27 24hr post exposure revealed an unhealthy cell 
population in which the integrity o f  the monolayer was compromised, dominated by 
rounded floating cells (dead cells), and a  lower cell count than the initiated population 
(may be attributable to necrosis and apoptosis). Several o f  the treated cell populations 
yielded very low levels o f  poor quality RNA, which were hence excluded from the 
analysis. HGC-27 also displays the same trend in c-FOS levels across the 4hr, 8 hr, and 
24hr control cells as discussed for AGS (low in 4hr control, lower still at 8hr, 
dramatically increasing at 24hr) in section 3.3.3.1a.
It is worthy o f noting that whilst the AGS and HGC-27 cancer cell lines display 
some marked similarities in terms o f  their c-FOS gene expression dynamics in response 
to H20 2 exposure, there are also some apparent differences. For example, whilst HGC-27 
showed clear dose dependent changes in c-FOS levels at all three time points, AGS only 
showed a very clear dose dependent response at the 8 hr time point (increase). Based on 
the data, and the knowledge o f the differences in the nature o f the cell lines (detailed in
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section 3.2.1.1 and 3.2.1.2), one can speculate that due to the more ‘primary’ 
characteristics o f the AGS cell line, being initiated from a primary gastric tumour that 
displayed no metastasis (Barranco, 1983), the cells may be more robust to oxidative 
stress, displaying an adaptive response at the earlier time point, only succumbing to 
oxidative stress as time progresses. The more advanced HGC-27 cell line derived from a 
lymph node metastasis o f a late gastric tumour, may have enhanced sensitivity to 
oxidative stress, hence showing more clear cut redox sensitive gene expression responses, 
even at the 4hr exposure time.
A striking observation comes to light upon inspection o f figure 3.8(c) which 
reveals that c-FOS expression dynamics in the primary WILLI cell line, in response to 
H2O2 treatment, differ completely from those seen in the two cancer cell lines.
3.3.3.1c c-FOS Expression in W IL L I
WILLI cells do not show any clear dose dependent expression o f c-FOS at the 4 
and 8 hr time points (figure 3.8(c)). The only dose dependency that can be observed is the 
statistically significant (P < 0.05) dose dependent increase in c-FOS levels at the 24hr 
time point. At this time point, c-FOS levels increase by approximately 1.6 -fold compared 
to the control at both the 250 and 500pM doses. This pattern o f c-FOS gene expression in 
WILLI differs dramatically from that observed in the two cancer cell lines, which 
showed some dose dependent increases in c-FOS levels at the earlier time points, 
followed by decreases at the 24hr time point. This is very interesting, since it tends 
toward the hypothesis that the cancer cells may inherently be more redox sensitive in 
their cellular responses when compared to a normal cell line. Another observation that 
supports this theory is that c-FOS levels appear to be fairly similar across the controls o f 
the three time points in WILLI (showing only a slight increase in the 8 hr control), 
suggesting that the normal cell line may either not generate ROS over the course o f  being 
in cell culture, or may have better antioxidant systems for returning cells to a state o f 
redox balance.
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3.3.3.2 VEGF Expression
The second predominant gene expression alteration, along with c-FOS, that was 
seen across the array experiments was either up- or down-regulation o f the VEGF gene 
encoding vascular endothelial growth factor (VEGF). Thus, in a manner similar to that 
described for c-FOS analysis in section 3.3.3.1, samples from HGC-27 (those used in the 
array experiments), AGS, and WILLI were analysed for relative VEGF expression levels 
by quantitative real-time PCR analysis. The results are summarised graphically in figure
3.9. Again, some RNA samples were o f poor quality and had to be omitted from the final 
analyses. One-way ANOVA revealed some statistically significant changes in VEGF 
levels (P < 0.05), highlighted in figure 3.9.
3.3.3.2a VEGF  Expression in AGS
No noticeable dose dependent responses in terms o f  VEGF gene expression were 
evident at the 4hr and 8 hr time points in figure 3.9(a). Twenty-four hour post exposure, a 
dose dependent decrease in VEGF levels was obvious. Treatment with H2O2 doses o f 250 
and 500|iM resulted in statistically significant reduction (P < 0.05) in VEGF levels, by 
approximately 3.7-fold and 5.7-fold respectively. A noteworthy observation was that the 
pattern o f gene expression levels in the control cells reflects that seen for c-FOS levels in 
AGS -  very low levels at 4hr (1.23E-01), lower still at 8 hr (7.57E-02), and then 
dramatically increasing at 24hr (1.28E+00). Again, this may be a cell culture 
phenomenon, whereby more time in cell culture leads to increased oxidative stress and 
hence increased redox sensitive gene expression, the impact o f  oxidative stress on VEGF 
expression being well documented (Shafer et al., 2002). The addition o f H2O2 may then 
contribute to enhanced oxidative stress which becomes manifest as cytotoxicity and
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Figure 3.9 Graphs illustrating VEGF gene expression (analysed by real-time PCR relative to ACTB) in 
control and H20 2 treated cells over different doses and time points in (a) AGS, (b) HGC-27, and (c) WILLI 
cell lines. Standard error bars shown. Statistically significant differences (P < 0.05) are highlighted by red 
stars (based on one way ANOVA). See text for further details. N = 2.
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hence significantly lower VEGF levels.
3 .33.2b VEGF  Expression in HGC-27
The overall picture o f VEGF expression levels in HGC-27 (figure 3.9(b)) appears 
to be dramatically different to that in AGS. At 4hr, exposure to various doses o f  H2O2 
appears to have no major effect on VEGF levels, other than a slight, yet significant 
approximately 1.8-fold decrease over the control at the 50pM dose. In contrast, dose 
dependent increases in VEGF levels are evident across the dose range at both the 8hr and 
the 24hr time point.
Relating the VEGF expression pattern with that o f  c-FOS in HGC-27, some 
differences come to light. While c-FOS expression displays very clear and significant 
dose dependent increases at the 4 and 8 hr time points, followed by a dose dependent 
decrease at 24hr, VEGF levels show no trend at 4hr, and then significant dose dependent 
increases 8  and 24hr exposure times. A possible explanation for this is that c-FOS may 
represent a first wave o f redox sensitive gene expression, whilst VEGF is representative 
of a delayed second wave o f gene expression response to the oxidative stress signal, and 
it is quite plausible that the two are linked, since VEGF is a target o f  c-FOS at the level o f 
transcription via AP-1 (Fujioka et a l, 2004; Ryuto et al, 1996). Indeed, VEGF expression 
is known to be regulated to an extent by upstream redox sensitive MAPK pathways (ERK 
in particular) (Schafer et a l , 2003; Milanini et a l, 1998), as is c-FOS further 
strengthening the link. Interestingly, when comparing gene expression levels in the HGC- 
27 control cells at the three time points, it appears that there is an opposite trend to that 
seen in the AGS cell line. Whilst there was a trend toward increasing VEGF levels as 
time elapsed in AGS, the reverse is true for HGC-27, VEGF levels being highest in the 
4hr control (4.34E-01), decreasing at 8hr (8.78E-02), and 24hr (1.74E-01). It has been 
reported that in some cell lines, high proliferative rate, as well as serum starvation are 
associated with low VEGF levels (Milanini et a l, 1998). It is possible in this instance that 
both o f these factors may explain the decreasing levels o f  VEGF expression in the control
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cells over time, since with time, cell division rate is likely to increase (HGC-27 having a 
greater rate o f proliferation compared to AGS), as is the effect o f  serum starvation.
It appears that in HGC-27, as for c-FOS, VEGF gene expression is more sensitive/ 
responsive to H2O2 -  induced oxidative stress in this experimental system compared to 
AGS cells. Based on the data available, one can only speculate that these differences may 
be due to differences in the cell line characteristics previously discussed (section 
3.3.3.1b). Perhaps there are biochemical differences in the cell lines that make them 
either more/ less susceptible to redox regulated gene expression by common pathways, or 
it is possible that completely different pathways operate in the different cell lines, thereby 
accounting for the differences in gene expression alterations. Differences in rate o f 
proliferation may also be important, with HGC-27 appearing to have a higher 
proliferative rate compared to AGS (by observation). Here, the two cancer cell lines show 
interestingly different responses, and what is even more interesting is that in this case, 
HGC-27 shows a more similar response to the normal WILLI cell line.
3.3.3.2c VEGF Expression in WILLI
WILLI (figure 3.9(c)) shows a similar VEGF expression pattern to that observed 
in HGC-27, with no clear trend at the 4hr time point (significant ~ 1.6-fold increase at 
250pM dose only), and in this case not such a clear trend 8 hr post exposure (significant ~
1.8-fold increase at 250pM dose only), a clear dose dependent response only being seen 
at the 24hr time point where VEGF levels increase significantly by approximately 4.4- 
fold at 250pM, and 5.5-fold at 500jiM.
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3.3.4 Real-Time PCR -  NFkB Related Gene Expression.
As explained in section 3.1.5 IkB and IL-8 expression were used as surrogate 
markers for NFkB activation, since both have been reported to be transcriptional targets 
o f the transcription factor and have been used in this manner in previously published 
studies (Jenkins et a l, 2004). Interestingly, these genes were not seen to be up-regulated 
in the microarray experiments, although this cannot be ruled out as their levels may not 
have been high enough to be picked up by eye (since the arrays require fairly high levels 
o f RNA for detection). Other NFkB regulated genes, e.g. {VCAM, RANTES, TNFA) were 
seen to be up-regulated, and so these two findings, taken together, warranted the study o f 
IkB and IL-8 gene expression by real-time PCR. The results are presented graphically in 
figures 3.10 and 3.11 and show that IkB  and IL-8 follow correlating expression patterns 
in all three cell lines, and so the trends for the two genes will be described together.
33.4a IkB and IL-8 Expression in AGS
Inspection o f  figure 3.10(a) and figure 3.11(a) reveals that at both the 4 and 8hr 
time points IkB and IL-8 gene expression show some up-regulation. At 4hr post exposure, 
both genes are significantly up-regulated at the 250pM H2O2 dose, for IkB, a fold 
increase o f  approximately 2.5 times was evident. For IL-8, a significant approximately
2.8-fold increase in gene expression was apparent. Despite these significant increases in 
gene expression, there is no clear dose dependent increase, since only the highest dose 
brought about an increase at this time point. Eight hour post exposure, there appears to be 
more tendency toward a positive dose dependency, being significant for IkB, and not 
significant (and to a somewhat lesser extent) for IL-8.
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Figure 3.10 Graphical representations o f IkB gene expression (analysed by real-time PCR relative to 
ACTB) in cells treated with a dose range o f H20 2 over a range o f time points in (a) AGS, (b) HGC-27, and 
(c) WILLI cell lines. Standard error bars shown. Statistically significant differences (P < 0.05) are 
highlighted by red stars (based on one way ANOVA). See text for further details. N = 2.
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Figure 3.11 Graphical representations o f IL-8 gene expression (analysed by real-time PCR relative to 
ACTB) in cells treated with a dose range o f H20 2 over a range o f time points in (a) AGS, (b) HGC-27, and 
(c) WILLI cell lines. Standard error bars shown, Statistically significant differences (P < 0.05) are 
highlighted by red stars (based on one way ANOVA). See text for further details. N = 2.
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Twenty-four hour post exposure there is a shift towards a negative dose dependent 
response, IkB expression levels decreasing (albeit not significantly) from control to 
treated cells. IL-8 expression shows the same trend, but the decreases are statistically 
significant, decreasing by approximately 4.5-fold and 11.4-fold in 250pM and 500pM 
treated cells respectively.
These observations appear to be fairly consistent with findings from other studies 
which suggest that NFkB -  induced IkB  and IL-8 expression usually occurs 4 -  8 hr post­
treatment with activating stimuli (Jenkins et al, 2004). The decreasing expression levels 
at the 24hr time point are likely due to cytotoxicity as discussed for c-FOS and VEGF. A 
point worth noting is that at all time points, control levels o f  IkB and IL-8 are fairly low 
and consistent, in contrast to the situation for c-FOS and VEGF\ and that this is the case 
in all three cell lines examined.
3.3.4b IkB and IL-8 Expression in HGC-27
It is evident from figure 3.10(b) and 3.11(b) that there are no clear-cut trends in 
IkB  and IL-8 gene expression at any o f the three time points in HGC-27. At the 4hr time 
point, both genes show statistically significant increases in gene expression at the 250pM 
dose, IkB level increasing approximately 3.8-fold, and IL-8 expression levels showing a 
remarkably high increase o f approximately 128-fold compared to control cells, but 
despite these significant increases, no clear dose dependent increase is observed.
Again, at 8hr there is no clear trend in the results, IkB  levels shows no significant 
changes at any o f the treatment doses. IL-8 expression 8 hr post exposure also shows no 
trend, nor any significant results.
IkB  expression levels show a very subtle dose dependent increase at the 24hr time 
point, with one significant approximately 1.9-fold increase in levels at the 250pM dose. 
There also appears to be a slight increase in levels at the 500pM dose, although this 
increase is not statistically significant. IL-8 expression levels show a similar pattern 24hr
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post exposure, this time both treatment doses inducing significant increases in IL-8 RNA 
levels, with approximately 27.1- and 18.7-fold increases at 250pM and 500pM doses 
respectively.
Overall, it is difficult to establish a relationship between H2O2 exposure and the 
expression o f the two NFkB -  regulated genes in HGC-27 since at some doses and time 
points there are significant increases, and decreases in their RNA levels, with no clear 
dose dependent patterns.
3.3.4c IkB and IL-8 Expression in WILLI
Again, in this cell line, as for HGC-27, there appears to be no clear trends in the 
gene expression data (fig. 3.10(c) and fig. 3.11(c)). For IkB, at 4hr, H2O2 appears to have 
no effect on expression levels at any treatment dose when compared to the control. IL-8 
expression is only impacted at the 250pM dose at 4hr, significantly increasing 
approximately 1.9-fold.
At 8 hr, both IkB and IL-8 show an initially subtle dose response, with RNA levels 
increasing slightly (and not significantly) at the 250pM dose, with a subsequent large and 
significant fold increase at the 500pM dose, increasing by approximately 10.3-fold for 
IkB, and 29.4-fold for IL-8.
At the 24hr time point, IkB levels do not appear to be affected by treatment with 
H2O2. For IL-8, again there is no clear trend in the gene expression alterations with 
dosing, apart from a significant 2.2-fold increase in gene expression levels at the 250pM 
dose.
Interestingly, unlike for c-FOS and VEGF, there doesn’t appear to be any clear 
dose responses in IkB  and IL-8 gene expression and no interesting major differences 
between the cell lines, instead the two genes appear to be up-regulated at very specific 
doses and time points, and this differs between the three cell lines. Noteworthy
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observations are that both AGS and HGC-27 show a maximal induction o f both NFkB 
regulated genes at the 4hr 250pM treatment, and this may be in line with observations in 
other studies in which gene induction peaked at 4hr in response to other stimuli such as 
bile acids, which may in fact act through ROS-dependent mechanisms (Jenkins et al., 
2007). In W ILLI, the maximal gene expression levels are seen following treatment with 
500pM H2O2 for 8hr. It may be that this normal cell line has better antioxidant defences 
that curb excessive redox signalling until a certain threshold level is surpassed.
Overall, the most responsiveness (with respect to oxidative stress induced NFkB 
related gene expression) is seen in the AGS cell line, and this provides support to several 
published studies that link ROS exposure to the up-regulation o f NFkB and subsequently 
IL-8 in AGS cells (Seo et a l} 2002). In all three cell lines, control levels o f both genes 
are low, and remain so over time, only increasing in response to certain dose treatments. 
This contrasts with c-FOS and VEGF control levels, which were in some instances high 
(section 3.3.3.2a, b, c). The clearest observation from this data is that the two cancer cell 
lines appear to be much more susceptible to oxidative stress induced IkB  and IL-8 gene 
expression compared to the normal WILLI cell line, implicating a possible role for 
aberrant NFkB signalling in carcinogenesis.
3.3.5 MAPK Pathway Studies
Since the central aim o f the work in this chapter was to study gene expression 
changes induced by the model ROS H2O2 and the upstream signal transduction pathways, 
elucidating links between the cellular signalling and the gene expression change 
endpoints required further experimentation in order to establish if  such relationships 
exist. With respect to the MAPK pathway, this consisted o f a MAPK inhibitor study, 
analysing the effects o f  MAPK signalling inhibition on a downstream target - c-FOS, by 
real-time PCR, and western blot analysis o f  active forms o f  MAPK proteins - 
phosphorylated ERK (pERK), and phosphorylated p38 (pp38), as well as western blot
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analysis o f  c-FOS protein level to determine if  expression changes seen at the RNA level 
translate to the protein level.
3.3.5.1 MAPK Inhibitor Study
In order to study the potential link between gene expression changes observed, 
and upstream oxidative stress -  induced activation o f  MAPK pathways a preliminary 
experiment was conducted using the HGC-27 cell culture system as the model, in which 
cells were pre-treated with 10pM o f the potent MEK/ ERK inhibitor U0126 as described 
in section 3.2.2.1, and the impact o f  ERK MAPK inhibition on downstream gene 
expression targets was assessed by quantitating any changes in c-FOS levels using real­
time PCR analysis. Prior to experimentation the effectiveness o f  U0126 to inhibit the 
ERK MAPK pathway was confirmed by western blots for active pERK (carried out as 
described in section 3.2.3.1), which showed that pERK levels diminished in inhibitor 
treated cells compared to a positive control (results not shown). Unfortunately, due to 
problems with inhibitor induced cytotoxicity (since blocking MAPK pathways has 
detrimental impacts on cellular biochemistry), the data presented are preliminary, and 
would need to be repeated further in order to validate the findings and draw strong 
conclusions. The results are presented graphically in figure 3.12.
It is quite clear that pre-treatment with the MEK/ ERK inhibitor had a 
downstream effect on c-FOS expression levels, since cells treated with H2O2 without 
prior inhibitor treatment resulted in increases in c-FOS RNA levels compared to 
untreated controls, whilst levels in inhibitor treated cells dramatically decreased 
compared to untreated control cells and cells treated with the same H2O2 dose m inus 
inhibitor. Treatment with 150pM H2O2 for 4hr resulted in an approximately 2.1-fold 
increase in gene expression compared with untreated control cells. Pre-treatment with 
U0126 followed by a 4hr treatment with 150pM H2O2 resulted in an approximately 8.3- 
fold decrease in c-FOS levels compared to the 4hr 150pM treated cells without inhibitor, 
and an approximately 3.9-fold decrease compared to control untreated cells. A similar
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effect is seen at the 250pM  dose, but such a clear effect is not seen at the 500pM  dose 
possibly due to inhibitor and oxidative stress induced cytotoxicty at this high dose, as 
well as H 2O 2 induced cytotoxicity in the cells treated in the absence o f inhibitor.
Figure 3.12 Graphical representation o f average c-FOS RNA expression levels in HGC-27 cells treated 
over a dose range of H20 2 either in the absence o f MEK/ ERK inhibitor U0126 (yellow bars) or after 30 
min pre-treatment with lOpM o f the inhibitor (black bars). Approximate fold-changes in gene expression 
are shown above the bars in the graph. Values in red are fold-changes compared to control values, and 
those shown in blue represent changes in dosed cells plus inhibitor compared to cells treated at the same 
dose minus inhibitor. Standard error bars shown. See text for further details. N =2.
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3.3.5.2 W estern Blots
W estern blots were carried out successfully on protein samples extracted from 
control and treated cells from AGS, HGC-27, and W ILLI using antibodies against 
pERK, p38, and fairly successfully using antibody against c-FOS.
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3.3.5.2a c-FOS W estern Blots
W estern blot analysis o f  c-FOS protein levels in both AGS and W ILLI revealed 
no significant changes following 4hr, 8hr, and 24hr treatments with 250pM  and 500pM  
H2O 2 when compared with controls. HGC-27 however, seemed to show a dose dependent 
increase in c-FOS protein levels at the 4hr time point and to a somewhat lesser extent 8hr 
post treatment, clear in figure 3.13.
Figure 3.13 c-FOS protein levels in HGC-27 (relative to ACTB) following treatment with either 250 or 
500gM H20 2 for 4, 8, and 24hr. Protein levels were analysed using western blots for c-FOS, followed by 
analysis o f band intensities using the ImageJ software downloaded from the NIH website 
http://rsb.info.nih.gov/ii/download.html. and normalizing against p-actin protein band intensities (see 
section 2.7.3 for further details). Standard error bars shown. Fold-changes in treated cells over controls are 
annotated. Results were analysed using one-way ANOVA and statistically significant results (P < 0.05) are 
highlighted with red stars. N = 2.
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Four hour treatment with 250pM H2O2 resulted in a 2-fold increase in c-FOS protein 
levels over control, whilst the 500pM dose induced an approximately 1.9-fold increase in 
levels. At the 8 hr time point, the 250pM dose resulted in an approximately 1.6-fold 
increase in c-FOS level compared to the level in 8 hr control cells, and an approximately 
1.4-fold increase in protein levels was seen following treatment with 500pM H2O2. One­
way ANOVA analysis confirmed that the increases in c-FOS protein levels at the 4 and 
8hr 250 and 500fiM doses were statistically significant at the 0.05 significance level (P < 
0.05). No significant changes in protein levels were seen at the 24hr time point. These 
observations reflect the real-time PCR results for c-FOS RNA levels, and indicate that, at 
least in the HGC-27 cell line, the gene expression changes seen to be induced by H2O2 
treatment occur at both the RNA and protein level.
3.3.5.2b pERK Western Blots -  Short Exposure Study
For all three cell lines pERK (phospho -  p42/p44) protein levels were analysed by 
western blots relative to total ERK (p42/p44) as described in sections 2.7*.3 and 3.2.3.1. 
The treatments were broken down into two groups -  a short exposure study, and a longer 
exposure study using the same time points as in the gene expression studies.
In the short exposure study, cells were treated with 150pM H2O2 (the lowest dose 
which was seen to cause significant changes in c-FOS RNA expression levels) for 5, 10, 
and 30 minutes. An untreated control and a positive control were included in the 
experiment. The positive control comprised cells treated with lOOng/ml EGF for 30min, a 
treatment well documented to cause ERK1/2 (p42/p44) activation (Gao et al., 2005). 
Interestingly, both cancer cell lines showed very similar changes in phosphorylation 
levels o f ERK following short H2O2 exposures. Examples o f western blots obtained from 
the experiments are shown in figure 3.14, and the data presented graphically in figure 
3.15. In HGC-27, pERK levels increase approximately 2-fold over the control level as 
quickly as 5min post treatment, to a similar intensity caused by EGF stimulation (~ 1.9- 
fold increase). pERK levels then fall back to basal levels by 30min post exposure (fig.
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3.15(a)). One-way ANOVA analysis showed that the increase in pERK levels in 5min 
150pM H2O2 treated and EGF treated cells was significantly different than the control 
level (P < 0.05).
A very similar result was seen in AGS cells, although ERK activation showed a 
slight delay compared to HGC-27, occurring lOmin post treatment compared to 5min, 
and levels remaining high even at 30min (fig. 3.15(b)). In AGS, lOmin post exposure to 
150pM H2O2, a clear and significant 1.6-fold increase in ERK phosphorylation was seen 
over the untreated control comparable to the significant 1.7-fold increase induced by EGF 
in the positive control.
WILLI showed similar changes in pERK levels to AGS, with a significant 1.6- 
fold increase in ERK phosphorylation induced lOmin post treatment with 150pM H2O2 
(fig. 3.15(c)).
It is quite clear then, from the results o f this short exposure study, that H2O2 can 
induce a very rapid activation o f the ERK MAPK pathway in all three cell lines, 
occurring the quickest in HGC-27 (5min post exposure), and slightly delayed in AGS and 
WILLI (lOmin post exposure). Activation of ERK appears to be sustained longest in 
AGS, where the level o f  active pERK remains elevated above control levels 30min post 
exposure, whilst in HGC-27 and W ILLI, levels return to basal control levels by 30min. 
This may provide an explanation for the difference in timing o f gene expression changes 
between cell lines. For example, c-FOS expression is up-regulated 4hr post treatment in 
HGC-27, whereas up-regulation is not seen in AGS until 8 hr post treatment, and it is 
possible that this may be related to the different dynamics o f ERK activation.
In any case, it appears that early changes in ERK signalling induced by H2O2 are 
likely to set in motion the cellular signalling required to lead to the later gene expression 
changes observed (section 3.3.3).
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Figure 3.14 An example o f a typical western blot result obtained. A blot for pERK (phospho - p42/p44) 
in HGC-27 cells following short exposures to 150pM H20 2, and a corresponding blot for total ERK 
(p42/p44) for the same samples, so ensuring any changes are true and not due to loading differences. 
Values shown in blue represent experimental duplicates o f the pixel intensity o f the bands following imageJ 
analysis. The values were used in subsequent analyses following normalisation o f pERK levels against total 
ERK. N = 2.
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Figure 3.15 Average pERK (phospho -  p42/p44) levels in (a) HGC-27, (b) AGS, and (c) WILLI 
analysed by western blots relative to total ERK (p42/p44) following treatments with 150pM H20 2 for 5, 10, 
and 30min. A positive EGF treated control, as well as a negative untreated control were included in the 
experiments. Standard error bars shown. Fold change differences compared to untreated control levels are 
annotated ( b l u e )  and statistically significant differences (P < 0.05) are highlighted with red stars (based on 
one way ANOVA). See text for further details. N = 2.
D  EGF +ve I— l-ve Control ®  150|iM  treatments
(a)
H
v
|# K K  L evels  n H O O -2 7  (ieHs ESqpuscdto IK xkiigen  IV ioxidb
2x * *l.vx :
(b)
(c)
li'MK I i*\vK ni.V ells rX|aMC(l to I IVmxklL-
I.6x T *
I.7X t
3.50BO4
pERKLevek ui VMI1J Cells Fxposed to Hyilugen Kroxide
1 .00BO4
9.0015-03
8.00F5-05
7.00B-05
O.OOB-05
SftCBOSW900&05
So0&05
2.00B05
100&05
O.OOE-KJO
— ' ' ■ ------- ---- ------— t
I
144
3.3.5.2c pER K  W estern Blots -  Long Exposure Study
From figure 3.16 it is clear that long H2O2 exposure does not have such a clear 
impact on ERK activation as does short exposure. In HGC-27 (figure 3.16(a)) there was 
some increase in pERK levels when cells were treated with 150pM H2O2 for both 4 and 
8hr, the 8hr exposure resulting in a significant 1.2-fold increase in ERK phosphorylation 
compared to control levels. No change in pERK levels following 24hr exposure was 
evident. So from the data it appears that ERK signalling may be rapidly activated by 
exposure to H2O2, but this increased activation subsides over time. It is quite plausible 
that this would occur, since the initial increase in activation would set in motion a 
cascade o f downstream events leading to changes in gene expression, which can then go 
on to mediate further changes at the level o f  the cell independently o f ERK activation. 
Another important consideration to make, however, is the experimental system - 
although cells are exposed to the ROS for 24hr, it is likely, since H2O2 readily diffuses 
across membranes and exerts its effects intracellularly, that it will be metabolised and 
broken down to less reactive species as time progresses.
pERK levels in AGS (figure 3.16(b)) show more clear-cut changes following long 
exposures, increasing 1.4-fold following 150jiM treatments at both the 4 and 8hr time 
points, maximal increase in ERK phosphorylation being evident following a 4hr exposure 
to 250pM H2O2, the changes being statistically significant. Again, no major changes in 
pERK levels appear to occur at the 24hr time point. These observations tie in with the 
results for AGS in the short exposure study, in which out o f  all o f the cell lines, AGS 
appeared to sustain ERK activation the longest, and this may hold true at the longer 
exposure times.
In W ILLI cells (figure 3.16(c)), H2O2 treatment does not appear to cause any 
changes in ERK phosphorylation levels compared to controls across all time points.
This clear difference between the normal and cancer cell lines can lead to the 
implication that MAPK signalling may be more sensitive to oxidative stress in the cancer
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Figure 3.16 Average pERK levels in (a) HGC-27, (b) AGS, and (c) WILLI analysed by western blots 
relative to total ERK following treatments with different doses o f H20 2 for 4, 8, and 24hr. Standard error 
bars shown. Fold change differences compared to untreated control levels are annotated ( b l u e )  and 
statistically significant differences (P < 0.05) are highlighted with red stars (based on one way ANOVA). 
See text for further details. N = 2.
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cell lines at longer exposure times, particularly in the less advanced AGS cell line, 
suggesting that aberrant ERK signalling may be an early change in the development o f 
cancer, and then being a central feature o f the progressing cancer phenotype (HGC-27).
3.3.5.2d p38 Western Blots -  Short Exposure Study
Figure 3.17 illustrates that short exposures to H2O2 resulted in a fairly similar p38 
activation response as ERK with the exception o f AGS. AGS shows a rather contrasting 
result for p38 compared to ERK (fig. 3.17(a)), whilst 150pM H2O2 had induced 
significant increases in pERK levels at lOmin post exposure, remaining high at 30min, no 
such observation is seen for p38, the ROS seemingly having no effect on p38 activation 
in this cell line.
Five minute treatment resulted in maximal increase in p38 phosphorylation in 
HGC-27 (fig. 3.17(b)), levels then slowly returning to basal control levels, as was the 
case for ERK phosphorylation.
Activation o f p38 in WILLI by H2O2 closely resembles the induced activation o f 
ERK in this cell line, levels o f active phosphorylated p38 peaking at lOmin post exposure 
with a significant 3.1-fold increase (fig. 3.17(c)).
Western blot for phosphorylated p38 was also carried out on the long exposure 
samples (as for pERK), however, no major changes in levels o f phosphorylated p38 
relative to total p38 were evident between control and treated samples at any o f the time 
points in any o f the cell lines.
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Figure 3.17 Average phosphorylated p38 levels in (a) AGS, (b) HGC-27, and (c) WILLI analysed by 
western blots relative to total p38 following treatments with 150pM H20 2 for 5, 10, and 30min. A positive 
EGF treated control, as well as a negative untreated control were included in the experiments. Standard 
error bars shown. Fold change differences compared to untreated control levels are annotated (blue) and 
statistically significant differences (P < 0.05) are highlighted with red stars (based on one way ANOVA). 
See text for further details. N = 2.
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3.3.6 NFkB Pathway Studies
Further studies into the NFkB pathway consisted o f western blots for p65 and 
IkBcx proteins and transfection assays using an NFkB-GFP reporter construct, in which 
activation o f NFkB was visualised by translocation o f the GFP signal (from the 
fluorescent GFP-p65 fusion protein) from cytoplasm to nucleus. Very limited success 
was observed in the western blots, and the results were inconsistent, perhaps owing to the 
quality o f the antibodies. As a result the data was inconclusive and not analysed. In the 
transfection experiments cells were exposed to 250pM H2O2 (since RT-PCR data 
revealed that this dose most commonly resulted in changes in the expression o f NFkB -  
regulated genes IkB and IL-8), for 30min and lh r (since nuclear translocation o f the 
transcription factor should be a fairly rapid event following its activation). Unfortunately, 
very poor transfection efficiencies were observed using the described protocol (section 
3.2.4.2) in all three cell lines, approximately 40%, 30%, and 50% in AGS, HGC-27, and 
WILL-1 respectively. In addition to this pitfall, a reasonable level o f  nuclear translocation 
was observed in control cells, constituting an excessive level o f background NFkB 
activation, possibly induced by the stress o f  the transfection conditions. Together, these 
factors made scoring nuclear translocation o f NFkB induced by H2O2 treatment very 
challenging. No clear changes in NFkB subcellular localisation were observed in treated 
HGC-27 compared to control, but this may be due to the very low transfection efficiency 
observed in this cell line, limiting the number o f cells expressing the construct, and the 
few that did, often showed nuclear localisation o f fluorescent p65 in the controls. WILLI 
cells showed the best transfection frequency o f all three cell lines, indicating the 
possibility that the cancer cell lines are more sensitive to the stresses o f  transfection 
coupled with subsequent oxidant exposure. Despite the reasonable transfection efficiency 
in WILLI cells, very little nuclear translocation o f NFkB was evident in control versus 
treated cells. AGS cells also demonstrated a satisfactory transfection efficiency (--40%), 
and interestingly out o f  all three cell lines, AGS was the only one to show more marked 
changes in NFkB subcellular localisation, increased nuclear translocation being observed 
following H2O2 treatment. An example image is shown in figure 3.18. Due to the
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experimental difficulties encountered, no quantitative data was obtained, and so the 
observations simply served as preliminary findings that were indicative o f  some oxidant 
exposure induced NFkB activity in AGS cells. The preliminary findings suggest it would 
be worth pursuing more sophisticated or better optimised methodologies for studying 
NFkB activation. Due to resource and time restrictions this was not possible in the 
present study.
Figure 3.18 Confocal laser Scanning Microscopy (CLSM) images o f AGS cells obtained using a Zeiss 
Confocal laser Scanning Microscope 510 Meta (Herts, UK) using the Argon 488nm excitation laser and the 
500nm emission laser to detect green fluorescence from GFP. Cells were observed, and images captured, 
using the 40x oil objective. In the untreated cell population, a predominantly cytoplasmic subcellular 
localisation o f NFkB was observed, whilst in treated cells, an increasing level o f nuclear translocation was 
apparent. See text for further details.
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3.4 Discussion
The dire consequences o f oxidative stress has been linked to several different 
types o f cancer, affecting diverse tissue types, particularly those in which inflammation is 
heavily implicated (de Visser and Coussens, 2006; Herrera et al, 2005; Balkwill and 
Coussens, 2004; Klaunig and Kamendulis, 2004; D ’Alessandro et al, 2003; Oshima et 
al, 2003; Coussens and Werb, 2002; Droge, 2002; Balkwill and Mantovani, 2001; 
Conner and Grisham, 1996; Guyton and Kensler, 1993; Cerutti and Trump, 1991). This is 
exemplified by H. pylori -  associated gastric carcinogenesis, in which chronic 
inflammation and accompanying oxidative stress are key players during disease 
progression (Correa, 2006; Macarthur et a l, 2004; Oshima et al., 2003; Shacter and 
Weitzman, 2002; Obst et a l, 2000; Ernst, 1999; Bagchi et a l, 1996; Baik et al, 1996; 
IARC monographs, 1994).
Persistent H. pylori infection elicits inflammatory reactions characterised by 
dense leukocyte infiltration at the infection site with a concomitant release o f a plethora 
of inflammatory mediators and bactericidal free radicals in attempts to ward off infection. 
Unfortunately H. pylori has evolved mechanisms o f evading the host inflammatory 
response, and so, in the absence o f  intervention therapies, chronic inflammation/ gastritis 
can develop with often detrimental consequences for the host, since the inflammatory 
milieu can cause damage to host cells (Correa and Miller, 1998) and can provide a tissue 
microenvironment which is tumour promoting. The oxidative stress component o f the 
chronic gastric inflammation is believed to be a key factor driving the development o f 
gastric cancer in a subset o f individuals. Indeed, one o f the mechanisms by which H  
pylori can cause gastric cancer is via oxidative stress, leading to DNA damage (Obst et 
al, 2000; Baik et a l, 1996), alterations in cell growth by perturbing the proliferation -  
apoptosis balance (Correa and Miller, 1998; Jones et a l, 1997; Peek et a l, 1997; Cahill et 
al, 1996; Moss et al, 1996; Lynch et a l, 1995), and changes in signal transduction and 
gene expression (Tuccillo et a l, 2005; Strowski et al, 2004; Caputo et al, 2003; 
Sepulveda et al, 2002; Chiou et a l, 2001; Mitsuno et a l, 2001; Peek, 2001; Maeda et a l, 
2000; Meyer-Ter-Vehn et a l, 2000; Keates et a l, 1999; Naumann et a l, 1999; Sharma et
al, 1998; Aihara et a l, 1997; Keates et al, 1997). In addition RO/NS associated with 
infection have been reported to result in decreased antioxidant defence mechanisms, and 
enhanced expression o f inflammatory genes, adhesion molecules, mediators o f cellular 
proliferation and oncogenic transcription factors (Baek et al, 2004; Kim, 2000) all o f 
which can drive cancer development.
The present work set out to further examine the oxidative stress component o f 
gastric disease, with a focus on oxidative stress induced signal transduction and gene 
expression changes. The MAPK and NFkB signal transduction pathways and their 
downstream transcription factors targets, AP-1 and NFkB respectively, were essential 
themes in the studies, since they are heavily implicated in inflammation associated 
cancers (Basseres and Baldwin, 2006; Karin, 2006; Waris and Ahsan, 2006; Viatour et 
al, 2005; Karin, 2004; Barnes and Karin, 1997); and are known to have redox sensitive 
components (Gliore et al, 2006; Manna et a l, 1998; Sen and Packer, 1996; Anderson et 
al, 1994; Schreck and Baeuerle, 1994; Meyer et al, 1993; Schreck et a l, 1992; Schreck 
et a l, 1991). Oxidative stress was mimicked using a cell culture model system in which 
cultured cells were exposed to various doses o f H2O2 for varying lengths o f time (Gille 
and Joenje, 1992). H2O2 was used since it provides a very simple model, is readily 
available, is easier to handle than several other unstable oxidants, has been used widely in 
literature (Williams et a l, 2005; Jenkins et al, 2001; Ruiz-Laguna and Pueyo, 1999; 
Wang et a l, 1998; Duthie et al, 1997; Kleiman et a l, 1990; Moraes et al, 1990), the 
effects o f the reactive species on DNA damage, mutation, and apoptosis are very well 
documented (Williams et a l, 2005; Jenkins et a l, 2001; Duthie et a l, 1997; Kleiman et 
al, 1990), and its impacts on cellular signalling and gene expression continue to emerge 
(Gloire et a l, 2006; DeYulia et al, 2005; Guyton et a l, 1996) . Important to the signal 
transduction theme o f the studies, H2O2 is now generally accepted (together with 
superoxide) as a carefully regulated metabolite that can relay signals and critical 
information to the cells nucleus (Veal et a l, 2007; Scandalios, 2005). Furthermore, 
several tumour cells have been shown to constitutively generate H2O2 (Xu et a l, 2004; 
Szatrowski and Nathan, 1991) at rates in the range o f 100 -  500pM /104 cells/ hr. Since 
the physiological levels o f  ROS generated in inflamed gastric mucosa is not clearly 
defined (partly due to the lack o f sensitive enough assays to detect the transient and
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constantly changing levels o f reactive metabolites in the stomach, and the added 
complexity o f a diverse array o f different RO/NS being present at any one time), a dose 
range was selected that spanned the LD50 o f H2O2 seen in toxicity tests (50 -  500pM, 
section 3.3.1), which also covered the range generated in tumour cells (Szatrowski and 
Nathan, 1991) as well as the dose ranges employed in the literature (Williams et a l , 
2005; Jenkins et a l, 2001; Duthie et al, 1997; Kleiman et al, 1990).
Three different cell lines were used in the model, in order to study potential cell 
line specific responses to H2O2 treatment with respect to magnitude and timing o f any 
induced signalling and gene expression changes. The normal primary cell line WILLI 
was used alongside an early gastric cell line AGS derived from a primary gastric tumour 
(Barranco et a l, 1983), and a more advanced gastric cell line HGC-27 derived from a 
lymph node metastasis (Tetsuo, 1976) so to reveal differences between primary and 
transformed cells, and cancer cells at different stages o f the disease (non-metastatic vs. 
metastatic).
The initial microarray experiments carried out using RNA obtained from control 
and dosed HGC-27 cells aimed to identify MAPK and NFkB related signal transduction 
changes induced by H2O2, in relation to dose and exposure time. Several genes were 
seen to be up- or down- regulated by H2O2 exposure, including oxidative stress response, 
inflammatory signalling, signal transduction, cell cycle control, DNA damage response, 
apoptosis, adhesion, angiogenesis and, invasion and metastasis related genes, all o f which 
are impacted during cancer development (Hanahan and Weinberg, 2000). Worth noting 
is the dynamics o f gene expression alterations, since they appeared to come in two 
‘waves’ -  an early first wave (~ 4hr post exposure) consisting predominantly o f up- 
regulation o f DNA damage response and cell cycle genes, oxidative stress response 
genes, signal transduction and transcription factor genes, and some genes involved in 
adhesion, angiogenesis, and invasion and metastasis. Later gene expression alterations 
comprised genes principally involved in apoptosis and inflammatory responses as well as 
more genes involved in angiogenesis and invasion and metastasis. It maybe that this 
second wave o f gene expression changes is a consequence o f the signal transduction and 
transcription factor changes that were induced at the earlier time points. At the cellular
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level, the dynamics o f the gene expression changes make sense. Indeed, amongst the 
early signal transduction changes observed were p38 MAPK, well documented to be 
involved in oxidative stress responses (Dolado et al., 2007; Emerling et al., 2005; Karin, 
2004; Freshney et a l, 1994), and RAF-1, part o f the ERK MAPK pathway, also 
implicated in oxidative stress responses as well as mitogenesis (Chang and Karin, 2001; 
Graves et al., 2000; Treinies et al., 1999). It is likely that this induced cellular signalling 
sets in motion a cascade o f cellular events that culminate in the later gene expression 
changes, notably apoptotic, inflammatory, and angiogenesis genes.
Interestingly, the two most consistently observed changes were up- regulation o f 
c-FOS and VEGF. c-FOS is a component (together with c-JUN) o f  the oncogenic AP-1 
transcription factor complex implicated in inflammation and carcinogenesis (Wisdom,
1999) (section 3.1.2.1). Induction o f AP-1 may indirectly cause inflammation (Abdel 
Latif et al., 2006) possibly accounting for later up-regulation o f the inflammatory 
response genes. c-FOS expression is seen to be up-regulated as part o f  the early response 
to H2O2 exposure, alongside up-regulation o f RAF-1, a  MAPKKK in the ERK1/2 
(p42/p44) MAPK pathway, a known upstream regulator o f c-FOS gene expression 
(Marais et al., 1993; Gille et al., 1992) (sections 3.1.2 and 3.1.2.1, fig. 3.1), providing a 
link between ROS exposure, signal transduction induction and increase in transcription 
factor activity. c-FOS is known to have oncogenic activity (Miller et al., 1984) and is 
frequently found to be over expressed in tumour cells (Milde-Langosch, 2005), and the 
expression o f Fos proteins is seen to be crucial for optimal activity o f AP-1 regulated 
genes (Schtitte et al., 1989).
Genes involved in invasion and metastasis, proliferation, differentiation and cell 
survival are seen to be regulated by AP-1 (Shaulian and Karin, 2002; Jochum et al., 2001; 
Shaulian and Karin, 2001; Van Dam and Castellazzi, 2001; Tulchinsky, 2000). Figure 
3.19 summarises the genes known to be downstream targets o f  AP-1. AP-1 and thus c- 
FOS can influence cell proliferation via cyclin D1 (CCND1) (Belguise et al., 2005; 
Milde-Langosch, 2005) and p21 (CDKN1A) (Milde-Langosch et a l ,  2000), invasion via 
MMP9 and TIMP1, and uPAR (Milde-Langosch et al., 2004; Kim et a l,  2004), and 
angiogenesis via the potent angiogenic factor VEGF (Milde-Langosch et a l,  2004).
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Interestingly some o f these genes were seen to be up-regulated in HGC-27 by the H 2O2 
exposure experiments, raising speculations o f a link between increased c-FOS expression 
and induction o f  AP-1 downstream target genes that are heavily implicated in the 
development o f  a carcinogenic phenotype.
Figure 3.19 AP-1 responsive genes implicated in cancer development. It is clear that active AP-1 is 
linked to the underlying pathology o f cancer at several levels including apoptosis, proliferation, 
differentiation, hypoxia, angiogenesis, invasion, and metastasis. See text for further details. Figure adapted 
from Milde-Langosch, 2005.
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Changes in c-FOS expression levels, most commonly over-expression, have been 
reported in several different cancer types including bone (Sunters et al., 2004; Franchi et 
al., 1998); breast (M ilde-Langosch et al., 2004); endometrial (Bam berger et al., 2001; 
Fujimoto et al. , 1995); cervical (Prusty and Das, 2005; Soto et al. , 1999); lung (Reddy
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and Mossmann, 2002; Volm et al., 1998); skin (Silvers et a l , 2003; Sakai, 1990) 
oesophageal (Wu et a l , 2004), hepatocellular (Yuen et a l , 2001) pancreatic (Lee and 
Charalambous, 1994; Wakita et a l , 1992), and gastric cancer (Meyer-ter-Vehn et a l ,
2 0 0 0 ) amongst others.
With respect to gastric cancer, H. pylori is now clearly a well known aetiological 
factor. Experimentation by Meyer-ter-Vehn et a l (2000) revealed that co-culturing 
gastric cells with virulent bacterial strains enhanced DNA binding o f AP-1, coupled with 
strong induction o f c-FOS mRNA expression. In addition H. pylori activates the ERK1/2 
(p42/p44) MAPK cascade, which ultimately results in increased c-FOS expression via 
Elk-1 (Marais et al, 1993; Gille et al, 1992). Whilst the effect o f  H. pylori on these 
signalling and gene expression pathways is, to an extent, known, the mechanisms are yet 
to be elucidated. These observations are interesting on the grounds that several o f  the 
gene expression alterations seen in the present study are related to MAPK signalling and 
AP-1 (by way o f c-FOS). Since the mechanism by which H. pylori acts to induce MAPK 
signalling and AP-1 activity are not fully defined, I hypothesise here that ROS may play a 
key role, providing the missing link between infection, inflammation, MAPK signalling, 
AP-1 activation and related gene expression changes, and hence gastric carcinogenesis.
Real-time PCR analysis provided evidence that oxidant exposure can indeed 
modulate c-FOS gene expression. Both cancer cell lines, particularly HGC-27 showed 
evidence o f dose dependent changes in gene expression following H2O2 exposure and the 
data fit very well with the changes in c-FOS levels that were observed in microarray 
experiments for HGC-27 (section 3.3.2, fig. 3.7). The two cancer cell lines displayed a 
similar overall trend in C-FOS gene expression dynamics in response to oxidant 
exposure. However, there appeared to be a time delay in significant H2O2 induced gene 
expression changes in AGS compared to HGC-27, H2O2 eliciting increases in c-FOS 
levels 4hr post dosing in HGC-27, no such changes being apparent in AGS until the 8 hr 
time point. These differences may reflect inherent differences in the cell biology o f the 
two cancer cell lines. AGS, being derived from a primary gastric tumour (Barranco et al, 
1983) may be more resilient to some oxidant induced molecular changes, in this case 
only longer exposure times resulting in significant oxidant induced c-FOS expression
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changes. The more advanced HGC-27 cell line is derived from a secondary lymph node 
metastasis o f a gastric adenocarcinoma. It is possible that at the later stages o f cancer 
progression the cells have either become more sensitive to the consequences o f oxidative 
stress, or have accumulated molecular changes that result in aberrant signalling, reflected 
here in a more rapid response to redox regulated gene expression changes. Indeed, 
mutations or aberrant expression o f components o f the RAS-RAF-MEK-ERK1/2 
signalling pathway are known to contribute to carcinogenesis (Leicht et a l, 2007; 
Roberts and Der, 2007; Schubbert et a l, 2007; Zebisch et al, 2007) affecting tumour 
initiation, progression and metastasis. In addition it has frequently been noted that 
differences in cellular biochemistry (e.g. antioxidant enzyme and metabolite levels) as 
well as differences in metastatic potential are likely to affect how a cell responds to an 
exposure/ stimulus (Barranco et a l, 1983; Nicolson et a l, 1978). Differences in 
proliferation rate could also account for the observed differences, HGC-27 demonstrating 
a rate greater than that o f AGS based on time in cell culture prior to sub-culturing. As 
such, a higher proliferation rate may account for higher levels o f gene expression and/ or 
enhanced sensitivity.
The primary WILLI cell line displayed completely different c-FOS gene 
expression dynamics in response to H2O2 than the two cancer cell lines, only showing 
marked changes at the 24hr time point. This is a very interesting finding and leads one to 
speculate the hypothesis that normal cells may be more resilient to oxidative stress and 
redox sensitive molecular changes compared to the cancer cells, which may inherently be 
more redox sensitive (Benhar et al, 2001; Toyokuni et a l, 1995). Further support for this 
comes from the observation that c-FOS levels are seen to increase in untreated cancer 
cells over time, a trend that is absent in W ILLI, and is likely to reflect a build up o f 
oxidative stress in the cancer cells over time, owing either to enhanced RO/NS generation 
in cancer cells themselves (Ding et a l, 2007; Obst et a l, 2000; Davies et a l, 1994a; 
Davies et a l, 1994b; Szatrowski and Nathan, 1991), and/  or less efficient antioxidant 
systems compared with normal cells (Batcioglu et a l, 2006; Navarro et a l, 1999). 
Interestingly H  pylori infection has been documented to modulate the activity o f cellular 
ROS scavenging enzymes, such that accumulating ROS in gastric cells fall to sub-lethal 
doses, and instead result in increased risk o f gastric cancer (Smoot et al, 2000).
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The second gene seen to be up-regulated in microarray experiments was VEGF-A. 
VEGF-A, also known as vascular permeability factor, or VEGF, is a prototypic 
angiogenic factor. It induces endothelial cell differentiation, and is essential during 
embryogenesis (Risau, 1997; Carmeliet et al, 1996; Ferrara, 1996) and wound repair 
(Jones et al, 1999). VEGF is well documented to play a role in tumour progression via 
neo-vascularisation, a critical event during malignant transformation which contributes to 
both local growth o f  a tumour and its metastatic potential at later stages o f the disease 
(Folkman, 1997; Hanahan and Folkman, 1996). VEGF is one o f the most potent inducers 
o f tumour angiogenesis (Ferrara, 1995; Kolch et al, 1995). The importance o f  VEGF in 
tumour angiogenesis and hence development is strengthened by two key observations:-
- Over-expression o f  VEGF and its receptors is seen in several human tumours 
including brain (Ryuto et a l, 1996); hepatocellular (von Marschall et a l, 2001); 
kidney and bladder (Brown et al, 1993a) and gastrointestinal (Brown et a l, 
1993b) cancers, the elevated levels often correlating with poor prognosis. Over­
expression o f VEGF is also important in other pathologies involving chronic 
inflammation.
- Inactivation o f VEGF protein by neutralizing antibodies inhibits tumour 
angiogenesis and growth in vivo (Kim et a l, 1993; Kondo et a l, 1993).
VEGF belongs to a family o f angiogenic factors, which include c-FOS induced growth 
factor VEGF-D (Figf) (Marconcini et a l, 1999; Orlandini et a l, 1996), and VEGF itself 
may also be regulated by a c-FOS mediated mechanism, since the VEGF promoter 
contains an AP-1 binding m otif (Ryuto et a l, 1996) amongst several Spl sites. O f 
particular relevance to the present findings is that several studies have established a  link 
between ERK MAPK activation and VEGF mRNA expression (Strowski et a l, 2004; 
Caputo et al, 2003; Pai et a l, 2001; Milanini et a l, 1998) most commonly via the Spl 
transcription factor (Strowski et al, 2004; Milanini et a l, 1998; Pedram et a l, 1997). A 
variety o f  cytokines and growth factors including EGF, TGFa and p, IL-8  and IL- 6  
(Cohen et a l, 1996; Detmar et a l, 1995; Frank et a l, 1995; Brogi et a l, 1994) as well as 
several transforming agents such as RAS and RAF (Grugel et al, 1995) have been shown 
to induce VEGF expression in a variety o f cell types often via the ERK MAPK pathway, 
yet the signalling cascades are yet to be fully elucidated. At the transcriptional level,
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regulation o f VEGF is complex, since its promoter contains binding sites for several 
transcription factors including AP-2 and Spl (Shima et a l, 1996; Levy et a l, 1995; 
Hagen et a l, 1992; Kadonaga et a l, 1987) as well as binding sites for AP-1 (Angel et a l, 
1987), hypoxia inducible factor (HIF-1) (Ikeda et a l, 1995; Levy et al, 1995), and 
possibly NFkB (Shima et a l, 1996). An interesting connection between oxidative stress, 
MAPK, VEGF, and gastric carcinogenesis becomes apparent considering a study by Cho 
et a l  (2001) in which H2O2 generated by activated neutrophils resulted in MAPK 
activation, and expression and release o f  VEGF from macrophages. This finding, coupled 
with several documentations that H. pylori can induce VEGF expression by way o f 
upstream ERK MAPK activation (Strowski et al, 2004; Caputo et a l, 2003), and that 
VEGF is seen to be up-regulated in gastric tumours (Tuccillo et a l, 2005; Tian et al, 
2001; Yamamoto et al, 1998; Brown et a l, 1993b) warranted the further investigation o f 
VEGF expression in the present study.
As for c-FOS, differences between the three cell lines were also noted in regard to 
VEGF expression dynamics, this time the two cancer cell lines showing very different 
responses to H2O2 exposure associated gene expression changes. Oxidant exposure 
appeared to have no effect on VEGF levels in AGS, aside from decreases in expression 
24hr post dosing. In contrast, HGC-27 and WILLI both displayed some dose dependent 
increases at the 8 hr and 24hr time points. Unlike the induction o f increased c-FOS 
expression in HGC-27, which occurred at 4hr post dosing, VEGF up-regulation was not 
observed until 8 hr, and also displayed up-regulation at 24hr, whereas c-FOS was down- 
regulated at the later time point. This difference in the timing o f  gene expression onset 
may reflect the phases o f gene expression changes that were highlighted by the 
microarray studies which suggested a link between oxidant exposure, ERK MAPK 
signalling, c-FOS, and VEGF expression. Based on the available data it appears that 
compared with AGS, HGC-27 VEGF expression is more responsive to H2O2 induced 
oxidative stress. These differences are again likely to be due to cell line specific 
differences in biochemistry which make them either more or less sensitive to redox 
regulated gene expression. It is also possible that completely different pathways may 
operate in the two cell lines, impacting VEGF expression in very different ways. Like
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HGC-27, WILLI also shows some dose dependent increases in VEGF levels at the 8 hr 
and 24hr time points.
The importance o f these findings with respect to gastric carcinogenesis is that 
since inflammation and its associated generation o f ROS are a key element o f  disease 
pathogenesis, gene expression changes seen to be induced by ROS may play an important 
role in the molecular pathways that underlie this. Here it was shown that c-FOS and 
VEGF levels can be modified by oxidant exposure, albeit in a time, and cell type 
dependent manner. Since H. pylori as been seen to induce up-regulation o f both c-FOS 
and VEGF (Tuccillo et al., 2005; Strowski et al.y 2004; Caputo et a l, 2003; Meyer-Ter- 
Vehn et al., 2000) by mechanisms which remain to be elucidated, these findings 
implicate ROS as possible mediators o f such bacterium — induced changes.
Changes related to the NFkB pathway were also examined using IkB and IL-8 
gene expression levels as markers o f NFkB activity. Interestingly, out o f  the three cell 
lines examined, AGS appeared to demonstrate the clearest dose dependent changes in IkB 
and IL-8 expression following H2O2 exposure, supporting findings by Seo et a l  (2002) 
which linked ROS to enhanced IL-8 expression and NFkB activation in AGS cells. No 
dose dependent responses were clear in HGC-27 and W ILLI. Instead what was observed 
was that some doses elicited significant increases in IkB and IL-8 levels at some time 
points, with no consistent trends. Again, the gene expression patterns were seen to differ 
somewhat between the cell lines. Some noteworthy observations include that maximal 
IkB and IL-8 induction was seen following the 4hr 250pM treatment in both AGS and 
HGC-27. This corresponds to findings by Jenkins et a l  (2004) which revealed a  peak in 
NFkB -  related gene induction at 4hr following exposure to activating stimuli such as 
bile acids, which may in fact act indirectly via enhancing cellular ROS generation 
(Jenkins et a l, 2007). The 250pM treatment dose also appeared to have the greatest effect 
on VEGF expression at the 4hr and 8hr time points; 250pM and 500pM having the 
greatest impact on c-FOS expression. These doses tend toward the higher side o f the 
L D 5 0  observed in MTS assays and are likely to result in cytotoxicity, but also, as 
evidenced in the present data, significant gene expression changes in the surviving cell 
population. In W ILLI maximal gene expression induction was seen in response to the 8 hr
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500pM treatment. The overall picture with respect to IkB and IL-8 gene expression is that 
the H2O2 induced changes differ in all three cell lines, AGS showing the greatest level of 
responsiveness, and WILLI showing the least. This may be due to cell line 
characteristics. The two cancer cell lines appear to be much more susceptible to oxidative 
stress induced gene expression changes than the normal WILLI cell line. This may be 
due to WILLI possessing more efficient antioxidant defence systems than the cancer cell 
lines, so helping to maintain a steady redox balance in treated cells, only being perturbed 
above a threshold level o f  oxidant exposure. A second possible explanation may be due 
to aberrant NFkB signalling in the cancer cell lines, making the pathway more redox 
sensitive than normal. This lends support to the several reports that link aberrant NFkB 
signalling to carcinogenesis (Karin, 2006; Rayet and Gelinas, 1999).
Based on the data, it is difficult to establish a clear relationship between H2O2 
exposure and NFkB regulated gene expression. Oxidant exposure does appear to affect 
IkB and IL-8 gene expression, causing significant up-regulation in some instances, but 
this occurs in a  clearly dose, and cell type specific manner. Several reports in the 
literature support this observation.
Taken together, the array and real-time PCR results helped to determine that frank 
cellular exposure to H2O2 (and its resultant oxidative stress) results in gene expression 
changes that appear to be linked to upstream MAPK and NFkB signalling pathways. 
Further experiments were hence carried out to obtain greater insight into the upstream 
signalling events. Some support for a link between H2O2 exposure and c-FOS gene 
expression to an upstream redox sensitive MAPK pathway was provided by a preliminary 
study in which the MEK (MAPKK) component o f the ERK MAPK pathway was 
inhibited in HGC-27, and the effects on c-FOS expression analysed by real-time PCR. 
Results showed that c-FOS expression could be diminished by inhibitor pre-treatment.
When analysing gene expression changes it is important to look beyond the RNA 
level to the protein level, since proteins are the ultimate effectors in the cell. As such c- 
FOS protein levels were examined in the three cell lines. The results revealed that no 
clear significant changes in c-FOS protein levels in response to H2O2 exposure were 
evident in AGS and WILLI cell lines, whilst some dose dependent increases in protein
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levels were observed in HGC-27 at the 4hr and 8 hr time points. The western blot data for 
HGC-27 was in accordance with the real-time PCR results for c-FOS RNA levels 
indicating that H2O2 -  induced c-FOS gene expression changes occur at both the RNA 
and protein level, and so is likely to have a knock on effect on cellular physiology and 
behaviour. In AGS and WILLI the changes in c-FOS RNA levels did not appear to 
translate to protein level changes. Interestingly in these two cell lines c-FOS RNA level 
changes did not occur to the magnitude seen in HGC-27, leading to the speculation that 
perhaps only above a certain threshold RNA level do protein level changes occur, 
possibly owing to factors such as RNA stability, and regulation at either the 
transcriptional or translational level. Interestingly, upstream signalling pathways such as 
MAPK cascades can also act to regulate gene expression at the post-translational level, 
for example, by enhancing mRNA stability and affecting translational control (Chang and 
Karin, 2001; Kotlyarov et a l , 1999). With respect to c-FOS, post translational control has 
been reported by way o f phosphorylation by a novel MAPK, FRK (Deng and Karin, 
1994), and the involvement o f this level o f  control in the present findings cannot be ruled 
out.
Upstream p42/p44 ERK activity levels were also examined further at the protein 
level, using pERK as a marker o f ERK activation. In short exposure studies, 150pM 
H2O2 induced significant and rapid activation o f ERK signalling. HGC-27 displayed the 
quickest H2O2 induced activation o f ERK a mere 5min post exposure. In AGS and 
W ILLI, activation was seen to occur after lOmin. The results clearly provide evidence 
that H2O2 can induce very rapid, albeit transient activation o f  the ERK MAPK pathway in 
all three cell lines. ERK activation was seen to be sustained the longest in AGS cells, 
pERK levels remaining elevated above control levels even after 30min whilst it had 
returned to basal control levels in HGC-27 and W ILLI. These differences in dynamics o f 
ERK activation may account for the difference in timing o f  downstream gene expression 
changes between the cell lines.
Long exposures to H2O2 did not appear to have such a significant impact on ERK 
activation as the short exposures. Some significant increases in pERK levels were evident 
in HGC-27 at the 4hr and 8 hr 150jjM treatments, in AGS at the 4hr 150pM, 250pM,
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500|iM, 8 hr 150}iM, and 24hr 150jiM treatments, and no significant changes were 
observed in W ILLI. The 150pM dose seemed to most consistently affect pERK levels, 
this dose also inducing the rapid ERK induction in short exposure experiments, and it 
was also seen to result in c-FOS and VEGF up-regulation suggesting that this dose may 
have the most impact on overall cellular behaviour. This is an interesting finding, since it 
corresponds to several published studies in which similar H2O2 doses resulted in the 
induction o f DNA damage (Duthie et a l, 1997; Kleiman et a l, 1990), point mutations 
(Jenkins et a l, 2001), and chromosomal aberrations (Williams et al, 2005). Moreover, 
this dose lies within the range o f H2O2 levels seen to be generated by several tumour cell 
lines (Szatrowski and Nathan, 1991).
O f the three cell lines, AGS seemed to be the most responsive with respect to 
oxidant induced increases in pERK levels at the long exposure times, and this fits in with 
the observation that ERK activation persisted the longest in AGS cells following the short 
H2O2 exposures. The difference between the cancer cell lines and the WILLI cell line 
support the idea that cancer cells are likely to be more sensitive to oxidative stress than 
the normal cell line. In the cancer cells MAPK signalling may be more sensitive to 
oxidative stress at longer exposure times, particularly in the less advanced AGS cell line. 
This suggests that aberrant ERK signalling may be an early change in oxidant linked 
cancer development driving oncogenic gene expression changes, and is also likely to be a 
central feature o f later disease phenotype (HGC-27). This is o f particular relevance since 
in vivo gastric conditions, especially in cases o f chronic gastritis (+/ - H. pylori infection), 
are likely to impose persistent oxidant insults on epithelial cells. Cells that may have 
already undergone an initiating event (e.g. ROS induced mutation) may then be more 
susceptible to further oxidant driven molecular changes. In addition, ERK is a known 
survival factor, favouring cell proliferation over apoptosis (Xia et a l, 1995) so enhanced 
activation o f ERK signalling in cancer is likely to favour cellular proliferation, and so 
disease progression.
Short exposures o f  H2O2 were also found to activate the p38 MAPK pathway, in a 
manner similar to that observed for ERK signalling, at least in HGC-27 and W ILLI, 
150pM H2O2 resulting in an increase in phosphorylated p38 following 5min treatment in
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HGC-27 and lOmin in W ILLI. Such changes were surprisingly not seen in the AGS cell 
line, the reason behind which is unclear based on the available data but may be due to 
aberrant p38 signalling in the cell line, or general cell line differences in the oxidant 
sensitivity o f the p38 MAPK pathway. This finding may be o f significance since whilst 
ERK favours cell survival and proliferation, p38 MAPK signalling is linked to the 
induction o f apoptosis (Xia et a l, 1995), as such, H2O2 - induced activation o f ERK, but 
not p38 in AGS cells may result in a shift in the proliferation -  apoptosis balance in 
favour o f  proliferation, an event which is central to cancer development (Hanahan and 
Weinberg, 2000).
With respect to NFkB, some significant changes in the expression levels o f IkB 
and IL-8 were evident in the real-time PCR studies, reflecting a potential oxidant induced 
activation o f NFkB. Reporter gene transfection experiments utilising a GFP-p65 fusion 
protein construct (Schmid et al, 2000) provided preliminary evidence that H2O2 caused 
nuclear translocation o f NFkB in AGS cells. H2O2 did not appear to elicit nuclear 
translocation o f NFkB in W ILLI. Due to very low transfection efficiency in HGC-27, it 
was not possible to determine the effects of oxidant exposure on nuclear translocation o f 
NFkB in this cell line, and unfortunately due to difficulties in the experimental protocol, 
it was not possible to obtain quantitative data for any o f the three cell lines. Fine tuning o f 
the protocol and further experimentation would be required to obtain a clearer picture.
In summary, the present work brought to light evidence supporting the importance 
of oxidative stress in gastric carcinogenesis, demonstrating that in addition to the 
induction o f oxidative DNA damage and mutations, oxidative stress can also act at the 
level o f signal transduction (e.g. MAPK and NFkB) and gene expression (e.g. c-FOS, 
VEGF. IkB , IL-8). Since several o f  the gene expression changes observed have been 
reported to be induced by H. pylori infection, the findings suggest that infection 
associated oxidative stress may be at the mechanistic base o f the infection induced 
changes, and add strength to the notion that oxidative stress forms a critical aspect o f H. 
pylori -  associated gastric cancer.
The most interesting finding was that the oxidant induced changes were often 
seen to occur in a  dose, time, and cell-specific manner, the two cancer cell lines showing
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more marked responses than the normal WILLI cell line. In addition differences were 
often observed between the two cancer cells, HGC-27 appearing to be more oxidant 
sensitive with respect to some molecular changes, and AGS being more sensitive to 
others -  likely owing to the different stages o f malignancy o f the two cell lines -  HGC-27 
being the more advanced o f the two, and as such the differences potentially reflect 
molecular changes that act at earlier or later stages o f disease progression* The c-FOS 
studies, for example, demonstrated that HGC-27 was more responsive to oxidant induced 
c-FOS expression than AGS, and that WILLI was the least responsive, at both the RNA 
and protein levels. It is very likely that such cell line and type specific differences are 
related to differences in cellular biochemistry, such as build up o f oxidative stress or less 
efficient antioxidant systems. Indeed a recent report demonstrated that cancer cells carry 
greater oxidant loads due to enhanced ROS generation, and that inhibiting antioxidants 
can kill them preferentially since they will accumulate more severe levels o f ROS, thus 
making them more sensitive to the detrimental effects o f  ROS than their normal 
counterparts (Trachootham et al, 2006). This fits nicely with the present findings and 
suggests that the enhanced oxidant sensitivity o f malignant cells can be exploited 
therapeutically.
Certainly, the further investigation of the biochemical differences between the 
three cell lines -  with a particular focus on how differences in antioxidant systems may 
be a reflection o f the observed differences in oxidant induced signalling and gene 
expression alterations, is warranted by the present findings. However, since the broader 
aim o f the research was to study the effects o f  inflammation and ROS on signalling 
changes in gastric cancer using in vitro and in vivo models, following chapters focus on 
these aspects.
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Chapter 4
Gastric Epithelial Cell -  Inflammatory Cell Co-culture Studies Part I: 
Optimisation o f HL-60 Immature Neutrophil Cell Line fo r Respiratory Burst
Induction
4.1 Introduction
The importance o f inflammatory processes in the pathogenesis o f malignant 
disease, in particular gastric cancer, is a central theme o f  the present research and has 
been detailed in sections 1.4.5 and 1.7. It is now well accepted that chronic inflammation 
o f the gastric mucosa lies at the root o f the pathogenesis o f  gastric cancer (Zavros et a l , 
2005). This chronic inflammation manifest as chronic gastritis has been linked to H  
pylori infection (Israel and Peek, 2001; Correa, 1992a; Marshall, 1986) but can also occur 
in the absence o f infection as a result o f other insults. Irrespective o f the cause, the 
chronic inflammation, is believed to generate a local tissue microenvironment 
characterised by dense inflammatory cell infiltrates, and an inflammatory milieu o f pro- 
inflammatory cytokines, arachidonic acid derivatives, as well as a plethora o f  reactive 
metabolites including RO/NS. Together these factors can instigate and drive 
carcinogenesis by:-
•  Induction o f DNA damage, hence increasing the likelihood o f initiating 
mutations (point mutations and chromosomal aberrations). The DNA 
damage associated with inflammation is often oxidative DNA damage 
(Farinati et a l, 2003; Obst et a l, 2000; Shimoda et a l, 1994; Weitzman 
and Gordon, 1990; Lewis and Adams, 1987; Weitzman and Stossel, 1981) 
caused by the ROS released from activated neutrophils in the locale;
•  Shifting the proliferation -  apoptosis balance in favour o f  proliferation. 
This may be the result o f an increase in apoptosis and a compensatory 
increase in proliferation, or simply as a consequence o f decreased 
apoptosis or increased proliferation (Buttke and Sandstrom, 1994);
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•  Driving changes in cellular signal transduction and gene expression. This 
can be the result o f shifts in local tissue concentrations o f cytokines and 
growth factors (Yoshimura, 2006; Dobrovolskaia and Kozlov, 2005; Baud 
and Karin, 2001) or by oxidative stress mediated changes in redox 
sensitive signal transduction cascades (as demonstrated in chapter 3 for 
MAPK and NFkB signalling in response to frank H2O2 exposures).
Together these changes favour the development o f malignant disease at the levels o f 
initiation and promotion, and interestingly can all be attributed to the effects o f ROS 
(Valko et a l, 2007; Valko et al., 2006; Klaunig and Kamendulis 2004; Droge, 2002; 
Turpaev, 2002; Conner and Grisham, 1996; Dreher and Junod, 1996). The effect o f ROS 
on cellular signal transduction and gene expression was examined in chapter 3.
Since a tissue inflammatory response has both cellular (neutrophils, macrophages, 
lymphocytes, etc.) and non-cellular components (inflammatory cytokines as well as a 
diverse array o f  metabolites including RO/NS) it is important to consider the effects of 
both components together since this allows a  closer modelling o f the in vivo situation. 
Indeed it has been suggested that the combinatorial effects o f  different aspects o f  the 
inflammatory response (e.g. ROS and lipid mediators o f inflammation) may have a 
greater impact on cells than single exposures (Lewis and Adams, 1987).
As such, the aims o f the present chapter were to optimise a co-culture system in 
which gastric epithelial cells could be cultured in the presence o f inflammatory cells 
stimulated to undergo an inflammatory response comprising release o f RO/NS amongst 
other pro-inflammatory mediators. This would constitute an in vitro model for the effects 
o f components o f  the inflammatory response on cellular signalling and gene expression 
that more closely mimics the in vivo tissue setting than the H2O2 oxidative stress inducing 
model used in chapter 3, since it takes into account the interaction between different cell 
types as well as the combinatorial effects o f inflammatory mediators and spectrum o f 
RO/NS.
This chapter describes the optimisation o f  an inflammatory leukocyte cell 
population induced to undergo an oxidative burst response. The cells could then later be 
introduced into a co-culture system with gastric epithelial cells so mimicking the tissue
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microenvironment characteristic o f inflammation (oxidative stress and inflammatory 
mediators) in order to examine the signalling and gene expression changes that such a 
setting may instigate. A variety o f treatments and techniques were used in the 
optimisation efforts, all o f  which are described in the sections that follow.
4.1.1 Importance of a Co-culture System
Since RO/NS are now recognised as key players in the underlying pathogenesis o f 
several diseases including cancer (Valko et al, 2007; Valko et a l, 2006; Klaunig and 
Kamendulis, 2004), great efforts have been put into establishing the cellular effects o f  the 
reactive molecular species at several levels from DNA damage and mutation induction, to 
the effects on cellular lipids and proteins, and changes in cellular signalling and gene 
expression (Gloire et a l, 2006; Williams et a l, 2005; Houle et al, 2003; Takada et a l, 
2003; Lee and Esselman, 2002; Jenkins et al, 2001; Toyokuni, 1999; Meyer et al, 1993; 
Schreck et a l, 1991). Unfortunately the majority o f such studies utilised in vitro systems 
in which cells were exposed to chemically generated RO/NS by way o f frank exposures. 
Such experiments do not take into account factors which may be important in the in vivo 
setting such as rate o f permeation o f the RO/NS into cells, half-life and dose o f  the 
RO/NS, as well as the fact that in reality cells are likely to be exposed to mixtures o f 
different RO/NS not just one type. The use o f  co-culture systems permits the 
investigation o f the cellular effects o f  biologically generated RO/NS so mimicking the in 
vivo biological microenvironment to a somewhat better extent.
4.1.2 The Inflammatory Model
During tissue inflammation activated inflammatory leukocytes, particularly 
neutrophils and macrophages, are a major source o f  RO/NS such as NO, H2O2 and 0 2 *' 
(Kim et a l, 2003; Pedruzzi et a l, 2002; Weitzman and Gordon, 1990, Babior, 1984a; 
Weitzman and Stossel, 1981). ROS are generated by NADPH oxidase which catalyses
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the one electron reduction o f oxygen to ( V ,  the spontaneous dismutation o f which leads 
to H2O2 generation (Babior, 1999; Forman et a l, 1998), and several other derivative 
species may be formed as a consequence. This increase on oxygen consumption is termed 
the ‘respiratory/ oxidative burst’ (Sandborg and Smolen, 1988; Babior, 1984b) and was 
first observed in 1933 (Baldridge and Gerard, 1933). This oxidative burst response is 
normally under stringent regulation such that it only occurs as and when needed thereby 
maintaining tissue homeostasis with respect to ROS levels so avoiding situations o f 
oxidative stress. If  this is not controlled then continued inflammatory leukocyte 
accumulation and activation with the coupled oxidative stress in tissues can lead to 
crippling chronic inflammatory conditions. The positive effects o f  the release o f 
leukocyte generated RO/NS is exemplified during infections where the potent metabolites 
kill off pathogens. Unfortunately if  it is not carefully controlled “collateral damage” in 
nearby tissues can result (Babior, 1999).
The oxidative burst response in inflammatory leukocytes is dependent upon the 
activation o f NADPH oxidase. NADPH oxidase can be activated by a number o f  different 
stimuli, both soluble and particulate in nature (Lundqvist et a l, 1996; Lundqvist et a l,
1994). Stimuli commonly present at sites o f inflammation can lead to the activation o f 
leukocyte NADPH oxidase, the most potent being opsonised microorganisms, C5a 
complement fragment, N-formyl methionine peptides (e.g. N-Formyl-L-methionyl-L- 
leucyl-L-phenylalanine (fMLP)), platelet activating factor (PAF), leukotriene B 4  ( L T B 4 ) ,  
etc. These natural inflammatory stimuli have dual properties as chemotactic factors -  
instigating the migration o f neutrophils and other leukocytes toward sites o f 
inflammation, and as inducers o f oxidative burst (Casimir and Teahan, 1994). Synthetic 
agents such as phorbol myristic acid (PMA) and other phorbol esters, fluoride, and 
calcium ionophore A23187 are also highly effective at stimulating oxidase activation and 
oxidative burst.
The metabolic phenomenon o f the oxidative burst normally occurs intracellularly 
in phagocytic inflammatory cells (neutrophils, monocytes, macrophages). Some o f the 
generated ROS may, however, be released extracellularly by way o f phagocytosis, or via 
simple diffusion through the plasma membrane in the case o f membrane permeable 
metabolites such as H2O2. In such instances the ROS, unless scavenged by antioxidants
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may inflict damage and toxicity on nearby cells, inducing DNA damage and mutation 
(Farinati et a l, 2003; Obst et al, 2000; Shimoda et a l, 1994; Weitzman and Gordon, 
1990), necrosis and apoptosis (Buttke and Sandstrom, 1994), as well as changes in gene 
expression and signal transduction (Valko et a l, 2007; Valko et a l, 2006; Klaunig and 
Kamendulis 2004).
On these grounds, and going back to the central theme o f the present research -  to 
study the effects o f oxidative stress and inflammatory processes on signal transduction 
and gene expression in gastric epithelial cells, an inflammatory model consisting o f 
activated inflammatory leukocytes (stimulated to undergo oxidative burst) co-cultured 
with gastric epithelial cells was developed. The components o f the co-culture system are 
summarised in figure 4.1 and detailed in the sections that follow.
4.1.3 Use of the HL-60 Cell Line
The use o f co-culture experimentation to study cell-to-cell interactions, 
inflammatory responses, and effects o f  bacteria such as H. pylori on cells has become 
increasingly well documented in the literature (Stone et a l, 2005; Kim et a l, 2004; Kim 
et al, 2003; Yang et al, 2003). Such experimental systems have also proved useful in 
analysing relationships between activation o f inflammatory leukocytes and mutagenesis 
in near-by cells (Kim et a l, 2003) since inflammatory processes are strongly implicated 
in carcinogenesis and may act by way o f RO/NS (Wietzman and Gordon 1990; 
Weitzman and Stossel, 1981). Studies using inflammatory leukocytes such as neutrophils 
often utilise cells isolated from fresh blood samples obtained from mice/ rats or 
consenting individuals (Shen et a l, 2002; Watanabe et a l, 2001; Knaapen et a l, 1999; 
Ariza et a l, 1996), or established cell lines such as the mouse macrophage cell line 
RAW264 (or its human derivative WBC264-9C) and the human promyelocytic cell line 
HL-60 (Kim et a l, 2003; Lundqvist et a l, 1996). The advantage o f using cells isolated 
from fresh blood is that they are more likely to behave normally in terms o f an 
inflammatory response compared to a transformed cell line. However, the use
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Figure 4.1 Summary o f co-culture system for studying the effects o f oxidative stress amongst other 
components o f an inflammatory response on signal transduction and gene expression changes in gastric 
epithelial cells. In this study the inflammatory component is the HL-60 promyelocytic cell line 
differentiated to neutrophils and stimulated to undergo an oxidative burst response. RO/NS generated by 
the intracellular oxidative burst may be released extracellularly by way o f phagocytosis or by simple 
diffusion across the plasma membrane in the case o f membrane soluble compounds such as H20 2.
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o f freshly isolated cells does have its drawbacks, for example -  their use relies on the 
availability o f fresh blood samples, preferably from the same donor to avoid problems 
with heterogeneity, and even if  the blood is drawn from the same donor there is still a 
likelihood o f obtaining heterogeneous populations o f cells that show variations in their 
response. For this reason the use o f an established readily available cell line, which would 
provide a relatively homogeneous population o f cells was preferred in the present work. 
Although a transformed cell line may respond differently to normal cells, the advantages 
associated with the cells being readily available as and when needed outweighed the 
disadvantages.
Since the aim o f the work was to mimic an inflammatory response that may be 
representative o f gastritis tissues, in which the inflammatory cell infiltrate is initially 
predominated by neutrophils (Schmausser et al., 2004; Israel and Peek, 2001; 
Shimoyama and Crabtree, 1998; Ernst et a l, 1997; Kozol et aL, 1991) (detailed in section 
1.4.5.1), the human promyelocytic cell line HL-60 was utilised since its differentiation 
into neutrophils can readily be induced using a variety o f polar compounds (Martin et al., 
1990; Collins e ta l,  1978).
The HL-60 cell line is a pluripotent leukocyte cell line o f the myeloid lineage, 
which upon maturity can give rise to a variety o f  cell types including monocytes/ 
macrophages and granulocytes - neutrophils, eosinophils, and basophils. The cell line was 
established from a 36-year old Caucasian female with acute promyelocytic leukaemia 
during leukopheresis (Collins et a l, 1977), and has since served an excellent model for 
the study o f myeloid differentiation and function (Vrba et a l, 2004; Martin et al, 1990; 
Bimie, 1988; Collins et a l, 1978). The cells are seen to behave as normal leukocytes in 
respect to their phagocytic capacity and responsiveness to chemotactic stimuli, and 
production and release o f TNFa following stimulation with phorbol myristic acid (PMA) 
(Gallagher et a l, 1979). In regard to their capacity for oxidative burst response, HL-60 
have been seen to respond in a similar, if  not enhanced, manner to peripheral blood 
neutrophils upon treatment with stimuli known to induce oxidative burst (Trayner et a l, 
1995; Sirak et a l, 1990). The cell line is pseudodiploid and is positive fo r  MYC  oncogene 
expression contributing to its transformed nature.
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Under cell culture conditions, 10% o f HL-60 cells can spontaneously differentiate 
into mature myelocytes (e.g. neutrophils, oesinophils) (Collins et a l, 1978). This 
proportion can be enhanced by treatment with polar-planar compounds such as dimethyl 
sulfoxide (DMSO), butyrate, hypoxanthine, PMA, actinomycin D, retinoic acid, etc. 
DMSO treatment is seen to cause differentiation o f  HL-60 cultures such that the cell 
population becomes a mix o f mature myelocytes, metamyelocytes, and banded and 
segmented neutrophils, with metamyelocytes and banded neutrophils predominating 
(Collins et al., 1978). It has been observed that functionally, HL-60 grown for 1-3 days in 
the presence o f 1.3% DMSO are capable o f O?  generation (via oxidative burst), 
phagocytosis, degranulation, and bacterial killing (Newburger et a l, 1979). Longer 
differentiation periods (up to 9 days) lead to enhanced function, with the maximal 
performance o f  each function being 50-100% o f that observed in normal neutrophils.
Here, HL-60 were induced to differentiate into neutrophils (or metamyelocytes 
and banded neutrophils) by incubation with 1.3% v/v DMSO as described by Newburger 
et a l (1979) and Collins et a l (1978) for periods o f  3, 4, and 5 days in attempts to 
optimise the treatment regimen for maximal induction o f  differentiation, whilst at the 
same time being feasible within the time constraints o f the research. Differentiation was 
subsequently assessed using morphological and functional criteria.
At the morphological level, cells were examined microscopically to check for 
characteristic features o f neutrophils. These include -  irregular shape, granulated 
cytoplasm, and irregular multi-lobate nuclei (in mature neutrophils) or donut-shaped 
nuclei (in immature banded neutrophils). At the functional level, differentiation status 
was assessed by measuring oxidative burst capacity o f the cells using the Nitro Blue 
Tetrazolium (NBT) assay (see methodologies section).
4.1.4 fMLP Stimulation
Several published reports on leukocyte oxidative burst have utilised a  range o f 
artificial stimuli -  such as PMA as well as other phorbol esters, opsonised zymosan, and 
calcium ionophore A23187 (Muranaka et a l, 2005; Kim et a l, 2003; Lojek et a l, 2002; 
Lundqvist et a l, 1996; Trayner et a l, 1995), as well as natural inflammatory stimuli such
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as fMLP (Muranaka et a l, 2005; Vrba and Modriansky, 2004; Lojek et a l, 2002; Shen et 
al, 2002; Mahomed and Anderson, 2000; DeLeo et al., 1998). The synthetic stimuli tend 
to act by way o f non-receptor mediated mechanisms, whilst the stimuli found naturally at 
sites o f tissue inflammation act via receptor mediated pathways. These receptor mediated 
pathways are coupled to intracellular signalling pathways by means o f heterotrimeric G 
proteins, leading to both oxidative burst induction and facilitation o f migration of 
leukocytes to the inflamed site (Casimir and Teahan, 1994; Baggiolini et a l, 1993). This 
natural inflammatory response is exemplified by fMLP. Interestingly, the response o f 
leukocytes to fMLP seems to be largely dependent upon the dose o f  the stimulus. For 
instance, doses less than lOOnM induce neutrophil migration along chemotactic gradients, 
whilst doses above lOOnM induce an oxidative burst response (Casimir and Teahan,
1994).
Since the co-culture model aimed to simulate a typical inflammatory response in 
the gastric mucosa, commonly caused by H. pylori infection, it was decided that a natural 
inflammatory stimulus would be used to induce an oxidative burst response in HL-60. 
Unfortunately for safety reasons, the use o f H  pylori factors was not possible, instead 
fMLP was chosen as it is widely used in the literature and is seen to be effective at doses 
between lOOnM and 5pM, with IjiM  being the most commonly employed dose (Shen et 
al, 2002; Mahomed and Anderson, 2000; DeLeo et a l, 1998). Furthermore, fMLP has 
been shown to induce H2O2 production in HL-60 cells to a  similar magnitude to that seen 
in fMLP stimulated blood neutrophils (Sirak et a l, 1990).
Until recently it was believed that undifferentiated HL-60 did not have the 
capacity to generate RO/NS in response to stimuli, however, Muranaka et a l  (2005) 
demonstrated that undifferentiated HL-60 possess NADPH oxidase activity and could 
generate considerable amounts o f ROS in response to stimuli such as fMLP, PMA, and 
calcium ionophore A23187, and even possibly in the absence o f stimuli (Trayner et al,
1995). Differentiation may enhance the oxidative burst potential o f HL-60 since it can 
lead to increased expression o f  components o f the NADPH oxidase (Muranaka et a l, 
2005). As such, fMLP stimulation o f both undifferentiated and differentiated HL-60 was 
carried out during the optimisation experiments.
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4.1.5 Priming with LPS
Whilst various stimuli such as PMA and fMLP are known to induce the oxidative 
burst in neutrophils, some studies show that pre-treating inflammatory leukocytes 
(neutrophils, monocytes, etc.) with bacterial lipopolysaccharide (LPS) can lead to a 
heightened oxidative burst compared to that induced by the stimuli alone (Zughaier et al, 
1999a; Zughaier et a l, 1999b). LPS has the ability to induce neutrophil activation at very 
low concentrations and pre-incubation with LPS has been shown to cause a significant 
“priming” effect for subsequent stimulation using other factors (Nielsen et a l, 1994; Aida 
and Pabst, 1990; Vosbeck et a l, 1990; Forehand et a l, 1989; Worthen et a l, 1988; 
Haslett et a l, 1985; Guthrie et a l, 1984). The term “priming” was coined to describe the 
enhanced leukocyte functions following exposure o f neutrophils to bacterial products 
including LPS (Casimir and Teahan, 1994). Indeed LPS has been seen to cause enhanced 
generation and release o f 0 2 *' following stimulation with fMLP or PMA (DeLeo et al, 
1998; Guthrie et a l, 1984). As such, it was decided that in order to optimise the oxidative 
burst potential in the HL-60 cells, experiments in which the cells were primed with LPS 
prior to fMLP stimulation would be carried out, and the release o f ROS assessed to 
determine if  LPS priming would be a worthwhile component o f the final treatment 
regime o f HL-60 prior to co-culture experiments. The dose o f LPS used to prime 
neutrophils was lOOng/ml since this dose has been reported to enhance NADPH oxidase 
assembly in neutrophils, leading to enhanced oxidative burst response following fMLP 
stimulation (10-fold increased 0 2 ’" generation) (DeLeo et a l, 1998). In order to establish 
the optimal priming regimen, HL-60 were exposed to LPS for either lh r or over night 
periods in both differentiated and undifferentiated cells, and the oxidative burst capacity 
assessed using a fluorescence based 96-well plate methodology and flow cytometry.
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4.1.6 Methodologies
4.1.6.1 Assessing Differentiation Status in HL-60: Microscopic Evaluation and the 
Nitro Blue Tetrazolium (NBT) Assay
Differentiated HL-60 appear different at the morphological level compared to 
their undifferentiated counterparts in that they more closely resemble mature myelocytes. 
DMSO differentiated HL-60 appear smaller, have a lower nuclear/ cytoplasmic ratio, 
have less prominent cytoplasmic granules, fewer, if  any, nucleoli, and marked 
indentation, convolution, and segmentation o f nuclei compared to immature 
undifferentiated cells (Collins et al., 1978). On these grounds the success o f 
differentiation induction can readily be determined by microscopic observation o f  cells.
The Nitro Blue Tetrazolium (NBT) assay has proved to be a very useful assay for 
the activity and functioning o f neutrophils in both normal and diseased states (Belcher 
and Czametzki, 1973; Gordon et al, 1973; Matula and Paterson, 1971; Park, 1971; Grush 
and Mauer, 1969; Park et a l, 1968). The test is routinely carried out in blood samples, 
although it has been adapted for use in cell culture conditions.
The test works on the basis that mature neutrophils, upon stimulation with a 
variety o f activating stimuli such as bacteria, bacterial extracts or products, PMA, etc. can 
reduce soluble NBT, by way o f  oxidants (e.g. 0 2 *") released during the oxidative burst, 
resulting in the formation o f insoluble formazan deposits which can be detected 
spectrophotometrically or microscopically. The amount o f formazan deposits in 
stimulated neutrophils is much greater than that seen in unstimulated counterparts 
(Freeman and King, 1972; Matula and Paterson, 1971; Park et a l, 1968), which is 
dependent on the neutrophils being functionally active (i.e. differentiated to a 
functionally mature state). Based on these grounds successful induction o f neutrophil 
differentiation in HL-60 should result in enhanced levels o f  formazan product following 
stimulation o f differentiated HL-60. In this case the N-formyl peptide fMLP was used as 
the oxidative burst inducing stimulus. Since the ultimate aim o f the present work was to 
optimise oxidative burst induction in leukocytes, a range o f fMLP doses (lOOnM, lpM ,
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and 5jxM) were used to stimulate HL-60 in order to establish the optimal dose for 
induction o f respiratory burst as well as assess the differentiation status o f the cells.
4.1.6.2 Assessing Oxidative Burst Activity in HL-60
The generation and release o f H2O2 and C V  from activated neutrophils during the 
respiratory/ oxidative burst is recognised as a critical component o f both cell-mediated 
immunity and the underlying pathogenesis o f  inflammation (Morel et a l, 1991). As such 
a large emphasis has been made on the development o f  sensitive and reliable methods for 
detecting oxidative burst activity (Model et al, 1997). In the present work two such 
methods were employed, a fluorescence based 96-well plate assay and a flow cytometric 
method. In both cases the fluorescent probe o f choice was dihydrodichlorofluorescein 
diacetate (H2DCF-DA) since it has been used extensively in the literature (Shen et al, 
1999; Trayner et a l, 1995; Rao et a l, 1992) and is believed to be specific for H2O2 (and 
so indirectly measures C>2*’)- The probe is very well established for detecting the 
oxidative burst response in mature myeloid cells and has been seen to be more effective 
than similar probes (Trayner et a l, 1995). To date the detection and measurement o f 
RO/NS in cells and tissues has proven to be very challenging, and whilst the use o f 
fluorescent probes has been criticised on the basis o f  the potential for false positive 
results (Rota et a l, 1999), they continue to be employed since they provide relatively 
fast, high-throughput methodologies for the detection o f RO/NS. Several citations 
support the use o f H2DCF-DA since it is a relatively specific probe which allows the real­
time monitoring o f cellular ROS accumulation (Shen et a l, 1999; Trayner et a l, 1995). 
The probe works on the basis that H2DCF-DA is initially non-fluorescent and membrane 
permeable but is cleaved by intracellular esterases upon entry to cells yielding a 
membrane impermeable derivative (DCFH) and so becomes sequestered inside cells 
(Shen et a l, 2002; Robinson et al, 1994; Bass et a l, 1983). Oxidation by intracellular 
ROS then gives rise to fluorescent DCF which also remains inside the cells (Bass et a l, 
1983), although the leakage o f  fluorescent DCF from cells has been reported (Ubezio and 
Civoli, 1994). As such, cells can be ‘loaded’ with the probe prior to treatment with fMLP
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and the oxidative burst response o f HL-60 can be detected using fluorescence detecting 
techniques. The amount o f fluorescence detected is proportional to the amount o f H2O2 
(and its reactive derivatives) generated (Robinson et a l , 1994).
4.1.6.2a Fluorescence Based 96-well Plate Assay
Cellular ROS as well as the leukocyte oxidative burst response can be measured 
using an automated high throughput 96-well plate based technology described by Trayner 
et a l  (1995). The assay works on the basis that the initially non-fluorescent probe H2DCF- 
DA can be oxidised, in the presence o f H2O2 (and its reactive derivatives) released by way 
o f  the oxidative burst, to a fluorescent product that can be detected using a fluorometer. 
This technique permits both the assessment o f the differentiation status o f  cells as well as 
the oxidative burst response, and the effects o f  different treatments on cells evaluated 
simultaneously in a single rapid experiment.
4.1.6.2b Flow Cytometry
The analysis o f the oxidative burst in inflammatory leukocytes has been very 
difficult and labour intensive to study, being time consuming and requiring large numbers 
o f cells. Fortunately the development o f flow cytometry methodologies has 
revolutionised research in this area since - owing to the sensitivity o f the technique and 
the single cell analysis approach - significantly fewer cells are required, the techniques 
are relatively easy and inexpensive to perform, and most importantly they permit the 
population o f cells to be subdivided based on light scatter (dependent on cell size and 
shape) and fluorescence intensity (dependent on the levels o f ROS) (Robinson et al, 
1994). Since the principal o f  the methods is the use o f probes that yield fluorescent 
products (in this case H2DCF-DA) upon reacting with cellular oxidants, the identification 
o f  cell populations with low or high fluorescence intensities allows the identification o f 
distinct populations o f cells with low or high oxidative burst potential respectively, as 
well as the percentage o f cells producing ROS following treatment with stimuli.
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4.1.6.3 Assessing Inflammatory Response in HL-60: ELISA for IL-8
In addition to the generation and release o f RO/NS, a typical inflammatory 
response also involves the release o f a plethora o f inflammatory mediators such as 
cytokines/ chemokines. In the case o f  neutrophils, bacterial infections (e.g. H  pylori 
infection o f the gastric mucosa) as well as other inflammatory stimuli can lead to the 
enhanced generation and release o f IL-8  (Altstaedt et al., 1996; Arnold et a l, 1994; 
Cassatella et a l, 1992), which, owing to its effect as a potent chemotactic agent for 
neutrophils, leads to further infiltration o f neutrophils to the site o f  inflammation, and so 
an enhanced inflammatory response. The enhanced inflammatory response may result as 
a consequence o f  the chemokines ability to activate a variety o f  neutrophil functions 
including oxidative burst by way o f priming an enhanced response to stimuli such as 
fMLP (Guichard et a l, 2005), degranulation (Peveri et a l, 1988), and adhesion (Detmers 
et al, 1990). As such IL-8  can be used as a marker o f a neutrophil inflammatory 
response. Thus, in order to determine i f  the treatment regimens o f HL-60 involving LPS 
priming and various fMLP treatments caused an inflammatory response beyond the 
release o f ROS, IL-8  protein levels were measured using ELISA.
4.2 Materials and Methods
4.2.1 Cell Culture of HL-60
The human promyeloblastic cell line HL-60 (derived from a 36-yr old Caucasian 
female with acute promyelocytic leukaemia) was obtained from the American Tissue 
Culture Collection (ATCC, Teddington, Middlesex, UK) and was cultured as described in 
section 2.1.1.6. When not in use for experimentation the cells were frozen down in liquid 
nitrogen following the procedure outlined in section 2.1.1.7. In all experimentation HL-
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60 were used between passages 1 - 1 5 ,  and only cultures with viability > 90% in the 
trypan blue viability assay (section 2 .1 .1 .8) were used.
4.2.2 Induction of Differentiation in HL-60
Densely populated HL-60 cultures (~ 1 x 106 viable cells/ml) were induced to 
undergo differentiation into neutrophils by the addition o f 1.3% v/v dimethyl sulfoxide 
(DMSO) (Gibco-BRL, Paisley, UK). Cells were exposed to DMSO for periods o f 3, 4, 
and 5 days and subsequently assessed for differentiation status by a variety o f means 
(described in section 4.2.3) in order to confidently determine the optimal regimen for 
inducing differentiation.
4.2.3 Assessment of Differentiation Status of HL-60
A variety o f techniques were employed to assess the differentiation status o f HL- 
60 populations following DMSO treatment so that the success and efficiency o f the 
induction regimens could be determined with a high degree o f  confidence. These 
procedures allowed HL-60 differentiation to be evaluated at the levels o f cellular 
morphology and functional biochemistry.
4.2.3.1 Morphological Evaluation: Microscopic Examination of Induced HL-60
4.2.3.1a Slide Generation
Following treatment with DMSO cells were harvested by centrifugation at 200 x g 
(1500rpm) for 5min, and the cells washed to remove all traces o f DMSO in sterile PBS 
(pre-warmed to 37°C) followed by a second 5min centrifugation step. Cells were 
subsequently re-suspended in 2ml PBS (pH7.4) in clean correspondingly labelled 
centrifuge tubes and microscope slides o f cells generated using the Cytospin4 
(ThermoShandon, Cheshire, UK). Glass microscope slides (pre-cleaned with 100% 
ethanol to remove grease and dirt) were assembled into cytospin clamps together with a
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filter card and funnel according to manufacturers instructions, and then placed into the 
Cytospin. Subsequently lOOpl o f each cell suspension was introduced into one funnel 
each and then spun down at 150 x g (1200rpm) for 8 min to produce a cytodot on the 
slides. The cell density on each slide was examined using a light microscope and the 
respective cell suspension was diluted or concentrated as and if  necessary to obtain a 
single (so scorable) layer o f cells on the slides. For each treatment three slides were 
prepared so that the data would be produced in triplicate. The resultant slides were fixed 
in 90% methanol at -20°C for lOmin and left to air dry prior to storage at -20°C until use.
4.2.3.1b Staining of Slides
Slides were thawed and submerged into a solution o f 1.25pg/ml acridine orange 
in glass coplin jars for lOsec. The slides were then washed to remove excess stain by 
placing in phosphate buffer (pH6 .8 ) for lOmin. Finally the slides were transferred to fresh 
phosphate buffer and left for lhr. Slides were air dried in the dark and stored at room 
temperature away from light.
4.2.3.1c Slide Visualisation and Scoring
Stained slides were viewed under an Olympus BX 50 fluorescence microscope 
using an UplanFl 100x/1.3 oil objective. Since acridine orange stains nuclei with bright 
green fluorescence and the cytoplasm orange/red, cells were visualised (after mounting a 
coverslip with a few drops o f PBS (pH7.4)) with a dual-bandpass filter set. Standard FITC 
and rhodamine filter sets were used to excite and capture green and orange/red fluorescence 
signals simultaneously. Images were captured with a  cooled CCD (charged -  coupled 
device) camera and analysed with the MacProbe version 4.1 software (Applied Imaging, 
Newcastle Upon Tyne, UK). Undifferentiated HL-60 and differentiated HL-60 cells 
(referred to as HL-60 and HL-60/N respectively from here on) were identified according to 
the morphological criteria described by Collins et al. (1978) stated below.
Undifferentiated HL-60 cells were identified based on the following morphological 
features:-
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•  Round nucleus;
•  2-4 nucleoli visible per nucleus;
•  High nuclear/cytoplasmic ratio.
For HL-60/N cells (differentiated):-
•  Cells are usually smaller in size;
•  Marked indentation, convolution and/or segmentation o f the nucleus;
•  Nucleoli are usually absent;
•  Low nuclear/cytoplasmic ratio.
Three slides were scored for each treatment, with 1000 cells examined per slide, resulting 
in a total o f  3000 cells per treatment. The cells were classified as either normal 
undifferentiated HL-60 or differentiated HL-60/N based on the criteria listed, and 
percentages o f the cell types were calculated as averages across the three slides scored per 
treatment.
Statistical analysis was performed using SPSS version 13.0. The data was 
analysed by way o f an unpaired t-test (since the cells were treated in two different and 
separate manners (control untreated and DMSO treated)) to determine any statistically 
significant differences in the percentage o f differentiated cells between the two treatment 
groups. Statistical significance was achieved when P < 0.05 (confidence levels > 95%).
4.23.2 Biochemical/Functional Evaluation: The Nitro Blue Tetrazolium (NBT) Assay
In order to assess the functional differentiation o f  HL-60 into neutrophils or 
immature neutrophil-like cells, NBT assay was employed. This assay works on the basis 
that differentiated neutrophils can be activated to produce and release superoxide, the 
presence o f which leads to the formation o f a reduced NBT formazan derivative which can 
be detected by spectrophotometry. The purpose o f  the assay was two-fold -  firstly to 
determine the success o f DMSO induced differentiation o f HL-60, and secondly to serve as
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an initial preliminary experiment in the optimisation o f  neutrophil activation and induction 
o f oxidative burst so establishing the best treatment regimen.
HL-60 that had been cultured in the presence or absence o f DMSO for 3, 4, and 5 
day intervals were harvested by centrifugation at 200 x g (1500rpm) for 5min. The cells 
were washed by re-suspending in PBS followed by a second centrifugation step. Next 8 x 
105 cells were re-suspended in 400pl HEPES-glucose buffer (lOmM HEPES; 150mM 
NaCl; 5mM KOH; 1.2mM MgCL; 1.3mM CaCh; 5.5mM D-glucose, pH7.5) in sterile 
1.5ml microfuge tubes, labelled according to the treatment regimen, and mixed with 400pl 
o f 0.1% (w/v) NBT (in HEPES-glucose buffer). N-Formyl-L-methionyl-L-leucyl-L- 
phenylalanine (fMLP) treatment doses o f lOOnM, 1 jiM, and 5pM were set up by adding the 
appropriate volumes o f the inflammatory stimulus to the test set-ups in order to stimulate 
neutrophil activation, and the reactions incubated for 15min at 37°C. Each reaction was 
carried out in triplicate. The reactions were stopped by placing the tubes on ice, and 
subsequently centrifuged for 24sec in a microfuge to pellet down the cells. Supernatant was 
discarded by gentle suction through a Pasteur pipette, and the pellets washed by re- 
suspending in 250pl 70% methanol to remove unreduced NBT followed by a second 
centrifugation step and removal o f supernatant. The cells were subsequently lysed by the 
addition o f 500pl 2M potassium hydroxide (KOH), and the reactions incubated overnight 
in the dark at room temperature. Addition o f 600pl DMSO after overnight incubation and 
subsequent vortexing for 15sec dissolved any blue formazan deposits that may have formed 
as a result o f  NBT reduction. The presence o f solubilised blue formazan was assessed 
spectrophotometrically by calculating the A620-A450 difference spectrum.
The successful induction o f HL-60 differentiation was detected based on the 
grounds that functionally differentiated cells should generate more reduced NBT than 
undifferentiated cells. The successful induction o f neutrophil activation and oxidative burst 
was detected on the basis that HL-60/N stimulated with fMLP should result in greater 
levels o f  reduced NBT than unstimulated HL-60/N.
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4.2.4 Optimisation of Neutrophil Activation and Oxidative Burst Induction: Combined 
LPS Priming -  fMLP Stimulation Regime
To determine if  LPS priming should be included in the treatment regimen for 
oxidative burst induction, HL-60 and HL-60/N were primed with LPS (from Escherichia 
coli 0111 :B4) for either a 1 hr or an overnight incubation period. LPS at a final 
concentration o f lOOng/ml was added to cells that had been cultured for 3 days either in the 
absence or presence o f DMSO, as detailed in section 4.2.2, on the third day, for either lh r 
or overnight. Following priming cells were harvested by centrifugation at 200 x g 
(1500rpm) for 5min, and washed twice in pre-warmed (37°C) PBS followed by another 
centrifugation step to remove all traces o f LPS. The cells were then subject to further 
treatment with fMLP and oxidative burst capacity assessed using the methods outlined in 
the sections that follow.
4.2.5 Assessing Oxidative Burst Activity in HL-60
HL-60 and HL-60/N, both unprimed and LPS primed were subject to stimulation 
with fMLP (see fig. 4.2 and table 4.1) and the oxidative burst response in the cells 
measured using a fluorescence based 96-well plate assay and flow cytometry. Care was 
taken to keep fluorescent specimens away from light during the experimental procedures.
4.2.5.1 Fluorescence Based 96-well Plate Assay for Oxidative Burst
A fluorescence based 96-well plate assay for the detection o f  ROS release from HL- 
60 following various treatments was carried out according to the method described by 
Trayner et a l  (1995) with some modifications. This assay serves dual functionality as both 
a test for oxidative burst activity, and as a test for myeloid differentiation, hence the results 
can be used in conjunction with the microscopic evaluation and NBT assay to confirm HL-
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60 differentiation status. The assay works on the basis that the initially non-fluorescent 
probe dihydrodichlorofluorescein diacetate (H2DCF-DA) can be oxidised, in the presence 
o f ROS released by way o f the oxidative burst, to a fluorescent product that can be detected 
using a fluorometer.
Both HL-60 and HL-60/N that had been grown for 3 days, and HL-60 and HL- 
60/N that had been grown for 3 days and primed with LPS overnight, were harvested by 
centrifugation at 200 x g (1500rpm) for 5min and re-suspended in 10ml serum free 
RPMI. Cells were then seeded into the appropriate wells o f 96-well microtitre dishes at 1 
x 105 cells/ well, the total volume in each well being lOOpl. An example o f a typical plate 
set up is shown in figure 4.2. Each treatment was performed in triplicate within a plate, 
and the plate set up was repeated twice, the final results being the averages o f the within 
and between plate readings. A dilution series o f H2O2 was included in the plate set up so 
that a calibration curve o f fluorescence to H2O2 concentration could be determined, so 
allowing quantification o f the amount o f the ROS released from HL-60 cells. Positive 
controls were also included in which cells were treated with 5pM terf-butyl 
hydroperoxide (TBHP), a known inducer o f  cellular ROS production, as well as medium 
blanks. Four separate stock solutions o f H2DCF-DA probe were prepared in Hanks 
solution (Gibco-BRL, Paisley, UK) either containing just probe, or probe plus the 
appropriate multiples (depending on the number o f wells) o f lOOnM fMLP, lpM  fMLP, 
or 5pM TBHP. To all stocks D-glucose was added to a  final concentration o f 30mM. 
Next 20pl o f  the appropriate stock probe solutions were added to corresponding wells in 
the plate, such that the final concentration o f probe was lOpM. The plates were then 
placed in the Fluostar Galaxy plate reader (BMG Labtech, Ayelsbury, UK) with the in- 
reader incubator set at 37°C so that the plate could routinely be read whilst the cells were 
still living, thereby producing real-time results o f  ROS release over time. The scanning 
filters were set for fluorescein with an excitation wavelength o f 485nm and an emission 
wavelength o f 538nm, and the plates were scanned every 2min for 4hr so producing a 
kinetic trace o f  oxidative burst activity.
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4.2.5.2 Flow Cytometry
HL-60 and HL-60/N that had been cultured for 3 consecutive days in the absence or 
presence o f  1.3% (v/v) DMSO and HL-60 and HL-60/N that had been cultured in the same 
manner for 3 days with an additional overnight LPS priming were harvested by 
centrifugation at 200 x g (1500rpm) for 5min. Cells were then re-suspended in 5ml pre­
warmed PBS (37°C) and cell counts obtained (section 2.1.1.8 ) for each cell suspension. The 
suspensions were adjusted either by diluting or concentrating so that the final cell count 
was ~ 1 x 106 cells/ml. Appropriate volumes o f cell suspension were prepared for each cell 
type (HL-60, HL-60 + LPS, HL-60/N, and HL-60/N + LPS) to account for the need for 1ml 
o f cell suspension per treatment (summarised in table 4.1). Cells were next ‘loaded’ with 
probe by the addition o f  H2DCF-DA (Molecular probes, Paisley, UK) to each cell 
suspension to a final concentration o f 20pM followed by a 30min incubation at 37°C in the 
dark with intermittent agitation. From here on the cell suspensions were protected from the 
light. Following the incubation period cell suspensions were centrifuged at 200 x g 
(1500rpm) for 5min and washed in cold (4°C) PBS to terminate probe loading. A second 
centrifugation step was performed and the cells re-suspended in Krebs Ringer Phosphate 
(KRP) buffer (118mM NaCl, 5mM KC1,4mM M gS04, ImM  CaCl2, ImM  KH2P 0 4, lOmM 
D-glucose, 16mM N aH P04 pH7.4) that had been pre-warmed to 37°C at ~ 1 x 106 cells/ml. 
Cells were then equilibrated to 37°C by incubation for 5min.
The cell suspensions were subsequently divided into 1ml aliquots in 5ml 
polypropylene round bottom flow cytometry tubes (BD Biosciences, Oxford, UK) and 
fMLP (lOOnM and lpM  doses) or TBHP (5pM dose) added as necessary to the appropriate 
tubes such that all treatments in table 4.1 could be analysed by flow cytometry. Four tubes 
were set up for each treatment corresponding to four different incubation time points -  
Omin, lOmin, 30min, and 45min so that a kinetic trace o f  ROS detection could be 
determined. For HL-60 and HL-60/N, cell samples that had not been loaded with probe (i.e. 
unstained) were also prepared to serve as controls for flow cytometry so allowing setting o f 
voltages and compensating for any spontaneous background fluorescence that the cells may 
generate.
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Table 4.1 Treatment of Cells for Flow Cytometry detection of oxidative burst activity.
U ndifferentiated Cells (HL-60) D ifferentiated Cells (HL-60/N)
HL-60 Control HL-60/N Control
HL-60 + LPS HL-60/N + LPS
HL-60 + lOOnM fMLP HL-60/N + lOOnM fMLP
HL-60 + LPS + lOOnM fMLP HL-60 + LPS + lOOnM fMLP
HL-60 + lpM  fMLP HL-60/N + lpM  fMLP
HL-60 + LPS + lpM  fMLP HL-60/N + LPS + lpM  fMLP
HL-60 +ve Control (+ 5pM TBHP) HL-60/N +ve Control (+ 5pM TBHP)
HL-60 + LPS +ve Control (TBHP) HL-60 + LPS +ve Control (TBHP)
HL-60 Control Unstained HL-60 Control Unstained
Following incubation for the appropriate time periods the samples were placed on 
ice to stop any further reactions (and prevent cell clumping) and each sample analysed by 
flow cytometry using the FACSAria (BD Biosciences, NJ, USA) after first running the 
unstained samples through to take account o f any spontaneous fluorescence in the cells. 
Following termination o f the reactions all samples were analysed by flow cytometry within 
a 30min period, shielding samples from light throughout. The 488nm Argon laser was used 
for excitation and the cells were identified using forward scatter (FSC) and side scatter 
(SSC) parameters. The total cell population was detected based on these parameters that 
detect size (FSC) and granularity (SSC) and a gate was drawn around this cell population 
(PI) for filter analysis. The PI population o f cells contained a non-fluorescent population 
o f  cells, as well as a fluorescent population o f cells (P2) -  presumably reflecting 
endogenous ROS activity in the cells. The parameters used for P2 population identification 
were FSC, SSC, and FITC fluorescence using 502nm long pass filter and 530/30nm band 
pass filter. The successful induction o f oxidative burst (changes in cellular oxidative 
activity) could be detected as an increase in the percentage o f  the P2 population, and/ or an 
increase in the mean FITC fluorescence intensity (MFI).
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4.2.6 Assessing Inflammatory Response in HL-60: ELISA for IL-8
ELISA for IL-8  was performed on the supernatants o f  cells that had been treated as 
summarised in table 4.1 (with the exception o f TBHP positive controls). Post-treatment the 
cells were subject to an additional 4hr incubation at 37°C in serum free RPMI plus 0.5% 
(v/v) protease inhibitor cocktail (Sigma-Aldrich, Poole, UK) so allowing sufficient time for 
IL-8  protein to be produced and/ or released into the supernatant. Following treatment and 
incubation, cells were spun down by centrifugation at 200 x g (1500rpm) for 5min and 1ml 
supernatant from each treatment aliquotted into correspondingly labelled 1.5ml microfuge 
tubes. The experiment in its entirety was repeated in duplicate. IL-8  ELISA was then 
performed on the supernatants using the PeliKine Compact™ human IL- 8  ELISA kit (Mast 
Group Ltd., Merseyside, UK) following the instructions in the manufacturer’s protocol 
with some modifications. The IL-8  capture antibody was first coated onto the provided 96- 
well plates by adding 55pl to 5.5ml coating buffer (0.5M Carbonate/bicarbonate buffer 
pH9.6). Capture antibody solution was then added to each well at 50|d/well and the plate 
incubated at 4°C overnight. The following day excess coating antibody solution was 
discarded and the plate dried by blotting on tissue. Blocking buffer (1% BSA in PBS) was 
subsequently added at 150pl/well and the plate incubated for lh r at room temperature. 
Blocking buffer was next aspirated and the plate washed 3 X  with washing buffer (PBS/ 
0.05% Tween). Standards (diluted in PBS with 1% BSA as optimised and prepared as a 
dilution series from supplied IL-8  standard as 0, 1, 2.5, 6.1, 15.4, 38.4, 96, and 240pg/ml) 
and samples were subsequently added to the plate at 50pl/well followed by lh r incubation 
at room temperature. Samples were then aspirated and the wells washed 4 X  with washing 
buffer. A  second incubation with a biotin-conjugated anti-IL-8  antibody was next 
performed. Biotinylated anti-human IL-8  antibody was diluted in IX  dilution buffer (1:5 
dilution in ctfUO o f dilution buffer supplied in kit) at 1 2 0 pl antibody to 12ml buffer per 
well to be analysed. The antibody solution was then added to the plate at 100pl/ well, the 
plate covered with an adhesive seal, gently agitated and incubated at room temperature for 
lhr. The biotin conjugate was then aspirated and the wells washed 4 X with washing 
buffer. Next, streptavidin-HRP (provided in the kit) was diluted at 1:10000 in assay buffer 
(1:5 dilution in (IH2O o f assay buffer supplied in kit) and 50pl added per well. The plate
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was then incubated for 30min at room temperature after which the solution was aspirated 
and the plate washed 6  X with washing buffer. HRP substrate solution (prepared by mixing 
equal volumes o f solutions A and B provided in the kit) was subsequently added at 
50|il/well followed by a 30min incubation in the dark at room temperature so allowing the 
coloured (yellow) product to develop. The reactions were stopped by the addition o f stop 
solution (1.8M H 2 SO4) at 50pl/well and the plate read at 450nm using an Anthos HTII 
plate reader (Labdesign, Sweden). Each sample was analysed in duplicate and the IL-8  
concentration in the samples was determined using the average A450 reading calibrated 
against the standard curve.
4.2.7 Statistical Analysis
All statistical analysis was carried out using the SPSS version 13.0 software 
package. Unless otherwise stated one way ANOVA (followed by Tukey and Duncan post 
hoc tests) was carried out to compare control and treated cells. Statistical significance was 
achieved when P < 0.05 at the 95% confidence level.
43 Results
43.1 Microscopic Determination of HL-60 Differentiation
Examination o f  the slides prepared for the three different periods o f differentiation 
induction revealed that both the 4 and 5 day DMSO treatments were cytotoxic to cells, with 
dead cells abundant in the examined cell populations. This made scoring o f  the 4 and 5 day 
slides very difficult, and only the slides from cells treated for 3 days were scorable. Figure
4.3 summarises the results for the 3 day differentiation treatment as the average percentage 
of differentiated cells in untreated control HL-60 and DMSO treated HL-60 based on the 
morphological criteria listed in section 4.2.3.1c, and an example o f the cells observed is 
shown in figure 4.4. It is clear that DMSO treatment induces an increase in the percentage
190
of HL-60/N cells in the cell population from 11.7% in untreated cells to 39.1% in treated 
cells. Unpaired t-test revealed that this increase in HL-60 differentiation induced by DMSO 
after 3 days was statistically significant (P < 0.05).
Figure 4.3 Average Percentage o f Differentiated HL-60 cells (HL-60/N) observed in untreated control cells 
and cells that had been treated with 1.3% (v/v) DMSO for 3 days. Standard error bars are shown. Statistically 
significant results (P < 0.05) based on one way ANOVA are highlighted with red stars. See text for further 
details. N = 3.
Cbrtrol DM SO Treated
Figure 4.4 Example o f HL-60 and HL-60/N cells observed by microscopic examination. Note the round 
nucleus, presence o f nucleoli, and high nuclear/ cytoplasmic ratio in HL-60 compared to the indented nucleus, 
lack o f nucleoli, and low nuclear/ cytoplasmic ratio in HL-60/N.
HL-60 HL-60/N
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It has been demonstrated that DMSO treatment results in a decrease in HL-60 viability if  
the cells are grown in the presence o f DMSO for more than 3 days (Mollinedo et a l, 1998) 
as well as an increase in the proportion o f cells undergoing apoptosis (Mollinedo et al, 
1998; Martin et a l, 1990). Moreover, HL-60 grown in the presence o f DMSO for 1-3 days 
have been shown to exhibit mature myelocyte functions such as oxidative burst, 
degranulation, phagocytosis, and bacterial killing (Newburger et a l, 1979). Taken together 
these observations provide support to the current findings that a  3 day DMSO treatment 
regimen induces significant differentiation o f HL-60 whilst retaining adequate cell viability 
for further experimentation.
4.3.2 NBT Assay
The NBT assay was performed on undifferentiated as well as differentiated HL-60 
(HL-60/N) that had been grown in the absence or presence o f 1.3% (v/v) DMSO 
respectively for periods o f 3, 4, and 5 days in order to determine the success o f 
differentiation as well as which cell population had a greater inherent capacity for ROS 
generation and hence NBT reduction. The results were the averages o f triplicate treatments 
and are represented graphically in figure 4.5. It is clear from figure 4.5 that for 3, 4, and 5 
day growth periods, HL-60/N resulted in a higher level o f  NBT reduction than HL-60, 
confirming functional differentiation and reflecting a  higher capacity for ROS generation 
and release in the differentiated cells. One way ANOVA revealed that in all three cases 
HL-60/N caused significantly greater reduction o f NBT compared to HL-60 (P < 0.05).
In addition, the assay was also carried out on HL-60/N that had been treated with 
lOOnM, lpM , and 5pM doses o f the inflammatory response stimulant fMLP for 15min to 
determine responsiveness o f cells. After a 3 day differentiation period, stimulation with 
fMLP resulted in enhanced NBT reduction in HL-60/N at all three doses used compared to 
unstimulated counterparts (fig. 4.5), seen to be statistically significant at all three doses (P 
< 0.05) with maximal NBT reduction, and hence ROS generation, seen with the lOOnM 
dose. Interestingly, after a 4 day differentiation period, stimulation o f HL-60/N with fMLP
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Figure 4.5 Results o f NBT Assay carried out in HL-60. The test was carried out on normal untreated HL- 
60, differentiated HL-60 (HL-60/N) in the absence o f fMLP stimulant, and on HL-60/N treated with lOOnM, 
lpM, and 5|iM doses o f fMLP stimulant. Standard error bars shown. Statistically significant results (P < 0.05) 
based on one way ANOVA are highlighted with red stars. See text for further details. N = 3.
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appeared to have no effect on the level o f NBT reduction compared to that detected in 
unstimulated HL-60/N, with only the 5pM  dose causing a significant increase in NBT 
reduction compared to unstimulated HL-60/N. Following a 5 day differentiation period 
HL-60/N stimulated with 1 OOnM fMLP gave rise to levels o f  NBT reduction significantly 
higher than that seen in unstimulated HL-60/N, 5pM  fMLP stimulation also caused a 
significant, though lesser increase in NBT reduction, whilst the 1 pM  dose did not appear to 
have such an effect (fig. 4.5). Thus, 5 day differentiation plus stimulation with lOOnM 
fMLP appeared to cause the maximum induction o f  respiratory burst in the HL-60/N cells. 
However, the 3 day differentiation regime plus fMLP stimulation also resulted in 
significantly enhanced oxidative burst activity, and due to time restraints and practicalities,
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it was decided that HL-60/N that had been induced to differentiate by way o f 3 day 
incubation with 1.3% (v/v) DMSO would be used in all subsequent experimentation. In 
addition, the morphological identification (section 4.3.1) o f  HL-60/N revealed that 3 day 
DMSO treatment induced significant HL-60 differentiation whilst 4 day and 5 day 
treatments may have caused decreased cell viability (possibly by way o f necrosis and 
apoptosis), and this may in fact account for the high levels o f  reduced NBT following a 5 
day DMSO treatment since dying cells tend to have high levels o f  ROS (Fialkow et al 
2007; Splettstoesser and Schuff-Wemer, 2002; Swain et a l, 2002). This observation 
provided further support to the decision to use the 3 day DMSO treatments for further 
optimisation experiments.
4.3.3 Fluorescence Based 96-well Plate Assay
A preliminary experiment in which HL-60 and HL-60/N were primed with LPS for 
either a lh r or an overnight incubation period was performed and the capacity o f the cells 
for oxidative burst was assessed using the fluorescence based 96-well plate assay. The 
results (not shown) indicated that both LPS priming periods resulted in a similar increase in 
ROS release from cells compared to unprimed counterparts, and as such it was decided that 
the overnight priming would be used in all subsequent experimentation for practical 
reasons.
Following on from this, the assay brought to light some interesting observations. 
Figure 4.6 summarises the time course for the induction o f H2DCF-DA fluorescence in HL- 
60 (fig. 4.6(a)) and HL-60/N (fig. 4.6(b)) following various optimisation treatments (fig. 
4.2) over a  4hr incubation time in the presence o f probe. On observation o f  figure 4.6(a) the 
following findings become apparent:-
- Overnight priming o f cells with LPS results in higher levels o f fluorescence 
and hence ROS generation over the 4hr period compared to unprimed cells;
- Treatment o f cells with fMLP alone resulted in a decrease in fluorescence 
levels compared to untreated HL-60 at both doses used;
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Figure 4.6 Time course for the induction o f fluorescence in (a) HL-60 and (b) HL-60/N -  unstimulated, 
stimulated with fMLP, primed with LPS, primed with LPS and stimulated with fMLP, or treated with TBHP 
as a positive control. N = 2.
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- A combination o f overnight priming with LPS plus stimulation o f cells with 
fMLP resulted in enhanced fluorescence induction compared to untreated cells 
to the same extent for both the lOOnM and lpM  doses used, although 
interestingly the levels o f fluorescence were not as intense as that induced by 
LPS priming alone;
- TBHP caused enhanced fluorescence and hence ROS generation in HL-60, 
LPS priming followed by TBHP treatment causing the maximal levels o f 
fluorescence out o f  all treatments;
- The greatest rate o f  fluorescence induction was observed within the lh r 
incubation period.
Figure 4.6(b) brings to light similar findings for HL-60/N:-
- As for HL-60, LPS priming o f HL-60/N also resulted in enhanced 
fluorescence (and hence ROS) levels compared to unprimed cells;
- Both fMLP treatments without prior LPS priming also caused decreased levels 
o f fluorescence in HL-60/N;
- Overnight LPS priming followed by treatment with either lOOnM or lpM  
fMLP resulted in enhanced levels o f fluorescence compared to untreated HL- 
60/N again to the same extent for both doses, however, in this case, in contrast 
to HL-60, the coupled priming -  stimulation treatments resulted in 
fluorescence levels greater than the levels induced by LPS priming alone;
- TBHP also caused enhanced fluorescence in HL-60/N, with the LPS priming 
followed by TBHP treatment again causing the maximal levels o f 
fluorescence out o f  all treatments;
- As for HL-60, the greatest rate o f fluorescence induction in HL-60/N was 
observed within the lh r incubation period.
Based on these observations in HL-60 the effect o f  the treatments on ROS generation could 
overall be ordered as:-
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HL-60 + LPS +ve control > HL-60 +ve control > HL-60 + LPS > 11L-60 + pps r lOOnM 
IMLP =  HL-60 + LPS + lpM  iM LP > HL-60 > HL-60 + lOOnM fMLP > HL-60 + ljxM 
fMLP with respect to the levels o f fluorescence and hence oxidative burst induction.
In HL-60/N the overall order o f treatments was:-
IIL-60/N + LPS +ve control >  HL-60/N +ve control > HL-60'N -r LPS -t- lOOnM 1MLP = 
HL-60/N + LPS + lpM  fMLP > HL-60/N + LPS > HL-60/N > HL-60/N + lOOnM fMLP > 
H L-60/N + lpM  fMLP.
These findings indicate that both HL-60 and HL-60/N can be successfully 
stimulated to undergo oxidative burst which can be detected using this sensitive 96-well 
plate based assay, and that the levels o f  fluorescence, and hence ROS generation, increase 
over time and persist over the 4hr incubation period. Overnight LPS priming enhances this 
effect. Interestingly both doses o f fMLP induced similar levels o f  fluorescence. Aside from 
the positive control treatments, LPS priming alone appeared to have the greatest effect on 
ROS generation in HL-60, followed by the coupled LPS priming -  fMLP stimulation 
treatments, whilst in HL-60/N the coupled priming -  stimulation treatments had the 
greatest effect. The fact that both the lOOnM and lpM  fMLP doses caused very similar 
levels o f fluorescence induction lend support to the results o f  the NBT assay in which the 
two doses appeared to have similar effects on the 3 day DMSO differentiated HL-60/N 
cells, the lOOnM dose causing slightly higher induction o f NBT reduction compared to the 
lpM  dose (fig. 4.4). Based on this observation it is apparent that the use o f either dose in 
subsequent experimentation would be sufficient to induce the desired effect o f  oxidative 
burst induction.
Interestingly, comparison o f the time course o f fluorescence induction in HL-60 and 
HL-60/N revealed that HL-60 may have an overall slightly greater inherent capacity for 
inflammatory oxidative burst, since untreated HL-60 appeared to cause greater levels o f 
fluorescence induction than HL-60/N and HL-60/N + LPS, and showed very similar results 
to HL-60/N + LPS + lOOnM fMLP (fig. 4.7). This result suggests that both HL-60 and HL- 
60/N can successfully undergo oxidative burst, and as such either could potentially be used 
in the final co-culture experiments.
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Figure 4.7 Fluorescence induction in HL-60 and HL-60/N controls and following either overnight LPS 
priming, or a combination o f LPS priming and stimulation with lOOnM fMLP. N = 2.
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An attempt was made to produce a calibration curve o f  fluorescence against H 2O2 
concentration since H2 DCF-DA can detect H 2O2 as well as other ROS such as superoxide 
(Trayner et al., 1995). The doses analysed were 50nM, lOOnM, 500nM, lpM , 10pM, 
50pM, lOOpM, 200pM , and 500pM. On analysis o f  the data (not shown) it became evident 
that the linear detection range for H2O 2 appeared to be between 200 and 500pM  and did not 
appear to be very accurate or useful for predicting the am ount o f  H 2O 2 released by the cells. 
In the context o f the aims o f  the present experimentation demonstrating that HL-60/ HL- 
60/N cells could be induced to undergo oxidative burst was more fundamental than 
quantification o f  the am ount o f  ROS released.
4.3.4 Flow Cytom etry
Flow cytometric analysis o f HL-60 and HL-60/N cells following a variety o f 
treatments (table 4.1) brought to light a high amount o f variation in the oxidative burst
198
response o f the cells. This is likely to reflect a number o f cellular and practical reasons. 
For instance, several reports indicate that the probe can be spontaneously oxidised so 
yielding fluorescence even in the absence o f stimuli (Trayner et a l, 1995; Robinson et 
al., 1994), and that this is commonly due to mitochondrial oxidants, and varies from cell 
type to cell type (Robinson et al, 1994). Fluorescence may also be detected in seemingly 
healthy untreated cells due to the induction o f apoptosis over time (since apoptosis is 
linked to increased ROS levels (Macho et a l, 1997; Zamzami et al, 1995)), or some 
other oxidative event. A practical problem that appeared to be encountered was that o f 
quenching/ photo-bleaching, since the amount o f fluorescence appeared to decrease over 
the 45min period, compared to the expected increase on the basis o f  the other results 
observed (section 4.3.3). This decrease in fluorescence may also be due to loss o f probe 
from the cells by gradual leakage which has been reported (Ubezio and Civoli, 1994). 
Another potential problem is one o f cell clumping. Activated inflammatory cells have as 
tendency to clump due to enhanced cell adhesiveness, and the cell clumps can hinder 
flow cytometric analysis and so bypass detection (Robinson et al., 1994). As such, a large 
proportion o f  activated cells may go unmeasured, causing underestimation o f oxidative 
burst activity.
Aside from these practical pitfalls, observation o f the data overall revealed some 
interesting findings, which can be seen from figure 4.8 for HL-60/N cells 
(undifferentiated HL-60 showed a similar pattern (unless otherwise stated), but to a lesser 
extent):-
-  HL-60/N appeared to be more responsive to fMLP stimulation compared to 
HL-60;
-  fMLP treatment alone caused a decrease in the percentage o f fluorescent 
cells compared to untreated cells, but did not cause marked changes in the 
mean fluorescence intensity (MFI);
-  LPS priming appeared to cause enhanced oxidative burst response in HL- 
60/N, causing an increase in the MFI, for example, 30min after probe 
loading, MFI increased approximately 2-fold in LPS primed HL-60/N 
compared to unprimed counterparts (fig. 4.8);
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Figure 4.8 Flow cytometry charts showing DCF fluorescence intensity (FITC 530/30) o f HL-60/N cells 
following 30min incubations with or without stimuli. Positive control cells were treated with 5|iM TBHP. 
See text for further details. Mean Fluorescence Intensities (MFI) significantly different than in control cells 
(P < 0.05) are highlighted (*) based on one way ANOVA. Percentage fluorescent cells significantly 
different to that in the control are also highlighted (t). N = 2.
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-  Coupled LPS priming - fMLP stimulation resulted in enhanced MFI in both 
HL-60 and HL-60/N, e.g. approximately 2.2-fold increase in LPS primed 
and lpM  fMLP stimulated HL-60/N (fig. 4.8). The coupled regimen 
appeared to cause some decrease in the percentage o f fluorescent cells, 
possibly owing to fMLP toxicity, since treatment o f cells with fMLP alone 
also caused a decrease in the percentage o f fluorescent cells. It is also 
possible that the LPS and fMLP together have a combinatorial toxic effect 
on the cells;
-  Fluorescence was detected in cells at time zero at levels comparable to that 
detected at 10 and 30min. This may be due to the inherent capacity o f 
unstimulated HL-60 and HL-60/N to undergo oxidative burst, or may be due 
to other cellular oxidative processes (e.g. mitochondrial in origin), or could 
be due to auto-fluorescence o f the probe;
-  By 45min the fluorescence intensity appeared to fall in both HL-60 and HL- 
60/N following all treatments compared to the 0, 10, and 30min time points. 
It is possible that this is due to photobleaching o f  the fluorescent signal over 
time, leakage of the probe from cells (Ubezio and Civoli, 1994), or loss of 
cells by cell death (necrosis and/ or apoptosis).
One way ANOVA revealed that LPS priming, combined LPS priming -  fMLP 
stimulation, and TBHP treatment (positive control) resulted in significantly enhanced 
fluorescence intensity, and hence ROS generation compared to controls (P < 0.05).
4.3.5 ELISA for IL-8
It is apparent from figure 4.9 that some treatments o f HL-60 and HL-60/N 
resulted in markedly elevated IL-8  protein levels released from cells into the culture 
medium compared to untreated controls. Interestingly untreated cells also exhibited some
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Figure 4.9 ELISA detection o f IL-8 levels in HL-60 and HL-60/N following various treatment regimens 
including LPS priming, fMLP stimulation, and coupled LPS priming -  fMLP stimulation. Standard error 
bars are shown. Treatments that caused significant increases (P < 0.05) in IL-8 levels released from cells 
compared to controls are highlighted with red stars (based on one way ANOVA). N = 2.
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IL- 8  protein expression and this is in line with several observations that 
polymorphonuclear (PM N) leukocytes like neutrophils can produce and secrete IL - 8  both 
in the unstimulated and stimulated state (Altstaedt et a l, 1996; Arnold et a l, 1994; 
Fujishima et al., 1993; Cassatella et al., 1992; Strieter et a l, 1992; Bazzoni et a l, 1991). 
In HL-60 all treatments appeared to induce up-regulation o f  IL - 8  protein expression and 
release from cells, although one way ANOVA revealed that only the lOOnM fMLP 
treatment caused statistically significant increases in IL - 8  levels compared to controls (~
4.1 -fold increase). In HL-60/N all treatments that caused up-regulation o f IL - 8  levels 
compared to untreated controls were seen to be statistically significant (P < 0.05). 
Interestingly these were treatments in which cells were treated either with LPS priming 
alone (~ 5.8-fold increase over control) or fMLP stimulation alone (both doses caused 
significant IL - 8  up-regulation ~ 7.6-fold at lOOnM and ~ 2.4-fold at lpM ). Treatments in
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which cells were LPS primed and stimulated did not appear to cause notable changes in 
IL-8  levels, perhaps owing to some antagonistic effects o f LPS and the fMLP on IL-8 
gene expression. This may also be related to the increase in ROS in the cells, since 
coupled priming and stimulation was seen to cause elevated ROS generation in the cells 
(sections 4.3.3 and 4.3.4). Elevated ROS levels in neutrophils has been linked to 
apoptosis (Splettstoesser and Schuff-Wemer, 2002) and so may account for the low IL-8  
levels observed.
Overall HL-60/N appeared to be more sensitive to an inflammatory response at 
the level o f enhanced IL-8  expression and release compared to HL-60.
4.4 Discussion
The aims o f the present chapter were to develop an optimised inflammatory cell 
model consisting o f neutrophils which could be stimulated to undergo an oxidative burst, 
and so could be used in subsequent co-culture experiments. The co-culture experiments 
would comprise the activated neutrophils co-incubated with gastric epithelial cells so 
providing a model o f inflammatory processes that may be important in early gastric 
carcinogenesis (starting at gastritis), with a particular emphasis on oxidative stress, by the 
induction o f signal transduction and gene expression changes.
For the inflammatory cell component o f the co-culture model the HL-60 cell line 
was employed. This cell line is a pluripotent immature promyelocytic cell line (Collins et 
a l , 1977) that can be induced to differentiate into morphologically and functionally 
mature myelocytes. The challenges faced were to optimise a differentiation regimen that 
could induce both morphological, and more importantly, functional maturity at the level 
of oxidative burst response in the cells so that a situation o f inflammation derived 
oxidative stress could be introduced in the co-culture system. The experimentation 
described in this chapter aimed to first optimise the induction o f  HL-60 differentiation to 
neutrophils, and then optimise the induction o f an inflammatory oxidative burst response, 
using a variety o f techniques to ascertain the success or failure o f treatments.
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Differentiation of HL-60 was seen to be successfully induced by 3 day incubation 
in the presence o f 1.3% (v/v) DMSO. Whilst a typical differentiation regime may involve 
longer incubation periods (Collins et a l, 1978), several reports suggest that incubation o f 
cells in the presence o f 1.25 -  1.3% (v/v) DMSO can lead to marked loss o f  cell viability
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and induction o f apoptosis after the 3 or 4 day in culture (Mollinedo et al, 1998; 
Martin et al, 1990). Furthermore it has been noted that HL-60 grown in the presence of 
DMSO for 1-3 days exhibited mature neutrophil functions including phagocytosis, 
oxidative burst, and degranulation (Newburger et a l, 1979). Indeed both morphological 
assessment (by way o f microscopy) and functional biochemical assessment (by way o f 
NBT assay) confirmed that a 3 day differentiation regimen induced significant 
morphological and functional differentiation o f cells, giving rise to a population o f cells 
(HL-60/N) that resembled mature myelocytes capable o f oxidative burst induction 
following stimulation with fMLP. The subsequent experimentation aimed to further 
ascertain and optimise the oxidative burst response in HL-60 cells. Since it has been 
reported that both undifferentiated and differentiated HL-60 are capable o f oxidative 
burst due to the possession o f NADPH oxidase (Muranaka et a l, 2005), both HL-60 and 
HL-60/N were used in the optimisation efforts.
LPS priming, in accordance to several published studies (DeLeo et al, 1998; 
Nielsen et al, 1994; Aida and Pabst, 1990; Vosbeck et a l, 1990; Forehand et a l, 1989; 
Worthen et a l, 1988; Haslett et a l, 1985; Guthrie et a l, 1984), was seen to enhance the 
oxidative burst capacity o f HL-60 and HL-60/N compared to unprimed counterparts 
when ROS levels in cells were assessed using the fluorescence based 96-well plate assay 
and flow cytometry. fMLP treatment o f cells was seen to cause a decrease in the 
fluorescence o f cells (and hence ROS generation) detected by both the 96-well plate 
assay and flow cytometry, whilst coupled LPS priming -  fMLP stimulation resulted in 
enhanced fluorescence, with maximal ROS generation detected at 30min using flow 
cytometry, and persisting over a 4hr period (detected using the 96-well plate based 
method).
For the most part the 96-well plate assay and the flow cytometry data appeared to 
correlate, the only discrepancy was that the 96-well plate assay showed that HL-60 may 
be more sensitive to oxidative burst induction, whilst flow cytometry data suggested that
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HL-60/N cells were more responsive. It is likely that this is due to the practical reasons 
previously discussed (e.g. auto-oxidation o f probe, photobleaching, etc.). The advantage 
o f the flow cytometry technique over the 96-well plate assay is that the former allows the 
detection of the percentage o f fluorescent cells and the mean fluorescence intensity (MFI) 
due to the single cell analysis capabilities o f the technique, whilst the 96-well plate assay 
simply detects overall fluorescence in a well containing ~ 1 x 105 cells. A high 
fluorescence reading in the 96-well plate assay may be the result o f  a low percentage o f 
highly fluorescent cells (i.e. very high ROS levels in few cells), or a high percentage o f 
dull fluorescent cells (i.e. low ROS levels in many cells), and so the flow cytometry data 
provides more insight into the population o f cells undergoing oxidative burst. Care must 
also be taken when examining data on ROS detection since ROS can arise from a number 
o f sources aside from oxidative burst, e.g. mitochondrial ROS (Robinson et a l, 1994), 
apoptotic cells (Macho et a l, 1997; Zamzami et a l, 1995), and are important in the 
normal physiology and biochemistry o f cells (detailed in section 1.6 and chapter 3).
Aside from this discrepancy, overall the two techniques for assaying 
inflammatory oxidative burst revealed some interesting findings. Noteworthy 
observations include the apparent oxidative burst capacity o f both HL-60 and HL-60/N in 
the absence o f stimuli which has been previously reported (Trayner et a l, 1995) 
(although this may in part be due to spontaneous oxidation and hence fluorescence o f the 
probe (Trayner et a l, 1995; Robinson et a l, 1994)). As already mentioned, in both cell 
types LPS priming caused enhanced fluorescence caused by enhanced ROS generation, 
as did the coupled LPS priming -  fMLP stimulation treatment. Interestingly, in HL-60, 
LPS priming alone appeared to induce a greater oxidative burst response than LPS 
priming and fMLP stimulation, whilst in HL-60/N, the reverse was true, indicating that 
HL-60/N may show a response more true to mature neutrophils in which priming is 
important (Casimir and Teahan, 1994). In both HL-60 and HL-60/N maximal ROS 
generation was induced by the positive controls (TBHP, LPS priming + TBHP).
In addition to ROS generation, activated neutrophils also release inflammatory 
mediators such as IL-8  (Altstaedt et a l, 1996; Arnold et a l, 1994; Fujishima et al, 1993; 
Cassatella et al, 1992 Strieter et a l, 1992; Bazzoni et a l, 1991), which may act alone 
(Kitadai et a l, 2000), or in conjunction with ROS (Sasayama et a l, 1997; Wozniak et al,
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1993) to induce cellular changes involved in gastric carcinogenesis. ELISA data made 
evident the enhanced cellular release o f IL-8  protein following various treatments. LPS 
priming alone and fMLP stimulation alone resulted in increased IL-8  levels in cell culture 
medium in both HL-60 and HL-60/N, whilst dual priming -  stimulation caused slight yet 
insignificant increases in IL-8  levels in HL-60, with no such effect seen in HL-60/N. This 
may be due to an increase in apoptosis (HL-60/N are more sensitive to apoptosis than 
HL-60 since they are terminally differentiated) which may be linked to the enhanced 
ROS levels (Macho et al, 1997; Zamzami et a l, 1995) induced by these treatments, so 
hindering IL-8  protein expression. Besides this observation, HL-60/N appeared to be 
more responsive with respect to IL-8  release, the levels detected reflecting those seen in 
H  pylori infected gastric mucosa (50 -  lOOpg/ml) (Yamaoka et a l, 1998).
On a broader scale, review o f all o f the data obtained in the optimisation 
experiments brought to light the following:-
- HL-60/N were overall more responsive than HL-60 with respect to mature 
inflammatory functions at the level o f oxidative burst response and IL-8  
release, and so will be used in the final co-culture model (chapter 5);
- Overnight LPS priming significantly enhanced oxidative burst induction and 
IL-8  release in HL-60/N and so will be used in the final model;
- Combined LPS priming -  fMLP stimulation caused more marked generation 
o f ROS in HL-60/N compared to other treatments with both the lOOnM and 
lpM  doses giving rise to similar effects. As such the combined priming -  
stimulation treatment regimen will be used in co-culture experimentation, 
with the lOOnM fMLP dose being employed to avoid potential problems 
associated with fMLP toxicity.
Thus, using a variety o f optimisation treatments and methodologies to detect their 
success in inducing neutrophil differentiation and oxidative burst induction, an optimised 
inflammatory cell model has been developed. Co-incubation o f HL-60/N, LPS primed 
and stimulated with lOOnM fMLP for at least 30min (up to 4hr) with gastric epithelial 
cells should thus lead to a situation of oxidative stress that may be representative of that 
in gastritis tissues (Shimoyama et al, 2002). Since some o f the generated metabolites
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such as H2O2 can diffuse out o f the neutrophils and into the cell culture 
microenvironment; other ROS also potentially being released by way o f phagocytosis, 
membrane blebbing, and apoptosis; the effects o f the ROS on signal transduction and 
gene expression in gastric epithelial cells can then be evaluated.
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Chapter 5
Gastric Epithelial Cell -  Inflammatory Cell Co-culture Studies Part II: 
Signal Transduction and Gene expression Analysis o f  Gastric Epithelial Cells in
Co-culture
5.1 Introduction
Gastric cancer is a complex disease in which chronic inflammation o f the gastric 
mucosa (gastritis) is a key early stage in the pathogenesis o f  the intestinal subtype o f the 
disease (detailed in sections 1.2.1 and 1.3.1). Inflammatory processes are themselves 
complex -  consisting o f a highly integrated and controlled network o f inflammatory cells, 
soluble inflammatory mediators, host cells, metabolic by-products, etc. Under normal 
circumstances this inflammation is tightly controlled and resolved as soon as the 
infectious agent is removed and/ or the tissue injury healed. Unfortunately in some 
instances this inflammation may persist, giving rise to chronic inflammatory conditions in 
which the tissues in the vicinity are constantly exposed to a plethora o f inflammatory 
components which can inflict damage on the host cells. As such chronic inflammation is 
now recognised as a key driving force in the pathogenesis o f  several diseases including 
cancer (section 1.7). In order to further understand the mechanistic nature o f the link 
between chronic inflammation and cancer it is fundamental to gain insights into the 
complex interactions between inflammatory components and the host tissues:
5.1.1 Tumour Microenvironment
The involvement o f host cell -  tumour cell interactions and tumour 
microenvironment in cancer development and progression has had a long standing 
history, tracing back to 1889 when Stephen Paget wrote:
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"When a plant goes to seed, its seeds are carried in all directions, but they can only live 
and grow i f  they fa ll  on congenial s o i l" (Paget, 1889),
hypothesising that the same was true for tumour cells. This theory lay low for almost a 
century, albeit receiving some attention in a pivotal monograph by Tarin (1972) entitled 
‘Tissue interactions in carcinogenesis’, and saw a greater revival in 1980 when Hart and 
Fidler demonstrated that tumour metastasis to other organ sites was not random but rather 
seemed to be targeted to sites with a more favourable microenvironment (Hart and Fidler, 
1980). Intense research has followed for over two decades o f recognition o f the 
complexity o f the disease (Rubin, 1985), and the role o f  tumour microenvironment has 
become increasingly well appreciated in recent years (de Visser and Coussens, 2006; 
Glick and Yuspa, 2005; Rubin, 2003; van Kempen et a l, 2003; Ahmad et a l, 2002; 
Cunha and Matrasian, 2002; Cunha et al., 2002; Skobe and Fusenig, 1998). Tissue 
microenvironment is known to be central to normal development (Anderson et a l, 2000; 
Bissell et a l, 1999; Torok-Storb et a l, 1999) so it is unsurprising that it plays a key role 
in determining tumour cell phenotype and cancer progression. The tumour ‘stroma’ 
collectively describes all o f  the components in the local vicinity o f the tumour excluding 
the tumour cells themselves, and consists o f a complex array o f molecular, mechanical, 
and cellular components. Both the stromal cells and molecular factors such as cytokines, 
enzymes, extracellular matrix (ECM) components, etc. play central roles, and complex 
cross-talk between the cells and molecules is critical in determining the malignant 
phenotype o f the cells in the vicinity (Eshel et a l, 2002; Park et a l, 2000; Yuan and 
Glazer, 1999; Witz et a l, 1996). The stroma has both temporal and spatial complexity, 
showing tissue specificity and a high degree o f heterogeneity within and between 
tumours and changes dynamically as a tumour progresses.
The stroma/ tumour microenvironment may influence disease progression by 
three distinct yet over-lapping mechanisms: -
1. By enhancing genetic instability o f  tumour cells via mutagenesis (Yuan and 
Glazer, 1999). For example, chronic inflammation may lead to genetic 
instability via mutations induced by phagocyte generated ROS (Weitzman and 
Gordon, 1990) (see section 6 .1.2.1);
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2. By inducing signalling cascades in tumour cells and thus altering gene 
expression patterns (Liotta and Kohn, 2001; Bissell et a l, 1999; Witz et al, 
1996); and
3. By exerting selective pressures on cells -  some molecules in the 
microenvironment may drive cancer development, whilst others may inhibit 
tumourigenicity (Witz et a l, 1996).
The tumour microenvironment (now viewed as the cells and molecules within the tumour 
itself as well as the host cells in the tissue surrounding the tumour, i.e. the host-tumour 
interface (Liotta and Kohn, 2001)) can thus act as a double edged sword, since some 
components may inhibit tumourigenicity and display anti-metastatic properties, whilst 
others may exert tumourigenic or pro-metastatic effects, the outcome largely depending 
on the context as a whole and the balance between the factors (Wemert, 1997; Witz et a l, 
1996). These observations imply that tissue microenvironment is important at all stages 
o f malignant disease, and is likely to have a key role in pre-malignant stages.
Epithelial cancers at different sites in the body frequently develop through a series 
o f pre-malignant stages, and the gradual progression to malignancy is often characterised 
by increasingly abnormal communications between cells in the tumour 
microenvironment, i.e. between the pre-malignant epithelial cells and the stromal cells. In 
some cases the likelihood o f  initiating mutations in the epithelial cells may be further 
enhanced by the microenvironment generated by the stromal cells, whilst in other 
instances changes in the stromal cells (mutations, gene expression changes, etc.) may 
lead to a reactive stroma which becomes the tumourigenic agent itself, giving rise to an 
unstable epithelium. This is exemplified by chronic inflammation in gastric tissues 
driving gastric carcinogenesis which was discussed in some detail in sections 1.3.1,
1.4.5.1, and 1.7, and briefly below.
5.1.2 Chronic Inflammation and Oxidative Stress in Gastric Cancer
The well established link between chronic inflammation and cancer was discussed 
in detail in section 1.7 as well as in previous chapters. The importance o f inflammation in
210
the pathogenesis o f cancer has received such recognition in recent years that it even 
featured as a cover story in the February 23rd 2004 issue o f  Time magazine entitled ‘The 
Secret Killer’ (http://www.tim e.com /tim e/m agazine/article/0.9171.993419.00.htmr).
In the context o f  microenvironment chronic smouldering inflammation generates 
a hostile stroma upon which the malignant potential o f pre-malignant stages o f the 
disease can be enhanced. The inflammatory effector cells found in the microenvironment 
o f  a tumour together with soluble mediators o f  inflammation including cytokines and 
leukotrienes, and enzymes such as COX-2 and matrix metalloproteinases (MMPs), as 
well as leukocyte - (and sometimes epithelial -) generated ROS make up an inflammatory 
milieu that is tumour promoting (Greten et al, 2004; Pikarsky et al, 2004; Wilson and 
Balkwill, 2002). This can occur via activation o f growth factors, as well as signal 
transduction and gene expression changes. In addition to the tumour promoting effect o f 
chronic inflammation, the inflammatory cells have also been reported to induce initiating 
mutations via the generation o f bactericidal and unfortunately for the host, mutagenic 
ROS (Weitzman et al, 1990). ROS have been implicated in the pathogenesis o f  several 
cancers, oxidative DNA damage induced by ROS being implicated in up to 50% o f all 
human cancers (Beckman and Ames, 1997). In addition, ROS can have a tumour 
promoting effect by inducing epigenetic changes such as signal transduction and gene 
expression changes (sections 3.1.1 -  3.1.4). Aberrant cell signalling can come about by 
way o f changes in extracellular growth signals (frequently a consequence o f mutations 
and/ or changes in local tissue microenvironment), changes in the cell surface receptors, 
andI or changes in the intracellular signalling cascades that translate the signal to the 
nucleus (Fedi et a l, 1997). Indeed all three o f  these mechanisms can be induced by 
excessive ROS, and hence oxidative stress, in the tissue microenvironment (Nathan, 
2003; Garcia-Ruiz et a l, 1997; Huang et al, 1996; Rao, 1996; Rosette and Karin, 1996; 
Sen and Packer, 1996; Lo and Cruz, 1995). The effects o f ROS on the MAPK and NFkB 
signalling pathways, two pathways heavily involved in inflammatory signalling and 
inflammation associated cancers (Baek et a l, 2004; Seo et a l, 2004; Chu et al, 2003; 
Chang and Karin, 2001; Li and Karin, 1999), were discussed in detail in chapter 3.
Chronic inflammatory microenvironments can commonly be observed in the 
gastrointestinal tract, manifest as fairly common conditions such as oesophagitis and
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gastritis which can be caused by a variety o f factors (MacNaughton, 2006). Gastric 
cancer o f the intestinal subtype has been causally linked to chronic inflammation, 
progressing through a  series o f pre-malignant stages (Correa, 1992a) starting with chronic 
superficial gastritis (chronic inflammation o f the gastric mucosa), and progressing 
through atrophic gastritis, intestinal metaplasia, dysplasia, and ultimately gastric cancer.
The ultimate ‘driving force’ o f gastric carcinogenesis is believed to be chronic 
gastric inflammation (gastritis) regardless o f  its cause (Zavros et a l, 2005) and is 
discussed in greater detail in chapter 6 . Probably the most common aetiological agent o f 
chronic gastritis is long term infection with H. pylori (Israel and Peek, 2001; Correa, 
1992a; Marshall, 1986) which may persist throughout an individual’s lifetime generating 
a  harsh inflammatory tissue microenvironment with both cellular and humoral 
components (Matysiak-Budnik and Megraud, 2006; Graham and Go, 1993), leading to 
impairment o f tissue structure and function. As detailed in sections 1.2.1 and 1.4 -
1.4.5.1, gastric cancer has a complex aetiology in which several factors come into play 
(age, sex, diet, H  pylori infection, etc.), and is further complicated by interactions 
between factors - both host and bacterial, including host genetic susceptibility, immune 
response, age at acquisition o f infection, and bacterial strain (related to virulence) 
(section 1.4.5). Such interactions can influence the extent o f  the chronic inflammation 
and so the risk o f developing gastric cancer, and also provides a possible explanation as 
to why only a  small minority (< 1%) o f H. pylori infected individuals go on to develop 
the disease (Correa, 1995).
A possible mechanism through which chronic inflammation may promote gastric 
carcinogenesis is via oxidative stress, an unavoidable by-product o f chronic inflammatory 
processes, originating from several sources including leukocytes, lymphocytes, and pro- 
inflammatory cytokines. In H. pylori infection inflammatory leukocytes generate and 
release potent ROS (Zhang et a l, 1996; Rautelin et a l, 1994) and oxidative stress may 
also result through the accumulation o f  bacterial generated superoxide (Nagata et a l, 
1998), as well as from ROS released by gastric epithelial cells following exposure to 
bacteria (Ding et a l ,  2007; Xu et a l, 2004; Obst et al, 2000; Bagchi et a l, 1996; Davies 
et a l, 1994a; Davies et al, 1994b), and as a consequence o f  reduced gastric ascorbic acid 
levels (Hohenberger and Gretschel, 2003; IARC, 1994; Ruiz et a l, 1994). Indeed this
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chronic infection associated oxidative stress has an impact on cells at the molecular level, 
being seen to cause marked increases in DNA damage (Farinati et a l, 2003; Obst et al, 
2000) as well as an increase in the mutation rate (Jenks et al., 2003; Touati et al, 2003); 
aberrations o f  cellular signal transduction and gene expression changes (Baek et a l, 
2004; Seo et al, 2004; Chu et al, 2003; Kim et a l, 2001; Lim et al, 2001; Kim et al, 
2000; Nardone et a l, 1999); and shifts in the proliferation/ apoptosis balance in favour o f 
enhanced cell survival and proliferation (Pritchard and Crabtree, 2006; van Grieken et a l, 
2003; Correa and Miller, 1998; Piotrowiski et a l, 1997; Bechi et a l, 1996; Fan et al, 
1996; Moss et a l, 1996). Together these changes favour the development o f neoplastic 
disease and provide links between chronic inflammation, oxidative stress, and the 
pathogenesis o f  gastric cancer.
5.1.3 Aims of the C hap ter
Since the overall aim o f the present research was to analyse the relationship 
between inflammation and gastric cancer with an emphasis on signal transduction and 
gene expression changes; initially using in vitro models o f inflammatory components and 
later shifting to an in vivo molecular study using inflamed gastric tissue specimens; the 
present chapter o f work set out to investigate the effect o f  inflammatory leukocytes on 
signalling and gene expression changes in gastric epithelial cells. In this way the in vivo 
tissue microenvironment in gastritis characterised by dense neutrophil and macrophage 
infiltrates and a plethora o f inflammatory factors including ROS can more closely be 
mimicked and studied, so providing a steady transition from the initial in vitro study with 
frank H2O2 exposures (chapter 3) to the in vivo study (chapter 6 ).
Since cancer has commonly been described as a disease o f aberrant signal 
transduction (Arbiser, 2004; Eshel et a l, 2002; Radisky et a l, 2001; Fedi et a l, 1997; 
Hunter, 1997; Kohn et a l, 1992) it is fundamental to obtain insights into how such 
changes can be induced. Mis-regulation o f the ERK1/2 (p42/p44) MAPK and NFkB 
signalling cascades, which control the activity o f the AP-1 and NFkB transcription
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factors respectively, has frequently been reported in H. pylori infected gastric tissues and 
gastric cancer (Maeda et a l, 2000; Meyer-Ter-Vehn et a l, 2000; Naumann et al, 1999; 
Aihara et a l, 1997; Malinin et a l, 1997; Muller et a l, 1997). Both o f these pathways 
have been reported to be activated by RO/NS (Genestra, 2007; Gloire et a l, 2006; 
McCubrey et al, 2006; Takada et a l, 2003; Jackson et al, 2002; Lee and Esselman, 
2002; Zhang et al, 2001; Bowie and O ’Neill, 2000) and further support for this was 
provided in chapter 3. In addition, one mechanism by which H  pylori drives gastric 
carcinogenesis is through oxidative stress (Xu et a l, 2004; Farinati et a l, 2003; Obst et 
al, 2000; Asaka et al, 1997; Bagchi et a l, 1996; Correa, 1988) derived from bacterial, 
and host sources (gastric epithelium and inflammatory leukocytes), and so it is quite 
plausible that inflammation associated oxidative stress may cause such changes in the 
gastric mucosa, with inflammatory leukocytes likely playing a key role, providing a link 
between H. pylori infection and gastric cancer development.
The effect o f inflammatory leukocytes was studied using the co-culture system 
optimised in the previous chapter. Briefly this involved co-culturing HGC-27 gastric 
epithelial cells (derived from gastric adenocarcinoma) with the HL-60 promyelocytic cell 
line that had been induced to differentiate into myelocytes, metamylocytes, and banded 
neutrophils by culturing cells in the presence o f 1.3% (v/v) dimethyl sulfoxide (DMSO) 
for 3 days prior to co-culture. The resultant population o f  differentiated cells was deemed 
HL-60/N for the presence o f neutrophils, and was primed overnight with LPS and co­
cultured with HGC-27 at different densities. Only the HGC-27 cell line was used in the 
co-culture studies for practical reasons since both gastric epithelial adenocarcinoma cell 
lines studied showed similar gene expression and signalling responses in regard to c-FOS 
and IL-8 expression and ERK1/2 (p42/p44) activation (chapter 3), and o f  the two cell 
lines, HGC-27 could be established in steady cell culture more readily and had already 
been more extensively studied through the array experiments (chapter 3). Since the extent 
o f inflammatory cell infiltrate can vary widely in chronic gastritis, and the extent o f 
inflammation is a recognised risk factor for the development o f malignant gastric disease, 
with more severe inflammation being associated with increased risk (Fox and Wang, 
2007; Axon, 2002; El-Omar et al, 2000; Correa, 1995; Gilmour, 1961), HGC-27 was co­
cultured with HL-60/N at different ratios in order to reflect different severities o f
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inflammation. The introduction o f lOOnM fMLP to the co-culture system stimulated 
activation o f HL-60/N and so the induction o f an oxidative burst response. As such the 
influence o f leukocyte derived oxidative stress on HGC-27 at the level o f  signal 
transduction and gene expression changes -  specifically the ERK1/2 (p42/p44) MAPK 
pathway (from here-on-in ERK1/2 (p42/p44) will be referred to as ERK) and c-FOS and 
IL-8 gene expression (in keeping with the previous studies in chapter 3 and further 
studies in chapter 6 ) -  could be assessed. c-FOS expression was assessed as a marker o f 
ERK MAPK signalling since the two were seen to be linked in preliminary 
experimentation described in chapter 3. In a similar manner IL-8 was studied as a marker 
o f  NFkB activity since IL-8 expression has been reported to be regulated by NFkB 
(Jenkins et a l,  2004). VEGF and IkB  were not studied in the present work since one 
marker for each pathway was adequate to gain insights into gene expression and 
signalling changes induced by co-culture.
5.2 Materials and Methods 
5.2.1 Cell Culture of HGC-27
The gastric adenocarcinoma cell line HGC-27 was cultured as described in 
sections 2.1.1.1 -  2.1.1.4 and 3.2.1. For co-culture experimentation cells between 
passages 5 - 1 5  were used, and cells were seeded into 80cm cell culture flasks at a 
density o f  1 x 105 cells/ml and incubated at 37°C in an atmosphere o f 5% CO2 overnight 
prior to the addition o f primed HL-60/N. Several flasks o f  cells were prepared for the co­
culture experiments (see section 5.2.3).
5.2.2 Cell Culture, Differentiation, and Priming of HL-60
HL-60 were cultured as described in sections 2.1.1.6 and 4.2.1, induced to 
differentiate into neutrophils or neutrophil-like cells (mature myelocytes, 
metamyelocytes, banded neutrophils; population collectively termed HL-60/N), and
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primed with LPS following the optimised methods outlined in sections 4.2.2, 4.2.4, and
4.2.5 that were shown to successfully optimise subsequent induction o f a measurable 
oxidative burst response in HL-60/N. Only cells with a viability o f > 90% were used in 
subsequent co-culture experimentation. Briefly this involved seeding HL-60 at a density 
of 1 x 106 cells/ml, and allowing cells to grow for 3 days in the presence o f 1.3% (v/v) 
DMSO in order to induce neutrophil differentiation. On the third day in culture LPS was 
introduced at lOOng/ml and cells incubated at 37°C overnight in order to prime cells for 
further stimulation. Subsequently cells were harvested by centrifugation at 200 x g 
(1500rpm) for 5min, and washed twice in pre-warmed (37°C) PBS followed by another 
centrifugation step to remove all traces o f  LPS. Six flasks o f cells were prepared in the 
exact same manner in order to achieve the high cell numbers needed for all co-culture 
experiments. The cells harvested from the six flasks o f  differentiated and LPS primed 
HL-60/N were pooled and re-suspended in serum free RPMI (plus 2mM L-glutamate) 
(Gibco-BRL, Paisley, UK) to a final volume and density o f cells that could accommodate 
for all co-culture experiments (see section 5.2.3 below).
5.2.3 C o-C ulture of HGC-27 and  HL-60/N
To mimic the gastric tissue inflammation characteristic o f  gastritis HGC-27 
gastric epithelial cells were co-incubated/ co-cultured with primed HL-60/N for 4hr and 
8hr periods. Since the density o f inflammatory cell infiltrate in gastritis can be highly 
variable, the extent determining the severity o f the inflammation, HL-60/N were 
introduced to the HGC-27 epithelial cell monolayer (at ~  75% confluence) at a range o f 
densities in order to emulate different degrees o f  inflammation. This was achieved by 
adding HL-60/N cell suspension to HGC-27 at HGC-27 to HL-60/N ratios o f 1:1, 2:1, 
and 4:1. Following addition o f HL-60/N to HGC-27, an inflammatory oxidative burst 
response was stimulated by the addition o f  lOOnM fMLP (demonstrated in chapter 4 to 
successfully induce a measurable oxidative burst response in HL-60/N) to appropriate 
flasks. The co-culture experiments performed were:-
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1. 4hr control -  HGC-27 (1 x 105 cells/ml) in 10ml serum free DMEM plus 10ml 
serum free RPMI
2. 4hr lOOnM fMLP control -  HGC-27 (in serum free DMEM) plus 10ml serum free 
RPMI plus lOOnMfMLP
3. 4hr 1:1 HGC-27: HL-60/N -  HGC-27 (1 x 105 cells/ml) plus 10ml HL-60/N cell 
suspension (1 x 105 cells/ml) in serum free RPMI to a final cell/ cell ratio o f 1:1
4. 4hr 1:1 HGC-27: HL-60/N + lOOnM fMLP
5. 4hr 2:1 HGC-27: HL-60/N (1 x 105 cells/ml: 0.5 x  105 cells/ml) + lOOnM fMLP
6 . 4hr 4:1 HGC-27: HL-60/N (1 x 105 cells/ml: 0.25 x 105 cells/ml) + lOOnM fMLP
7. 8 hr control
8 . 8hr + lOOnM fMLP control
9. 8hr 1:1 HGC-27: HL-60/N
10. 8 hr 1:1 HGC-27: HL-60/N + lOOnM fMLP
11. 8 hr 2:1 HGC-27: HL-60/N + lOOnM fMLP
12. 8 hr 4:1 HGC-27: HL-60/N + lOOnM fMLP
Following treatments HL-60/N were removed from HGC-27 by decanting the cell 
suspension from the flasks and washing the HGC-27 monolayer twice with pre-warmed 
PBS (37°C) to remove all HL-60/N and any traces o f fMLP. The effective removal o f all 
inflammatory leukocyte cells was confirmed by examination o f cells under the light 
microscope. HGC-27 and HL-60/N appear very different morphologically, the former 
being an attached irregular shaped epithelial cell line much larger in size compared to the 
rounder HL-60/N cells which grow in suspension, and so the cell types can readily be 
distinguished and the removal o f HL-60/N easily determined. Duplicates for each 
treatment (1 -  12) were carried out so that RNA could be extracted from HGC-27 
following treatment and removal o f HL-60/N from one flask, and protein extracted from 
the other for downstream signal transduction and gene expression analysis.
The experiment in its entirety was performed in duplicate on different days, and 
the RNA and protein yielded from each treatment pooled and analysed.
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5.2.4 RNA Extraction from HGC-27
Following co-culture o f HGC-27 and HL-60/N, HL-60/N were removed as 
described in section 5.2.3 and HGC-27 cells harvested by trypsinisation following the 
methods detailed in section 2.1.1.4. RNA was subsequently extracted as described in 
section 2.4. Contaminating DNA was removed from the RNA samples yielded using the 
DNA/ree™  kit (Ambion, Warrington, UK) according to manufacturer’s instructions 
(section 2.4.3) and RNA quality and quantity assessed following the protocols outlined in 
sections 2.4.5. RNA samples were aliquotted into 20fil aliquots and stored at -80°C until 
use to avoid excessive freeze thawing. Samples were used for up to two freeze-thaw 
cycles and then discarded so avoiding problems associated with RNA stability.
5.2.5 Protein Extraction from HGC-27
Total cellular protein was extracted, processed, and quantified from inflammation 
exposed and control HGC-27 as described in section 2.6. Protein concentration was 
quantified using the 2D quant kit (GE Lifesciences, Bucks, UK) as detailed in section
2.6.1 and the samples aliquotted into 20pl aliquots and stored at -80°C until use.
5.2.6 Confirmation of Oxidative Impact of Co-culture on HGC-27: Analysis of 
Levels o f Oxidised Proteins in HGC-27
Whilst the successful induction o f an inflammatory oxidative burst response in 
HL-60/N was demonstrated in chapter 4, it was essential to test that under co-culture 
conditions this oxidative burst generated a setting o f oxidative stress that directly 
impacted HGC-27 at the molecular level. This was achieved by assessing the levels o f
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oxidised proteins in protein extracts obtained from HGC-27 post co-culture (section 
5.2.5) using the OxyBlot™ kit (Chemicon, Hampshire, UK) as per manufacturer’s 
instruction. The assay works on the basis that modification o f proteins by ROS introduces 
carbonyl groups into the protein side chains, which can be modified by treatment with 
2,4-Dinitrophenylhydrazine (DNPH) giving rise to dinitrophenyl (DNP) residues which 
can be readily detected using specific anti-DNP antibodies.
The appropriate volumes o f samples constituting 15pg protein were aliquotted in 
duplicate into 1.5ml microfuge tubes (a positive control provided in the kit consisting o f 
oxidised proteins was also included) followed by the addition o f 1 volume 1 2 % (w/v) 
SDS to denature proteins. Subsequently 1 volume (relative to total volume) o f  IX  DNPH 
was added to one o f each o f  the duplicate sample tubes, and 1 volume IX  derivatisation- 
control solution added to the other as a control to ensure that any changes in antibody 
binding seen were truly due to ROS mediated protein modifications. The tubes were then 
incubated at room temperature for 15min. The reactions were subsequently stopped by 
the addition o f  37.5% (v/v) neutralisation solution to each tube. Samples were next 
Spotted onto nitrocellulose membranes by carefully pipetting lp l  o f  sample at a time, 
allowing the spot to dry and then reapplying until a total o f  1 0 pl was loaded for each 
sample. The membrane was allowed to dry for 45min prior to a 1 hr incubation in 
blocking buffer (1% BSA in PBS/ 0.05% Tween) at room temperature with gentle 
agitation to block non-specific sites. The primary antibody solution was prepared as a 
1:100 dilution o f primary rabbit anti-DNP antibody (supplied in kit) in blocking buffer 
and the membrane incubated in the solution for lh r at room temperature with gentle 
agitation. Next the membrane was rinsed 3 X with PBS/ 0.05% Tween before incubating 
in secondary antibody solution (1:200 dilution o f  goat anti-rabbit IgG (HRP-conjugated) 
(supplied in kit) in blocking buffer) for lh r at room temperature with gentle agitation. 
After the incubation period the membrane was rinsed 3 X  in PBS/ 0.05% Tween and any 
excess solution drained prior to chemiluminescence detection using the ECL kit (GE 
Lifesciences, Bucks, UK) and exposure o f  the membrane to X-ray film (GE Lifesciences, 
Bucks, UK) as described in section 2.7.3. The final blot was scanned as a JPEG format 
image and analysed with respect to signal intensity using the ImageJ software 
downloaded from the NIH website (http://rsb.info.nih.gov/iK see section 2.7.3). The
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assay was performed in duplicate on separate days and results expressed as averages of 
the data obtained.
5.2.7 Real-Time PCR Analysis of c-FOS and IL-8 Levels
In order to determine if  inflammatory conditions and leukocyte-derived ROS in 
the co-culture system lead to changes in ERK MAPK and NFkB signalling, and as such 
either increases or decreases in the levels o f  c-FOS and IL-8 downstream gene expression 
targets, gene expression levels were analysed by real-time PCR.
Real-time PCR was carried out separately for c-FOS and IL-8 using P-actin 
(ACTB) as an internal standard in both cases (see chapter 3, table 3.2 for primer 
sequences). For all analyses 500ng sample RNA was used and standard curves were 
generated using pooled RNA from cell culture and gastric biopsy specimens seen to 
express c-FOS and IL-8. The same standard curve RNA was used in each plate o f the 
entire experimental run so minimisation potential sources o f  variation in the data (see 
section 2.5.1 for further details).
5.2.8 Western Blot Analysis of pERK Levels
Western blots were performed on post co-culture HGC-27 protein samples for 
pERK in order to assess ERK MAPK activation in the cells following the methods 
outlined in sections 2.7.3 and 3.2.3.1.
5.2.9 Statistical Analysis
The SPSS version 13.0 software package was used for statistical analysis. One 
way ANOVA (followed by Tukey and Duncan post hoc tests) was used to compare data 
in control and treated samples to determine if  co-culture with inflammatory leukocytes
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induced significant signal transduction and gene expression changes in HGC-27. 
Statistical significance was achieved when P < 0.05 (confidence levels > 95%).
53 Results
53.1 Co-culture Induced Protein Oxidation in HGC-27
In order to confirm that co-culture with activated HL-60/N generated an 
inflammatory setting in which the release o f ROS (and hence oxidative stress) could 
directly impact HGC-27 at the molecular level, the levels o f ROS modified proteins in
'TW
HGC-27 cells post co-culture were measured using the OxyBlot oxidised protein 
detection kit. This assay detects oxidised proteins in whole cell protein lysates using a dot 
blot type methodology in which oxidised protein side chains are derivatised into moieties 
that can be specifically and sensitively detected using an antibody when the proteins are 
spotted onto a membrane. Figure 5.1 shows an example o f a typical blot experiment for 
the 4hr co-culture protein samples from which it is evident that co-culture with HL-60/N 
either in the presence o f  absence o f lOOnM fMLP resulted in increased levels o f  oxidised 
proteins compared to untreated or fMLP treated controls. Figure 5.2 summarises the data 
in graphical format and again illustrates that co-culture o f HGC-27 with HL-60/N 
resulted in enhanced levels o f  oxidised proteins compared to cells not co-cultured with 
HL-60/N or treated with lOOnM fMLP alone. Using one way ANOVA statistical analysis 
to compare the results in control and treated cells it was seen that although co-culture 
with HL-60/N caused a clear increase in protein oxidation in HGC-27, the increases were 
not statistically significant.
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Figure 5.1 Typical result o f an OxyBlot™ experiment showing the levels o f oxidised protein in 4hr 
control and treated/ inflammation exposed HGC-27 cells. It is evident that co-culture o f cells with HL- 
60/N, either unstimulated or fMLP stimulated, results in higher levels o f oxidised proteins (visible as darker 
spots) compared to cells not exposed to HL-60/N or treated with lOOnM fMLP alone. 1:1 signifies a one to 
one co-culture ratio o f HGC-27 to HL-60/N. Refer to text for further details. N = 2.
4hr 4hr + 1 OOnM 4hr 1:1 4hr 1:1 +
control fMLP lOOnM fMLP
. 0  •  #
Figure 5.2 Graphical representation o f OxyBlot™ assay data. The Blot images obtained were analysed 
using the ImageJ software (section 5.2.6) and spot intensity was seen to be proportional to the levels o f 
oxidised protein (see fig. 5.1). Standard error too small to be shown as bars. N = 2.
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5.3.2 c~FOS Gene Expression in HGC-27 Post Co-culture
Figure 5.3 illustrates c-FOS expression levels in HGC-27 following various co­
culture treatments. Interestingly co-culture with LPS primed HL-60/N in the absence or 
presence o f fMLP stimulation did not cause an expected increase in c-FOS expression 
levels, and interestingly, where statistically significant changes in gene expression levels 
were observed following co-culture, they tended to be decreases compared to the level in 
untreated controls (P < 0.01). For example, at both 4 and 8 hr time points, co-culture o f 
HGC-27 with HL-60/N at a HGC-27 to HL-60/N ratio o f 4:1 plus lOOnM fMLP resulted 
in a significant decrease in c-FOS level compared to the respective control for each time 
point (fig. 5.3). A noteworthy observation is that at both time points the level o f  c-FOS 
expression in control cells appeared to be high and that treatment with lOOnM fMLP 
resulted in significant down-regulation, as did some o f the co-culture treatments with 
fMLP stimulation (2:1 and 4:1 co-cultures + lOOnM fMLP at 4hr, and 4:1 co-culture + 
lOOnM fMLP at 8 hr). Interestingly, the 1:1 co-culture model, both in the presence and 
absence o f fMLP did not cause significant down-regulation o f  c-FOS gene expression at 
4 hr and 8hr. This can lead one to speculate that certain conditions o f inflammation -  in 
this case high levels o f  inflammatory cells (1:1) do not cause c-FOS down-regulation 
whilst less marked inflammation (and so less oxidative stress) (2:1 and 4:1), and fMLP 
treatment alone do. As such, it is likely that in the in vivo setting the level o f  tissue 
inflammation can influence the outcome o f  the expression o f oncogenic c-FOS.
5 3 3  IL-8 Gene Expression in HGC-27 Post Co-culture
In contrast to the findings for c-FOS, IL-8 gene expression was significantly up- 
regulated by co-culture o f HGC-27 with HL-60/N both in the presence and absence o f 
lOOnM fMLP at both 4hr and 8 hr exposure times (P <  0.01) (fig. 5.4). Interestingly the 
level o f  IL-8 up-regulation appeared to be related to the co-culture ratio, and hence the 
degree o f  inflammation and oxidative stress.
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Figure 5.3 Graphical representation of average c-FOS gene expression (analysed by real-time PCR 
relative to (3-actin) in control, lOOnM fMLP treated, and HL-60/N exposed HGC-27 cells (with or without 
lOOnM and with either 1:1, 2:1, or 4:1 HGC-27/ HL-60/N co-culture ratio). Standard error too small to be 
shown as bars. Statistically significant differences (P <0 .01) are highlighted with red stars (based on one 
way ANOVA). See text for further details. N = 2.
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For example, at 4hr post co-culture, a 1:1 co-culture ratio (plus or minus fMLP) resulted 
in markedly enhanced IL-8 levels, compared to that in control cells and cells treated with 
lOOnM fMLP alone, than the 2:1 and 4:1 ratios, IL-8 expression levels declining 
gradually as the ratio o f  HGC-27 to HL-60/N increased (fig. 5.4). Another noteworthy 
observation was that at both the 4 and 8 hr exposure times, maximal IL-8 induction was 
observed following co-culture o f HGC-27 with HL-60 at 1:1 in the absence o f  fMLP 
stimulation, and the addition o f  fMLP appeared to cause a decrease in IL-8 gene 
expression. These observations suggest that under conditions o f tissue inflammation, up- 
regulation o f  IL-8 gene expression is a likely molecular change. The likelihood o f  IL-8 
over-expression appears to be positively related to the degree o f  inflammation, and may 
be affected negatively by the presence o f  fMLP in the vicinity.
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Figure 5.4 Graph illustrating average IL-8 gene expression (analysed by real-time PCR relative to (3- 
actin) in control, lOOnM fMLP treated, and HL-60/N exposed HGC-27 cells (with or without lOOnM and 
with either 1:1, 2:1, or 4:1 HGC-27/ HL-60/N co-culture ratio). Standard error too small to be shown as 
bars. Statistically significant differences (P < 0.01) are highlighted with red stars (based on one way 
ANOVA). See text for further details. N = 2.
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5.3.4 pERK  Levels in HGC-27 Post Co-culture
pERK levels in HGC-27 following co-culture experimentation were analysed by 
western blotting to determine if  exposure to inflammatory cells with the associated 
increase in oxidative stress could cause changes in cellular signal transduction at the level 
o f the ERK MAPK pathway. The results are illustrated graphically in figure 5.5, 
examination o f  which reveals that in some instances co-culture o f  HGC-27 with HL-60/N 
could induce significant increases in pERK levels in HGC-27 compared to cells not 
exposed to HL-60/N (seen with one way ANOVA, P < 0.01). Specifically, 4hr co-culture 
with HL-60/N at a 1:1 density with or without fMLP stimulation resulted in significant 
increases in pERK levels compared to un-exposed control cells and cells exposed to
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lOOnM fMLP alone (~ 1.6-fold increase over un-exposed control cells in both cases). At 
the 4hr time point, co-culture with HL-60/N at lower ratios o f inflammatory cells to 
gastric epithelial cells did not appear to cause any marked change in pERK levels, 
suggesting that the induction o f  ERK signalling is dependent upon the severity o f  
inflammation, significant changes in ERK phosphorylation only being induced in 
situations o f more intense inflammation with greater density o f  inflammatory cells. At the 
8hr time point, co-culture with HL-60/N at any ratio, and in the presence or absence o f 
fMLP stimulation, did not have any significant impact on pERK levels in HGC-27.
Figure 5.5 Average pERK levels in control, lOOnM fMLP treated, and HL-60/N exposed HGC-27 cells 
(with or without lOOnM and with either 1:1, 2:1, or 4:1 HGC-27/ HL-60/N co-culture ratio) analysed by 
western blots relative to total ERK following co-culture experiments. Standard error bars shown. 
Statistically significant differences (P < 0.01) are highlighted with red stars (based on one way ANOVA).
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5.4 Discussion
The effect o f  inflammatory leukocytes on c-FOS and IL-8 gene expression, and 
ERK MAPK signalling in gastric epithelial cells was analysed in the present study using 
a co-culture system to mimic the inflammatory conditions in gastritis. The relevance o f 
the study stems from the fact that chronic gastric inflammation (gastritis) is heavily 
implicated in the earliest stages o f the pathogenesis o f  gastric cancer (Zavros et al, 2005; 
Sipponen et al., 1998; Correa, 1992a). This oncogenic setting o f  chronic tissue 
inflammation can be dissected into several components which may act alone, or 
synergistically to drive the development o f malignant gastric disease, and include pro- 
inflammatory mediators such as cytokines, growth factors, and RO/NS, all o f  which can 
be derived from host epithelial cell and leukocyte sources in the vicinity.
The effect o f cytokines and RO/NS on cells has been well studied using in vitro 
experimentation whereby cells are directly exposed to various concentrations o f the 
biological molecules or compounds (Genestra, 2007; Gloire et a l, 2006; McCubrey et 
al, 2006; Takada et al, 2003; Klotz, 2002; Lee and Esselman, 2002; Fan et a l, 2001; Lin 
et al, 2001; Suzuki et al, 2001), and indeed chapter 3 described the effects o f H2O2 
exposures on cells with respect to MAPK and NFkB signalling and downstream 
expression o f  c-FOS and IL-8. It is o f  particular importance, however, to study the 
combinatorial effects o f the compounds that may be present in an in vivo inflammatory 
setting. In response to infection (e.g. H. pylori) or injury in the gastric mucosa, 
inflammatory leukocytes generate and release a diverse array o f pro-inflammatory 
compounds and metabolites. For example, as detailed in section 1.4.5.1, in response to H. 
pylori infection, the gastric epithelium and neutrophils in the vicinity release an array of 
inflammatory mediators including IL-8  (Crabtree et a l, 2004; Crabtree, 1998; Crabtree, 
1996a; Crabtree et al, 1994a; Crabtree et a l, 1994b) IL-6 , IL -lp , TNFa, IFNy (Smythies 
et a l, 2000; Lindholm et a l, 1998; Messa et a l, 1996; Mohammadi et a l, 1996; Moss et 
al, 1994; Noach et al, 1994) and a plethora o f  RO/NS (Mizuki et a l, 2000; Rautelin et 
al, 1993; Mooney et a l, 1991). As such, in order to obtain better insights into how pro- 
inflammatory mediators and RO/NS found persistently at sites o f chronic inflammation 
affect nearby epithelial cells, using an in vitro model that more closely mimics the in vivo
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setting, it is fundamental to expose gastric epithelial cells to the compounds from their 
natural biological source, i.e. leukocytes. This was achieved using a co-culture system in 
which the HGC-27 gastric adenocarcinoma cell line was co-incubated with the HL-60/N 
cell line optimised for oxidative burst induction as described in chapter 4. HGC-27 was 
co-cultured with LPS primed HL-60/N at HGC-27 to HL-60/N ratios o f 1:1, 2:1, and 4:1 
in order to mimic different intensities o f inflammation since the degree o f inflammation 
may impact an individuals risk o f developing gastric cancer, with more severe 
inflammation being linked to a greater risk o f developing the disease (Fox and Wang, 
2007; Axon, 2002; El-Omar et al., 2000; Correa, 1995; Correa and Miller, 1995; 
Gilmour, 1961). Induction o f the neutrophil oxidative burst was further enhanced in some 
instances by the addition o f lOOnM fMLP. RNA and protein were then extracted from 
HGC-27 in order to assess any changes in c-FOS and IL-8 RNA levels and ERK MAPK 
signalling, at the level o f  ERK phosphorylation, induced by co-culture. OxyBlot™ 
analysis revealed that the co-culture conditions induced oxidative modifications o f 
proteins in HGC-27, confirming the impact o f  co-culture derived oxidative stress on the 
gastric epithelial cells.
With respect to c-FOS, exposure o f HGC-27 to inflammatory HL-60/N cells, 
either in the presence or absence o f fMLP stimulation, did not cause the expected 
increase in c-FOS expression levels (based on the observations o f  oxidative stress 
induced up-regulation o f c-FOS in chapter 3). Rather, significant down-regulation o f the 
gene was observed following treatment o f  HGC-27 with lOOnM fMLP in the absence of 
HL-60/N, and following co-culture at 2:1 and 4:1 ratios plus lOOnM fMLP (significant 
decreases in c-FOS levels (P < 0.01) in all three treatments at 4hr, and lOOnM fMLP 
control and 4:1 co-culture + lOOnM fMLP at 8hr). Interestingly no significant changes in 
c-FOS expression levels were apparent following 1:1 co-culture treatments both in the 
presence and absence o f lOOnM fMLP at both time points. These findings lead to the 
speculation that the severity o f inflammation may have an impact on c-FOS gene 
expression, since less intense inflammation (lower densities o f  inflammatory leukocytes) 
caused down-regulation o f  c-FOS whilst more intense inflammatory conditions (1:1 co­
culture ratio) had no apparent effect on c-FOS levels. The results are slightly confounded 
in that c-FOS RNA levels were found to be high in un-exposed control HGC-27 for
228
reasons that are unclear based on the present data. The high levels o f c-FOS seen in the 
controls may be due to some aspect o f  the cell culture system, and as such the observed 
decreases in c-FOS expression may be misleading. In the case that the decreases observed 
are due to true down-regulation o f  gene expression, a possible explanation is that c-FOS 
expression levels were saturated in the controls, the introduction o f further expression 
inducing stimulus (e.g. oxidative stress) may then trigger control and negative feedback 
pathways that either keep c-FOS levels constant or result in the observed decreases. A 
second possibility is that the increase in oxidative stress combined with other aspects o f 
the inflammatory co-culture system may cause a sub-toxic environment in which 
proliferation o f HGC-27 is suppressed so accounting for the decreases in c-FOS 
expression. It is very difficult to account for the findings without further experimentation 
(e.g. following the proliferation rate o f HGC-27 post co-culture), but it is clear that the 
severity o f inflammation is likely to determine the outcome o f c-FOS gene expression, 
and this is likely to be the case in the in vivo gastric setting.
The data on IL-8 gene expression revealed some very interesting findings. At both 
4 hr and 8hr time points a  similar trend was observed whereby the 1:1 co-culture ratio in 
the absence o f fMLP caused maximal IL-8 induction which then gradually declined when 
fMLP was added to the system and as the density o f HL-60/N in the co-culture system 
decreased (2:1 and 4:1) (fig. 5.4). At the 4hr time point all four co-culture treatments 
caused significant increases in IL-8 levels compared to un-exposed controls, whilst at the 
8hr time point the 1:1 co-culture, 1:1 co-culture plus fMLP, and 2:1 co-culture plus fMLP 
resulted in significant up-regulation (P < 0.01). These results contrast with the results for 
c-FOS since co-culture treatments caused significant up-regulation o f  IL-8 in HGC-27 
with a clear trend. A noteworthy finding is that, as was the case for c-FOS, the level o f  
IL-8 gene expression appeared to be related to the co-culture ratio and hence the degree 
o f inflammation. In this case, IL-8 gene expression was seen to be maximal in HGC-27 
exposed to the highest density o f HL-60/N (1:1). Interestingly the addition o f fMLP to 
the co-culture system appeared to have a negative impact on IL-8 gene expression levels 
at both time points. This can be seen clearly when comparing the level o f  IL-8 RNA in 
HGC-27 exposed to HL-60/N at a ratio o f 1:1 in the absence o f lOOnM fMLP compared 
to the 1:1 co-culture plus lOOnM fMLP. This could be due to an inhibitory effect caused
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fMLP, or the combination o f LPS priming and fMLP. This speculation fits the IL-8  
ELISA data in chapter 4 where it was seen that LPS priming o f HL-60/N alone and 
treatment with lOOnM fMLP alone caused significant increases in IL- 8  protein levels in 
HL-60/N, whilst combined LPS priming -  fMLP stimulation resulted in no significant 
change in IL- 8  levels compared to untreated HL-60/N controls. This finding is very 
interesting since it conflicts with several reports in the literature that both LPS and fMLP 
are potent inducers o f IL-8 gene expression (Han et a l, 2007, Huang et al, ,2001; 
Innocenti et a l, 2001; Cassatella et a l, 1992) with LPS acting by way o f  induction o f 
ROS generation and concomitant activation o f redox sensitive NFkB (Han et a l, 2007). 
Interestingly however, review o f the literature brought to light that the effects o f LPS and 
fMLP on IL-8 gene expression varies greatly in different cell lines, likely owing to the 
different gene expression control pathways that predominate in different cell types 
(Carlson et a l, 2007; Liboni et a l, 2005; Cassatella et a l, 1992). In this case LPS is not 
likely to directly impact gene expression in HGC-27 since it is not present in the co­
culture system. However, LPS priming o f HL-60/N may indirectly effect expression 
changes in HGC-27 by altering the way HL-60/N cells respond to fMLP, so influencing 
the release o f pro-inflammatory mediators and RO/NS which may impact cell signalling 
and gene expression in HGC-27. With respect to fMLP, Carlson et a l (2007) 
demonstrated that at physiological concentrations (10 — lOOnM), fMLP can inhibit TNFa 
induced activation o f NFkB, providing a possible explanation for the observed decrease 
in IL-8 gene expression since NFkB is a key regulator o f IL-8 expression (Jenkins et al, 
2004). Based on the present data the cause o f the apparent decrease in IL-8 levels 
following addition o f lOOnM fMLP is unclear and would require further experimentation 
to obtain greater insights.
As observed for both c-FOS and IL-8 gene expression, the induction o f ERK 
phosphorylation (and hence MAPK signalling) also appeared to be related to the density 
o f HL-60/N in co-culture, and hence to the extent o f  inflammation. Specifically the levels 
o f pERK in HGC-27 increased significantly (P < 0.01) when the cells were co-incubated 
for a 4hr period with HL-60/N at the highest density, i.e. 1:1 co-culture, both in the 
absence and presence o f  lOOnM fMLP (~ 1.6-fold increase in pERK levels over un­
exposed control cells in both cases). At the 4hr time point both the 2:1 and 4:1 co-culture
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treatments (both plus lOOnM fMLP) had no significant impact on pERK levels in HGC- 
27. At the 8 hr time point none o f the co-culture treatments caused significant changes in 
ERK phosphorylation, leading to the conclusion that only the 1:1 co-culture treatments, 
and hence the most intense inflammatory cell culture microenvironement can induce 
ERK activation, and that ERK phosphorylation appears to occur within a 4hr period, with 
the increase in phosphorylation being transient since it is not seen at 8hr. Relating the 
findings to in vivo circumstances, these observations suggest that in some instances o f 
gastric inflammation, most likely severe inflammation with dense leukocyte infiltrates, 
the tissue microenvironment can induce ERK MAPK signalling by way o f ERK 
phosphorylation, and that this is likely to occur in a transient manner, possibly 
responding to dynamic/ fluctuating changes in the inflammatory conditions, e.g. waves o f 
increased oxidative stress, which could lead to a more consistent overall ERK MAPK 
signalling. In addition, an initial fairly rapid activation o f ERK signalling may set in 
motion a series o f  downstream signalling and gene expression events that lead to changes 
in cell behaviour. In some instances such epigenetic changes may drive the development 
o f an oncogenic phenotype. Interestingly, whilst pERK levels appeared to correlate with 
c-FOS expression following H2O2 treatment o f HGC-27 in chapter 3, no such association 
was seen here. It may be that some other aspect o f  the co-culture system impacted c-FOS 
expression, overshadowing any possible effects o f ERK MAPK signalling. It is also 
possible that, in the co-culture system, factors that both induce and inhibit c-FOS 
expression may be present, and so antagonism between factors may lead to a delayed 
induction o f ERK regulated c-FOS expression beyond the time scale o f the present 
experimentation. It must also be noted that the possible discrepancy in the c-FOS data 
(mis-leadingly high levels in controls) may account for the observed differences in pERK 
and c-FOS levels. Further experimentation would be required to ascertain the underlying 
mechanisms for the observations.
In summary the present work demonstrated that co-culture o f HGC-27 gastric 
epithelial adenocarcinoma cells with HL-60/N inflammatory leukocytes could cause 
activation o f ERK MAPK signalling by way o f increased ERK phosphorylation, and 
increased expression o f IL-8 (implying possible involvement o f NFkB signalling), but not 
significant increases in c-FOS gene expression. It is quite likely that these changes are
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caused by the oxidative stress conditions generated by HL-60/N in the co-culture setting 
(confirmed in the OxyBlot studies for detection o f oxidative protein modifications), and 
as such the data for pERK and IL-8 fit nicely with the data in chapter 3 which 
demonstrated that frank exposure o f HGC-27 to various doses o f  H2O2 could cause 
activation o f pERK and over-expression o f IL-8. The data for c-FOS gene expression 
following co-culture do not fit the H2O2 exposure data in chapter 3, and so it is likely that 
other pathways for controlling c-FOS expression come into play in the co-culture setting. 
Indeed, whilst it is quite plausible that oxidative stress in the co-culture system causes the 
observed signalling and gene expression changes, so tying the present observations to 
those in chapter 3, other factors must not be ruled out. For example, the combinatorial 
effects o f  several different RO/NS may also be coupled to synergistic/ antagonistic 
effects o f other pro-inflammatory mediators that may be released from HL-60/N such as 
cytokines (e.g. IL-8  -  see chapter 4), leukotrienes, growth factors, etc. In addition direct 
cell -  to -  cell contact between HGC-27 and HL-60/N may influence signal transduction 
and gene expression. Based on the present data and experimental design the mechanistic 
nature o f the signalling and gene expression changes cannot clearly be determined and 
further experimentation would be required, for example, repeating the experiments with 
the addition o f antioxidant enzymes or compounds would ascertain any involvement o f 
RO/NS in the observed changes.
What is clear is that in both in vitro models studied (chapter 3 and present), 
components o f an inflammatory response; be it RO/NS, cytokines, cell -  to -  cell contact, 
etc.; appear to induce significant signal transduction and gene expression changes in 
gastric epithelial cells. The data provides potential mechanistic links between chronic 
inflammation and gastric carcinogenesis. It is important, however, to bear in mind that in 
vitro observations may not always translate to the in vivo tissue setting, and as such it is 
fundamental to study these changes in gastric biopsy specimens.
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Chapter 6
ERK1/2 MAPK Activity and c-F O S  gene expression in pre-malignant gastric
tissues.
6.1 Introduction
A common feature o f  all cancers is the genetic instability that they come to 
exhibit with advancement o f  disease (Hanahan and Weinberg, 2000; Loeb and Loeb, 
2000; Cahill et a l, 1999; Lengauer et a l, 1998). An initiating mutation followed by a 
series o f further mutational hits can result in the evolution o f  a tumour mass via complex, 
and yet to be fully understood mechanisms involving natural selection at the cellular level 
(Merlo et a l, 2006; Aranda-Anzaldo, 2001, Rubin, 2001; Cahill et a l, 1999; Vogelstein 
and Kinzler, 1993; Nowell, 1976). A single mutation in a cell may drive waves o f cellular 
multiplication and clonal expansion, further cellular complexity being accumulated in the 
process resulting in tumour growth, disorganization, and enhanced malignant potential. 
This process is dependent upon the generation o f  cells with different proliferative 
capacities in a group o f growing cells. The cells that exhibit a growth advantage are 
selected for during the waves o f clonal expansion resulting in tumour formation. This 
growth advantage may arise by several distinct yet interrelated mechanisms: -
1. Mutation and/ or down-regulation o f tumour suppressor genes by genetic or 
epigenetic mechanisms,
2. Mutation and/ or up-regulation o f  oncogenes via genetic or epigenetic 
mechanisms,
3. Aberrations in signal transduction (often a consequence o f 1. and 2.).
Accumulating genomic instability is at the root o f these changes (Oda et a l, 2005; Zheng 
et a l, 2004). The ultimate outcome o f such molecular changes is that normal cells give
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rise to highly malignant derivatives that display physiological and molecular 
characteristics that confer a selective growth advantage (Nowell, 1976; Foulds, 1954).
A tumour resulting from the accumulation o f molecular changes is essentially a 
heterogeneous mass o f  cells, with distinct groups o f  cells originating from different 
rounds of clonal expansion, all harbouring one type o f growth advantage or another. The 
multiple layers o f complexity o f cancers are evident in that over 2 0 0  types o f the disease 
are known, affecting different sites in the body, different tumour subtypes being found in 
different organs, and the tumours themselves showing heterogeneity in their cellular and 
molecular make-up. Despite this, in recent decades some common features o f cancer cells 
have come to light, summarised in figure 6.1. O f particular interest in the present 
investigations is the fact that all o f these functional characteristics can result from 
changes in cellular signal transduction, and that this can be linked to our ever increasing 
understanding o f the role o f reactive oxygen species (ROS) in both the initiation and 
promotion o f malignant disease (detailed in chapters 1 and 3) with a focus here on gastric 
cancer.
6.1.1 Signal Transduction and the Cancer Phenotype
Cell behaviour is largely orchestrated by complex networks o f inter- and intra­
cellular signal transduction pathways. Research over the past two decades or so has put a 
huge emphasis on unravelling the complexities o f signal transduction pathways at the 
level o f  pathway components, individual signal transduction modules, and interactions 
between pathways. As such the ‘cellular circuitry’, likened to integrated electronic 
circuits in regard to their intricacy, has been delineated to an extent (section 1 .8 , fig. 
1 .1 0 ), key features being inducing signals/ ligands, cell surface receptors, and the flow o f 
molecular information from the cell surface to the nucleus involving kinases and 
phosphatases. More importantly, the mechanisms by which such signalling goes awry in 
disease states have come to be better understood (Finkel and Gutkind, 2003), including 
atherosclerosis, asthma, diabetes, rheumatoid arthritis, neurodegenerative diseases, and 
cancer.
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Cancer, in fact, has often been described as a disease o f mis-regulated signal 
transduction (Arbiser, 2004; Eshel et a l, 2002; Radisky et a l, 2001; Fedi et a l, 1997; 
Hunter, 1997; Kohn et al., 1992) since cancer cells proliferate and grow when they 
should not, and do not undergo programmed cell death (i.e. apoptosis) when they should, 
resulting in a shift in cellular homeostasis to excessive proliferation, a situation which can 
provide the background upon which further molecular anomalies can lead to neoplastic 
progression.
Figure 6.1 Common features o f cancer cells. It is hypothesised that most if not all human cancers acquire 
this set o f functional capabilities, although the means by which they are acquired during disease 
development can vary greatly. Taken from Hanahan and Weinberg, 2000.
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The aberrant signal transduction is often a causal effect o f mutations in oncogenes and 
tumour suppressor genes which are frequently components o f the signal transduction 
pathways themselves.
Proliferation and growth in normal cells requires the processing o f mitogenic 
signals, often from growth factors, extracellular matrix components or cell — to — cell 
contact. In contrast, tumour cells can proliferate in the absence o f  such stimuli, and often 
generate many o f their own growth signals (autonomous signalling), resulting in a ‘self- 
sufficiency in growth signalling’ phenotype (Hanahan and Weinberg, 2000). Defective 
signalling can arise as a result o f  -  changes in extracellular growth signals (frequently a 
consequence o f mutations and/ or changes in local tissue microenvironment), changes in 
the cell surface receptors, and/ or changes in the intracellular signalling cascades that 
translate the signal to the nucleus (Fedi et a l, 1997). The signal transduction alterations 
in cancer cells favours their increased proliferation, and can result from over-activity of 
cellular survival and mitogenic signalling, the decreased activity o f apoptotic signalling, 
or both resulting in an imbalance in cellular homeostasis. In some cases excessive 
apoptotic signalling can lead to enhanced mitogenic signalling in attempts to compensate 
for the disproportionate cell death, again tilting the balance toward increased 
proliferation. The balance between mitogenic and apoptotic signalling is exemplified by 
the fine balance between the ERK1/2 (p42/p44) and JNK/ p38 MAPK pathways; the 
former favouring proliferation, and the latter two driving apoptosis; disruption o f which 
is manifest in many cancers (Dolado et a l, 2007; Dhillon et a l, 2007; Kennedy et a l, 
2007). The NFkB pathway is also seen to play a pivotal role, mis-regulation again 
influencing cell survival (Bubici et a l, 2006) (section 1.8.2 and 3.1.3).
In previous decades, cancer research focussed on a somewhat reductionist view o f 
tumours, where tumours were viewed simply as the cancer cells and the genes within 
them. This view changed dramatically when it was realised that tumours are often 
complex and could function as independent organs, capable o f  regulating their own 
signalling, gene expression, and hence behaviour irrespective o f their host. They consist 
o f a heterogeneous population o f cells -  both malignant in nature, and normal stromal 
cells such as fibroblasts and inflammatory cells, intertwined with endothelial cells 
making up capillaries so providing tumours with their own blood supply (van Kempen et
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al, 2003; Radisky, 2001; Hanahan and Weinberg, 2000; Bissell et a l, 1999) as well as 
non-cellular matrix components. In addition to the autonomous growth signalling in 
cancer cells themselves, their growth can also be influenced by changes in the paracrine 
signalling from normal cells in the vicinity (Hanahan and Weinberg, 2000). In this way 
the normal host cells may ultimately support neoplastic progression, since they can 
provide the appropriate microenvironment that favours neoplasia.
The importance o f tissue microenvironment at all stages o f  neoplastic disease, in 
particular gastric cancer, have been outlined in sections 5.1.1 and 5.1.2 with a particular 
emphasis on chronic inflammation and oxidative stress, since these conditions appear to 
provide a context upon which gastric carcinogenesis can occur (Obst et a l, 2000; 
Stadtlander and Waterbor, 1999; Correa and Shiao, 1994).
6.1.2 Gastric Cancer -  Link with Chronic Inflammation and Oxidative Stress
Whilst the incidence o f gastric cancer has seen a steady decline in recent years, it 
sustains its reputation as the second largest cause o f  cancer related death worldwide 
(Parkin et a l, 2001), largely due to late diagnosis and a dismal prognosis. At the 
histological level, the intestinal subtype is deemed the ‘epidemic’ type, and develops 
through a  well defined series o f pre-malignant steps (also known as the Correa model 
(Correa, 1992a; Correa, 1988; Correa, 1975)) outlined in figure 1.3 and section 1.2.1. 
Briefly, the sequence o f events begins with chronic superficial gastritis (chronic 
inflammation o f the gastric mucosa), subsequently progressing through atrophic gastritis, 
intestinal metaplasia (IM), dysplasia, and ultimately gastric cancer.
Chronic inflammation has long been viewed as the crucial primary stage o f  gastric 
carcinogenesis, and as such is believed to be the ultimate ‘driving force’ o f  disease 
pathogenesis regardless o f its cause (Zavros et a l , 2005). Several factors may cause 
chronic gastric mucosal inflammation/ gastritis, including physical stress, dietary factors, 
medications, etc. However, chronic infection with the bacterium H. pylori is the most 
common aetiological agent (Israel and Peek, 2001; Correa, 1992a; Marshall, 1986). 
Colonisation o f the gastric epithelium with the bacterium induces a chronic host 
inflammatory reaction consisting o f cellular and humoral components that may persist
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throughout an individual’s lifetime (Matysiak-Budnik and Megraud, 2006; Graham, 
1993). The extent o f chronic inflammation depends on several interacting factors -  both 
host and bacterial, including host genetic susceptibility, immune response, age at 
acquisition o f infection, and bacterial strain (related to virulence) (section 1.4.5). This 
multi-factorial nature o f gastric disease may provide and explanation as to why only a 
small minority (< 1%) o f  H  pylori infected individuals go on to develop gastric cancer 
(Correa, 1995).
Although the link between chronic inflammation and gastric cancer is now clearly 
recognised, the mechanisms remain to be fully elucidated. Chronic inflammation may 
promote gastric carcinogenesis by the generation o f a hostile tissue microenvironment 
characterised by oxidative stress. Oxidative stress is an unavoidable by-product o f  
chronic inflammation, originating from several sources including leukocytes, 
lymphocytes, and pro-inflammatory cytokines. In response to H  pylori infection 
inflammatory leukocytes generate and release potent ROS (Zhang et al, 1996; Rautelin 
et a l, 1994). In addition to ROS, leukocytes also release a diverse array o f cytokines into 
the local microenvironment which can, in turn, further exacerbate the oxidative stress by 
recruiting more leukocytes (e.g. IL-8  is a potent neutrophil recruiter) and enhancing 
generation o f ROS (e.g. TNFa (Garcia-Ruiz et a l, 1997; Lo and Cruz, 1995)). Oxidative 
stress may also arise from an accumulation o f bacterial generated superoxide (Nagata et 
al, 1998), from bacterial induction o f ROS generation and release from epithelial cells 
(Ding et a l , 2007; Obst et al, 2000; Teshima et a l, 1998; Bagchi et al, 1996; Davies et 
al, 1994a; Davies et a l, 1994b), and from reduced gastric ascorbic acid levels (Capurso 
et a l, 2003). Chronic inflammation associated oxidative stress linked to H. pylori 
infection has been reported to cause elevated levels o f  oxidative DNA damage in the 
gastric epithelium (Farinati et al, 2003; Obst et a l, 2000) as well as an increase in 
mutation rate (Jenks et a l, 2003; Touati et al, 2003); perturbation o f cellular signal 
transduction leading to gene expression changes (Baek et a l, 2004; Ding et a l, 2004; Seo 
et a l, 2004; Chu et a l, 2003; Kim et a l, 2001; Lim et a l, 2001; Kim et a l, 2000; 
Nardone et a l, 1999; Muller et al, 1997); and shifts in the homeostatic balance between 
proliferation and apoptosis in the favour o f enhanced cell survival and proliferation 
(Pritchard and Crabtree, 2006; van Grieken et a l, 2003; Piotrowiski et a l, 1997; Bechi et
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al, 1996; Fan et al, 1996; Moss et al, 1996 ). All o f these changes can together initiate 
and drive neoplastic disease, and it is quite plausible that a mechanistic molecular link 
exists between chronic inflammation, accompanying generation o f ROS and the 
pathogenesis o f  gastric cancer, changes in signal transduction and gene expression being 
the amongst the likely candidates that connect the molecular dots.
6.1.2.1 Signal Transduction and Gene Expression Changes in Gastric Cancer
The importance o f  aberrant signal transduction in the pathogenesis o f cancer 
cannot be overlooked, and has been discussed in the context o f H  pylori -  associated 
gastric carcinogenesis in previous chapters (sections 1.8.1, 1.8.2, 3.1.4, and fig. 3.3). 
Central here are the MAPK and NFkB families o f signalling pathways that lead to the 
activation of AP-1 and NFkB transcription factors amongst others (Maeda et a l, 2000; 
Meyer-Ter-Vehn et al, 2000; Naumann et a l, 1999; Aihara et al, 1997; Malinin et al, 
1997; Muller et a l, 1997). H. pylori has been shown to be capable o f  activating both 
families o f signal transduction pathway in vitro, leading to downstream gene expression 
changes -  up-regulation o f IL-8 being the best characterised (Peek, 2001; Maeda et al, 
2000; Meyer-Ter-Vehn et a l, 2000). These molecular changes appear to be critical in H. 
pylori -  associated gastric carcinogenesis leading to changes in cellular proliferation, 
angiogenesis, invasion and metastasis. Other molecular changes that have been observed 
which may also be attributable to changes in cellular signal transduction include up- 
regulation o f cyclin D1 (CCND1) -  only seen in gastric tumours and may be caused by 
excessive MAPK signalling (Belguise et a l , 2005; Milde-Langosch, 2005); COX-2 over- 
expression -  reported in H  pylori positive gastritis, precancerous lesions (atrophic 
gastritis and intestinal metaplasia), as well as in gastric cancer (Nardone et al, 2004; 
Tatsuguchi et al, 2004), and may be caused by aberrant activity o f NFkB; and c-FOS -  
seen to be over-expressed in H. pylori -  infected gastric mucosa and precancerous lesions 
(Yang et a l, 2003b) as well as in gastric cancer (Meyer-ter-Vehn et a l , 2000). c-FOS is a 
key component o f the AP-1 transcription factor detailed in sections 1.8.1 and 3.1.2.1 
which controls the expression o f genes related to cell cycle control such as cyclin D 
(CCND1) (Belguise et a l , 2005; Milde-Langosch, 2005) amongst others.
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In gastric tumour samples signalling changes that have been reported in the 
literature include up-regulation o f the EGF-RJ ERB-B and HER2I NEU  cell surface 
receptors (Moon et a l, 2005; Barnard et al., 1995; Yarden and Ullrich, 1988); increased 
activity o f transforming growth factor — betal (TGF-B1) (Hawinkels et a l, 2007); and 
down-regulation o f EGFR related protein (EGFRP) (Moon et al, 2005), a negative 
regulator o f EGF-R. In addition aberrant ERK1/2 (p42/p44) MAPK signalling has been 
detected in gastric cancer (Liang et a l , 2005; Wang et a l, 2003).
So it is clear that changes in cellular signal transduction are critical in the 
pathogenesis o f gastric cancer, driving progression at all stages o f the disease. 
Unfortunately the data on signal transduction changes in pre-malignant stages o f the 
disease are lacking with respect to the pathways affected, and the mechanistic nature o f 
the induction o f changes. As such, this is a fertile area o f  research, which promises, with 
improved knowledge and understanding, the hope o f identifying early molecular targets 
for therapeutic intervention.
6.13 Aims of the Chapter
With regard to signal transduction changes, H. pylori has been seen to rapidly 
activate ERK1/2 (p42/p44), p38, and JNK MAPKs, and NFkB signalling in cell culture 
systems leading to the activation o f AP-1 and NFkB transcription factors and the 
expression o f downstream genes (Meyer-Ter-Vehn, 2000; Keates et a l, 1999; Naumann 
et al, 1999). Such changes have also been seen to be induced by ROS (Genestra, 2007; 
Gloire et a l, 2006; McCubrey et al, 2006; Takada et a l, 2003; Jackson et a l, 2002; 
Zhang et a l, 2001; Sen and Packer, 1996) (refer to sections 3.1.2 and 3.1.3 for further 
details), and as in previous chapters, I speculate here that inflammation associated ROS 
and oxidative stress may provide a mechanistic link between H  pylori infection and 
gastric disease on the basis o f two key observations:-
1. Infection is known to cause chronic gastric inflammation with accompanying 
release o f  ROS into the gastric tissue microenvironment and is recognised as one
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mechanism by which H. pylori is believed to act (Correa, 2006; Farinati et al., 
2003; Obst et al, 2000; Baik et a l, 1996), and
2. ROS induced formation o f  DNA damage and changes in cellular proliferation are 
important factors in the development o f gastric cancer (Farinati et a l, 2003; 
Stadtlander and Waterbor, 1999; Baik et al, 1996; Correa and Shiao, 1994).
Again, the focus o f  the work is cellular signal transduction and gene expression 
changes at the levels o f  the ERK MAPK pathway (specifically the ERK1/2 (p42/p44) 
pathway; further references to ERK thus concern ERK1/2 (p42/p44)) and a downstream 
gene expression target c-FOS. This chapter describes studies that were carried out to 
assess ERK MAPK activity and c-FOS gene expression in pre-malignant gastric biopsies, 
so linking in vitro work that was carried out in previous chapters showing that ROS could 
lead to ERK activation and c-FOS up-regulation, to an in vivo setting, following the same 
theme of signal transduction changes and downstream consequences on gene expression. 
ERK MAPK signalling was examined as a measure o f  general ROS induced signal 
transduction in vivo. Alterations in NFkB signalling were assessed in the pre-malignant 
biopsies at the level o f IL-8 RNA levels by a colleague in the laboratory (Mrs. Jane 
Mikhail).
The hypothesis being tested is that redox sensitive signal transduction changes 
such as ERK MAPK signalling and downstream gene expression changes may be 
important in pre-malignant stages o f Correa’s pathway to gastric cancer. This hypothesis 
is formed on the grounds that gastritis and its preceding chronic inflammation are 
characterised by dense leukocyte infiltrates and high levels o f  ROS (Morgan et a l, 2003; 
Mamett, 2000) and hence oxidative stress, which have been demonstrated to cause P53 
mutations (Morgan et al., 2003) and chromosomal aberrations (Williams et al, 2005), 
and may drive early changes in signal transduction and gene expression that could play a 
role in progression o f pre-malignant disease toward gastric cancer.
The ERK MAPK pathway has been implicated in carcinogenesis and is known to 
be activated by H  pylori infection (Chen et al, 2006; Meyer-Ter-Vehn et al, 2000), 
although the mechanism remains obscure. By assessing ERK activity in pre-malignant 
gastric biopsies from patients with or without H. pylori infection, an association between
241
the two can be further established. Also, increased levels o f ERK activity have been 
reported in gastric cancer (Liang et a l 2005), warranting the investigation o f changes in 
ERK MAPK signalling in pre-malignant stages o f  the disease. In addition, by linking 
findings to the inflammatory state o f the tissues it may be possible to determine whether 
or not chronic inflammatory processes lead to ERK activation in pre-malignant gastric 
disease, so providing a mechanistic link that may relate to in vitro findings in previous 
chapters, where oxidative stress was seen to activate ERK signalling and downstream c- 
FOS expression. c-FOS has been reported to be up-regulated early on in pre-malignant 
gastric lesions in a Mongolian gerbil model (Yang et a l, 2003b), and hence may play a 
pivotal role in tumour progression. The present study serves to provide in vivo human 
data on the expression status o f  c-FOS in pre-malignant gastric tissues, as well as 
assessing the potential role o f in vivo chronic inflammation in the up-regulation o f the 
gene, again in order to relate findings to the in vitro findings in previous chapters so 
providing a more complete picture.
6.2 Materials and Methods
6.2.1 Enrolment of Patients to the Study
Prior to the in vivo studies, ethical approval was obtained from the local board o f 
ethics (Iechyd Morgannwg Health Local Research Ethics Committee) for all aspects o f 
the investigation that required the handling o f fresh human tissues.
Patients over the age o f  18 (and thus able to give consent) attending upper GI 
endoscopy clinic at Singleton and Morriston District General Hospitals (Swansea, UK) 
were invited to participate in the study. Patients were briefed about the study and were 
provided with written information. Those then wishing to participate in the study gave 
verbal and written consent by signing a consent form (see appendix II). Exclusions to the 
study were patients taking proton pump inhibitors or nonsteroidal anti-inflammatory 
drugs (NSAIDs), those who had had previous upper GI surgery, had undergone recent H. 
pylori eradication, or could not adequately give consent. At the same time as patients 
were asked to give consent, a questionnaire was also carried out (see appendix II) to
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obtain information about sex, age, ethnicity, family history o f GI tract disease, diet, 
smoking, alcohol and drug intake, and previous H  pylori infection.
Biopsy samples were taken from consenting patients during endoscopy using a 
standard gastric biopsy forceps. Three adjacent small biopsy samples were taken from 
what appeared to be diseased sites in the gastric mucosa (fundus, body, or antrum), and 
three samples from an adjacent unaffected ‘normal’ area as an internal control. All 
biopsies were rinsed with water to remove blood prior to placing in appropriate storage 
buffers. O f the three biopsies at each site, one was placed in formaldehyde and sent for 
histological examination and assessment o f H. pylori status (by GI pathologist Dr. Paul 
Griffiths), one was placed in RNA/tfter™ (Ambion, Warrington, UK), and one was 
placed in lOOmM Tris-base pH 10 + 0.01% protease inhibitor cocktail (Sigma-Aldrich, 
Poole, UK). The RNA/afer™ rapidly permeates tissues and inactivates RNases, thereby 
stabilising RNA by preventing its degradation. The Tris-base buffer with protease 
inhibitors stabilises cellular proteins. The latter two biopsy samples were placed on ice 
and transported back to the laboratory for RNA and protein extraction respectively.
Twenty-five patients were sampled in total. The male: female ratio o f the patients 
was approximately 1.3: 1 and their median age at sampling was 68.5 with a range o f 28 -  
8 5  years.
6.2.2 RNA Extraction from Biopsies
Total RNA was isolated from tissue samples by the TRIspin method (Reno et al, 
1997). Biopsies were placed, using sterile forceps, into microfuge tubes and the samples 
kept on ice throughout. Biopsy tissue was homogenised in 500pl Trizol reagent 
(Invitrogen, Paisley, UK) using an Ultra-Turrax T8  homogeniser (IKA- Werke GMBH & 
Co, Staufen, Germany). I f  several RNA extractions were to be performed at a time, the 
homogeniser head was washed in distilled water followed by 1 0 0 % ethanol and a final 
rinse in fresh distilled water between samples so avoiding cross contamination.
Subsequent to homogenisation, the tissues were incubated at room temperature 
for 5min prior to addition o f lOOpl chloroform (Sigma-Aldrich, Poole, UK) to the 
resultant tissue lysate. The tubes were next vigorously agitated for 15sec and then
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allowed to stand for another 5min at room temperature. The samples were centrifuged 
for 15min at 4°C and 11,300 x g (1 l ,0 0 0 rpm) resulting in phase separation to a lower red 
phenol/ chloroform phase, a white interphase and an upper colourless aqueous phase 
containing the RNA. The aqueous phase o f each sample was then transferred to a fresh 
1.5ml microfuge tube and one volume o f 70% ethanol added and immediately mixed in 
by pipetting. All subsequent steps performed to purify the extracted RNA utilised the 
RNeasy Mini kit (QIAgen, Crawley, West Sussex, UK) following the manufacturer’s 
recommendations.
Contaminating DNA was removed from samples using the DNA/ree™ kit 
(Ambion Ltd, Cambridgeshire, UK) and RNA yields quantified by spectophotometry, as 
outlined in the methods sections 2.4.3 and 2.4.4, to determine both concentration and the 
260/280 ratio. Only samples with a ratio within 1.7 -  2.2 were considered free o f DNA 
contamination, and so used for subsequent analysis. RNA quality was assessed as 
outlined in section 2.4.5. Each resultant RNA sample was then divided into 20pl working 
aliiquots, stored at - 80°C until use.
6.2.3 Protein Extraction from Biopsies
Biopsies were placed into microfuge tubes containing 500pi ice cold modified 
RlIPA buffer (50mM Tris-HCl pH7.4, 1% IGEPAL, 0.25% Sodium Deoxycholate, ImM 
EDTA, ImM  Sodium orthovanadate, Im M  Sodium fluoride, plus ImM  AEBSF and lpg/ 
mil Leupeptin) using sterile forceps. The samples were homogenised on ice using an 
UIltra-Turrax T8  homogeniser (IKA- Werke GMBH & Co, Staufen, Germany) at high 
speed for 3 X 1 min intervals until tissue was evenly dispersed into solution. 1 volume o f 
2X  western blot loading (Lamelli) buffer (250mM Tris pH6 .8 , 4% (w/v) SDS, 10% (v/v) 
glycerol, 0.006% (w/v) bromophenol blue, 2 % (v/v) P-mercaptoethanol) was 
subsequently added to samples, the samples gently mixed by inverting and boiled at 
10)0°C in a heating block to denature proteins. Protein concentration was determined 
using a 2D Quant Kit (GE Lifesciences, Bucks, UK) as detailed in section 2.6,1. Samples 
were then divided into 20jil working aliquots and stored at - 80°C until use.
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6.2.4 Real-time PCR for c-FOS Gene Expression
In order to determine whether increases or decreases in c-FOS expression were 
selected for at particular pre-malignant histological grades, c-FOS levels in biopsy 
specimens were assessed by real-time PCR as described in section 2.5 — 2.5.1.3 and 
3.2.2.5a. The PCR primers used in the real-time analysis were c-FOS and P-actin (ACTS) 
(refer to chapter 3 table 3.2 for primer sequences). For the analysis 500ng sample RNA 
was used and standard curves were generated from pooled RNA from cell culture and 
gastric biopsy specimens seen to express c-FOS. The same standard curve RNA was used 
in each plate o f an experimental run for all replicates so ruling out a potential source o f 
variation in the quantitative data (refer to section 2.5.1.1 for further details).
6.2.5 W estern Blotting
Western blots were performed on biopsy protein samples for pERK in order to 
assess ERK MAPK activation in pre-malignant gastric tissues according to the methods 
outlined in sections 2.7 -  2.7.3 and 3.2.3.1.
6.2.6 C orrelation Between c-FOS Gene Expression and  pER K  Levels
The existence o f any possible relationship between c-FOS RNA and pERK 
protein levels in the biopsy samples were assessed in order to investigate links between 
ERK MAPK signalling and c-FOS expression. This was achieved by Pearson’s test to 
examine correlation between the two variables. Statistical significance was observed 
when P < 0.05.
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6.3 Results
6.3.1 Patients
A total o f 25 patients were successfully enrolled into the pre-malignant gastric 
study, and biopsy samples collected. The details are summarised in table 6.1. The male: 
female ratio o f  the patients was approximately 1.3: 1 and their median age at sampling 
was 68.5 with a range o f 28 -  85 years.
At the time o f sampling biopsies taken from areas o f the gastric mucosa that the 
endoscopist deemed normal were labelled ‘N ’, and biopsies taken from what appeared to 
be diseased sites were labelled ‘D \  The results of the histo-pathological diagnoses are 
presented in table 6 ,1. No information was available regarding the inflammatory scores in 
the specimens based on the Sydney system (Dixon et a l, 1994) since this is not a routine 
part o f pathological reporting in the Swansea NHS trust.
It can be seen from table 6 .1  that the endoscopic diagnosis was not always 
consistent with the true histo-pathological diagnosis. This sampling problem was difficult 
to avoid, since the majority o f  the patient pool was over the age o f 60, and in view o f the 
fact that gastritis has a tendency to spread throughout the gastric mucosa with age 
(Siurala et a l, 1985; Morson et a l, 1980), it was often challenging to identify a truly 
normal region o f the stomach. Gastritis and inflammation are diagnosed by endoscopy 
simply by looking for red irritated regions o f the stomach mucosa (not clearly defined 
lesions), but it must not be overlooked that other factors may cause such irritation, for 
instance alcohol, excessive salt intake, medications, etc. and as such, biopsies that were 
believed to be o f diseased stomach were often found to be normal. The few matched 
normal and diseased specimens were generally obtained from younger patients (late 
forties to early fifties), and in attempts to obtain greater numbers o f  matched specimens 
slightly younger patients were targeted. However, the majority o f patients attending 
outpatient endoscopy clinic presenting with upper GI complaints were o f an older age 
pool. A consequence o f this is that very few (if any after exclusion criteria were applied)
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matched specimens were obtained, and so in the RNA and protein expression analyses, 
the biopsies were classified according to histo-pathology and each patient assessed 
individually. These findings really highlight the difficulties that can be encountered in 
such clinical studies.
6.3.2 c-FOS Expression
Real time PCR analysis indicated that expression levels o f  c-FOS were highly 
variable in the pre-malignant gastric biopsy samples. Figure 6.2 highlights the variability 
in c-FOS expression levels in the sample cohort studied. For each histo-pathological 
subgroup a lot o f variation was seen, with no clear trend as to whether up- or down- 
regulation o f the gene was selected for with disease progression, or at particular pre- 
malignant histological stages. Overall the variability in c-FOS expression levels was 
manifest at both the inter- and intra-patient levels.
. A noteworthy observation is that in cases where the ‘N ’ and ‘D ’ biopsies from a 
patient were o f  the same pre-malignant classification, the c-FOS levels in the two 
samples was markedly different in some instances. For example, in the two normal 
biopsies (2N and 2D) that were obtained from patient 2 from distinct yet adjacent sites in 
the stomach one exhibited a relative c-FOS level o f  3.29, while an approximately 3-times 
higher level o f  9.96 was detected in the second normal biopsy. This variation was not 
limited to normal samples (patients 2, 6 , 15, and 22), and can also be seen for 
inflammation/ gastritis (patient 10, 16, and 25), and IM samples (patient 11). This is an 
interesting observation since it suggests that c-FOS expression tends to vary spatially 
within the gastric mucosa o f some individuals whereas it is fairly consistent in others 
(e.g. patients 7, 9, 20, 24). It may be that the spatial differences in c-FOS expression are 
related to localised differences in the gastric microenvironment, for instance, small 
segments o f irritated cells exposed to cellular stresses such as oxidative stress may lay 
adjacent to relatively unstressed cells; alternatively, some regions o f  the stomach may 
exhibit a greater intensity o f inflammation/ inflammatory milieu,
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characterised by more severe inflammatory leukocyte infiltration and a plethora o f pro- 
inflammatory factors, compared to segments in near proximity. These factors could 
potentially impact the level o f  c-FOS expression at both the levels o f  upstream signalling 
pathways (in particular the ERK MAPK pathway discussed in previous chapters) and 
more directly at the level o f transcription, and so may account for the observed 
variability. In addition the differences in expression levels may be related to the fact that, 
due to the problems encountered with obtaining diseased and matched normal samples, 
biopsies were often from different anatomical regions o f the stomach. Differences in the 
cell types and the local microenvironment at the different sites may then account for the 
observed results.
Another interesting observation was that in a subset o f  patients in which an 
inflammation/ gastritis sample and an IM sample were obtained, the level o f c-FOS 
expression was higher in the inflammation/ gastritis biopsies compared to the IM 
biopsies. This is evident in patients 1, 3, and 12 (fig. 6.2) and suggests that some 
component o f  tissue inflammation may favour enhanced c-FOS gene expression which is 
absent in IM samples. It is quite plausible that this may be related to the level o f 
inflammation and ROS in the tissue samples o f different histo-pathology, since a study by 
Morgan et a l  (2003) demonstrated high levels o f ROS in gastritis samples compared to 
normal stomach tissue as well as IM and gastric cancer. This would lead to the 
speculation that enhanced ROS in inflammation/ gastritis samples could trigger oxidative 
stress signalling and c-FOS expression.
Whilst no clear trends are apparent, figure 6.2 indicates there is an overall 
tendency towards higher c-FOS expression in normal and inflammation/ gastritis samples 
compared to the IM samples, and this again ties in with the study o f Morgan et a l  (2003). 
No trend was observed with respect to samples obtained from H. pylori infected 
individuals (patients 3, 12, 16, 19, and 25), with varying c-FOS levels in all samples -  
some exhibiting higher expression (e.g. patient 3) compared to others (e.g. 12). Intra­
patient variation is also evident, with c-FOS levels being quite distinct between the 
patient biopsy pairs (e.g. patient 25).
Overall, based on the relatively small size o f the pre-malignant biopsy sample 
cohort, and the difficulties encountered during endoscopic sampling, it is very difficult to
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draw strong conclusions as to the involvement o f c-FOS in pre-malignant gastric disease. 
Ideally a larger sample cohort, preferably consisting o f within patient matched normal 
and diseased gastric tissue (in the present study no matched normal and diseased samples 
were studied in the RNA analysis), all taken from the same anatomical region o f the 
stomach; e.g. antrum; in order to rule out differences in gene expression at different sites, 
would be studied in order to obtain a clearer picture o f  any trends that may exist.
The variability in the c-FOS expression data does not rule out possible signalling 
changes in the pre-malignant tissues, and so ERK MAPK activity was assessed at the 
level o f western blots for pERK.
6.3.3 Patients for Protein Studies
O f the 25 biopsy sample pairs collected, protein was successfully extracted with 
good yields from all samples. As a result only patients that were excluded for clinical 
reasons (table 6 .1) were omitted from the western blot analyses.
6.3.4 ERK MAPK Activity in Pre-malignant Gastric Biopsies
Observation o f figure 6.3 reveals that pERK levels in pre-malignant gastric tissues 
display a somewhat similar pattern to c-FOS gene expression (fig. 6.2) particularly with 
respect to the high degree o f variability between patients. Figure 6.3 highlights the 
amount o f variation in pERK levels in all samples analysed. Interestingly in the two 
matched normal and diseased samples that were obtained (patients 5  and 18, both 
matched normal and inflammation/ gastritis), patient 5 displayed a subtle increase in 
pERK levels in the inflammation/ gastritis specimen compared its matched normal 
counterpart (~ 1.2-fold increase), whilst patient 18 showed a decrease in pERK level in 
the inflammation/ gastritis biopsy compared to the matched normal sample (~ 1 .6 -fold 
decrease). As such the high level o f variation in pERK levels in the small sample cohort 
made it difficult to determine i f  any relationship between ERK signalling and disease 
truly existed.
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As for c-FOS expression (fig. 6.2), one o f the most interesting findings with 
respect to pERK levels was that marked intra-patient differences were evident in cases 
where the ‘N ’ and ‘D’ biopsies from a patient were o f the same pre-malignant 
classification (fig. 6.4). For example, in the two normal biopsies that were obtained from 
patient 6  (6 N and 6 D), from distinct yet adjacent sites in the stomach, one displayed a 
relative pERK level of 2.76E-01, whilst the level detected in the second normal biopsy 
was 1.84E-01. A similar trend was seen in normal patients 15 and 22, the most marked 
differences seen in patient 15 where one biopsy had a relative pERK level o f 5.23E-01 
compared to an approximately 2.6-fold lesser value o f 1.99E-01 in the second sample.
Overall there appear to be no clear trends relating pERK levels and histo- 
pathology, the levels being highly variable across normal, inflammation/ gastritis, and IM 
samples, as well as samples from H  pylori positive patients.
Again, as for c-FOS RNA levels, this variability was not restricted to patients 
with two normal biopsies, but was also evident for inflammation/ gastritis (patient 25), 
and intestinal metaplasia (patient 11). In some patients however, as for c-FOS, the pERK 
levels were fairly consistent where the two biopsies were o f the same histo-pathology, for 
example, patients 2, 7, 9, 10, 20, and 24. Again it is possible that this intra-patient 
variation in ERK activity may be a consequence o f  spatial differences in gastric 
microenvironment, and may be related to samples being obtained from different 
anatomical regions o f the stomach as detailed in section 6.3.2.
When comparing c-FOS expression data with the pERK western blot data, it 
became apparent that there was some correlation between c-FOS and pERK levels, going 
back to the link between ERK MAPK activity and c-FOS gene expression studied in 
chapter 3. This is highlighted in figure 6.4 where it is clear that upon comparison o f only 
the patients that yielded two biopsy samples, in most cases the c-FOS expression patterns 
were reflective o f the pERK levels (in ~ 67% o f  the patients). In patients 1, 6 , and 25, 
opposite patterns were observed, for example, in patient 1 biopsy IN  showed a low level 
o f  c-FOS expression, the level being much higher in biopsy ID, whilst biopsy IN 
exhibited a higher level o f  pERK which was seen to be diminished in biopsy ID. In the 
remainder o f the patients (2 and 10) c-FOS expression levels differed between the 6N ’
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and ‘D’ biopsies, whilst pERK levels were fairly consistent, for example, in patient 2 
biopsy 2N displayed a low level o f c-FOS RNA, the level being much higher in biopsy 
2D, whereas pERK levels were consistent in both biopsy samples.
Interestingly, using Pearson’s test for association between c-FOS and pERK 
levels in samples, it was found that there was no statistically significant correlation 
between the two variables (P > 0.05) due to the 33% o f cases where c-FOS gene 
expression and pERK levels were not reflective o f one another. This is an interesting 
observation since it suggests that there may be an association between ERK MAPK 
activity and c-FOS gene expression at the level o f transcription in some cases, as was 
seen in chapter 3. However, the fact that ERK activity and c-FOS expression are not 
always reflective o f each other, in some cases being opposite, lend to the notion that other 
mechanisms for controlling c-FOS expression are in place, and that some negative 
feedback may exist between the upstream signal transduction pathway and its 
downstream gene expression target, further strengthening the findings in chapter 3.
This may vary from individual to individual, and may be related to other factors 
such as diet, family history, smoking habits, etc. Attempts were made to identify such 
factors which may contribute to gene expression and signal transduction differences by 
way o f a clinical questionnaire (see appendix II). Unfortunately no clear associations 
were apparent due to the large amount o f inter- and intra-patient differences in the data, 
and the sample cohort not being large enough to allow sufficient groupings according to 
dietary factors, cigarette smoking, alcohol habits, and family history.
6.4 Discussion
ERK MAPK signalling changes and c-FOS RNA expression changes in pre- 
malignant gastric tissues were analysed in the present study to determine i f  such changes 
are involved in early stage disease pathogenesis in Correa’s pathway to gastric cancer, 
and to assess i f  any changes could be related to chronic tissue in fla m m ation
Twenty-five patients were successfully recruited into the studies yielding tissue 
samples from gastritis and intestinal metaplasia (IM) pre-malignant stages. Chronic
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inflammation and gastritis samples were grouped together in one histological grouping 
(inflammation/ gastritis).
c-FOS RNA expression levels were seen to be highly variable at both the inter- 
and intra-patient level and no clear trends were apparent, apart from a slight tendency 
toward higher c-FOS levels in normal and inflammation/ gastritis samples compared to 
IM, and H. pylori status did not appear to affect gene expression. These subtle differences 
may be related to the ROS levels in the tissues since a previous study by Morgan et a l 
(2003) demonstrated that ROS levels were highest in gastritis samples, followed by 
normal tissues, then IM, and cancer, the present observations tying in with these findings. 
Based on these results and the pitfalls in the experimental design (regarding the small 
sample cohort and difficulties in obtaining matched normal and gastritis tissues), the 
involvement o f c-FOS in gastric carcinogenesis could not be clearly determined. It is 
unsurprising that c-FOS RNA expression showed such marked variation since gastric 
tumours, like other GI tract tumours are often seen to be highly unstable and genetically 
heterogeneous (Owonikoko et a l, 2002; Lindforss et al, 2000) (often showing marked 
differences in gene expression patterns in different segments o f  a solid neoplasm), and so 
the genetic profile o f the pre-malignant stages is likely to be highly variable too (Wang et 
al, 2007). It is important to note that whilst c-FOS RNA levels showed marked 
variability, this may not translate to the protein level, and so the involvement o f  c-FOS in 
gastric carcinogenesis can not be ruled out based on these findings. As such, it would be 
important to assess c-FOS protein levels in the biopsy samples.
Other factors that may account for the variability in gene expression include a 
variety o f  environmental and host factors. For example, some individuals may harbour 
genetic polymorphisms in key inflammatory genes that lead to heightened inflammatory 
responses. Genetic polymorphisms o f IL-lp  amongst other pro-inflammatory cytokines 
have been associated with increased gastric cancer risk (Rad et al, 2004; El Omar et al, 
2003; Rad et a l, 2003; Figueiredo et a l, 2002; Machado et a l, 2001; El Omar et al, 
2000). These polymorphisms can give individuals harbouring them an enhanced genetic 
susceptibility to developing gastric cancer since they are likely to develop more severe 
inflammatory responses (with more dense leukocyte infiltrate, cytokine release and ROS 
generation) to gastric injury or infection, and a positive association exists between the
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intensity o f chronic inflammation and gastric cancer. Dietary factors and smoking habits 
have also been linked to gastric cancer risk (Lunet et al., 2005; Tsugane et al, 2004; 
Bergin et al., 2003; Fox et al., 2003; Fox et al., 1999; Tredaniel et al., 1997) and may 
influence pre-malignant changes, however, no such association was evident in the present 
study. This was determined based on the answers provided in patient questionnaires. 
However, one must be wary o f the accuracy o f such information since patients often do 
not provide full details about diet and often underestimate their smoking habits.
The gastric tissue microenvironment may also account for the variability in c-FOS 
gene expression since it is subject to dynamic changes due to exposures to a variety of 
compounds such as food allergens, alcohol, medications, bile acids etc. as well as 
temporal-spatial variations in oxidative stress (the gastric mucosa is constantly exposed 
to waves o f  luminal oxidative stress arising from digested food, bacteria, shed mucosal 
cells, etc. (Smith et al., 1996; Fukumura et al., 1995; Hiraishi et al., 1994)), gastric 
acidity, and ascorbic acid content o f gastric juice, all o f which may influence signal 
transduction and gene expression changes. A recent study by Jenkins et al. (2007) 
showed that bile acids can affect cellular signal transduction (specifically NFkB 
signalling) through ROS mediated mechanisms, and so the fluctuating levels o f bile acids 
in gastric juices bathing cells may lead to fluctuations in local oxidative stress. These 
factors can vary in the different anatomical regions o f the stomach due to the differences 
in the cell types and secretions found at the different sites. This was a pitfall o f  the 
present studies since biopsies were often taken from different regions o f the stomach, and 
is likely to contribute to the variation in the expression data. Ideally the experiments 
would be repeated with all samples taken from the same stomach region, e.g. the antrum, 
so removing a potential source o f variation. The variability in the expression data may 
also stem from the differing proportions o f diseased: normal cells in the biopsy 
specimens. In instances where the majority o f cells in a diseased biopsy are normal 
stromal cells, their expression levels may mask any abnormal patterns in the diseased 
cells.
As for c-FOS, there was an overall marked amount o f variation in the pERK data. 
Interestingly, in some patients pERK and c-FOS levels were seen to be related to an 
extent, supporting findings in chapter 3 which demonstrated that ERK activation was
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linked to downstream c-FOS gene expression. The observation that ERK activity and c- 
FOS levels were not always associated suggests that other mechanisms o f controlling c- 
FOS expression are likely to be important. It is possible that a mechanism distinct from 
ERK MAPK signalling was regulating c-FOS expression in cases where the two were not 
reflective, and perhaps negative feedback between the two could account for cases where 
pERK levels were seen to be increased and c-FOS levels appeared to be decreased.
In summary, the present studies have demonstrated that c-FOS expression and 
ERK activity are highly variable in gastric biopsy samples and that no clear involvement 
o f such molecular changes in pre-malignant gastric tissues could be established based on 
the experimental design. The gene expression and signalling changes observed may be 
the end points o f several mechanisms. For instance, since chronic inflammation and 
gastritis are accompanied by tissue injury and cell loss mediated by ROS (Ding et al, 
2007; Naito and Yoshikawa, 2001), any increases in ERK signalling and c-FOS 
expression in such samples are unsurprising since they provide the mitogenic signalling 
and gene expression changes required to evoke proliferation, so replacing lost cells 
(Chang and Karin, 2001; Treinies et a l, 1999). I f  such persistent oxidative stress 
signalling changes occur in a subset o f individuals it is possible that these early changes 
set in motion a cascade o f cellular events that may drive gastric carcinogenesis.
The key findings from the studies were:-
- pERK activity and c-FOS RNA expression were seen to be highly variable in the 
sample cohort study, with no clear trends regarding the pre-malignant stages and 
the onset o f  the changes, hence the involvement o f the signalling and gene 
expression changes in gastric carcinogenesis remains unclear;.
- H. pylori status did not appear to impact c-FOS expression levels or ERK activity;
- Some association between pERK and c-FOS was apparent, strengthening findings 
in chapter 3 that implicated ERK MAPK signalling as an upstream control of 
ROS induced c-FOS gene expression;
- There was a  high degree o f variability in the data, possibly reflecting inter-patient 
differences in diet, genetic susceptibility, etc., and intra-patient variation, likely 
due to spatial differences in gastric tissue microenvironment. Normal gastric
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mucosa has previously been shown to be more genetically unstable than matched 
oesophageal tissue (Williams et a l, 2005), and so it is unsurprising that genetic 
heterogeneity be present in pre-malignant lesions. The variation may also be a 
consequences o f samples being taken from different anatomical regions o f the 
stomach, and so it would be worthwhile to repeat the experiments with all 
samples being obtained from the same region, e.g. antrum;
- There were pitfalls in the experimental design that made it difficult to establish 
the significance o f the molecular changes with respect to pre-malignant histology. 
The root o f the problems lay in the difficulty in clearly distinguishing gastritis and 
normal tissues endoscopically. This resulted in a patient pool with very limited 
matched normal and diseased samples.
Further studies with a larger sample cohort (to remove the effects o f variation) and better 
success with obtaining matched normal and diseased samples (all from the same region 
o f the stomach) would ascertain whether changes in ERK signalling and c-FOS 
expression are important pre-malignant molecular changes on the path to gastric cancer.
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Chapter 7
Final Discussion
The potential involvement o f RO/NS in disease and ageing has been an area o f 
interest since 1956, when Harman first proposed the free radical theory o f ageing, in 
which it was speculated that cumulative cellular damage induced by radicals may 
contribute to the ageing process (Harman, 1956). Since then, a boom in the field o f free 
radical research has provided insight and strength to the hypothesis that RO/NS play 
crucial roles in biology and medicine (Scandalios, 2002; Beckman and Ames, 1998; 
Guyton and Kensler, 1993; McCord and Fridovich, 1969). A particular area o f  interest 
included the now very well documented involvement o f  reactive metabolites in cancer 
development (Valko et a l ,  2007; Fukuruma et a l, 2006; Ristow, 2006; Waris and Ahsan, 
2006; Klaunig and Kamendulis, 2004; Oshima et a l, 2003; Klaunig et a l, 1998; Poulsen 
et al, 1998; Wink et a l, 1998; Knight, 1995; Toyokuni et a l, 1995; Feig et a l, 1994; 
Guyton and Kensler, 1993; Trush and Kensler, 1991; Breimer, 1990; Vuillaume, 1987; 
Ames, 1983).
Oxidative stress and carcinogenesis are intimately intertwined in a manner which 
can both initiate disease, and drive its further progression, since oxidants are complete 
carcinogens - impacting the initiation and promotion stages via the induction o f DNA 
damage and mutations, and enhanced cellular proliferation respectively (Valko et a l, 
2006; Behrend et a l, 2003; Olinski et a l, 1998; Poulsen et a l, 1998; Dreher and Junod, 
1996; Cerutti and Trump, 1991). Excessive oxidative stress can instigate oncogenic 
changes in cells, and cells that go on to develop a transformed oncogenic phenotype often 
produce elevated levels o f  reactive species, which can go on to drive further disease 
progression. Indeed, it is often observed that cancer cells/ tumour samples contain greater 
levels o f  RO/NS and hence oxidative and nitrosative stress than their normal disease free 
counterparts (Obst et al, 2000; Davies et a l, 1994a; Davies et a l, 1994b; Halliwell et al, 
1992; Szatrowski and Nathan, 1991). Experimentation by Szatrowski and Nathan (1991) 
revealed that several different tumour cell lines constitutively generate H2O2 at rates 
between 100 — 500pM /104 cells/ hr over several hours at a constant rate. Thus a vicious
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cycle exists, resulting in cells being continuously bombarded with oxidants and their 
damaging effects.
The present work set out to further evaluate the involvement o f components o f an 
inflammatory response, in particular ROS and resultant oxidative stress, in gastric 
carcinogenesis. Gastric cancer o f the intestinal sub-type is well documented as 
developing through a defined series o f pre-malignant stages starting with chronic gastritis 
and gradually progressing through atrophic gastritis, intestinal metaplasia, dysplasia, and 
ultimately invasive gastric cancer (Correa and Shiao, 1994; Correa, 1992a; Correa, 1988; 
Correa et a l, 1975) with chronic inflammation being central in both the initiation and 
promotion o f the disease (Zavros et a l , 2005; Israel and Peek, 2001; Ernst, 1999; Ernst et 
a l , 1997; Correa, 1992a). With the realisation o f the global burden o f the disease, 
constituting the 2 nd largest cause o f cancer related deaths worldwide, large research 
efforts have brought to light key findings with regard to the pathogenesis and underlying 
molecular biology o f the disease (detailed in chapter 1).
Chronic inflammation o f the gastric mucosa/ gastritis, regardless o f its cause, is 
now generally accepted as an early driving force in gastric carcinogenesis (Zavros et al, 
2005). In the case o f H. pylori -  associated gastritis, the infection elicits a marked 
inflammatory response, characterised by infiltration o f leukocytes which release a 
plethora o f pro-inflammatory mediators and bactericidal free radicals in attempts to ward 
o ff infection (Peek and Crabtree, 2006; Peek and Blaser, 2002; Ernst et al.9 1997). 
Unfortunately for the host, the bacterium has evolved mechanisms o f  evading the 
inflammatory response, and as such, in the absence o f antibiotic intervention therapy, 
persistent infection may develop, leading to chronic inflammation and a hostile gastric 
tissue microenvironment in which leukocyte - (and gastric epithelium -) generated 
reactive metabolites can inflict harm on the host cells (Correa and Miller, 1998) (detailed 
in section 1.4.5.1). Both bacterial factors and host inflammatory response contribute to 
disease pathogenesis by conferring an increase in oxidative stress. Based on these 
grounds, it is speculated that the oxidative stress component o f  H. pylori infection maybe 
a key driving force in disease development and progression, since the reactive species can 
account for almost all o f  the molecular changes seen to be induced by the bacterium, 
either acting independently or synergistically. H. pylori infection is known to cause
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oxidative DNA damage (Obst et al, 2000; Baik et a l, 1996), alterations in cell growth by 
perturbing the proliferation -  apoptosis balance (Correa et a l, 2004; Moss et al, 2001; 
Correa and Miller, 1998; Peek et a l, 1997; Cahill et a l, 1996; Moss et a l, 1996), and 
changes in signal transduction and gene expression (Tuccillo et a l, 2005; Strowski et al, 
2004; Caputo et a l, 2003; Sepulveda et a l, 2002; Chiou et a l, 2001; Mitsuno et al, 
2001; Peek, 2001; Maeda et a l, 2000; Meyer-Ter-Vehn et a l, 2000; Keates et al, 1999; 
Naumann et al, 1999; Sharma et a l, 1998; Aihara et a l, 1997; Keates et a l, 1997), 
These cellular effects can also be induced by oxidative stress (Dreher and Junod, 1996; 
Guyton and Kensler, 1993; Cerutti and Trump, 1991), and links between H. pylori 
infection, oxidative stress, and such changes is well established (Baek et a l, 2004; Seo et 
al, 2004; Xu et a l, 2004; Chu et a l, 2003; Kim et a l, 2000; Bagchi et a l, 1996) further 
strengthening the notion that H  pylori -  associated gastric carcinogenesis can be 
mediated by oxidative stress. Indeed the bacterium is known to cause inflammation and 
ROS generation and release in gastric epithelial cells (Xu et a l, 2004; Obst et al, 2000; 
Bagchi et a l, 1996; Farinati et a l, 1996). Two recent studies into protein changes 
induced by H  pylori in gastric epithelial cells speculate that ROS are fundamental to the 
changes -  resulting in decreased antioxidant defence mechanisms, and enhanced 
expression o f inflammatory genes, adhesion molecules, mediators o f  cellular proliferation 
and oncogenic transcription factors (Kim, 2005; Baek et a l, 2004).
Despite these advances the mechanistic nature o f disease development with 
respect to the effects o f inflammation remains to be clearly defined. The overall aims o f 
the present research were to obtain further insights into the link between inflammation 
and gastric cancer at the molecular level (with an emphasis on signal transduction and 
gene expression changes) using a combination o f in vitro and in vivo models. The 
hypothesis being tested was that: -
Chronic gastric inflammation & accompanying generation o f  Reactive Oxygen Species 
(ROS) plays a significant role in gastric carcinogenesis by the induction o f  molecular 
changes (signal transduction, and gene and protein expression changes).
265
In vitro tissue culture models were first employed -  one in which cells (two gastric 
cancer cell lines (AGS and HGC-27) and one normal fibroblast cell line (W ILLI)) were 
exposed to various doses o f a model ROS, hydrogen peroxide (H2O2), for varying lengths 
o f time in order to mimic the oxidative stress component o f a gastric inflammatory 
response (chapter 3); and one in which gastric epithelial adenocarcinoma cells (HGC-27) 
were co-cultured with inflammatory leukocytes so more realistically mimicking an in 
vivo inflammatory response (chapter 5). The in vitro studies were then translated to an in 
vivo study in which signalling and gene expression changes consistently observed in the 
cell culture studies were assessed in pre-malignant gastric biopsies in order to determine 
whether such changes may be truly important in early stages o f gastric carcinogenesis 
(chapter 6 ).
The data presented in chapter 3 revealed that H2O2 treatment o f cells in culture 
(with sub-toxic doses) can cause some significant changes in cellular gene expression, 
impacting DNA damage response, cell cycle control, apoptosis, signal transduction, 
inflammation, angiogenesis, invasion and metastasis, all o f  which are known to be 
affected in neoplastic development (Hanahan and Weinberg, 2000). This finding 
strengthens the notion that oxidative stress is a key driving force in cancer development. 
Microarray experiments on HGC-27 RNA from control and treated cells shed some light 
on the impact o f  oxidative stress on MAPK signalling, reflected in up-regulation o f p38 
MAPK (MAPK14), RAF1 (MAP3K), and c-FOS, and the potential involvement o f the 
NFkB pathway, since several NFkB regulated genes were seen to be up-regulated in 
response to H2O2 exposure (e.g. VCAM, RANTES, TNFA). The most consistent gene 
expression alterations detected in the array experiments were up-regulation o f  c-FOS and 
VEGF, the levels o f which were subsequently quantified by real-time PCR. The real-time 
PCR gene expression studies were carried out on RNA from three cell lines -  AGS, 
HGC-27 and WILLI (treated in the same manner), and confirmed that frank oxidant 
exposure could indeed induce significant changes in c-FOS and VEGF levels, showing 
dose dependency in some instances. Interestingly the outcome seemed to differ between 
the cell lines, reflecting possible differences in the redox sensitivity o f the different cells, 
different antioxidant profiles, or differences in the signalling pathways. Most often it was 
seen that the cancer cells (ASG and HGC-27) showed clearer dose responses at earlier
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time points than the normal WILLI cell line. This may, in addition to the aforementioned 
reasons, be due to aberrant signal transduction in the cancer cell lines, possibly brought 
about by mutation. Aberrant signalling, such as ability to trigger excessive signalling in 
response to stimuli that would not normally elicit such a marked response, or self- 
sufficiency in signalling, is in fact one o f the hallmarks o f cancer (Hanahan and 
Weinberg, 2000). Interestingly, the importance o f altered responsiveness to stimuli or a 
so-called ‘response modification’ has been proposed to be central to carcinogenic 
development by oxidants for over twenty years (Cerutti, 1989, Cerutti, 1985). The 
involvement o f MAPK signalling in the response to H2O2 was validated by western 
blotting, which revealed rapid activation o f ERK1/2 (p42/ p44) MARK signalling in all 
three cell lines, and p38 signalling in HGC-27 and W ILLI. ERK signalling was most 
persistent in AGS cells, and the apparent absence o f p38 signalling in this cell line is 
suggestive o f  a shift toward enhanced proliferation since ERK signalling favours cell 
survival and proliferation whilst the p38 pathway favours apoptosis (Halliwell and 
Gutteridge, 2007).
Some evidence o f a link between ERK signalling and downstream c-FOS 
expression was provided by a preliminary inhibitor study, however, further 
experimentation would be required to validate this. It is also important not to overlook 
the complexity o f  MAPK signalling when trying to establish links, since several layers of 
control exist, often as autocrine loops. For example, MAPKs can indirectly regulate the 
expression o f both their activating ligands and their inhibitors, so introducing inherent 
control in MAPK signalling (Chang and Karin, 2001), which is often lost in cancer cells. 
Interestingly MAPK signalling can regulate the expression o f  VEGF (seen to be up- 
regulated in the present studies), VEGF protein, in turn, upon release from cells, can act 
in an autocrine manner to activate further MAPK signalling (Yashima et a l, 2001; 
Doanes et a l, 1999; Takahashi et a l, 1999). In addition, some reports suggest that VEGF 
can modulate cellular redox status (Abid et a l, 2001) such that it can impact NFkB 
signalling (Wang et a l, 2001). This is important in the context o f  gastric carcinogenesis, 
and suggests a possible rote for VEGF not only in the later angiogenic stages o f disease, 
but also early on in the progression sequence at the stage o f gastritis. Gastritis associated 
tissue injury and inflammation results in enhanced ROS levels in affected tissues
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compared to controls (Morgan et al, 2003). Based on these findings ROS exposure has 
the potential to induce VEGF over-expression. This may then go on to result in further 
production o f ROS, enhanced MAPK and NFkB signalling, enhanced inflammatory 
cytokine expression, and an overall hostile tissue microenvironment. It is possible that 
VEGF, may, in addition to H2O2 exposure, account for some o f the NFkB related gene 
expression changes observed. The potential link between c-FOS and VEGF expression is 
also interesting, since if  a true link can be validated by further experimentation, it would 
suggest that VEGF may act as c-FOS effector in malignancy, providing a link between 
the oncogene and angiogenesis (Marconcini et al, 1999).
Looking at the data as a whole, the overall picture is that oxidant exposure can 
elicit enhanced MAPK signalling, and up-regulation o f  the nuclear oncogene c-FOS, a 
component o f the AP-1 transcription factor, and potentially enhanced NFkB signalling, 
albeit in a dose, time, and cell line specific manner. This can favour neoplasia since it can 
shift the proliferation -  apoptosis balance toward enhanced proliferation and enhanced 
cell survival, and can enhance inflammation through the induction o f inflammatory 
response genes such as IL-8 and TNFA (Karin, 1995). This can then further drive 
enhanced inflammatory responses, proliferation, cell survival, and angiogenesis (by IL- 
8 ). IL-8  also drives the generation o f ROS (Naito and Yoshikawa, 2002) leading to 
further oxidative stress resulting in a vicious cycle in which a hostile microenvironment 
o f oxidative stress is favoured. Taken together these findings strongly support the 
hypothesis that oxidative stress is a key driving force in carcinogenesis, not only by the 
induction o f mutations, but also via signal transduction and gene expression changes. The 
H2O2 doses that caused the most significant changes correspond to doses that have been 
reported to cause point mutations and chromosome damage (Williams et a l, 2005; 
Jenkins et al, 2001; Duthie et al, 1997; Kleiman et a l, 1990), and also lie in the range o f 
ROS levels reported to be generated by cancer cells (Szatrowski and Nathan, 1991), 
making the findings o f clinical significance. As such, dose and timing o f  exposure seems 
to be important, low doses causing no significant changes, and excessively high doses 
causing cytotoxicity and may also inactivate signal transduction (e.g. high levels o f 
oxidative stress inhibit MAPK signalling via the activation o f phosphatases (Jackson et 
al, 2002)). Matysiak-Budnika and Megraud (2006) reported that the intensity o f gastric
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inflammation (as a consequence o f gastritis (+/ - H. pylori infection)) determines an 
individuals risk to gastric cancer, and it may be that this is related to the levels o f  ROS in 
the tissues, and the lengths o f time for which cells are exposed. A very recent study by 
Ding et al. (2007) demonstrated that both H. pylori infection and exposure to H2O2 
caused dose dependent increases in ROS generation by gastric epithelial cells, and that 
this was enhanced by pre-treatment with inflammatory cytokines. This finding provides 
yet further weight to the hypothesis that ROS are central to gastric carcinogenesis, but 
also implies added complexity since inflammatory mediators are likely to have an impact. 
This warranted the further research that was carried out in subsequent chapters which 
took a further interest in the inflammatory component o f disease pathogenesis.
Chapters 4 and 5 set out to take the in vitro studies to a more biologically/ 
clinically relevant level by mimicking an inflammatory response as it is likely to occur in 
vivo with RO/NS originating from a biological source (inflammatory leukocytes) in 
conjunction with other inflammatory mediators. Specifically chapter 4 involved 
optimising an inflammatory response in the promyelocytic HL-60 cell line (giving rise to 
a mature myelocyte cell population (consisting o f myelocytes, metamylocytes, and 
banded neutrophils with the capacity for oxidative burst) in preparation for subsequent 
co-culture experiments in which this inflammatory cell population was co-incubated with 
gastric epithelial adenocarcinoma cells (HGC-27) and any consequent signalling and 
gene expression changes in HGC-27 analysed. After optimisation efforts to induce 
neutrophil differentiation (since neutrophils are one o f the most common inflammatory 
cell types present at sites o f infection and inflammation (Yoshikawa and Naito, 2001; 
Crabtree, 1996a; Kozol, 1990)), priming, and induction o f  a  detectable oxidative burst as 
well as release o f inflammatory cytokines, a treatment regimen was established. Briefly 
this involved culturing HL-60 in the presence o f 1.3% (v/v) dimethyl sulfoxide (DMSO) 
for 3 days prior to co-culture. The resultant population o f differentiated cells was deemed 
HL-60/N for the presence o f  neutrophils, and was primed overnight with LPS and co­
cultured with HGC-27 at different densities. The degree o f  inflammatory cell infiltrate 
can fluctuate widely in chronic gastritis, and the extent o f  inflammation is recognised as a 
risk factor for the development of malignant gastric disease, the more severe the 
inflammation the greater the risk (Fox and Wang, 2007; Axon, 2002; El-Omar et a l ,
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2000; Correa, 1995; Gilmour, 1961). As such, HGC-27 was co-cultured with HL-60/N at 
different ratios (HGC-27: HL-60/N at 1:1, 2:1, and 4:1) in order to reflect different 
severities o f inflammation. Activation o f HL-60/N was then stimulated via the 
introduction o f lOOnM fMLP to the co-culture system resulting in an oxidative burst 
response.
Utilising this co-culture model in chapter 5, the influence o f leukocyte derived 
oxidative stress on HGC-27 at the level o f signal transduction and gene expression 
changes -  specifically the ERK1/2 (p42/  p44) MAPK pathway and c-FOS and IL-8 gene 
expression (in keeping with the previous studies in chapter 3 and further studies in 
chapter 6 ) was analysed. c-FOS expression was assessed as a marker o f  ERK MAPK 
signalling since the two were seen to be linked in preliminary experimentation described 
in chapter 3, in addition to assessing ERK activation at the level o f ERK phosphorylation. 
In a similar manner IL-8 was studied as a marker o f NFkB activity since IL-8 expression 
has been reported to be regulated by NFkB (Jenkins et a l , 2004). Following co-culture, 
RNA and protein were extracted from cells and the levels o f  oxidised proteins measured 
to determine the impact o f  the co-culture system with respect to oxidative stress. The 
results confirmed that the system generated an inflammatory setting in which release o f 
ROS (and hence oxidative stress) could directly impact HGC-27 at the molecular level 
since co-culture with HL-60/N in the absence and presence o f  fMLP was seen to cause an 
increase in the levels o f  oxidised proteins in the gastric epithelial cells. Interestingly co- 
culture did not cause the expected increase in c-FOS expression as was observed as a 
consequence o f chemical induced oxidative stress in chapter 3. Instead where significant 
changes in c-FOS levels were seen, they tended to be significant decreases. The most 
interesting observation was that c-FOS expression level appeared to be related to the 
level o f ‘tissue inflammation’ in the co-culture system, with no down-regulation seen in 
the 1:1 co-culture both in the absence or presence o f fMLP stimulation, whilst significant 
decreases in c-FOS expression were evident at both the 2:1 and 4:1 co-culture systems. 
This raised the speculation that the severity o f inflammation may have an impact on c- 
FOS gene expression, since less intense inflammation (lower densities o f inflammatory 
leukocytes -  2:1 and 4:1 co-culture) caused down-regulation o f c-FOS whilst more 
intense inflammatory conditions (1:1 co-culture) had no significant effect on c-FOS
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levels. High levels o f c-FOS were seen in the un-exposed controls, and as such the 
decreases in c-FOS expression observed may be misleading, and may in fact be related to 
some aspect o f the cell culture system. Possible explanations for the observed decreases 
in c-FOS levels, in the case that the decreases were due to true down-regulation o f gene 
expression, include negative feedback control; whereby c-FOS expression is saturated in 
un-exposed controls, the introduction o f gene expression inducing stimuli in the co- 
culture system may then instigate down-regulation o f expression; and/ or a sub-toxic 
effect o f excessive oxidative stress (amongst other aspects o f the co-culture system) 
leading to decreased proliferation in HGC-27 and so an overall reduction in gene 
expression. Without further experimentation (e.g. assessing the proliferation rate o f 
HGC-27 post co-culture) it is very difficult to establish reasoning behind the 
observations.
Unlike c-FOS, co-culture caused significant up-regulation o f IL-8 gene 
expression. An interesting finding that came to light however, was that as for c-FOS, IL-8 
expression also appeared to be related to the co-culture ratio and hence to the degree o f 
inflammation and oxidative stress. For example, at both the 4hr and 8 hr time points the 
1:1 co-culture system in the absence o f fMLP caused maximal induction o f IL-8 
compared to the 2:1 and 4:1 co-culture systems in which HGC-27 cells were exposed to 
lower densities o f HL-60/N and thus less severe inflammatory conditions. Since IL-8 
expression was seen to be consistently up-regulated in the co-culture experiments, albeit 
being related to the degree o f inflammation, one can speculate that IL-8 is a likely 
molecular change under conditions o f tissue inflammation which has previously been 
reported (Naito and Yoshikawa, 2002; Maeda et a l, 2001; Shimada and Terano, 1998; 
Crabtree and Lindley, 1994), with the likelihood o f up-regulation being positively related 
to the degree o f inflammation.
As for c-FOS and IL-8, ERK phosphorylation was seen to be related to the co- 
culture ratio and so the severity o f  inflammation, with significant increases in pERK 
levels being evident following exposure o f HGC-27 to HL-60/N at a ratio o f  1:1 both in 
the absence and presence o f fMLP stimulation, with the lower HL-60/N densities (2:1 
and 4:1) having no effect. Interestingly there appeared to be some discrepancy between c- 
FOS expression and ERK activation, since the expected positive association between the
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two (based on the findings in chapter 3) was not apparent following co-culture. It may be 
that some other aspect o f the co-culture system impacted c-FOS expression so 
overshadowing any possible effects o f  ERK MAPK signalling, and further 
experimentation would be required to ascertain the underlying mechanisms for the 
observations.
Based on these findings one thing that became very clear was that the severity o f 
inflammation (likened to a ‘dose’ dependency) is likely to determine the outcome o f  c- 
FOS and IL-8 gene expression as well as ERK MAPK signalling, and that this is likely to 
be the case in the in vivo gastric setting. It is then likely that only in a small number o f 
individuals in which the degree o f inflammation is severe enough, but at the same time 
sub-toxic/ sub-lethal to the cells (i.e. within a ‘dose’ window, or above a threshold 
‘dose’), do such changes which may drive gastric carcinogenesis occur, and may help to 
account for the frequent observation that only a subset o f  individuals with chronic 
gastritis (+/ - H. pylori infection) go on to develop malignant gastric disease (Peek and 
Crabtree, 2006; Farthing, 1998).
Together the two in vitro models o f components o f inflammatory gastritis brought 
to light that MAPK and NFkB signalling changes together with downstream gene 
expression targets can be altered quite clearly in situations o f oxidative stress (chapter 3) 
and to a reasonable (although less clear) extent as a consequence o f  exposure to 
inflammatoiy leukocytes as a biological source o f RO/NS and inflammatory mediators. 
In order to determine if  such alterations were o f clinical significance they were also 
examined in gastric biopsy specimens in an in vivo study.
In chapter 6  ERK MAPK signalling and c-FOS gene expression were assessed as 
markers o f oxidative stress induced signalling and gene expression changes in vivo. Since 
the in vitro studies demonstrated that oxidative stress could induce such changes, it was 
important to determine if  the findings translated to the in vivo tissue setting, specifically 
looking at pre-malignant gastric tissues. The hypothesis being tested was that redox 
sensitive signal transduction changes such as ERK MAPK signalling and downstream 
gene expression changes may be important in pre-malignant stages o f Correa’s pathway 
to gastric cancer so driving disease pathogenesis. Twenty-five patients were successfully 
recruited into the studies yielding tissue samples from inflammation/ gastritis and
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intestinal metaplasia pre-malignant stages as well as samples from H  pylori infected 
individuals. Results indicated that whilst c-FOS expression levels appeared to be overall 
high in normal and chronic inflammation/ gastritis tissues compared to IM samples, there 
was a great amount o f  variation in expression levels (both at the inter- and intra-patient 
levels), which seem to reflect the levels o f  ROS detected in pre-malignant gastric tissues 
by Morgan et a l (2003) suggesting that ROS may have an impact on the gene expression 
changes. Overall, it was not possible to determine the involvement o f c-FOS expression 
in gastric carcinogenesis and its relation to pre-malignant lesions (in particular 
inflammation/ gastritis). pERK levels also showed a lot o f variation across the samples 
with no clear trends with respect to ERK activity and pre-malignant disease progression 
nor H  pylori status. It was seen that there was some association between pERK and c- 
FOS in the samples providing further strength to findings in chapter 3 that implicated 
ERK MAPK signalling as an upstream control o f  ROS induced c-FOS gene expression, 
as well as indicating that the changes observed in the in vitro studies are likely to be 
important at the clinical level. The in vivo study suffered pitfalls in the experimental 
design which largely made the data inconclusive. A fairly small sample cohort was 
obtained with very few matched normal and diseased samples, biopsies often taken from 
different anatomical regions o f the stomach, due to difficulties in diagnosing pre- 
malignant lesions at the endoscopic level. These problems resulted in data that could not 
be analysed in a statistically sound manner and so any relation between c-FOS 
expression, pERK levels, and tissue inflammation (and hence oxidative stress) could not 
be clearly established. The findings highlight the difficulties that can be encountered in 
clinical studies.
Looking at the research presented as a whole some interesting themes emerged. In 
relation to the overall aims o f the studies, much o f the data presented lent support to the 
hypothesis that oxidative stress (amongst other aspects o f  the tissue inflammation 
characteristic o f  gastritis) may drive early stages o f the pathogenesis o f  gastric cancer by 
way o f signal transduction and associated gene expression changes. In chapter 3 it was 
seen that chemically induced oxidative stress could clearly induce MAPK signalling and 
downstream gene expression changes, in particular c-FOS. NFkB -  related gene 
expression changes as a consequence o f this oxidative stress were also evident to an
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extent. When the ERK -  related signalling and gene expression changes were then 
analysed in the second in vitro model, which more closely mimicked the biological 
conditions o f tissue inflammation, it was seen that whilst inflammatory conditions could 
induce ERK signalling, c-FOS over-expression was not induced, suggesting that under 
such conditions, in which oxidative stress as well as other components o f the 
inflammatory response may simultaneously impact different aspects o f cellular 
biochemistry and signalling, any association between ERK signalling and c-FOS 
expression may be overshadowed. IL-8 was seen to be up-regulated in these studies, 
bringing to light potential involvement o f the NFkB pathway.
Based on the in vitro findings it became fundamental to determine if  such changes 
in c-FOS gene expression and ERK signalling could also be detected in pre-malignant 
gastric biopsies. The finding that c-FOS expression was overall higher (across individual 
patient samples) in normal and inflammation/ gastritis tissues compared to IM, together 
with the apparent relation between c-FOS expression levels and the ROS levels 
previously detected in the different histo-pathological stages (Morgan et al., 2003) were 
the most interesting findings from the in vivo study, since together they support the 
hypothesis that oxidative stress is a key player in the induction o f potentially oncogenic 
signalling and gene expression changes in pre-malignant gastric tissues. With respect to 
ERK signalling, the data also revealed a high degree o f  variability, with no clear trends 
being observed across the pre-malignant stages. Overall, due to the discussed problems 
encountered with the clinical study, the data obtained did not permit any solid 
conclusions to be drawn regarding c-FOS expression and pre-malignant gastric disease 
progression. Based on the findings the involvement o f  c-FOS expression changes and 
ERK signalling in gastric carcinogenesis are unclear and cannot be ruled out without 
further experimentation (ideally with a larger sample cohort consisting o f matched 
control and diseased samples (all obtained from the same anatomical region o f the 
stomach)). NFkB -  related gene expression was also assessed in the pre-malignant 
biopsies by a colleague in the laboratory (Mrs. Jane Mikhail) by looking at IL-8 as a 
marker o f NFkB activity, and preliminary data revealed that IL-8 was up-regulated in 
gastritis samples as well as in samples from H. pylori infected patients, leading to 
speculations that aberrant NFkB signalling is a likely event in gastric carcinogenesis.
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Overall the data from the in vitro and in vivo studies provides evidence that 
oxidative stress amongst other components o f inflammation can cause signalling and 
gene expression changes that may be important in driving the development o f gastric 
cancer at the level o f  MAPK and NFkB signalling and downstream gene expression 
changes.
In chapter 3, aside from the effects o f chemically induced oxidative stress on 
signal transduction and gene expression, the notable differences in responses to oxidant 
induced changes between the three cell lines emerged as a fundamental finding from the 
studies. Oxidant induced changes were often seen to occur in a dose, time, and cell line 
specific manner, with the two cancer cell lines (AGS and HGC-27) showing more 
marked responses than the normal WILLI cell line. Additionally, differences were often 
seen between the two cancer cells, with HGC-27 appearing to be more oxidant sensitive 
with respect to some molecular changes, and AGS being more sensitive to others. This is 
likely due to the different stages o f malignancy o f the two cell lines -  HGC-27 being the 
more advanced o f the two, and so the differences may reflect molecular changes that 
come into play at earlier or later stages o f  disease progression. In the c-FOS expression 
data, for example, up-regulation was induced more rapidly in HGC-27 compared to AGS. 
It is very likely that such differences reflect inherent differences in the cell biology o f the 
two cancer cell lines. Since AGS is established from a  primary gastric tumour (Barranco 
et a l , 1983) this cell line may be more resilient to some oxidant induced molecular 
changes, with the more advanced HGC-27 cell line (derived from a secondary lymph 
node metastasis o f a gastric adenocarcinoma) being more sensitive to some o f the 
consequences o f  oxidative stress. Alternatively, being more advanced, HGC-27 is more 
likely to have accumulated molecular changes that result in aberrant signalling (e.g. 
mutations or aberrant expression o f components o f the RAS-RAF-MEK-ERK signalling 
pathway which are known to contribute to carcinogenesis (Leicht et a l, 2007; Roberts 
and Der, 2007; Schubbert et a l, 2007, McCubrey et a l, 2006)). Interestingly, it has 
frequently been noted that differences in cellular biochemistry (e.g. antioxidant enzyme 
and metabolite levels) as well as differences in metastatic potential are likely to affect 
how a cell responds to an exposure/ stimulus (Aune and Pogue, 1989; Barranco et al, 
1983; Nicolson et a l, 1978), and such differences may help to explain the cell line
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specific responses. Another plausible explanation lies in differences in proliferation rate. 
HGC-27 demonstrated a higher rate o f proliferation than that o f AGS (observed simply 
based on cell culture properties), and so higher proliferation rate may account for higher 
levels o f  gene expression and/  or enhanced sensitivity in HGC-27.
The primary WILLI cell line was the least responsive o f the three cell lines and 
this raised the hypothesis that normal cells may be more resilient to oxidative stress and 
redox sensitive molecular changes compared to the cancer cells, which may inherently be 
more redox sensitive (Benhar et a l, 2001; Toyokuni et a l, 1995). In addition, the 
observation that c-FOS levels were seen to increase in untreated cancer cells over time 
but not in W ILLI, led to the speculation that oxidative stress can build up in the cancer 
cells over time which may make them more redox sensitive. This build up o f  oxidative 
stress is likely to be due either to enhanced RO/NS generation in cancer cells themselves 
(Ding et al., 2007; Schumacker, 2006; Benhar et a l, 2001; Halliwell et a l, 1992; 
Szatrowski and Nathan, 1991; Aune and Pogue, 1989), andJ or less efficient antioxidant 
systems compared with normal cells (Batcioglu et a l, 2006; Navarro et a l, 1999). The 
balance between oxidants and antioxidants is fundamental here. In cancer cells lower 
levels o f cellular antioxidants can lead to a build up o f oxidants. I f  the balance is such 
that oxidant levels are maintained at sub-lethal levels an individual may be at a greater 
risk o f  gastric carcinogenesis. Interestingly H. pylori infection has been reported to 
impact the activity o f cellular ROS scavenging enzymes, such that accumulating ROS in 
gastric cells fall to sub-lethal doses, resulting in an increased risk o f gastric cancer 
(Smoot et a l, 2000).
Differences between the cell lines were also noted for VEGF, I kB , and IL-8 expression, as 
well as in ERK and p38 signalling, and were detailed in section 3.4.
Since the overall aim o f the present research was to assess the involvement o f 
ROS and inflammation in cancer associated signal transduction and gene expression 
changes initially using in vitro models (chapters 3, 4, and 5) and then shifting to an in 
vivo study (chapter 6 ), time did not permit the further study o f the signal transduction 
pathways in detail. None-the-less, the findings have opened up the doors to continued 
research. Further studies in continuation o f the findings in chapter 3 that would be of 
particular interest would be to study in greater depth the differences observed between
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the three cell lines. The differences in cell line responsiveness to H2O2 exposure are 
likely to reflect inherent biochemical differences in the cells such as variations in 
antioxidant defence systems. In recent years there has been an increase in evidence that 
H2O2 is an important signalling molecule and that antioxidant enzymes play key roles as 
sensors and regulators o f H2O2 -  induced signal transduction (Veal et al, 2007). Based on 
this it would certainly be worth examining differences in the antioxidant profiles o f the 
cell lines in relation to their response to oxidant exposures so to gain insights into the 
observed differences. One way in which this may be achieved would be to examine the 
levels o f a few antioxidant enzyme markers such as superoxide dismutase and catalase in 
the cells by way o f western blotting. Such studies may also be important in a clinical 
context since inter-individual differences in antioxidant enzyme levels may account for 
differences in susceptibility to disease. Additionally, it has recently been reported that 
cancer cells carry greater oxidant loads due to enhanced ROS generation, and that by 
inhibiting antioxidants it may be possible to achieve targeted killing o f the cancer cells 
since they will accumulate more severe (often lethal) levels o f  ROS rendering them more 
sensitive to the detrimental effects o f  ROS than their normal counterparts (Trachootham 
et al., 2006). As such, further insights into the oxidant and antioxidant profiles o f normal 
cells versus cancer cells, as well as cancer cells at different stages o f  the disease, would 
be a  fruitful area o f  further research that could lead to findings which would add further 
weight to such reports. The enhanced oxidant sensitivity o f malignant cells may then be 
exploited therapeutically.
The cell line differences may also be due to differences in proliferation rates and 
induction o f  apoptosis, higher proliferations could account for overall higher levels o f  
gene expression in one cell type versus another, as could high induction o f apoptosis (or 
death via necrosis) account for lower gene expression. As such, it would be o f interest to 
study in greater detail the proliferation rates and induction o f cell death. A variety of 
experimental techniques are available that could be employed for studying proliferation 
and cell death (apoptosis and necrosis) including cell counting o f live cells routinely 
during cell culture, scoring o f apoptotic and necrotic cells in Geimsa stained slide 
preparations (Fenech et a l, 1999), as well as more elaborate techniques such as ELISAs 
for caspase enzymes to more sensitively assay the induction o f  apoptosis, and methods
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that employ fluorescent antibodies for cell surface markers o f  proliferation and apoptosis 
followed by fluorescent microscopy and/ or flow cytometry based visualisation.
It would also be worthwhile to conduct more inhibitor studies to validate links 
between MAPK signalling and c-FOS expression, and analysing a potential link between 
c-FOS and VEGF gene expression by inhibiting c-FOS and analysing the impact on 
VEGF (possibly using siRNA for c-FOS). To further pursue the NFkB studies it would be 
worth optimising the transfection experiments using the GFP-p65 reporter plasmid to 
gain further insights into the involvement o f NFkB activation. Ideally this would be 
examined in real-time using live cells, directly following the cytoplasmic to nuclear 
shuttling o f the transcription factor under the confocal microscope. Alternatively the 
cellular localisation o f  NFkB could be examined via immunohistochemistry using a 
fluorescent antibody coupled with visualisation by standard fluorescence microscopy.
Since the induced signal transduction and gene expression changes observed are 
likely to favour proliferation and cell survival, it would be worth studying the effects o f 
oxidant exposure on cellular proliferation and apoptosis (using the methods previously 
discussed) in order to establish if  indeed a shift in the proliferation -  apoptosis balance 
toward enhanced proliferation exists. This would be o f  particular interest to gain further 
understanding into the observation that o f  all three cell lines AGS appeared to sustain 
ERK activation the longest and did not show activation o f the p38 MAPK pathway based 
on the data presented. Such signalling dynamics would likely favour enhanced 
proliferation since ERK is a survival factor and drives enhanced proliferation, whilst p38 
generally induces apoptosis (Halliwell and Gutteridge, 2007). Proliferation and apoptosis 
studies could help to determine if  such changes impact the cells at the physiological level 
causing shifts in the proliferation -  apoptosis balance, such that the changes may drive 
gastric carcinogenesis.
Stemming from the co-culture studies, given more time and resources it would be 
worthwhile to further optimise the inflammatory model such that the cause(s) o f the 
observed changes could be more clearly identified. Since gene expression and signalling 
changes observed may be due to any one or a combination o f the effects o f  oxidative 
stress, inflammatory mediators, and cell -  to — cell contact between the gastric epithelial 
cells (HGC-27) and the inflammatory leukocytes (HL-60/N), further experiments in
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which each factor could be eliminated and signalling and gene expression changes 
analysed would help obtain further insights. For example by co-culturing HGC-27 and 
HL-60/N in trans-well plates whereby the two cell lines would be separated by the trans­
well filters, through which only soluble mediators and RO/NS o f certain molecular 
dimensions could pass, would rule out any effects o f cell -  to -  cell contact. The impact 
o f oxidative stress could be determined by the introduction o f potent broad spectrum 
antioxidants into the system, if  the previously observed changes were no longer apparent 
following antioxidant treatment this would confirm the involvement o f RO/NS in 
inducing the changes. In order to study any possible effects o f inflammatory mediators 
released by HL-60/N a combination o f the trans-well co-culture system and sequestering 
RO/NS by the introduction o f antioxidants could be employed. Alternatively the effects 
o f inflammatory mediators, such as IL-8 , on signal transduction and gene expression in 
HGC-27 could be more directly studied by exposing HGC-27 to physiologically/ 
clinically relevant doses o f the mediators and analysing gene expression and signalling 
changes that may be induced.
Since chapter 3 highlighted that induced ERK MAPK signalling is highly likely to 
be an upstream event in inducing c-FOS gene expression, it would be o f interest to study 
in greater detail the apparent discrepancy between ERK signalling and c-FOS expression 
in the co-culture experiments where no apparent association was seen between the two. It 
is plausible that other aspects o f the co-culture system may be influencing c-FOS 
expression, for example the presence o f factors that both positively and negatively effect 
c-FOS gene expression may be present leading to delayed ERK regulated c-FOS gene 
expression that could not be detected within the time scale o f the experimentation. As 
such, it would be worth repeating the experiments for longer periods o f time such as 12hr 
and 24hr to see i f  any c-FOS over-expression came to light. The further experiments 
described in which the two cell types could be separated in trans-well plates also removes 
the cell -  to -  cell contact factor that could potentially affect ERK associated c-FOS gene 
expression, and so conducting the co-culture experiments in this manner may also make 
clearer any signalling and gene expression changes. It would be important, also, to carry 
out ERK inhibitor studies in this context in order to see if  inhibiting ERK signalling has 
any knock on effects o f  c-FOS and/ IL-8  gene expression. NFkB studies would also be
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interesting to follow up, looking directly for activation o f the transcription factor by 
assessing its subcellular localisation following co-culture. As detailed in section 5.4 the 
discrepancy in the c-FOS data (in that c-FOS levels were high in controls and falling 
following some o f the co-culture treatments) may be due to a sub-toxic effect o f the 
oxidative stress and/ inflammation in the system leading to decreased proliferation rate 
and hence an overall reduction in c-FOS gene expression. In order to establish if  the 
decreased c-FOS levels were due to reduced proliferation rate, simple experiments to 
assess any changes in proliferation rate o f HGC-27 post co-culture could be performed. 
To take the co-culture studies to the next level, making them more clinically relevant to 
H. pylori associated gastric carcinogenesis it would also be fascinating to include the 
bacterium itself, or bacterial extracts in the model. This could involve direct co-culture o f 
H  pylori with gastric epithelial cells, the use o f trans-well plates, and a combination o f 
gastric epithelial cells, inflammatory leukocytes, and H. pylori such that the bacterium 
would elicit an inflammatory response more representative o f the true in vivo situation. 
Finally, following the cell line differences observed in chapter 3, it would be interesting 
to repeat the co-culture studies with AGS and W ILLI, so identifying if  the different cell 
lines also respond differently in an inflammatory setting.
Given more time it would also be valuable to expand the in vivo study so as to 
include a larger sample cohort with more matched normal and diseased samples, with the 
samples being obtained from the same anatomical region o f the stomach (e.g. antrum) in 
order to eliminate the problems encountered with the studies that hindered data analysis. 
This may even out the observed high degree o f variability in the data which likely 
reflected inter-patient differences in diet, genetic susceptibility, etc. as well as intra- 
patient variation due to spatial differences in gastric tissue microenvironment (possibly a 
consequence o f sampling from different regions). As such, this would permit a more 
confident analysis o f the importance o f ERK activation and c-FOS over-expression in the 
molecular pathogenesis o f  gastric cancer. To determine i f  changes detected in the 
biopsies are associated with/ attributable to oxidative stress, it would be worthwhile to 
assess the levels o f markers o f oxidative stress in the tissue samples such as levels of 
nitrotyrosine and inducible nitric oxide synthase (iNOS) by way o f 
immunohistochemistry in a similar manner to Mannick et a l  (1996). In addition, to
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elaborate on the apparent association between the degree o f inflammation and gene 
expression changes observed in the co-culture studies, a key area o f future research 
would be to study c-FOS gene expression and ERK signalling in gastric biopsies in 
relation to grades o f inflammation (inflammatory scores assessed by a pathologist based 
on the updated Sydney system (Dixon et a l, 1994)), in order to determine if  the level o f 
c-FOS expression and ERK activation are related to the severity o f inflammation in the in 
vivo setting. To further the study it would also be interesting to collect gastric juice and 
blood samples from the patients at the time o f biopsy collection, and analyse the levels o f 
oxidants and antioxidants (in a manner similar to You et a l (2000) and Ruiz et a l 
(1994)) so determining if  individuals with a greater oxidant and/  or lower antioxidant 
load may be more susceptible to the observed signalling and gene expression changes. 
Finally pERK and c-FOS levels could be assessed in dysplastic tissues as well as in 
gastric tumour tissue to establish if  the changes are important in later stages o f the disease 
as well as the earlier inflammatory stages.
In summary the extensive research conducted, and the data presented, implicate 
an important role for oxidative stress amongst other components o f tissue inflammation 
in gastric carcinogenesis via the induction o f signal transduction and gene expression 
changes, specifically seen here to impact MAPK and NFkB signalling and downstream 
gene expression changes. The findings certainly add strength to the notion that 
inflammation and oxidative stress are key players in gastric carcinogenesis, likely 
impacting disease pathogenesis as early as gastritis. In addition, the gene expression 
changes seen to be induced by oxidative stress have been reported to be induced by H. 
pylori^ and as such the findings implicate oxidative stress as a potential mechanism 
through which the bacterium may exert its effects. On these grounds it is clear that 
therapeutic approaches that block the generation of, and/ or sequester excessive RO/NS 
in pre-malignant gastric tissues, such as antioxidant supplementation, and/ or 
administration o f anti-inflammatory drugs (Nardone and Rocco, 2004; Correa, 2004; 
Jones-Blackett et al, 1999), are likely to be very useful in the prevention and 
management o f intestinal type gastric cancer. In addition, more specific therapies 
targeting the signal transduction pathways affected, may prove useful (Kaminska, 2005; 
Karin, 2004).
281
Whilst the data helped to establish a potential role o f ROS and inflammation in 
pre-malignant gastric disease the picture remains somewhat incomplete, having opened 
up the doors to more fruitful investigations. Further research in this arena will surely add 
to our understanding o f the underlying molecular pathogenesis o f  gastric malignancy and 
may aid in the development o f novel therapies at the level o f  antioxidant and anti­
inflammatory based regimens so helping to reduce the global burden o f this devastating 
disease.
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Appendix I -  Array Gene Tables 
AI.l Human Cancer Pathway Finder Array Gene Table.
Array Layout Table with Gene Symbol and Position Information
HS-006
AKT1 ANGPT1 ANGPT2 APAF1 ATM BAD BAX BCL2
1 2 3 4 5 6 7 8
BCL2L1 BIRC5 BRCA1 BRCA2 CASP8 CASP9 CCND1 CCNE1
9 10 11 12 13 14 15 16
CD44 CDC25A CDH1 CDK4 CDKN1A CDKN1B CDKN2A CFLAR
17 18 19 20 21 22 23 24
COL18A1 CTNNB1 EGF EGFR ERBB2 ETS2 FGF2 FGFR2
25 26 27 28 29 30 31 32
FLT1 FOS HGF ICAM1 IFNA1 IFNB1 IGF1 IL8
33 34 35 36 37 38 39 40
ITGA1 ITGA2 ITGA3 ITGA4 ITGA5 ITGA6 ITGAV ITGB1
41 42 43 44 45 46 47 48
ITGB3 ITGB5 JUN KAU KISS1 MAP2K1 MAPK14 MDM2
49 50 51 52 53 54 55 56
MMP1 MMP2 MMP9 MTA1 MICA(MUC18L) MYC NCAM1 NFKB1
57 58 59 60 61 62 63 64
NFKBIA NME4 PDGFA PDGFB PIK3CB PIK3R1 PLAU PLAUR
65 66 67 68 69 70 71 72
PRKDC CHEK2(RAD53) RAF1 RASA1 RBI S100A4 SERPINB2 SERPINB5
73 74 75 76 77 78 79 80
SERPINE1 SRC TEK TERT TGFB1 TGFBR1 THBS1 THBS2
81 82 83 84 85 86 87 88
TIMP1 TNF TNFRSF10B TNFRSF12 TNFRSF1A TNFRSF6 TP53 VEGF
89 90 91 92 93 94 95 96
PUC18 PUC18 PUC18 Blank Blank Blank GAPD GAPD
97 98 99 100 101 102 103 104
PPIA PPIA PPIA PPIA RPL13A RPL13A ACTB ACTB
105 106 107 108 109 110 111 112
HS-006 gene table
Position UniGene Genebank Symbol Description Gene name
1 Hs.71816 NM 005163 AKT1 v-akt murine thymoma viral oncogene homolog 1 Akt-l
2 Hs.2463 NM 001146 ANGPT1 Human angiopoietin-1 mRNA Angiopoietin 1
3 Hs.l 15181 NM 001147 ANGPT2 Homo sapiens angiopoietin-2 mRNA Angiopoietin-2
4 Hs.77579 NM 001160 APAF1 Apoptotic protease activating factor Apaf-1
5 Hs.194382 NM 000051 ATM
Ataxia telangiectasia mutated (includes complementation 
groups A, C and D) ATM
6 Hs.76366 U66879 BAD BCL2-antagonist of cell death Bad
7 Hs.159428 L22474 BAX BCL2-associated X protein Bax
8 Hs.79241 M14745 BCL2 B-cell CLL/lymphoma 2 Bcl-2
9 Hs.305890 Z23115 BCL2L1 BCL2-like 1 Bcl-x
10 Hs.l 578 U75285 BIRC5 Apoptosis inhibitor 4 (survivin) Survivin (API4)
11 Hs. 194143 U68041 BRCA1 Breast cancer 1, early onset BRCA1
12 Hs.34012 X95177 BRCA2 Breast cancer 2, early onset BRCA2
13 Hs. 19949 NM 001228 CASP8 Caspase 8, apoptosis-related cysteine protease FLICE
14 Hs.100641 U60521 CASP9 Caspase 9, apoptosis-related cysteine protease Mch6
15 Hs.82932 M64349 CCND1 Cyclin D1 (PRAD1: parathyroid adenomatosis 1) Cyclin D1
16 Hs.9700 M73812 CCNE1 Cyclin El Cyclin El
17 Hs.16%10 M59040 CD44
CD44 antigen (homing function and Indian blood group 
system) CD44
18 Hs.1634 NM 001789 CDC25A Cell division cycle 25A
CDC25a,
phosphotase
19 Hs. 194657 Z13009 CDH1 Cadherin 1, type 1, E-cadherin (epithelial) E-cadherin
20 Hs.95577 M14505 CDK4 Cyclin-dependent kinase 4 Cdk4
21 Hs.l79665 L47233 CDKN1A Cyclin-dependent kinase inhibitor 1A (p21, Cipl) p21w#f1 /p21Cipl
22 Hs.238990 U10906 CDKN1B Cyclin-dependent kinase inhibitor IB (p27, Kipl) p27Kipl
23 Hs.1174 U26727 CDKN2A
Cyclin-dependent kinase inhibitor 2A (melanoma, pi 6, 
inhibits CDK4) pl6ink4
24 Hs.195175 AF010127 CFLAR CASP8 and FADD-like apoptosis regulator CASPER
25 Hs.78409 AF018081 COL18A1 Collagen, type XVIII, alpha 1 Endostatin
26 Hs.171271 NM 001904 CTNNB1 Catenin (cadherin-associated protein), beta 1 (88kD) B catenin
27 Hs.2230 X04571 EGF Epidermal growth factor (beta-urogastrone) EGF
28 Hs.77432 X00588 EGFR Epidermal growth factor receptor EGFR
29 Hs.323910 Ml 1730 ERBB2
v-erb-b2 avian erythroblastic leukemia viral oncogene 
homolog 2 Erb-2
30 Hs.85146 J04102 ETS2
Human erythroblastosis virus oncogene homolog 2 (ets- 
2) mRNA c-Ets2
31 Hs.284244 NM 002006 FGF2 Fibroblast growth factor 2 (basic) FGF2
32 Hs.278581 M55614 FGFR2 Fibroblast growth factor receptor 2 FGFR2
33 Hs. 138671 NM 002019 FLT1
Homo sapiens vascular endothelial growth factor 
receptor (FLT1) mRNA (Fms-related tyrosine kinase 1) FLT1
34 Hs.25647 V01512 FOS Human cellular oncogene c-fos c-Fos
35 Hs.809 X57574 HGF Hepatocyte growth factor (hepapoietin A; scatter factor) HGF
36 Hs. 168383 NM 000201 ICAM1
Intercellular adhesion molecule I (CD54), human 
rhinovirus receptor ICAM-1
37 Hs.37026 NM 024013 IFNA1 Homo sapiens interferon, alpha 1 IFNA1
38 Hs.93177 M28622 IFNB1 Interferon, beta 1, fibroblast IFN-bl
39 Hs.85112 M27544 IGF1 Insulin-like growth factor 1 (somatomedin C) IGF-1
40 Hs.624 M17017 IL8 Interleukin 8 IL-8
41 Hs. 116774 X68742 ITGA1 Integrin, alpha 1 Integrin al
42 Hs.271986 XI7033 ITGA2
Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 
receptor)
Integrin a2/ 
LFAlb
Position UniGene Genebank Symbol Description Gene name
43 Hs.265829 M59911 ITGA3
Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of 
VLA-3 receptor) Integrin a3
44 Hs.40034 L12002 ITGA4
Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of 
VLA-4 receptor) Integrin a4
45 Hs. 149609 X06256 ITGA5 Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) Integrin a5
46 Hs.227730 X53586 ITGA6 Integrin, alpha 6 subunit Integrin a6
47 Hs.295726 NM 002210 ITGAV
Integrin, alpha V (vitronectin receptor, alpha polypeptide, 
antigen CD51) Integrin aV
48 Hs.287797 NM 002211 ITGB1
Integrin, beta 1 (fibronectin receptor, beta polypeptide, 
antigen CD29 includes MDF2, MSK12) Integrin bl
49 Hs.87149 J02703 ITGB3 Integrin, beta 3 (platelet glycoprotein Ilia, antigen CD61)
Integrin b3 
(CD61)
50 Hs. 149846 J05633 ITGB5 Integrin, beta 5 Integrin b5
51 Hs.78465 J04111 JUN v-jun avian sarcoma virus 17 oncogene homolog c-jun
52 Hs.323949 NM 002231 KA11 Kangai 1 (suppression of tumorigenicity 6, prostate...) KAI1
53 Hs.95008 NM 002256 KISS1 KiSS-1 metastasis-suppressor KISS1
54 Hs.3446 NM 002755 MAP2K1
Protein kinase, mitogen-activated, kinase 1 (MAP kinase 
kinase 1) MEK1
55 Hs.79107 NM 001315 MAPK14 p38 mitogen activated protein (MAP) kinase p38 MAPK
56 Hs. 170027 Z12020 MDM2
Mouse double minute 2, human homolog of; p5 3-binding 
protein Mdm2
57 Hs.83169 X05231 MMP1 Matrix metalloproteinase 1 (interstitial collagenase)
Collagenase-1 
(MMP-1)
58 Hs. 111301 J03210 MMP2
Matrix metalloproteinase 2 (gelatinase A, 72kD 
gelatinase, 72kD type IV collagenase)
Gelatinase A 
(MMP-2)
59 Hs.151738 J05070 MMP9
Matrix metalloproteinase 9 (gelatinase B, 92kD 
gelatinase, 92kD type IV collagenase)
Gelatinase B 
(MMP-9)
60 Hs. 101448 U35113 MTA1 Metastasis associated 1 Mta-1
61 Hs.90598 NM 000247 MICA Homo sapiens MICA gene, allele MUC-18 MUC-18
62 Hs.79070 X00364 MYC v-myc avian myelocytomatosis viral oncogene homolog c-myc
63 Hs. 167988 U63041 NCAM1 Neural cell adhesion molecule 1 NCAM1
64 Hs.83428 M58603 NFKB1
Nuclear factor of kappa light polypeptide gene enhancer 
in B-cells 1 (pi 05) NFkB
65 Hs.81328 M69043 NFKBIA
Nuclear factor of kappa light polypeptide gene enhancer 
in B-cells inhibitor, alpha IkBa (mad3)
66 Hs.9235 NM 005009 NME4
Homo sapiens non-metastatic cells 4, protein expressed 
in (NME4), mRNA Nm23-E4
67 Hs.37040 X06374 PDGFA Platelet-derived growth factor alpha polypeptide PDGFa
68 Hs.l 976 NM 002608 PDGFB
Platelet-derived growth factor beta polypeptide (simian 
sarcoma viral (v-sis) oncogene homolog) PDGF2/SIS
69 Hs.239818 NM 006219 PIK3CB Phosphoinositide-3-kinase, catalytic, beta polypeptide PI3Kpll0b
70 Hs.6241 M61906 PIK3R1
Phosphoinositide-3-kinase, regulatory subunit, 
polypeptide 1 (p85 alpha) PBK p85 alpha
71 Hs.77274 D00244 PLAU Plasminogen activator, urokinase uPA
72 Hs. 179657 NM 002659 PLAUR Human urokinase-type plasminogen activator receptor uPAR
73 Hs.l 55637 NM 006904 PRKDC
Homo sapiens protein kinase, DNA-activated, catalytic 
polypeptide DNA-PK
74 Hs. 146329 NM 007194 CHEK2 Protein kinase Chk2 Chk2/Rad53
75 Hs.85181 X03484 RAF1 v-raf-1 murine leukemia viral oncogene homolog 1 c-raf-1
76 Hs.758 NM 002890 RASA1 RAS p21 protein activator (GTPase activating protein) 1 GAP
77 Hs.75770 M15400 RBI Retinoblastoma 1 (including osteosarcoma) Rb
78 Hs.81256 NM 002% 1 S100A4
Homo sapiens SI00 calcium-binding protein A4 (calcium 
protein, calvasculin, metastasin, murine place Mtsl
79 Hs.75716 J02685 SERPINB2 Human plasminogen activator inhibitor PAI-2
Position UniGene Genebank Symbol Description Gene name
80 Hs.55279 NM 002639 SERPINB5
Serine (or cysteine) proteinase inhibitor, clade B 
(ovalbumin), member 5 Maspin
81 Hs.82085 M16006 SERPINE1 Plasminogen activator inhibitor, type I PAI-1
82 Hs. 198298 K03218 SRC Human c-src-1 proto-oncogene c-Src
83 Hs.89640 NM 000459 TEK
TEK tyrosine kinase, endothelial (venous malformations, 
multiple cutaneous and mucosal) Tie-2
84 Hs. 115256 AFO15950 TERT Telomerase reverse transcriptase Telomerase
85 Hs.l 103 X02812 TGFB1 Transforming growth factor, beta 1 TGFbl
86 Hs.220 LI1695 TGFBR1
Transforming growth factor, beta receptor I (activin A 
receptor type Il-like kinase, 53kD) ALK-5
87 Hs.87409 NM 003246 THBS1 Homo sapiens thrombospondin 1 (THBS1) Thrombospondinl
88 Hs.l 08623 L12350 THBS2 Human thrombospondin 2 (THBS2) mRNA Thrombospondin2
89 Hs.5831 NM 003254 TIMP1
Tissue inhibitor of metalloproteinase 1 (erythroid 
potentiating activity, collagenase inhibitor) TIMP1
90 Hs.241570 X01394 TNF Tumor necrosis factor (TNF superfamily, member 2) TNFa
91 Hs.51233 AFO16266 TNFRSF10B Homo sapiens TRAIL receptor 2/DR5
Trail Receptor 
(DR5)
92 Hs. 180338 U74611 TNFRSF12 TRAMP/Apo-3/DDR3 DR3 (Apo3)
93 Hs.159 M33294 TNFRSF1A Tumor necrosis factor receptor superfamily, member 1A TNFR1
94 Hs.82359 X63717 TNFRSF6 Tumor necrosis factor receptor superfamily, member 6
Fas (Apo-1) 
(CD95)
95 Hs.l 846 M14694 TP53 Tumor protein p53 (Li-Fraumeni syndrome) p53
96 Hs.73793 M32977 VEGF Vascular endothelial growth factor VEGF
97 N/A L08752 PUC18 PUC18 Plasmid DNA pUC18
98 N/A L08752 PUC18 PUC18 Plasmid DNA pUC18
99 N/A L08752 PUC18 PUC18 Plasmid DNA pUC18
100 Blank Blank Blank Blank 0
101 Blank Blank Blank Blank 0
102 Blank Blank Blank Blank 0
103 Hs. 169476 M33197 GAPD Glyceraldehyde-3 -phosphate dehydrogenase GAPDH
104 Hs. 169476 M33197 GAPD Glyceraldehyde-3-phosphate dehydrogenase GAPDH
105 Hs.342389 NM 021130 PPIA Homo sapiens peptidylprolyl isomerase A Cyclophilin A
106 Hs.342389 NM 021130 PPIA Homo sapiens peptidylprolyl isomerase A Cyclophilin A
107 Hs.342389 NM 021130 PPIA Homo sapiens peptidylprolyl isomerase A Cyclophilin A
108 Hs.342389 NM 021130 PPIA Homo sapiens peptidylprolyl isomerase A Cyclophilin A
109 Hs. 119122 NM 012423 RPL13A Ribosomal protein LI3a (23 Kda highly basic protein) RPL13A
n o Hs. 119122 NM 012423 RPL13A Ribosomal protein L13a (23 Kda highly basic protein) RPL13A
111 Hs.288061 X00351 ACTB Beta Actin b-actin
112 Hs.288061 X00351 ACTB Beta Actin b-actin
AI.2 Human Nitric Oxide Array Gene Table.
Array Layout Table with Geoe Symbol and Position Information
HS-034
ABCC1 ADM AGTR1 ALAS2 BCL2 BNIP3 CCL2 CCL3
1 2 3 4 5 6 7 8
CCL5 CDKN1A CFTR COL1A1 COL2A1 COL3A1 CSF1 CXCL2
9 10 11 12 13 14 15 16
CYP19 CYP2D6 CYP3A4 DDIT3 EDN1 EDNRB EGR1 EPO
17 18 19 20 21 22 23 24
FLJ37174 FLT1 FMR1 FN1 FTL GADD45A GADD45B GCLC
25 26 27 28 29 30 31 32
GCLM HBG1 HLA-DRA HMOX1 HPRT1 HRMT1L1 HRMT1L2 HSPA4
33 34 35 36 37 38 39 40
HSPCA ICAM1 IGFBP1 IL10 IL1B IL2 IL4 IL6
41 42 43 44 45 46 47 48
IL8 ILK JUNB LAMC1 MMP1 MMP2 MMP7 MMP9
49 50 51 52 53 54 55 56
MRPl-ESTs MT1G MYB MYC NCAM1 NFKBIA NOS2A OGGI
57 58 59 60 61 62 63 64
OPRM1 PDGFA PDGFB PLA2G2D PLAT POLYDOM PPP1R15A PRKDC
65 66 67 68 69 70 71 72
PRKG1 PRMT3 PTGS2 S100A10 SERPINE1 SFTPA1 SHC1 SLC6A6
73 74 75 76 77 78 79 80
SLC7A1 SLC7A2 SOD1 SOD2 SPARC TFRC TGFB1 TIMP1
81 82 83 84 85 86 87 88
TNF TNFRSF1A TNFRSF6 TXNRD1 TYR VCAM1 VEGF ZNF2
89 90 91 92 93 94 95 96
PUC18 PUC18 PUC18 Blank Blank Blank GAPD GAPD
97 98 99 100 101 102 103 104
PPIA PPIA PPIA PPIA RPL13A RPL13A ACTB ACTB
105 106 107 108 109 110 111 112
HS-034 gene table
Position UniGene Genebank Symbol Description Gene name
1 Hs.89433 NM 004996 ABCC1
A TP-binding cassette, sub-family C (CFTR/ MRP), 
member 1 (multiple drug resistance protein 1) MRP1
2 Hs.394 NM 001124 ADM Adrenomedullin Adrenomedullin
3 Hs.89472 NM 031850 AGTR1 ANGIOTENSIN RECEPTOR 1 ATI
4 Hs.323383 NM 000032 ALAS2
Aminolevulinate, delta-, synthase 2 
(sideroblastic/hypochromic anemia) ANH1
5 Hs.79241 M14745 BCL2 B-cell CLL/lymphoma 2 Bcl-2
6 Hs.79428 AF002697 BNIP3 BCL2/adenovirus E1B 19kDa interacting protein 3 Nip3
7 Hs.303649 X14768 CCL2
Chemokine (C-C motif) ligand 2, small inducible cytokine 
A2 precursor (Monocyte chemotactic protein 1) MCP1/SCYA2
8 Hs.73817 M23452 CCL3
Chemokine (C-C motif) ligand 3 (Macrophage 
inflammatory protein 1-alpha) MIP-la/SCYA3
9 Hs.241392 NM 002985 CCL5
Chemokine (C-C motif) ligand 5; small inducible cytokine 
A5 SCYA5/RANTES
10 Hs. 179665 L47233 CDKN1A Cyclin-dependent kinase inhibitor 1A (p21, Cipl) P21/Wafl/CIPl
11 Hs.663 M28668 CFTR
Cystic fibrosis mRNA, encoding a presumed 
transmembrane conductance CFTR
12 Hs. 172928 NM 000088 COL1A1 Collagen, type I, alpha 1 COL1A1
13 Hs.81343 NM 001844 COL2A1
Collagen, type II, alpha I (primary osteoarthritis, 
spondyloepiphyseal dysplasia, congenital) COL2A1
14 Hs. 119571 NM 000090 COL3A1
Collagen, type HI, alpha 1 (Ehlers-Danlos syndrome type 
IV, autosomal dominant) COL3A1
15 Hs. 173894 M37435 CSF1 Colony stimulating factor 1 (macrophage) MCSF
16 Hs.75765 NM 002089 CXCL2
Chemokine (C-X-C motif) ligand 2, Macrophage 
inflammatory protein-2-alpha precursor (MIP2-alpha) MtP-2a/GROb
17 Hs.79946 Y07508 CYP19
Cytochrome P450, subfamily XIX (aromatization of 
androgens) AROl
18 Hs.333497 NM 000106 CYP2D6
Cytochrome P450, subfamily IID (debrisoquine, sparteine, 
etc., -metabolizing), polypeptide 6 CYP2D6
19 Hs. 178738 NM 017460 CYP3A4
Cytochrome P450, subfamily IIIA (niphedipine oxidase), 
polypeptide 4 CYP3A4
20 Hs.337761 S40706 DDIT3 DNA-damage-inducible transcript 3 GADD153/CHOP
21 Hs.2271 Y00749 EDN1 Endothelin 1 Endothelin 1
22 Hs.82002 D90402 EDNRB Endothelin receptor type B ETRB/ETB
23 Hs.326035 X52541 EGR1 Early growth response 1 Krox-24
24 Hs.2303 NM 000799 EPO Homo sapiens erythropoietin EPO
25 Hs.322469 AK091014 FLJ37174
Homo sapiens cDNA FLJ37174 fis, clone 
BRACE2028406, mRNA sequence FLJ37174
26 Hs.381093 NM 002019 FLT1
Fms-related tyrosine kinase 1 (vascular endothelial growth 
factor/vascular permeability factor receptor) VEGFR1
27 Hs.89764 NM 002024 FMR1 Fragile X mental retardation 1 FRAXA
28 Hs.287820 X02761 FN1 Fibronectin 1 Fibronectin-1
29 Hs. 128899 NM 000146 FTL Ferritin, light polypeptide FTL
30 Hs.80409 M60974 GADD45A Growth arrest and DNA-damage-inducible, alpha GADD45
31 Hs. 110571 AF078077 GADD45B Growth arrest and DNA-damage inducible, beta GADD45 b
32 Hs.151393 AK094940 GCLC Glutamate-cysteine ligase, catalytic subunit GCS
33 Hs.89709 NM 002061 GCLM Glutamate-cysteine ligase, modifier subunit GCLM
34 Hs.283108 NM 000559 HBG1 Hemoglobin, gamma A HBG1
35 Hs.76807 K01171 HLA-DRA Major histocompatibility complex, class II, DR alpha HLA-DRA 1
36 Hs.202833 X06985 HMOX1 Heme oxygenase (decycling) 1 HEME1
37 Hs.82314 M31642 HPRT1 Hypoxanthine-guanine phosphoribosyltransferase HPRT1
38 Hs.235887 NM 001535 HRMT1L1 HMT1 hnRNP methyltransferase-like 1 (S. cerevisiae) PRMT2
39 Hs.20521 NM 001536 HRMT1L2 HMT1 hnRNP methyltransferase-like 2 (S. cerevisiae) PRMT1
40 Hs.90093 LI2723 HSPA4 Human heat shock protein 70 Hsp70
41 Hs.289088 X15183 HSPCA Heat shock 90kDa protein 1, alpha HSP90A/HSP86
Position UniGene Genebank Symbol Description Gene name
42 Hs. 168383 NM 000201 ICAM1
Intercellular adhesion molecule 1 (CD54), human 
rhinovirus receptor ICAM-1
43 Hs. 102122 NM 000596 IGFBP1 Insulin-like growth factor binding protein 1 IGFBP1
44 Hs. 193717 M57627 IL10 Interleukin 10 EL-10
45 Hs. 126256 Ml 5330 1L1B Interleukin 1, beta IL-lb
46 Hs.89679 U25676 IL2 Interleukin 2 IL-2
47 Hs.73917 Ml 3982 1L4 Interleukin 4 IL-4
48 Hs.93913 M14584 IL6 Interleukin 6 (interferon, beta 2) IL-6
49 Hs.624 M17017 IL8 Interleukin 8 IL-8
50 Hs.6196 NM 004517 ILK Integrin-Iinked kinase P59
51 Hs.198951 X51345 JUNB Jun B proto-oncogene Jun-B
52 Hs.214982 J03202 LAMC1 Laminin, gamma 1 (formerly LAMB2) LAMB2
53 Hs.83169 X05231 MMP1 Matrix metalloproteinase 1 (interstitial collagenase) Collagenase-1
54 Hs.l 11301 J03210 MMP2
Matrix metalloproteinase 2 (gelatinase A, 72kD gelatinase, 
72kD type IV collagenase) MMP-2
55 Hs.2256 X07819 MMP7 Matrix metalloproteinase 7 (matrilysin, uterine) MMP-7
56 Hs. 151738 J05070 MMP9
Matrix metalloproteinase 9 (gelatinase B, 92kD gelatinase, 
92kD type IV collagenase) MMP-9
57 Hs.13188 N59493 MRPl-ESTs
Human HepG2 partial cDNA, clone hmd5d04m5, mRNA 
sequence MRPl-ESTs
58 Hs.433391 NM 005950 MT1G Metallothionein 1G MT1G
59 Hs.l 334 Ml 5024 MYB V-myb avian myeloblastosis viral oncogene homolog c-Myb
60 Hs.79070 NM 002467 MYC V-myc avian myelocytomatosis viral oncogene homolog c-Myc
61 Hs. 167988 U63041 NCAM1 Neural cell adhesion molecule 1 NCAM
62 Hs.81328 M69043 NFKB1A
Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells inhibitor, alpha IKBA/MAD-3
63 Hs. 193788 L09210 NOS2A Nitric oxide synthase 2A (inducible, hepatocytes) NOS
64 Hs.96398 NM 002542 OGGI 8-oxoguanine DNA glycosylase OGH1
65 Hs.2353 L25119 OPRM1 Opioid receptor mu 1 MORI
66 Hs.37040 X06374 PDGFA Platelet-derived growth factor alpha polypeptide PDGFa
67 Hs.l 976 NM 002608 PDGFB
Platelet-derived growth factor beta polypeptide (simian 
sarcoma viral (v-sis) oncogene homolog) PDGF2/SIS
68 Hs. 189507 NM 012400 PLA2G2D Phospholipase A2, group UD SPLASH
69 Hs.274404 NM 000930 PLAT Homo sapiens plasminogen activator, tissue (PLATa) T-PA
70 Hs.271350 NM 024500 POLYDOM Likely ortholog of mouse polydom FLJ13529
71 Hs.76556 NM 014330 PPP1R15A
Homo sapiens protein phosphatase 1, regulatory (inhibitor) 
subunit 15A GADD34
72 Hs. 155637 NM 006904 PRKDC
Homo sapiens protein kinase, DNA-activated, catalytic 
polypeptide DNA-PK
73 Hs.2689 NM 006258 PRKG1 Protein kinase, cGMP-dependent, type I PRKG1
74 Hs. 152337 BC019339 PRMT3
Protein arginine N-methyItransferase 3 (hnRNP 
methyltransferase S. cerevisiae)-like 3 PRMT3
75 Hs.196384 NM 000963 PTGS2
Homo sapiens prostaglandin-endoperoxide synthase 2 
(prostaglandin G/Hsynthase and cyclooxygenase) Cox-2
76 Hs. 119301 NM 002966 S100A10
SI00 calcium binding protein A10 (annexin II ligand, 
calpactin L light polypeptide (pi 1)) ANX2L
77 Hs.82085 M16006 SERPINE1
Serine (or cysteine) proteinase inhibitor, clade E (nexin, 
plasminogen activator inhibitor type 1), member 1 PAI-1
78 Hs.301254 NM 005411 SFTPA1 Surfactant, pulmonary-associated protein A1 SFTPA1
79 Hs.81972 U73377 SHC1
SHC (Src homology 2 domain-containing) transforming 
protein 1 SHC
80 Hs.l 194 Z18956 SLC6A6
Solute carrier family 6 (neurotransmitter transporter, 
taurine), member 6 TAUT
81 Hs.2928 NM 003045 SLC7A1
Solute carrier family 7 (cationic amino acid transporter, y+ 
system), member 1 CAT-1
82 Hs.l 53985 AL832016 SLC7A2
Solute carrier family 7 (cationic amino acid transporter, y+ 
system), member 2 CAT-2
Position UniGene Genebank Symbol Description Gene name
83 Hs.75428 X02317 SOD1
Superoxide dismutase 1, soluble (amyotrophic lateral 
sclerosis 1 (adult)) fCu-Zn] Cu/ZnSOD
84 Hs.372783 NM 000636 SOD2 Superoxide dismutase 2, mitochondrial IPO-B/MNSOD
85 Hs. 111779 NM 003118 SPARC
Homo sapiens secreted protein, acidic, cysteine-rich 
(osteonectin) ON
86 Hs.77356 Ml 1507 TFRC Transferrin receptor (p90, CD71) TFRC
87 Hs.l 103 X02812 TGFB1
Transforming growth factor, beta 1 (Camurati-Engelmann 
disease) TGFbl
88 Hs.5831 NM 003254 TIMP1
Tissue inhibitor of metalloproteinase 1 (erythroid 
potentiating activity, collagenase inhibitor) TIMP1
89 Hs.241570 X01394 TNF Tumor necrosis factor (TNF superfamily, member 2) TNFA
90 Hs.l 59 M33294 TNFRSF1A Tumor necrosis factor receptor superfamily, member 1A TNFR1
91 Hs.82359 X63717 TNFRSF6 Tumor necrosis factor receptor superfamily, member 6 Fas/Apo-l/CD95
92 Hs. 13046 NM 003330 TXNRD1 Thioredoxin reductase 1 TR1
93 Hs.2053 NM 000372 TYR Homo sapiens tyrosinase (oculocutaneous albinism LA) Tyrosinase
94 Hs. 109225 M30257 VC AMI Vascular cell adhesion molecule 1 VCAM-1
95 Hs.73793 NM 003376 VEGF Vascular endothelial growth factor VEGF
96 Hs. 192285 NM 021088 ZNF2 Zinc finger protein 2 (Al-5) Al-5
97 N/A L08752 PUC18 PUC18 Plasmid DNA pUC18
98 N/A L08752 PUC18 PUC18 Plasmid DNA pUC18
99 N/A L08752 PUC18 PUC18 Plasmid DNA pUC18
100 Blank Blank Blank Blank 0
101 Blank Blank Blank Blank 0
102 Blank Blank Blank Blank 0
103 Hs. 169476 M33197 GAPD Glyceraldehyde-3-phosphate dehydrogenase GAPDH
104 Hs. 169476 M33197 GAPD Glyceraldehyde-3 -phosphate dehydrogenase GAPDH
105 Hs.342389 NM 021130 PPIA Homo sapiens peptidylprolyl isomerase A Cyclophilin A
106 Hs.342389 NM 021130 PPIA Homo sapiens peptidylprolyl isomerase A Cyclophilin A
107 Hs.342389 NM 021130 PPIA Homo sapiens peptidylprolyl isomerase A Cyclophilin A
108 Hs.342389 NM 021130 PPIA Homo sapiens peptidylprolyl isomerase A Cyclophilin A
109 Hs. 119122 NM 012423 RPL13A Ribosomal protein LI3a (23 Kdahighly basic protein) RPL13A
110 Hs. 119122 NM 012423 RPL13A Ribosomal protein LI3a (23 Kda highly basic protein) RPL13A
111 Hs.288061 X00351 ACTB Beta Actin b-actin
112 Hs.288061 X00351 ACTB Beta Actin b-actin
Appendix II -  Patient Documents for in vivo Study
AII.1 Patient Information Leaflet.
TITLE:
Research Project looking at the cause of gastric disease.
[Gene expression analysis of Helicobacter pylori induced gastric disease.]
Professor JN Baxter, Endoscopy Unit, Morriston Hospital, Dr L Thomas, Endoscopy 
unit, Singleton Hospital.
Patient information leaflet for endoscopy patients
Version number: 3 
26th January 2005
When you come to the endoscopy unit for the endoscopy that has been arranged for you, 
you will be invited to take part in a research study. Before you agree to this, please read 
this information leaflet and discuss it with friends or family. I f  anything is unclear and 
you need to ask any questions please contact us before (see end o f leaflet for contact 
information), or when you attend for the appointment. Please take time to decide if  you 
wish to participate.
Why are we doing this research?
A germ is often found in the stomach, that can cause different diseases in the stomach. In 
our study, we want to look for this germ and then, very closely at the cells lining the 
stomach. Hopefully this will help explain what triggers disease, and improve our ability 
to diagnose and treat gastric diseases.
Why have I been chosen for this study?
This study intends to enrol patients attending the endoscopy clinics at Singleton 
/Morriston Hospital, you have been chosen as you are one o f these patients.
Do I have to take part?
It is up to you to decide whether or not you wish to take part in the study. If  you do not 
wish to take part, the endoscopy that has been arranged for you will take place as 
planned, and your future care will not be affected. If  you agree to take part you may 
change your mind at any time.
What will happen if I take part?
If  you do agree then you will be asked questions, by a doctor when you arrive in the 
hospital, and then asked to sign a consent form and participate. I f  you are taking certain 
tablets or have had surgery on your stomach, then we may not ask you to participate.
If you agree to take part, then it will not involve any additional hospital visits.
What do I have to do?
When you come to the endoscopy unit we will need to collect certain details from you. 
Your age, sex, family history, eating and drinking habits, smoking habits and medication 
history. All the information we collect will remain confidential. This will take no longer 
than ten minutes.
What is the procedure being tested?
We plan to analyse (in detail) the active genes present in stomach tissue, this is to be 
performed in the molecular biology lab at Swansea University. By analysing the active 
genes o f diseased tissue versus normal tissue, we hope to better understand the basis o f 
the disease. In addition the level o f  certain factors, such as dietary antioxidants will be 
assessed in blood and gastric juice samples.
What are the alternatives for diagnosis or treatment?
There is currently no alternative to endoscopy for looking for diseases o f the stomach. 
What are the possible side-effects of taking part?
During the endoscopy we routinely need to take 2-3 small samples o f tissue to help us 
make a diagnosis. This we do with a biopsy, whereby we take very small bites o f tissue, 
we also sometimes collect some cells for analysis with a small brush. For this study we 
will need 2-3 extra biopsies and 1-2 brushings, which we can look at closely in the 
laboratory. Both procedures take a minute or two and you will be unable to feel them. A 
Blood sample and gastric juice sample will also be collected.
What are the possible disadvantages and risks of taking part?
Taking any biopsies carries a very small risk, hence taking extra biopsies for this study 
theoretically extends this risk. However, the doctors involved in this study are very 
experienced at collecting biopsies during endoscopy and have had no previous problems 
with taking biopsies from the stomach o f patients.
What are the possible benefits of taking part?
From our studies o f your (and other patient’s) stomach tissue, blood, and gastric juice, we 
may be able to understand the mechanism whereby certain stomach diseases occur. This 
knowledge may therefore aid in our efforts to diagnose and treat patients with gastric 
disease.
What if something goes wrong?
There are no special compensation arrangements to anyone taking part in this research 
project. You are a patient o f  Swansea NHS Trust and as such the NHS complaints 
mechanisms are available to you if  needed.
Will my taking part be kept confidential?
Yes, your tissue, blood and gastric juice samples will be analysed at Swansea University, 
but your name will be removed first, hence you will not be identified.
What will happen to the results of this study?
When the research study stops all the information will be analysed and the results used to 
improve our knowledge of gastric disease. They may be published in the scientific 
literature, but you will not be identified.
After the tissue samples have been analysed for this research project they will be 
incinerated, following the guidelines at the University.
Who is organising and funding this study?
The research study is under the supervision o f Professor J Baxter, Dr G Jenkins* 
Professor J Parry. Professor Baxter is a consultant surgeon at Morriston hospital and 
supervises endoscopy lists at Morriston hospital. He, or one o f his registrars, under his 
supervision, will take the biopsies, blood sample, and gastric juice sample at Morriston 
Hospital. Dr Thomas or one o f her colleagues will take the biopsies, blood, and gastric 
juice samples at Singleton Hospital. Dr Jenkins and Professor Parry are molecular 
biologists in University o f Wales Swansea and are responsible for the supervision o f the 
laboratory work, in accordance with the University guidelines. The study is being funded 
by a charity called Tenovus.
Who has reviewed this study?
This research project has been approved by the Local Research Ethics Committee.
I f  you need any further information please contact Professor Baxter and his team at 
Morriston Hospital (01792 703573)
Thank you for taking the time to read this leaflet.
Professor Baxter.
Dr. L. Thomas.
AII.2 Patient Consent Form.
Gene expression analysis of Helicobacter pylori induced gastric disease.
Professor Baxter, Consultant Surgeon, Morriston Hospital.
Dr Thomas, Consultant Gastroenterologist, Singleton Hospital.
Patient consent form
Version 3
1 have read the patient information leaflet and received a verbal explanation o f  the proposed research 
project.
I consent to the taking o f additional biopsies and brushings during the endoscopic procedure for research 
purposes.
I agree for information about me to be held but I understand that the information I give will not be 
communicated to anyone outside the research team.
Patient name:
Patient Signature: Date:
I have supplied the written information on this research project, given a verbal explanation and answered 
any questions posed.
Investigator name:
Investigator signature: Date:
AII.3 Patient Questionnaire.
Gene expression analysis of Helicobacter pylori induced gastric cancer.
Professor Baxter, Consultant Surgeon, Morriston Hospital.
Dr Thomas, Consultant Gastroenterologist, Singleton Hospital.
Patient profile
Name:
Date o f  birth: Sex: Race:
Family history o f GI cancer:
Family history peptic ulcer disease:
Smoking history:
Alcohol history:
Dietary habits (salt, fruit, vegetables, meat):
Drug history:
Employment history:
Endoscopic diagnosis (+ location):
Histological diagnosis:
Helicobacter pylori status: [1] histological [2] PCR
Helicobacter pylori strain:
